{"meta":{"query_hash":"619242c0199c","filters":{"venue":"Expert Opinion on Pharmacotherapy"},"cohort_total":239,"direct_labels_cover":0,"predictions_cover":239,"exported":239,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/619242c0199c","api":"https://metacan.xera.ac/api/v1/cohort?venue=Expert+Opinion+on+Pharmacotherapy"},"results":[{"id":"W11866677","doi":"10.1517/14656566.3.3.265","title":"Paleomagnetism and Rock Magnetism of \"SEDEX\" Zn-Pb-Cu Ores in Black Shales in Australia and Yukon and of Fluorite Veins in Granite in Newfoundland.","year":2011,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Geomagnetism and Paleomagnetism Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; University of Windsor","keywords":"Geology; Paleomagnetism; Geochemistry; Fluorite; Rock magnetism; Paleontology","score_opus":0.0359867616465035,"score_gpt":0.30850535029951537,"score_spread":0.2725185886530119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W11866677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705926,0.028417813,0.0000070628553,0.00013647087,0.00012616818,0.00040262126,0.000029740368,0.0000044704034,0.0002830191],"genre_scores_gemma":[0.91524893,0.08411411,0.00029037587,0.00012100016,0.000050463088,0.000041076986,0.000019651912,0.000021097734,0.00009330943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984173,0.00014858639,0.0005051774,0.00048090896,0.00013027815,0.00031775286],"domain_scores_gemma":[0.9995698,0.000037417572,0.000112307855,0.00018150483,0.000023090575,0.0000759119],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020416308,0.00028697512,0.0004061735,0.00033266994,0.000021047346,0.000010385445,0.00012933751,0.00017786394,0.00007116358],"category_scores_gemma":[0.00001281905,0.00028469725,0.000034858393,0.00019848009,0.0001864471,0.000021102764,0.00007007471,0.00015240822,9.1938983e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011337252,0.00051462936,0.5921558,0.00012385409,0.00002072089,0.000025419691,0.0071984055,0.000017402352,0.38690475,0.00014130915,0.00018068578,0.011583304],"study_design_scores_gemma":[0.0069347345,0.0024890124,0.9654488,0.00022875686,0.0000024663027,0.000011550198,0.00034757887,0.00016456665,0.021718489,0.00029921712,0.001994702,0.00036015062],"about_ca_topic_score_codex":0.005399059,"about_ca_topic_score_gemma":0.007829891,"teacher_disagreement_score":0.37329295,"about_ca_system_score_codex":0.00000969826,"about_ca_system_score_gemma":0.000017739636,"threshold_uncertainty_score":0.99996054},"labels":[],"label_agreement":null},{"id":"W1503429060","doi":"10.1517/14656566.2011.604617","title":"Hyperemesis gravidarum: pathogenesis and the use of antiemetic agents","year":2011,"lang":"en","type":"letter","venue":"Expert Opinion on Pharmacotherapy","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Hyperemesis gravidarum; Medicine; Antiemetic; Nausea; Pathogenesis; Intensive care medicine; Anesthesia; Internal medicine","score_opus":0.1466441607780156,"score_gpt":0.35410801759989696,"score_spread":0.20746385682188137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1503429060","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14183901,0.06895759,0.00038453477,0.76036704,0.011606857,0.012801536,0.0011834744,0.00058437174,0.0022755729],"genre_scores_gemma":[0.034374297,0.07390093,0.0013260545,0.8842776,0.0022062694,0.000259356,0.0003369733,0.00023020808,0.0030883574],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778336,0.00029973054,0.00045762255,0.0005174691,0.0005713721,0.00037041682],"domain_scores_gemma":[0.99869686,0.000207447,0.0002867025,0.0005946677,0.000098688055,0.00011563189],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012667484,0.00050955836,0.0008336485,0.00023107225,0.00010039385,0.000028999373,0.00018552635,0.00031326496,0.0006994361],"category_scores_gemma":[0.000021586338,0.00029729016,0.00036123907,0.00013964112,0.00036084504,0.00006782746,0.000035279452,0.0005266283,0.00003638839],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014251418,0.00038650792,0.0023781804,0.000115695155,0.0012691543,0.00042817043,0.00067035365,2.5326113e-7,0.0013959734,0.000025639145,0.9526137,0.039291214],"study_design_scores_gemma":[0.010410284,0.00054928544,0.0028488396,0.00020951658,0.00010986081,0.0000660537,0.0000059107306,0.000025074643,0.0070305145,0.0000332394,0.97853154,0.00017986365],"about_ca_topic_score_codex":0.000062917155,"about_ca_topic_score_gemma":6.417059e-8,"teacher_disagreement_score":0.1239105,"about_ca_system_score_codex":0.00004288069,"about_ca_system_score_gemma":0.000053629836,"threshold_uncertainty_score":0.9999479},"labels":[],"label_agreement":null},{"id":"W1621345808","doi":"10.1517/14656566.2015.1067680","title":"Choosing drugs for the treatment of diabetic neuropathy","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Glycemic; Intensive care medicine; Diabetes mellitus; Disease; Diabetic neuropathy; Population; Polyneuropathy; Physical therapy; Surgery; Internal medicine","score_opus":0.16214112568720937,"score_gpt":0.47438614460186174,"score_spread":0.3122450189146524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1621345808","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006089883,0.9939353,0.00013556411,0.00024018883,0.0017961168,0.00358401,0.000079808575,0.00005079093,0.0001721275],"genre_scores_gemma":[0.0000081705775,0.9957083,0.00033810158,0.00067474815,0.001116671,0.001432031,0.000141313,0.00013786928,0.00044279196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99834293,0.00016670479,0.00047127006,0.00041226234,0.0003207887,0.00028603518],"domain_scores_gemma":[0.9985584,0.00039452055,0.0003052446,0.0005047982,0.00007553735,0.00016147384],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020074531,0.0005124948,0.0014701723,0.00014134825,0.000097160526,0.000016102997,0.00015912765,0.00012844047,0.00011757299],"category_scores_gemma":[0.000008400107,0.0002630217,0.00081242237,0.00015566988,0.000042470805,0.000023892184,0.0000072726293,0.00010485071,0.000030505274],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017071709,0.0010502577,4.7260846e-7,0.0006029958,0.0006816861,0.0000040544683,0.0005734208,3.2127542e-7,0.000045473276,0.000049915965,0.00291232,0.99390835],"study_design_scores_gemma":[0.0045966716,0.0025197002,3.494624e-7,0.0024953703,0.00024704274,0.000011171406,0.000024729372,0.00006746002,0.0007786482,0.000021436928,0.98904413,0.0001932623],"about_ca_topic_score_codex":0.000012384255,"about_ca_topic_score_gemma":4.0665018e-8,"teacher_disagreement_score":0.9937151,"about_ca_system_score_codex":0.00027922296,"about_ca_system_score_gemma":0.00021697098,"threshold_uncertainty_score":0.9999822},"labels":[],"label_agreement":null},{"id":"W1667748414","doi":"10.1517/14656566.2015.1086747","title":"The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Medicine; Gastroparesis; Small intestinal bacterial overgrowth; Constipation; Internal medicine; Gastroenterology; Adverse effect; Cisapride; Disease; Intensive care medicine; Irritable bowel syndrome; Gastric emptying; Stomach","score_opus":0.05051051495634989,"score_gpt":0.3442491884464837,"score_spread":0.29373867349013383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1667748414","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026319629,0.97094524,0.000015966485,0.0001296064,0.00032767627,0.0021118287,0.000086813925,0.000028085362,0.00003513273],"genre_scores_gemma":[0.0030190598,0.995935,0.00023602063,0.0000577513,0.00010611107,0.0002440843,0.00034229914,0.000045866956,0.000013787961],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983538,0.00022219986,0.00048950256,0.00039258142,0.00029288404,0.0002490288],"domain_scores_gemma":[0.99887896,0.00019031143,0.00029628433,0.00026439762,0.00009924061,0.00027082633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011990451,0.00041952133,0.00090650655,0.0001498959,0.000055555953,0.00002428302,0.00009578475,0.000058017933,0.000036734495],"category_scores_gemma":[0.000040665363,0.0002390559,0.00014094089,0.00014219685,0.0001824444,0.000042718333,0.000011252623,0.0001404934,0.0000032999021],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012458046,0.0027649961,0.035398792,0.0010355765,0.00017424567,0.000027719614,0.00014173986,9.131981e-7,0.0000014719622,0.00003231751,0.00024975708,0.94771445],"study_design_scores_gemma":[0.0088883005,0.007870644,0.029851617,0.0077396715,0.00007734111,0.000036112906,0.000017959113,0.00001007208,0.000002135479,0.0000076107376,0.94528824,0.0002103196],"about_ca_topic_score_codex":0.00003786001,"about_ca_topic_score_gemma":0.0000057069506,"teacher_disagreement_score":0.9475041,"about_ca_system_score_codex":0.00022781096,"about_ca_system_score_gemma":0.00035337507,"threshold_uncertainty_score":0.97484165},"labels":[],"label_agreement":null},{"id":"W1740551684","doi":"10.1517/14656566.2015.1088829","title":"Will personalized drugs for cardiovascular disease become an option? – Defining ‘Evidence-based personalized medicine’ for its implementation and future use","year":2015,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Personalized medicine; Precision medicine; Disease; Intensive care medicine; Bioinformatics; Internal medicine; Pathology","score_opus":0.20933489707651082,"score_gpt":0.5118279032799685,"score_spread":0.3024930062034577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1740551684","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012195987,0.3765244,0.0022979635,0.0059890887,0.6001949,0.005877121,0.0076150224,0.00026503205,0.000016924625],"genre_scores_gemma":[0.0006247565,0.2885138,0.0017019007,0.01055511,0.6835056,0.00536736,0.008769014,0.00043560876,0.0005268499],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99309576,0.0016182825,0.0010163349,0.0017309634,0.0015058202,0.0010328396],"domain_scores_gemma":[0.9929396,0.0030424118,0.0006230667,0.0005791602,0.0013613045,0.0014544376],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034775736,0.0012281508,0.0014947203,0.00049646245,0.0008989361,0.00017579814,0.00068515574,0.0010243045,0.0011053097],"category_scores_gemma":[0.0003384026,0.0011319248,0.0010915798,0.00025809804,0.00036197738,0.0009744714,0.000055696597,0.0010668138,0.000011027822],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016370894,0.00041977825,0.000014038808,0.0003888952,0.0026611974,0.000007317278,0.004640339,0.00039130123,0.005518607,0.0020193455,0.89860046,0.068967834],"study_design_scores_gemma":[0.036586728,0.00077385746,0.0000033978488,0.00019494379,0.00087409787,0.0000017259129,0.00067367917,0.006959477,0.0020011428,0.00028023412,0.95044714,0.0012035926],"about_ca_topic_score_codex":0.000054761145,"about_ca_topic_score_gemma":0.0000012919043,"teacher_disagreement_score":0.0880106,"about_ca_system_score_codex":0.00034102568,"about_ca_system_score_gemma":0.0010467329,"threshold_uncertainty_score":0.99980783},"labels":[],"label_agreement":null},{"id":"W1852373983","doi":"10.1517/14656566.2010.512006","title":"Mipomersen as a potential adjunctive therapy for hypercholesterolemia","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; Apolipoprotein B; Population; Gastroenterology; Lipoprotein(a); Lipoprotein; Endocrinology; Cholesterol","score_opus":0.07210830279709016,"score_gpt":0.43681410121708286,"score_spread":0.36470579841999273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1852373983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024352366,0.9864957,0.00020651313,0.00063155656,0.004291121,0.007326369,0.000118063675,0.00018048912,0.0007258551],"genre_scores_gemma":[0.000006400247,0.9787675,0.00059830496,0.007482825,0.008714111,0.0029293604,0.00060245313,0.00035642163,0.0005426266],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99641037,0.00030217343,0.0007510436,0.0010689386,0.0008061063,0.00066135847],"domain_scores_gemma":[0.9978187,0.00010687412,0.00034307397,0.001074637,0.0001797501,0.00047696257],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060781225,0.000917844,0.0025993895,0.00036079093,0.00021161097,0.0000624631,0.0003435912,0.0008151151,0.000581427],"category_scores_gemma":[0.00002253836,0.0006489622,0.0027990474,0.00026233346,0.00009655805,0.000089644556,0.000026263531,0.0012145145,0.0001693086],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010089477,0.0004309955,1.217215e-7,0.0012478613,0.0011531224,0.000017783414,0.0001586929,1.4726723e-7,0.00036650253,0.000065362896,0.0073604537,0.98819],"study_design_scores_gemma":[0.008115917,0.0014506917,0.0000013938517,0.0032805789,0.00010657885,0.00034336222,0.00002245122,0.0000068134127,0.0004415215,0.000022401751,0.98560274,0.00060555525],"about_ca_topic_score_codex":0.00005420174,"about_ca_topic_score_gemma":3.86886e-7,"teacher_disagreement_score":0.9875845,"about_ca_system_score_codex":0.00022613125,"about_ca_system_score_gemma":0.00089710695,"threshold_uncertainty_score":0.9995962},"labels":[],"label_agreement":null},{"id":"W1917089101","doi":"10.1517/14656566.2015.1074179","title":"The evolving role of dabigatran etexilate in clinical practice","year":2015,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabigatran; Medicine; Edoxaban; Rivaroxaban; Apixaban; Warfarin; Direct thrombin inhibitor; Atrial fibrillation; Stroke (engine); Vitamin K antagonist; Idarucizumab; Anticoagulant; Intensive care medicine; Pharmacodynamics; Anesthesia; Internal medicine; Pharmacokinetics","score_opus":0.16853925879063442,"score_gpt":0.5070706961620863,"score_spread":0.3385314373714519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1917089101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35899082,0.17333542,0.0006830373,0.26780143,0.019932602,0.006304733,0.000010566162,0.00061128614,0.1723301],"genre_scores_gemma":[0.93883836,0.045044683,0.0026575774,0.0082916785,0.003936448,0.000014666556,0.0000131969,0.000061640625,0.0011417443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985617,0.00021656771,0.0005284428,0.00017568335,0.00035950087,0.00015814052],"domain_scores_gemma":[0.99879265,0.0005892813,0.00017963315,0.00022079563,0.00010607456,0.00011155742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012632711,0.00010974208,0.00023070759,0.00007468135,0.00004561538,0.000017980272,0.00010738307,0.000055282067,0.00007501897],"category_scores_gemma":[0.00037047133,0.00007214661,0.00012804028,0.000178841,0.000056118693,0.00015000593,0.000017814793,0.00016414988,0.000032986787],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012414765,0.00032888568,0.08650624,0.000018913572,0.0004373008,0.000017615674,0.0056890515,0.0001419703,0.034405135,0.008219874,0.04633713,0.8054831],"study_design_scores_gemma":[0.004683154,0.00033885383,0.006224904,0.00003902155,0.000004585032,0.00000348578,0.0008488961,0.0016024197,0.0061006867,0.00018090887,0.9798865,0.00008662868],"about_ca_topic_score_codex":0.0000305348,"about_ca_topic_score_gemma":8.6716597e-7,"teacher_disagreement_score":0.93354934,"about_ca_system_score_codex":0.00004157641,"about_ca_system_score_gemma":0.00006911411,"threshold_uncertainty_score":0.29420537},"labels":[],"label_agreement":null},{"id":"W1941427190","doi":"10.1517/14656566.2012.689825","title":"Combination therapy in type 2 diabetes mellitus: adding linagliptin to a stable regimen of metformin and a sulfonylurea","year":2012,"lang":"en","type":"letter","venue":"Expert Opinion on Pharmacotherapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Linagliptin; Medicine; Metformin; Glycemic; Sulfonylurea; Regimen; Type 2 Diabetes Mellitus; Hypoglycemia; Pharmacology; Diabetes mellitus; Internal medicine; Type 2 diabetes; Incretin; Dipeptidyl peptidase-4 inhibitor; Endocrinology","score_opus":0.04079503441523548,"score_gpt":0.3364745502938849,"score_spread":0.29567951587864943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1941427190","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16799584,0.251362,0.000040627052,0.553613,0.005709144,0.012052562,0.00010873794,0.00041906716,0.008698994],"genre_scores_gemma":[0.021130987,0.23940285,0.0026297937,0.7245193,0.003641231,0.0011845699,0.0013525145,0.00035826067,0.0057805115],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979656,0.00012180149,0.00045153234,0.00046806785,0.00045167073,0.000541365],"domain_scores_gemma":[0.99903834,0.00015726715,0.00021657186,0.00036890456,0.00009436044,0.00012453133],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036840653,0.0004536899,0.00077262655,0.0007137858,0.000041066833,0.000031181527,0.0001536102,0.0002803877,0.0004211021],"category_scores_gemma":[0.000014358067,0.00037558717,0.00011244846,0.00039739962,0.000043635268,0.0001582277,0.00003897482,0.00043510777,0.000028778539],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008089589,0.0008799768,0.0007717891,0.00021089721,0.0006477964,0.000016485588,0.00219271,0.0000014492223,0.009331723,0.00019837596,0.757244,0.22769582],"study_design_scores_gemma":[0.0051691565,0.0017659521,0.00018710262,0.0006007748,0.000018746718,9.577783e-7,0.00004864967,0.00004613312,0.03241328,0.000041655032,0.95938015,0.00032744958],"about_ca_topic_score_codex":0.00005104326,"about_ca_topic_score_gemma":5.3604543e-7,"teacher_disagreement_score":0.22736837,"about_ca_system_score_codex":0.00018326912,"about_ca_system_score_gemma":0.00005056002,"threshold_uncertainty_score":0.9998696},"labels":[],"label_agreement":null},{"id":"W1967359512","doi":"10.1517/14656566.7.12.1653","title":"The neurokinin<sub>1</sub>receptor antagonist aprepitant as an antiemetic for moderately emetogenic chemotherapy","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nausea and vomiting management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Aprepitant; Antiemetic; Medicine; Retching; NK1 receptor antagonist; Vomiting; Pharmacology; Anthracycline; Ondansetron; Chemotherapy; Nausea; Cyclophosphamide; Anesthesia; Oncology; Internal medicine; Breast cancer; Cancer; Receptor; Substance P; Neuropeptide","score_opus":0.08242888505116366,"score_gpt":0.42824047697160517,"score_spread":0.34581159192044153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967359512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037761495,0.9866258,0.00044923558,0.001538875,0.0037037965,0.0062961434,0.0001175422,0.00037956316,0.00051143946],"genre_scores_gemma":[0.0000887955,0.986137,0.0003240657,0.0059132497,0.0038318161,0.0017377399,0.0006952758,0.0005107153,0.0007613794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950985,0.00046602945,0.0013147881,0.0013718634,0.0007813518,0.00096752186],"domain_scores_gemma":[0.9970522,0.000494819,0.0007191356,0.0012009667,0.00017594587,0.00035693715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007945092,0.0011918556,0.0020174256,0.00036347413,0.0007561026,0.0003197137,0.0007130169,0.00035503466,0.00013451336],"category_scores_gemma":[0.000038489812,0.0008032234,0.0013219237,0.00045843868,0.0001735964,0.00013227176,0.00004736352,0.0006348625,0.00015777406],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012590988,0.000772795,7.8688885e-7,0.0012680594,0.00077576935,0.000011361566,0.00010959845,0.0000016622034,0.0048103617,0.00046814955,0.07271948,0.9178029],"study_design_scores_gemma":[0.004547473,0.0015963488,0.000002013734,0.0018764774,0.00014081996,0.00004765613,0.000025400715,0.00024018575,0.013687913,0.000075185286,0.976941,0.00081955956],"about_ca_topic_score_codex":0.000015801548,"about_ca_topic_score_gemma":9.3366725e-7,"teacher_disagreement_score":0.9169833,"about_ca_system_score_codex":0.00029260467,"about_ca_system_score_gemma":0.00041214647,"threshold_uncertainty_score":0.99944186},"labels":[],"label_agreement":null},{"id":"W1968477526","doi":"10.1517/14656566.3.7.865","title":"Hormonal therapies in acne","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Acne; Medicine; Flutamide; Hormone; Hormonal therapy; Antiandrogens; Endocrine system; Spironolactone; Androgen; Physiology; Antiandrogen; Endocrinology; Internal medicine; Androgen receptor; Dermatology; Prostate cancer; Cancer; Aldosterone","score_opus":0.13041342788945864,"score_gpt":0.45582349975928155,"score_spread":0.3254100718698229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968477526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009087996,0.9949768,0.0000044840694,0.0005020272,0.0009082126,0.0012223773,0.000019546434,0.00008495683,0.0022725065],"genre_scores_gemma":[0.000012111252,0.9937332,0.000088891415,0.0022947094,0.0013398522,0.00037746425,0.0001639643,0.000119183154,0.0018705823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817437,0.00015403616,0.0004653739,0.000507954,0.00031395737,0.00038432368],"domain_scores_gemma":[0.99922097,0.00011222954,0.00015428463,0.00033036797,0.000019035673,0.00016312154],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011148218,0.0006027908,0.001574596,0.0003527117,0.00007665362,0.000025356057,0.00014916784,0.00030588932,0.0017448666],"category_scores_gemma":[0.000003962428,0.0003672977,0.0005707198,0.00029142678,0.000046253797,0.000059882834,0.000016050048,0.00046303673,0.00035362234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010510238,0.000832013,0.000004363792,0.0006630207,0.00041436238,0.00007720096,0.0003484531,9.873997e-8,0.000018082661,0.000030012805,0.03782545,0.95968187],"study_design_scores_gemma":[0.0029116431,0.00059226307,0.000007393814,0.0069717406,0.0000307457,0.000070190086,0.000012570127,0.000014160986,0.000024450766,0.0000050111134,0.9890145,0.00034534474],"about_ca_topic_score_codex":0.000015030434,"about_ca_topic_score_gemma":1.9705047e-7,"teacher_disagreement_score":0.9593365,"about_ca_system_score_codex":0.00018095825,"about_ca_system_score_gemma":0.00008898518,"threshold_uncertainty_score":0.99987787},"labels":[],"label_agreement":null},{"id":"W1969921902","doi":"10.1517/14656566.3.4.417","title":"Pharmacoeconomics of long-term treatment of rheumatoid arthritis","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Rheumatoid arthritis; Leflunomide; Sulfasalazine; Etanercept; Hydroxychloroquine; Infliximab; Antirheumatic drugs; Methotrexate; Azathioprine; Antirheumatic Agents; Quality of life (healthcare); Intensive care medicine; Arthritis; Disease; Population; Pharmacoeconomics; Internal medicine","score_opus":0.08982429485987818,"score_gpt":0.42961837180263257,"score_spread":0.3397940769427544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969921902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032780008,0.99575055,0.0000124176295,0.000117987314,0.0009359353,0.0019648394,0.00021249629,0.00007153304,0.0006064386],"genre_scores_gemma":[0.00010927889,0.9981887,0.00011342106,0.00014338228,0.00041862644,0.00040568179,0.00025190783,0.00018246252,0.0001865467],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99676436,0.00024644492,0.0014347443,0.00059419224,0.00046013488,0.0005001422],"domain_scores_gemma":[0.99794656,0.00023445692,0.00072014896,0.0006401322,0.00011028817,0.00034842122],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014311688,0.0007456947,0.0033254402,0.0005944849,0.00007184362,0.000023092036,0.00029096956,0.00024496912,0.005281074],"category_scores_gemma":[0.000009046082,0.0005871666,0.0013285755,0.00024246592,0.00024882922,0.00010210232,0.00002314418,0.0002649767,0.0001465037],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035541516,0.001937222,0.000028147944,0.001282572,0.0015346997,0.000036803518,0.00044290844,2.7711476e-7,0.00022206514,0.000061602055,0.0037272265,0.99037105],"study_design_scores_gemma":[0.0077455775,0.0020460493,0.0000043848463,0.017146038,0.0000060415764,0.00023577166,0.000010262494,0.000011545219,0.005627436,0.000003750218,0.9667753,0.00038784934],"about_ca_topic_score_codex":0.00003125779,"about_ca_topic_score_gemma":0.0000010416031,"teacher_disagreement_score":0.9899832,"about_ca_system_score_codex":0.00023787766,"about_ca_system_score_gemma":0.0002933473,"threshold_uncertainty_score":0.999658},"labels":[],"label_agreement":null},{"id":"W1970579734","doi":"10.1517/14656566.8.18.3133","title":"Management of glioblastoma","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Temozolomide; Carmustine; Lomustine; Radiation therapy; Oncology; Glioma; Chemotherapy; Adjuvant; Internal medicine; Glioblastoma; Chemoradiotherapy; Cancer research; Cyclophosphamide","score_opus":0.1013787361650628,"score_gpt":0.4678047214229079,"score_spread":0.3664259852578451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970579734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007144617,0.99331146,0.0000150935175,0.00010615738,0.0010705371,0.001597995,0.000024352836,0.00007488289,0.0037923856],"genre_scores_gemma":[0.000009686397,0.9976543,0.0005518349,0.0005213314,0.00047788082,0.00035500297,0.000077462166,0.00011289729,0.0002395648],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801356,0.000061905266,0.00066596584,0.00047074797,0.000483022,0.00030480177],"domain_scores_gemma":[0.99888176,0.00008837665,0.00030676404,0.0004947281,0.000044813627,0.00018356036],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001462968,0.00051171833,0.0014923332,0.00046556766,0.000039242153,0.000009791403,0.00016954535,0.00018523817,0.0009966899],"category_scores_gemma":[0.0000012459608,0.00035818297,0.00079769955,0.00039709551,0.000045140263,0.000024568699,0.00002661581,0.0001983656,0.00020314212],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020522764,0.0013632954,0.000001168294,0.003824713,0.0014707971,0.00022268113,0.000045271358,1.2480001e-7,0.000011360773,0.00048379536,0.011867973,0.9805036],"study_design_scores_gemma":[0.002771523,0.00069376547,0.000002466638,0.020704566,0.00012024901,0.00006445382,0.000012916379,0.0000013702308,0.0015027988,0.0000035382132,0.97387165,0.00025071984],"about_ca_topic_score_codex":0.0000050586973,"about_ca_topic_score_gemma":6.165029e-8,"teacher_disagreement_score":0.98025286,"about_ca_system_score_codex":0.00018153076,"about_ca_system_score_gemma":0.00005205623,"threshold_uncertainty_score":0.99991655},"labels":[],"label_agreement":null},{"id":"W1971210903","doi":"10.1517/14656566.3.10.1421","title":"Pharmacotherapy of postpartum depression","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Diathesis; Medicine; Bipolar disorder; Depression (economics); Postpartum depression; Psychiatry; Postpartum period; Pharmacotherapy; Major depressive disorder; Psychological intervention; Pregnancy; Lithium (medication); Mood","score_opus":0.11404874451524291,"score_gpt":0.45700835935035866,"score_spread":0.3429596148351157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971210903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000176752,0.9916295,0.000010805752,0.00022173596,0.003529479,0.0021923778,0.000109561835,0.00016525586,0.0021236504],"genre_scores_gemma":[0.000031742577,0.99313724,0.00017637144,0.0027596687,0.001436831,0.00040877584,0.0001695528,0.00022651188,0.0016533198],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643415,0.00034303017,0.0012429369,0.0007338371,0.000673333,0.000572689],"domain_scores_gemma":[0.997904,0.00019195312,0.00074623356,0.0006588384,0.00006825444,0.00043073177],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021526801,0.0008236423,0.0022755398,0.00044947016,0.000115048904,0.000018420564,0.00037018897,0.00038449527,0.004724604],"category_scores_gemma":[0.000006866299,0.0006100184,0.00086990034,0.0003013347,0.000086689935,0.00009274687,0.000036764464,0.00072662067,0.00030425054],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009257468,0.0009751777,0.000017469723,0.030459005,0.00034322377,0.000035950536,0.00024992277,1.8956841e-7,0.0001643072,0.000036989906,0.009294404,0.9574976],"study_design_scores_gemma":[0.0025306365,0.0006097533,0.0000036815156,0.103237934,0.000049917027,0.00016934209,0.0000032692762,0.000015512276,0.0065058763,0.000004531929,0.8864359,0.00043364355],"about_ca_topic_score_codex":0.00001667919,"about_ca_topic_score_gemma":5.222884e-8,"teacher_disagreement_score":0.957064,"about_ca_system_score_codex":0.00017056946,"about_ca_system_score_gemma":0.00014919894,"threshold_uncertainty_score":0.9996351},"labels":[],"label_agreement":null},{"id":"W1971893169","doi":"10.1517/14656566.7.2.119","title":"Pharmacogenetics for off-patent antipsychotics: reframing the risk for tardive dyskinesia and access to essential medicines","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institutes of Health","keywords":"Medicine; Tardive dyskinesia; Pharmacogenetics; Cognitive reframing; Psychiatry; Pharmacology; Intensive care medicine; Schizophrenia (object-oriented programming); Genotype; Genetics; Psychotherapist; Gene","score_opus":0.22415024684781412,"score_gpt":0.5288736713795347,"score_spread":0.3047234245317205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971893169","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030261472,0.9776815,0.0029645294,0.006729441,0.0039391466,0.007999988,0.00045941156,0.00007487229,0.00012083874],"genre_scores_gemma":[0.00002171579,0.97854036,0.0010002132,0.010550218,0.0072539286,0.0020938176,0.00022804076,0.00017580477,0.00013587794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968595,0.00025480616,0.00089809945,0.00088120566,0.0004788447,0.0006275668],"domain_scores_gemma":[0.99661267,0.0018290097,0.0006097093,0.000376992,0.00023362132,0.00033802915],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071746175,0.0007881636,0.0017026418,0.00020428798,0.000562812,0.00015205344,0.00047909084,0.0002191279,0.000121766236],"category_scores_gemma":[0.00011827701,0.00045946505,0.00064784026,0.0003140832,0.00014127773,0.00010841565,0.00009823022,0.0005055981,0.000009254898],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018986061,0.00024158698,0.0000146659195,0.0023822947,0.0011556637,0.0000036098354,0.00018327277,0.0000046702967,0.00008417337,0.000017338398,0.15227126,0.8417429],"study_design_scores_gemma":[0.0047177146,0.0006476784,0.000017323922,0.0024492403,0.0009768471,0.000032417924,0.000034746423,0.0004194655,0.00044593957,0.000027127175,0.9897113,0.00052020204],"about_ca_topic_score_codex":0.000023865075,"about_ca_topic_score_gemma":0.0000014592897,"teacher_disagreement_score":0.84122264,"about_ca_system_score_codex":0.0000917886,"about_ca_system_score_gemma":0.00011068522,"threshold_uncertainty_score":0.9997857},"labels":[],"label_agreement":null},{"id":"W1972631406","doi":"10.1517/14656566.5.7.1555","title":"Pharmacological management of metastatic boney pain","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bone health and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Intensive care medicine; Quality of life (healthcare); Population; Cancer; Internal medicine; Environmental health","score_opus":0.15312277648835515,"score_gpt":0.49526205442915183,"score_spread":0.3421392779407967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972631406","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000015085053,0.9940254,0.000100049045,0.00043022065,0.0009931468,0.003169258,0.00004929745,0.000111445006,0.0011196847],"genre_scores_gemma":[0.000009366001,0.9922223,0.0024391573,0.003186771,0.00017546656,0.0009608607,0.00026804794,0.000112679045,0.0006253309],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99697024,0.0004582922,0.0009687776,0.00060030265,0.00052744045,0.00047495344],"domain_scores_gemma":[0.9985751,0.00017405831,0.00044386962,0.00035997233,0.00004271154,0.00040432546],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004876073,0.00064032257,0.002070934,0.00028143733,0.00007214103,0.000009207297,0.00018313612,0.00017107275,0.0016160043],"category_scores_gemma":[0.0000046625223,0.00043470124,0.0007429678,0.00035801862,0.00007161954,0.000036264486,0.000026403075,0.00041313027,0.00018216955],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033514624,0.0020065245,0.0000010047227,0.015259314,0.002414011,0.0002004261,0.000055951947,4.669089e-7,0.00000639382,0.00024324947,0.009108943,0.97036856],"study_design_scores_gemma":[0.005999201,0.0010068228,0.0000015987061,0.019918002,0.00035997893,0.000054317326,0.000011371207,0.000005615546,0.000102943435,0.000025743479,0.97222257,0.0002918582],"about_ca_topic_score_codex":0.000024522238,"about_ca_topic_score_gemma":4.865134e-8,"teacher_disagreement_score":0.9700767,"about_ca_system_score_codex":0.00039094218,"about_ca_system_score_gemma":0.00031251126,"threshold_uncertainty_score":0.99981046},"labels":[],"label_agreement":null},{"id":"W1972663496","doi":"10.1517/14656566.6.10.1693","title":"Combination therapy versus single agent chemotherapy in non-small cell lung cancer","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Vinorelbine; Docetaxel; Gemcitabine; Oncology; Chemotherapy; Lung cancer; Internal medicine; Cisplatin; Combination chemotherapy; Quality of life (healthcare); Performance status; Intensive care medicine","score_opus":0.08944024370707172,"score_gpt":0.4632380360425038,"score_spread":0.3737977923354321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972663496","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000155715,0.9884364,0.000034681678,0.0009792238,0.003306165,0.0039654328,0.000048782214,0.000115049384,0.0029585434],"genre_scores_gemma":[0.00007840492,0.99054813,0.00025273208,0.0029522441,0.0015710073,0.0022565152,0.0004259299,0.00024307931,0.0016719579],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974557,0.0001425324,0.00071775785,0.00077537383,0.0004146634,0.000493972],"domain_scores_gemma":[0.998714,0.00013646904,0.00039000926,0.00046545485,0.000083491774,0.00021051994],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012943978,0.0007803703,0.0013994753,0.0005037379,0.00010631994,0.00005419396,0.00024299895,0.00032816976,0.0015531856],"category_scores_gemma":[0.000002751809,0.00061174197,0.00056080666,0.00049607904,0.000041103107,0.00010267361,0.0000138301975,0.00046530852,0.000057560006],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065110275,0.0027457662,0.000012519589,0.00068972347,0.0006519654,0.000012123839,0.00130272,0.000007692282,0.00016251356,0.000015784879,0.010762806,0.98298526],"study_design_scores_gemma":[0.023402955,0.0007888784,0.000013923548,0.0046304874,0.000086955784,0.0000046489863,0.000028498143,0.00009478447,0.0008592424,0.0000012066054,0.969557,0.00053140963],"about_ca_topic_score_codex":0.0001533472,"about_ca_topic_score_gemma":0.000007692273,"teacher_disagreement_score":0.9824539,"about_ca_system_score_codex":0.0020017168,"about_ca_system_score_gemma":0.000571798,"threshold_uncertainty_score":0.9996334},"labels":[],"label_agreement":null},{"id":"W1974384804","doi":"10.1517/14656566.4.4.475","title":"Assessment and management of acute pain in high-risk neonates","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Neonatal intensive care unit; Acute pain; Intensive care medicine; Pain assessment; Psychological intervention; Pain management; Reliability (semiconductor); Physical therapy; Pediatrics; Anesthesia; Psychiatry","score_opus":0.04282670808845209,"score_gpt":0.4325960528435088,"score_spread":0.38976934475505676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974384804","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019604004,0.99396044,0.0011292823,0.00014454528,0.00035200553,0.0030173117,0.000034374138,0.00013794226,0.0012044811],"genre_scores_gemma":[0.000013612603,0.98479986,0.0127755245,0.0009682775,0.00016304711,0.00085219264,0.00012984914,0.00010253288,0.0001950832],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969178,0.00079610193,0.00083779736,0.0006466437,0.00046805994,0.00033359998],"domain_scores_gemma":[0.99865186,0.00019743065,0.00050336076,0.00050019805,0.000028389419,0.000118744356],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015276561,0.0005520386,0.0016051433,0.00073927204,0.000037943893,0.000017695102,0.00023522742,0.00020621209,0.00019040854],"category_scores_gemma":[0.0000046417026,0.0004554546,0.00028029963,0.0005181276,0.000057229892,0.000057733036,0.000059271882,0.0004595982,0.000005832057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044160442,0.00037323585,0.00016361562,0.0049531767,0.0011318146,0.00005971083,0.0000266445,1.6358116e-7,0.000004933962,0.0006457886,0.012822974,0.97977376],"study_design_scores_gemma":[0.0021684496,0.00051330245,0.00018232978,0.008056217,0.00023437898,0.000006652572,0.000013357158,0.000028410943,0.000013823851,0.00008759342,0.9883313,0.00036414794],"about_ca_topic_score_codex":0.00003267748,"about_ca_topic_score_gemma":1.3771758e-7,"teacher_disagreement_score":0.97940964,"about_ca_system_score_codex":0.00029785043,"about_ca_system_score_gemma":0.00007467069,"threshold_uncertainty_score":0.9997897},"labels":[],"label_agreement":null},{"id":"W1976895177","doi":"10.1517/14656560903078428","title":"Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; University of Calgary","funders":"","keywords":"Mometasone furoate; Fluticasone propionate; Medicine; Asthma; Glucocorticoid; Drug; Fluticasone; Dry-powder inhaler; Bioavailability; Corticosteroid; Dosing; Clinical trial; Pharmacology; Inhaler; Internal medicine","score_opus":0.04175288918043532,"score_gpt":0.40529818003224005,"score_spread":0.36354529085180476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976895177","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007429816,0.99383736,0.000032073676,0.00013837276,0.00026391156,0.004834066,0.000060100083,0.000032282,0.00005882751],"genre_scores_gemma":[0.00018241687,0.9973528,0.00019339351,0.0009938815,0.0004052119,0.0005395278,0.0001721346,0.00007344833,0.00008717953],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821097,0.00013003817,0.0006149983,0.0004993261,0.00028521765,0.00025945995],"domain_scores_gemma":[0.9990147,0.00008833011,0.0002846667,0.00043244378,0.000036100522,0.00014375513],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019045178,0.00041932365,0.0011444766,0.00024524928,0.000052396073,0.000015058356,0.00020923848,0.00013275999,0.00010845032],"category_scores_gemma":[0.000003585085,0.00024885096,0.00034624623,0.00026203666,0.00006341665,0.000056157838,0.000021185133,0.00020240479,0.0000063104103],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008106011,0.00063873845,0.000012474062,0.00305929,0.00036816025,0.000013239838,0.000109092194,0.0000015995134,0.00000904181,0.000049686023,0.0005883688,0.9943397],"study_design_scores_gemma":[0.005615638,0.0010749324,0.0006880712,0.011761256,0.000083578765,0.00003789269,0.000051871364,0.00005657227,0.000050454637,0.000003097937,0.9803069,0.00026968293],"about_ca_topic_score_codex":0.0000063984653,"about_ca_topic_score_gemma":2.068388e-7,"teacher_disagreement_score":0.99407005,"about_ca_system_score_codex":0.000047999914,"about_ca_system_score_gemma":0.00007964936,"threshold_uncertainty_score":0.99999636},"labels":[],"label_agreement":null},{"id":"W1977389467","doi":"10.1517/14656560903222281","title":"Dapagliflozin: where does it fit in the treatment of type 2 diabetes?","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health","funders":"","keywords":"Dapagliflozin; Medicine; Hypoglycemia; Type 2 diabetes; Glycemic; Diabetes mellitus; Regimen; Pharmacotherapy; Drug class; Intensive care medicine; Concomitant; Clinical trial; Drug; Pharmacology; Internal medicine; Endocrinology","score_opus":0.09096050532522067,"score_gpt":0.42677421191226106,"score_spread":0.3358137065870404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977389467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000089780355,0.9920801,3.4257718e-7,0.0016244579,0.001032535,0.0026950059,0.00002119747,0.00004937892,0.002407205],"genre_scores_gemma":[0.000016066106,0.9939102,0.000080768106,0.002496294,0.00078893657,0.00050357747,0.00020748228,0.000072513176,0.0019241392],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784595,0.00022974356,0.0006314549,0.0004950857,0.0004059788,0.00039178767],"domain_scores_gemma":[0.99874085,0.00018284308,0.00027325726,0.00067447015,0.00003618537,0.000092375936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016516326,0.0006334053,0.0016908739,0.00032965202,0.000044599794,0.000028887054,0.00029244868,0.0001746556,0.00083538995],"category_scores_gemma":[0.0000036384079,0.00029825457,0.00060823245,0.00044262328,0.000049453043,0.000052229665,0.000009937946,0.00016604346,0.00010073919],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009129817,0.002757612,0.00001123482,0.0009940299,0.00057946955,0.000017985769,0.0007599703,4.1736487e-7,0.000011797527,0.00005421636,0.03680135,0.9579206],"study_design_scores_gemma":[0.0027867225,0.002672318,0.0000050432786,0.005845109,0.00016644971,0.0000014654493,0.00006379566,0.000006841077,0.00016158567,0.000010260254,0.98800695,0.00027346844],"about_ca_topic_score_codex":0.000011300701,"about_ca_topic_score_gemma":0.0000027477058,"teacher_disagreement_score":0.95764714,"about_ca_system_score_codex":0.00027833576,"about_ca_system_score_gemma":0.0000916402,"threshold_uncertainty_score":0.99994695},"labels":[],"label_agreement":null},{"id":"W1977936853","doi":"10.1517/14656566.9.8.1291","title":"Antidepressant therapy in post-stroke depression","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Medicine; Sertraline; Post-stroke depression; Depression (economics); Nortriptyline; Stroke (engine); Citalopram; Antidepressant; Randomized controlled trial; Fluoxetine; Internal medicine; Psychiatry; Physical therapy; Activities of daily living; Anxiety; Amitriptyline","score_opus":0.06869704480743827,"score_gpt":0.4222142348065993,"score_spread":0.35351718999916104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977936853","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002545127,0.99245954,0.0000107313235,0.00022396044,0.002776334,0.0024667042,0.00007494082,0.00016448613,0.0015688066],"genre_scores_gemma":[0.000024080733,0.9935911,0.00025312766,0.0030006955,0.0013140853,0.0005218182,0.00021665494,0.0001914349,0.000886985],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966177,0.000422187,0.0009717901,0.00087719114,0.0006267743,0.00048438172],"domain_scores_gemma":[0.99814206,0.00052037486,0.00033926615,0.00064157025,0.00009705738,0.0002596566],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001649122,0.0007683893,0.0021068612,0.0010533837,0.00010026645,0.000026310008,0.00028014882,0.000513232,0.0011022975],"category_scores_gemma":[0.000046710196,0.00052254007,0.0013212445,0.00037434153,0.00010511285,0.00011473687,0.000027444456,0.0008725503,0.00020108084],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005509404,0.0007993902,0.00020468475,0.00055127835,0.00024493292,0.0000522999,0.00031788505,7.3224663e-7,0.0005845416,0.000005351628,0.010658992,0.98602897],"study_design_scores_gemma":[0.0044239257,0.0006404123,0.00021810993,0.008387789,0.000008286185,0.0002424339,0.00002441252,0.000010944866,0.00060065015,0.0000013241416,0.98494834,0.0004933982],"about_ca_topic_score_codex":0.00003139678,"about_ca_topic_score_gemma":3.4421438e-7,"teacher_disagreement_score":0.98553556,"about_ca_system_score_codex":0.00024600304,"about_ca_system_score_gemma":0.00044653867,"threshold_uncertainty_score":0.9998108},"labels":[],"label_agreement":null},{"id":"W1982242297","doi":"10.1517/14656566.2011.600689","title":"Montelukast for the treatment of asthma in the adult population","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St Joseph's Health Care; McMaster University","funders":"","keywords":"Montelukast; Medicine; Asthma; Intensive care medicine; Population; Concomitant; Leukotriene; Bronchoconstriction; Clinical trial; Inhaler; Randomized controlled trial; Leukotriene receptor; Internal medicine","score_opus":0.11549415947633151,"score_gpt":0.4459149460032207,"score_spread":0.33042078652688917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982242297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035126806,0.99541867,0.000033868375,0.0002449624,0.00065334945,0.0033996715,0.00006512494,0.000020478014,0.0001287501],"genre_scores_gemma":[0.00009357727,0.99562496,0.0000354449,0.0011766197,0.0011428825,0.0016073941,0.00014807655,0.000060033755,0.00011103504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860233,0.00020350037,0.00051219034,0.0002805116,0.00021183302,0.00018962093],"domain_scores_gemma":[0.9988796,0.0003132645,0.00027706858,0.0004181413,0.00005306338,0.000058873506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001226405,0.00035455683,0.00084511476,0.00013960515,0.00008266964,0.0000098508945,0.00020475451,0.00013184558,0.00015020174],"category_scores_gemma":[0.000010599327,0.00014611118,0.0007278949,0.00016773294,0.00005012402,0.000028066615,0.000003807923,0.000114298025,0.000010104873],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038849915,0.0009958169,0.000017141041,0.0005455581,0.00014790466,0.000002078956,0.00095643644,5.913133e-7,0.0000027856822,0.00019658123,0.0028563172,0.9938903],"study_design_scores_gemma":[0.0019633435,0.0014182922,0.0001016516,0.0020988719,0.0000494637,0.000008842003,0.00011322829,0.000024204797,0.000029577095,0.0000059061326,0.994047,0.00013965584],"about_ca_topic_score_codex":0.000091686146,"about_ca_topic_score_gemma":0.0000033344727,"teacher_disagreement_score":0.99375063,"about_ca_system_score_codex":0.0000992424,"about_ca_system_score_gemma":0.00009459985,"threshold_uncertainty_score":0.5958241},"labels":[],"label_agreement":null},{"id":"W1986388359","doi":"10.1517/14656560802653206","title":"Economic evaluation of docetaxel for breast cancer","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Docetaxel; Medicine; Taxane; Breast cancer; Oncology; Cancer; Internal medicine; Prostate cancer; Adjuvant; Chemotherapy; Intensive care medicine","score_opus":0.19665257186682186,"score_gpt":0.5538454632338995,"score_spread":0.35719289136707766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986388359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012223531,0.9909661,0.0000060586294,0.000918776,0.0026403118,0.0037645868,0.00095770624,0.00004286858,0.00069139246],"genre_scores_gemma":[0.000019708259,0.9923222,0.00007221224,0.0012731607,0.0032677401,0.0021906272,0.00042021766,0.00008662255,0.000347528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981794,0.00016831922,0.00061223295,0.0004827689,0.00029420928,0.0002630821],"domain_scores_gemma":[0.9988636,0.00012563689,0.0004726454,0.00026429814,0.00014589654,0.00012794352],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035723628,0.0004545671,0.0015696443,0.00027381742,0.000049802624,0.000009266142,0.00014618767,0.00021666352,0.0057037226],"category_scores_gemma":[0.0000026848593,0.00035255813,0.00075329375,0.000105477506,0.0000417688,0.000052401603,0.000006837262,0.00017358774,0.000033854743],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063764775,0.0004518605,0.0000015436547,0.0010204338,0.0008792935,4.5304165e-7,0.00007307777,0.000007488756,0.0000866467,0.000043292785,0.06621949,0.93057877],"study_design_scores_gemma":[0.008374915,0.00052129664,0.0000095402365,0.0034879711,0.0006478212,0.00003478441,0.0000031143531,0.00017254715,0.0003786761,0.000022486027,0.9860704,0.00027646963],"about_ca_topic_score_codex":0.000053840573,"about_ca_topic_score_gemma":0.0000025745755,"teacher_disagreement_score":0.9303023,"about_ca_system_score_codex":0.00096282485,"about_ca_system_score_gemma":0.0011838544,"threshold_uncertainty_score":0.99989265},"labels":[],"label_agreement":null},{"id":"W1986471715","doi":"10.1517/14656566.9.15.2575","title":"Pharmacological treatment in moderate-to-severe Alzheimer's disease","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Donepezil; Memantine; Disease; Randomized controlled trial; Population; Clinical trial; Alzheimer's disease; Stage (stratigraphy); Caregiver burden; Intensive care medicine; Internal medicine; Pediatrics; Dementia","score_opus":0.1559657550852251,"score_gpt":0.4879294005533507,"score_spread":0.3319636454681256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986471715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000094723335,0.99049354,0.0000136767285,0.0008715003,0.00067476876,0.0057103722,0.0000871006,0.00012805563,0.0019262631],"genre_scores_gemma":[0.00010903448,0.98853403,0.00008378122,0.0047578597,0.0010522153,0.004042717,0.00038179086,0.00014112172,0.00089742604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99617815,0.00052354595,0.00070316246,0.0010670389,0.00074297143,0.00078511704],"domain_scores_gemma":[0.99819297,0.00018206057,0.00012896197,0.00036381008,0.00008003445,0.0010521848],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00013115049,0.00088027463,0.0017847646,0.00070320984,0.00013156421,0.00004324561,0.00027245603,0.00020793898,0.0036600644],"category_scores_gemma":[0.0000134757465,0.0006053626,0.00079076877,0.0005570783,0.00007893882,0.0000818984,0.00005330662,0.00051973376,0.0008521664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026781221,0.0033417149,0.00005922317,0.0002339256,0.00091894047,0.0007411721,0.00012557145,0.0000033496021,0.000021933462,0.000014384228,0.018092567,0.97376907],"study_design_scores_gemma":[0.0065053785,0.0015567729,0.000068564106,0.0028616148,0.00012520011,0.0000835324,0.000009093494,0.00006672822,0.0002221414,0.000004413133,0.987922,0.0005745256],"about_ca_topic_score_codex":0.000023774326,"about_ca_topic_score_gemma":3.512068e-7,"teacher_disagreement_score":0.9731946,"about_ca_system_score_codex":0.00060166337,"about_ca_system_score_gemma":0.0008657358,"threshold_uncertainty_score":0.9999258},"labels":[],"label_agreement":null},{"id":"W1986801377","doi":"10.1517/14656566.7.4.489","title":"Multidisciplinary Symposium on Head and Neck Cancer","year":2006,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Head and neck cancer; Head and neck squamous-cell carcinoma; Head and neck; Oncology; Chemoradiotherapy; Cancer; Disease; Chemotherapy; Multidisciplinary approach; Carcinogenesis; Internal medicine; Surgery","score_opus":0.03996260949890074,"score_gpt":0.4031644089716113,"score_spread":0.3632017994727106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986801377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7985247,0.047935016,0.00002365676,0.05135598,0.0025357273,0.0010972547,0.000028482584,0.000400895,0.098098285],"genre_scores_gemma":[0.8302252,0.12705748,0.0005637561,0.019203696,0.00442651,0.00048435034,0.00002405445,0.00020767451,0.017807277],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905103,0.000026369516,0.00016241141,0.0003284973,0.00019694929,0.00023473526],"domain_scores_gemma":[0.9996422,0.000034387067,0.000040042003,0.0001509248,0.000023383096,0.00010904862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004358224,0.00020052132,0.00026823411,0.00009001364,0.00012580244,0.000010444306,0.000042878208,0.000051146668,0.0005857098],"category_scores_gemma":[0.0000014492458,0.00015270888,0.000058961672,0.00009194591,0.00005704244,0.000035730056,0.00001414279,0.000120303615,0.00004653264],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041541555,0.0017352618,0.020489765,0.000070594004,0.00020451038,0.00004129795,0.0023800267,0.000044252665,0.4571342,0.0010690022,0.4265099,0.08616704],"study_design_scores_gemma":[0.007317906,0.0012129645,0.024307676,0.00041186754,0.0000033692838,0.00000946034,0.0000470222,0.00030560358,0.07755644,0.000024587638,0.88855875,0.00024437357],"about_ca_topic_score_codex":0.0002511044,"about_ca_topic_score_gemma":0.000009361451,"teacher_disagreement_score":0.46204883,"about_ca_system_score_codex":0.00007303402,"about_ca_system_score_gemma":0.000032793007,"threshold_uncertainty_score":0.64131117},"labels":[],"label_agreement":null},{"id":"W1987019231","doi":"10.1517/14656566.2014.972936","title":"Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; TRIUMF","funders":"National Institute of Mental Health; Foundation for the National Institutes of Health","keywords":"Pharmacotherapy; Olanzapine; Medicine; Psychiatry; Sertraline; Body dysmorphic disorder; Psychotherapist; Schizophrenia (object-oriented programming); Psychology; Anxiety; Antidepressant","score_opus":0.04438572038806491,"score_gpt":0.44008674423094163,"score_spread":0.3957010238428767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987019231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004134141,0.98251635,0.00072655594,0.00020832595,0.0052527115,0.009103873,0.00016267163,0.0004943393,0.0015310207],"genre_scores_gemma":[0.000015852835,0.9886827,0.00013494371,0.0052886456,0.00095614226,0.0024657655,0.0011602374,0.00070985686,0.00058586005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9865264,0.00565617,0.0036924365,0.001962321,0.0010187357,0.0011438844],"domain_scores_gemma":[0.99268705,0.00058499916,0.0037265616,0.0023181613,0.00022153674,0.00046172406],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0015214044,0.0020442707,0.008171874,0.0010611223,0.00023271739,0.00007869291,0.0024168377,0.00063236867,0.0123046925],"category_scores_gemma":[0.000038506252,0.0016287917,0.0020613326,0.0015600228,0.00021422515,0.0002588713,0.00005666129,0.0011803448,0.0010154785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019876035,0.0022958184,0.0000018707204,0.37370315,0.003491674,0.000019421788,0.00093670987,0.0000033173492,0.00006698722,0.001167845,0.036621537,0.5814929],"study_design_scores_gemma":[0.002920177,0.0005813501,4.2706816e-7,0.18269108,0.0004215892,0.000045617373,0.000068485,0.00004494362,0.000041572795,0.000023646653,0.8118497,0.001311397],"about_ca_topic_score_codex":0.000092267306,"about_ca_topic_score_gemma":0.0000020492632,"teacher_disagreement_score":0.7752282,"about_ca_system_score_codex":0.00025615958,"about_ca_system_score_gemma":0.00020412309,"threshold_uncertainty_score":0.99976236},"labels":[],"label_agreement":null},{"id":"W1987774319","doi":"10.1517/14656560903004184","title":"Pharmacotherapy for women's sexual dysfunction","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Pharmacotherapy; Sexual dysfunction; Pharmacology; Internal medicine","score_opus":0.15962365311473006,"score_gpt":0.47600544174443155,"score_spread":0.31638178862970145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987774319","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000034584298,0.9820107,0.0012054596,0.0007097571,0.009375955,0.003930539,0.00008789289,0.00072500965,0.0019512171],"genre_scores_gemma":[8.9881274e-7,0.94813913,0.00024923045,0.021373501,0.008027772,0.0033448038,0.00045432322,0.00028905532,0.018121297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957559,0.0002325609,0.0011322269,0.0013016715,0.00071438384,0.0008632399],"domain_scores_gemma":[0.9976515,0.0004362147,0.0005386274,0.00062282354,0.00024465867,0.00050614536],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047113514,0.0012296567,0.0027411,0.0007936887,0.00039348865,0.00008209575,0.00023394432,0.00050371914,0.0034865886],"category_scores_gemma":[0.00004247842,0.00094471,0.00089097634,0.00065438525,0.00009278894,0.0001530549,0.000019613366,0.00071074854,0.0004910367],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026245057,0.00068053434,5.64502e-7,0.001401118,0.0010107626,0.0000044524677,0.00029942475,9.828229e-7,0.00013908747,0.000098451936,0.23220514,0.761535],"study_design_scores_gemma":[0.008507008,0.004667749,0.0000012159128,0.0015325446,0.000099098164,0.000092060516,0.00018653431,0.000030322119,0.00013153309,0.000025677647,0.9838656,0.00086064433],"about_ca_topic_score_codex":0.0000053358935,"about_ca_topic_score_gemma":1.0960038e-7,"teacher_disagreement_score":0.7606743,"about_ca_system_score_codex":0.00079802226,"about_ca_system_score_gemma":0.0003715226,"threshold_uncertainty_score":0.99930036},"labels":[],"label_agreement":null},{"id":"W1988876914","doi":"10.1517/14656566.6.5.707","title":"Duloxetine: pharmacoeconomic implications of an antidepressant that alleviates painful physical symptoms","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Treatment of Major Depression","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Duloxetine; Medicine; Antidepressant; Major depressive disorder; Venlafaxine; Reuptake inhibitor; Vortioxetine; Psychiatry; Fluoxetine; Agomelatine; Duloxetine Hydrochloride; Internal medicine; Serotonin; Mood; Alternative medicine; Anxiety","score_opus":0.09491935300903415,"score_gpt":0.46409916664202505,"score_spread":0.3691798136329909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988876914","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008377621,0.99389535,0.000018736846,0.00078554964,0.00071072805,0.0024684444,0.00023230127,0.0003064251,0.00074470195],"genre_scores_gemma":[0.0006625909,0.992861,0.0003975884,0.0011348908,0.0026435475,0.0007969792,0.001006576,0.00028291982,0.00021396276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966359,0.0003842471,0.0009268111,0.0010896751,0.00044829628,0.0005150386],"domain_scores_gemma":[0.99711317,0.00037483897,0.00083973026,0.0011509052,0.000074079144,0.00044725454],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021979053,0.000988576,0.0025060598,0.00044450798,0.00012114455,0.000038038634,0.00056122174,0.00029486147,0.0012129927],"category_scores_gemma":[0.000011138077,0.00073381775,0.0011059592,0.00021383837,0.00013519647,0.00024742694,0.00006586856,0.0005476603,0.0001824199],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023701078,0.00274985,0.000046522666,0.0009517783,0.0008802635,0.000007196916,0.0001870805,0.0000044357716,0.0011428356,0.0000544882,0.009728225,0.98401034],"study_design_scores_gemma":[0.0042821434,0.00058897806,0.00008452893,0.0047595124,0.00023372076,0.00008542345,0.000009816704,0.0001354968,0.0044354303,0.0000109630455,0.9847755,0.00059850095],"about_ca_topic_score_codex":0.000015153954,"about_ca_topic_score_gemma":2.5371097e-7,"teacher_disagreement_score":0.9834118,"about_ca_system_score_codex":0.00026261463,"about_ca_system_score_gemma":0.00023788735,"threshold_uncertainty_score":0.9997},"labels":[],"label_agreement":null},{"id":"W1989418652","doi":"10.1517/14656566.8.7.1001","title":"Aripiprazole: pharmacology and evidence in bipolar disorder","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Aripiprazole; Bipolar disorder; Medicine; Mania; Tardive dyskinesia; Psychiatry; Tolerability; Bipolar I disorder; Akathisia; Treatment of bipolar disorder; Mood; Antipsychotic; Adverse effect; Pharmacology; Schizophrenia (object-oriented programming)","score_opus":0.13076910169560088,"score_gpt":0.4762390120830116,"score_spread":0.3454699103874107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989418652","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012838415,0.9955481,0.0000445766,0.0006077957,0.0014312365,0.002028161,0.000015689706,0.00009798332,0.00021361881],"genre_scores_gemma":[0.00002223469,0.99605453,0.00016963077,0.0021568313,0.00075023,0.0004280221,0.00007487864,0.0001394048,0.00020422893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971873,0.0002676873,0.0007890524,0.0008429681,0.0003576916,0.0005552827],"domain_scores_gemma":[0.9987163,0.0003648092,0.00023593182,0.00035385226,0.00003712885,0.00029197693],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038877752,0.0007396039,0.0016363206,0.0007275419,0.000088793364,0.000025532878,0.0001957648,0.0004193323,0.000897666],"category_scores_gemma":[0.000014945041,0.0005639686,0.00034623756,0.00052887655,0.000123729,0.00011374694,0.000047101243,0.0008582077,0.00011912233],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026567403,0.0008256981,0.00034533686,0.002055291,0.00035881865,0.00003894383,0.00024013226,1.312916e-7,0.000054081298,0.000038814083,0.002080716,0.9936964],"study_design_scores_gemma":[0.0033737777,0.00047396365,0.000095155105,0.007867655,0.000096172655,0.00016810259,0.00001415773,0.000013286512,0.00009657075,0.000004867818,0.9873319,0.00046435982],"about_ca_topic_score_codex":0.00011428693,"about_ca_topic_score_gemma":0.000009263737,"teacher_disagreement_score":0.993232,"about_ca_system_score_codex":0.00025397286,"about_ca_system_score_gemma":0.00026166358,"threshold_uncertainty_score":0.9996812},"labels":[],"label_agreement":null},{"id":"W1997303941","doi":"10.1517/14656566.6.2.165","title":"Pityriasis versicolor: a review of pharmacological treatment options","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Pityriasis; Medicine; Dermatology; Malassezia; Tinea versicolor; Etiology; Topical agents; Pathology","score_opus":0.18231492790249207,"score_gpt":0.5175295203484694,"score_spread":0.3352145924459774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997303941","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013336177,0.9929284,0.0000025864242,0.000972857,0.00074072403,0.0036025413,0.00040344204,0.00010382071,0.001244323],"genre_scores_gemma":[0.00000117147,0.99050796,0.00028951865,0.0052988105,0.0011566239,0.0013945826,0.000666536,0.00009446837,0.00059033674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973991,0.0002896163,0.0008629164,0.0006398615,0.0004485762,0.00035992454],"domain_scores_gemma":[0.9984253,0.00016726292,0.00046249904,0.0004633006,0.000084463776,0.00039716478],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010506098,0.0007391443,0.0025804588,0.00025869074,0.000088026936,0.000010805394,0.0002053706,0.00021545612,0.00808582],"category_scores_gemma":[0.000012695955,0.00047664193,0.001972325,0.000370924,0.00007867715,0.000056880155,0.0000255892,0.00023213752,0.0003613586],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002457789,0.004072421,8.9551065e-7,0.007111387,0.0027534317,0.00003549734,0.000020935964,1.18681506e-7,0.000009996121,0.000057800073,0.051455833,0.93423593],"study_design_scores_gemma":[0.00435778,0.0015888059,0.0000014649395,0.051069207,0.001503527,0.000048713933,0.0000026064392,0.0000025401412,0.00007036694,0.0000014415064,0.94103855,0.0003149997],"about_ca_topic_score_codex":0.000019372763,"about_ca_topic_score_gemma":1.09655446e-7,"teacher_disagreement_score":0.9339209,"about_ca_system_score_codex":0.00084095873,"about_ca_system_score_gemma":0.0006532471,"threshold_uncertainty_score":0.99976856},"labels":[],"label_agreement":null},{"id":"W1999259854","doi":"10.1517/14656566.6.5.819","title":"An evaluation of paroxetine in generalised social anxiety disorder","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Paroxetine; Social anxiety; Anxiety; Psychiatry; Medicine; Pharmacotherapy; Anxiety disorder; Placebo; Clinical psychology; Psychology; Antidepressant; Alternative medicine","score_opus":0.22232938192537394,"score_gpt":0.5528664276615541,"score_spread":0.3305370457361802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999259854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019167912,0.99125075,0.00011708775,0.00013933303,0.003445229,0.0022046457,0.000186251,0.000102772254,0.0023622643],"genre_scores_gemma":[0.0006897648,0.9911278,0.00018026613,0.00061957724,0.003869052,0.0023072422,0.0008410618,0.00021474122,0.00015048351],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99374205,0.0022765095,0.0011655941,0.0012552049,0.0010163198,0.00054433645],"domain_scores_gemma":[0.99773705,0.00019262994,0.0009531221,0.0005834562,0.00038165256,0.00015208963],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012145938,0.0008487385,0.0015362845,0.0010950825,0.00013364421,0.000037917835,0.00062155677,0.00059787394,0.008776292],"category_scores_gemma":[0.00004429127,0.0007223442,0.00052219594,0.0014365918,0.00011858975,0.00020956523,0.000027609618,0.0005191809,0.00014726527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023617658,0.003023551,0.0001686071,0.00022535173,0.00033763333,8.3219123e-7,0.0021534371,0.00000576923,0.000018611408,0.00007321866,0.01357158,0.9801852],"study_design_scores_gemma":[0.005667761,0.00021766218,0.00016302531,0.0007754415,0.00008933199,0.000005177044,0.00015250298,0.00005937175,0.000045151584,0.000044882003,0.99212027,0.0006593973],"about_ca_topic_score_codex":0.00009783777,"about_ca_topic_score_gemma":0.0000058915084,"teacher_disagreement_score":0.9795258,"about_ca_system_score_codex":0.0003346382,"about_ca_system_score_gemma":0.00025389204,"threshold_uncertainty_score":0.99952275},"labels":[],"label_agreement":null},{"id":"W2000257366","doi":"10.1517/14656566.1.4.683","title":"Pharmacotherapy of hypercholesterolaemia: statins in clinical practice","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Adverse effect; Gemfibrozil; Pharmacology; Statin; Cerivastatin; Lovastatin; Atorvastatin; Bezafibrate; Clinical trial; Internal medicine; Cholesterol; Pravastatin","score_opus":0.1386396925910737,"score_gpt":0.5305010941545557,"score_spread":0.39186140156348204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000257366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047444795,0.99122053,0.000033958313,0.00054996484,0.001567643,0.0033302833,0.00007224971,0.000093180344,0.0030847595],"genre_scores_gemma":[0.0000073230235,0.98499066,0.001362363,0.009701821,0.002869941,0.00046222907,0.00017066252,0.00025412315,0.00018087441],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928163,0.0018820495,0.0025607946,0.0010184436,0.0011235275,0.00059886987],"domain_scores_gemma":[0.99689186,0.0006386649,0.0008026515,0.0011107249,0.00013667037,0.00041942307],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002414763,0.00080105796,0.0039395457,0.00054182514,0.00005943008,0.000026734066,0.00039737418,0.00064666825,0.0011060198],"category_scores_gemma":[0.000079557125,0.0006188209,0.001939702,0.00067659334,0.0001342149,0.000190337,0.000025320554,0.0018883713,0.00013020674],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011459163,0.0019800514,0.0000045848988,0.0026765005,0.0009863127,0.000082685714,0.00029331664,0.0000010778884,0.000019431014,0.000027419828,0.0063139265,0.9864688],"study_design_scores_gemma":[0.007639203,0.001017834,0.000009349154,0.009783038,0.00012452055,0.00024246423,0.000033579036,0.000009011852,0.000095063384,0.0000035850512,0.9805679,0.0004744575],"about_ca_topic_score_codex":0.00013022618,"about_ca_topic_score_gemma":7.4749653e-7,"teacher_disagreement_score":0.98599434,"about_ca_system_score_codex":0.00029374255,"about_ca_system_score_gemma":0.0011149052,"threshold_uncertainty_score":0.9998071},"labels":[],"label_agreement":null},{"id":"W2001996774","doi":"10.1517/14656566.2015.1022531","title":"Transdermal contraception methods: today’s patches and new options on the horizon","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Estrogen; Family planning; Intensive care medicine; Progestin; Popularity; Dosing; Transdermal; Gynecology; Population; Internal medicine; Pharmacology; Adverse effect; Environmental health","score_opus":0.26223119611235746,"score_gpt":0.5186390858378908,"score_spread":0.2564078897255333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001996774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014900964,0.9792051,0.0014655871,0.013120669,0.0018791247,0.0034891877,0.000026333322,0.00014287005,0.0006562745],"genre_scores_gemma":[0.0000071244153,0.9873328,0.0012758215,0.0037248123,0.005916129,0.0006743701,0.0001288434,0.000118580174,0.000821518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963555,0.0011775168,0.0007026341,0.000857315,0.0004755474,0.00043152907],"domain_scores_gemma":[0.99802446,0.00041349608,0.00033086614,0.0006091794,0.00012372616,0.00049827935],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001269666,0.0006400896,0.0014320477,0.00023280462,0.00022294329,0.00005856248,0.00017134416,0.00036787416,0.0005812061],"category_scores_gemma":[0.000073849136,0.00038499522,0.00043345286,0.00026857396,0.00010949137,0.00011742999,0.000011194778,0.0009090229,0.00012102114],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050924846,0.00021401244,3.6480068e-7,0.0004997159,0.00018167758,0.0000024224332,0.0005850214,4.7113315e-7,0.00031279057,0.0007830978,0.036924277,0.9599869],"study_design_scores_gemma":[0.002099995,0.0013516914,0.000007500652,0.0030874026,0.00008470001,0.00006933154,0.0001049485,0.000022224227,0.00018884511,0.00012541859,0.992502,0.00035598897],"about_ca_topic_score_codex":0.00004408641,"about_ca_topic_score_gemma":6.5182525e-7,"teacher_disagreement_score":0.9596309,"about_ca_system_score_codex":0.00025278347,"about_ca_system_score_gemma":0.00059145194,"threshold_uncertainty_score":0.99986017},"labels":[],"label_agreement":null},{"id":"W2004568544","doi":"10.1517/14656566.2013.825606","title":"New and emerging treatments for osteoarthritis management: will the dream come true with personalized medicine?","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; Personalized medicine; Intensive care medicine; Psychological intervention; Disease; Alternative medicine; Bioinformatics; Internal medicine; Pathology; Psychiatry","score_opus":0.05105887081883347,"score_gpt":0.3860866797604262,"score_spread":0.33502780894159273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004568544","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013723003,0.98723394,0.00019957514,0.0016394174,0.0010074836,0.008327858,0.0000557561,0.00013420197,0.0013880694],"genre_scores_gemma":[0.0000025740687,0.9797186,0.0019434292,0.0016497412,0.0014115273,0.0026646985,0.00051837746,0.00022096804,0.011870079],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975226,0.00013963788,0.00054484955,0.00079548015,0.00048467805,0.00051274797],"domain_scores_gemma":[0.998575,0.00019722099,0.00031242022,0.0004977429,0.000055516703,0.0003621488],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013835436,0.0009032487,0.0017697967,0.00028173177,0.00029516598,0.00006024087,0.00021225004,0.00019007848,0.0013389362],"category_scores_gemma":[0.000004080123,0.0004778824,0.0003954046,0.0002394923,0.00014696171,0.00014539107,0.000027299182,0.00024126146,0.00003453765],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004664454,0.0001285067,0.0000012679401,0.00084784324,0.0011424074,0.000029717614,0.0008101967,1.9606704e-8,0.000028187236,0.0010437458,0.013714545,0.98178715],"study_design_scores_gemma":[0.02612726,0.0057908604,6.118902e-7,0.014031445,0.0006330979,0.00023515035,0.00025722507,0.0000021276194,0.00005978284,0.00006489106,0.95235753,0.00043998848],"about_ca_topic_score_codex":0.000028292128,"about_ca_topic_score_gemma":0.0000013264294,"teacher_disagreement_score":0.98134714,"about_ca_system_score_codex":0.00014129622,"about_ca_system_score_gemma":0.00009630722,"threshold_uncertainty_score":0.9997673},"labels":[],"label_agreement":null},{"id":"W2005776181","doi":"10.1517/14656566.7.5.607","title":"Sativex<sup>®</sup>: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neuropathic pain; Tolerability; Multiple sclerosis; Cannabidiol; Dosing; Spasticity; Placebo; Clinical trial; Chronic pain; Gabapentin; Anesthesia; Pharmacology; Physical therapy; Internal medicine; Cannabis; Adverse effect; Alternative medicine; Psychiatry","score_opus":0.14919064783503377,"score_gpt":0.4493601433132434,"score_spread":0.30016949547820965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005776181","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020030579,0.9763084,0.000008119564,0.0008096722,0.00011455348,0.002611003,0.00006582702,0.000015091922,0.00003673922],"genre_scores_gemma":[0.004185465,0.99458057,0.00002376373,0.00039545336,0.00036217432,0.0002778828,0.000050740702,0.000053805597,0.00007016152],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941646,0.0032916798,0.0011930104,0.0006139395,0.00045693267,0.00027985525],"domain_scores_gemma":[0.99768424,0.0012746918,0.0003147591,0.00050365797,0.000078936624,0.00014371838],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025440904,0.00043013744,0.0019558775,0.0002286264,0.000056264886,0.000019293904,0.00016847518,0.00022513593,0.00005452211],"category_scores_gemma":[0.00017453694,0.00024669073,0.000450532,0.00032446926,0.0004453173,0.0000293064,0.000022434706,0.0004085701,0.0000010880942],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050733524,0.0030106877,0.0012304178,0.0015302524,0.00012839785,0.000005462363,0.0011295043,0.0000019681981,0.000047278627,0.000009637843,0.0024625873,0.9899365],"study_design_scores_gemma":[0.006018567,0.004817293,0.002869094,0.0032238995,0.000039939878,0.000011897844,0.00006436633,0.00041888832,0.00006363755,0.0000022726726,0.9822754,0.00019474707],"about_ca_topic_score_codex":0.00018462793,"about_ca_topic_score_gemma":0.000002085447,"teacher_disagreement_score":0.98974174,"about_ca_system_score_codex":0.000097769735,"about_ca_system_score_gemma":0.00020448818,"threshold_uncertainty_score":0.9999985},"labels":[],"label_agreement":null},{"id":"W2006569343","doi":"10.1517/14656566.4.12.2355","title":"Tinzaparin in the treatment of venous thromboembolism","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Medicine; Heparin; Warfarin; Deep vein; Venous thromboembolism; Low molecular weight heparin; Clinical trial; Thrombosis; Venous thrombosis; Anticoagulant; Internal medicine","score_opus":0.05540608515966367,"score_gpt":0.3817815458490013,"score_spread":0.32637546068933765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006569343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9121476,0.025370214,0.000056046134,0.005720271,0.0020001568,0.0029625865,0.00000830083,0.000092183596,0.051642653],"genre_scores_gemma":[0.8796997,0.111929975,0.00024929654,0.007378169,0.0002915093,0.0002929017,0.000011513768,0.000037437672,0.00010947615],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987215,0.00015318251,0.0002973381,0.0002611122,0.0003016572,0.00026520938],"domain_scores_gemma":[0.9993663,0.00008398824,0.00008191053,0.00037912835,0.000025587211,0.000063115964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020569508,0.00020425559,0.0005070453,0.00013793615,0.000058505386,0.0000120007535,0.000118611424,0.000051368126,0.0006626925],"category_scores_gemma":[0.0000070556034,0.00012828043,0.00014676728,0.00021748568,0.00005039715,0.00003529117,0.0000034245716,0.00008022236,0.00003988858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001547093,0.12342489,0.0046261856,0.00013177376,0.0016594182,0.00017462859,0.10763133,0.00022670053,0.08523752,0.10327186,0.12271278,0.4493558],"study_design_scores_gemma":[0.0047729835,0.002981078,0.009538184,0.000057667596,0.00000860972,0.000011292234,0.00060009153,0.000025049127,0.058600184,0.00018472546,0.9230799,0.00014024157],"about_ca_topic_score_codex":0.00013038094,"about_ca_topic_score_gemma":0.0000032186658,"teacher_disagreement_score":0.8003671,"about_ca_system_score_codex":0.000098074495,"about_ca_system_score_gemma":0.000044562355,"threshold_uncertainty_score":0.7256018},"labels":[],"label_agreement":null},{"id":"W2008546357","doi":"10.1517/14656566.7.10.1305","title":"Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Mood disorders; Psychiatry; Disease; Neuroprotection; Anxiety; Psychological intervention; Mood; Bipolar disorder; Neuroscience; Bioinformatics; Psychology; Pharmacology; Internal medicine","score_opus":0.22770844625025552,"score_gpt":0.4688431981785058,"score_spread":0.24113475192825026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008546357","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016387314,0.9908249,0.00003371271,0.0023529723,0.00026860982,0.0020865104,0.00006789777,0.00008261257,0.004266441],"genre_scores_gemma":[0.000075780656,0.9964381,0.0002314876,0.00016613748,0.000445286,0.00066530134,0.0007541404,0.00014240632,0.0010813933],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99771065,0.00022563229,0.00040257553,0.0006442535,0.0005702055,0.0004466978],"domain_scores_gemma":[0.99919724,0.00013696235,0.00011235364,0.00030316523,0.00004615817,0.00020413872],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014557064,0.00059158547,0.001006273,0.0007323202,0.0002741181,0.00005254173,0.0001028172,0.00015306618,0.00027479551],"category_scores_gemma":[6.36764e-7,0.00038418523,0.00026181384,0.00034275657,0.0001734062,0.000068112866,0.000009281074,0.00031643853,0.000020589703],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017901741,0.0014678462,0.00017848262,0.0010128677,0.0007588232,0.000009984865,0.00021951378,5.929186e-7,5.059563e-7,0.00021400409,0.0022531054,0.9937053],"study_design_scores_gemma":[0.0042249155,0.001973096,0.00008258013,0.0021163903,0.0001209505,0.00004233192,0.000056132085,0.000017001623,0.0000049414703,0.000101200996,0.9909226,0.00033791366],"about_ca_topic_score_codex":0.00012999182,"about_ca_topic_score_gemma":0.000015713116,"teacher_disagreement_score":0.9933673,"about_ca_system_score_codex":0.00017765258,"about_ca_system_score_gemma":0.0002898793,"threshold_uncertainty_score":0.999861},"labels":[],"label_agreement":null},{"id":"W2009031791","doi":"10.1517/14656566.2013.781154","title":"Pharmacotherapy of fever control among hospitalized adult patients","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Thermal Regulation in Medicine","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Inland Hospital; University of Calgary","funders":"","keywords":"Medicine; Antipyretic; Pharmacotherapy; Intensive care medicine; Clinical trial; Hyperthermia; Internal medicine; Pharmacology; Analgesic","score_opus":0.038530625930422564,"score_gpt":0.4100111238548252,"score_spread":0.37148049792440263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009031791","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064733,0.9880145,0.00011501477,0.00036920267,0.0035167804,0.0063837226,0.000108242726,0.00034965848,0.0004955078],"genre_scores_gemma":[0.00029885824,0.98847413,0.00024193997,0.006195035,0.0018626808,0.0011929394,0.0003963824,0.0005399795,0.00079805154],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947876,0.00052296714,0.001856223,0.00088820833,0.0013164693,0.00062853826],"domain_scores_gemma":[0.99620634,0.0003151164,0.0014693405,0.000860291,0.00062344683,0.0005254646],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028963544,0.0011693258,0.0036307862,0.0006430729,0.00007545872,0.000027385795,0.00051547255,0.0005396743,0.005508244],"category_scores_gemma":[0.00007038366,0.0008216369,0.0012135382,0.0005069757,0.00031868235,0.0002022456,0.000026167801,0.00075282773,0.00020056966],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057794055,0.0014013064,0.0003292581,0.0025029634,0.001541041,0.000005694579,0.00035872028,0.0000012475845,0.00034402526,0.0000634314,0.059780065,0.9330943],"study_design_scores_gemma":[0.021453528,0.00080644677,0.00029633727,0.011732968,0.00017295763,0.000008671897,0.000010905629,0.00007204802,0.00067956443,0.000006903916,0.964085,0.00067467947],"about_ca_topic_score_codex":0.00005242369,"about_ca_topic_score_gemma":7.1047715e-8,"teacher_disagreement_score":0.9324196,"about_ca_system_score_codex":0.00031083552,"about_ca_system_score_gemma":0.00024593575,"threshold_uncertainty_score":0.99942344},"labels":[],"label_agreement":null},{"id":"W2009126972","doi":"10.1517/14656566.2011.633511","title":"Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nosocomial Infections in ICU","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Pneumonia; Intensive care medicine; Hospital-acquired pneumonia; Antibiotics; Staphylococcus aureus; Dosing; Methicillin-resistant Staphylococcus aureus; Internal medicine; Microbiology","score_opus":0.11693127733150879,"score_gpt":0.4578364837173711,"score_spread":0.3409052063858623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009126972","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006442777,0.98577,0.0003771548,0.00025527048,0.0057198317,0.007190292,0.00014688562,0.00014140246,0.00033475502],"genre_scores_gemma":[0.00005916722,0.9921968,0.00033620544,0.00029182844,0.0022059048,0.004332362,0.00014257409,0.00017519173,0.00025995495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978366,0.00019362573,0.0008105529,0.0005615012,0.00022113229,0.0003766162],"domain_scores_gemma":[0.99766773,0.0008102549,0.0005883296,0.000625641,0.00016971768,0.00013833503],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000174931,0.0007050367,0.0016767083,0.0003497546,0.0003849563,0.00002684121,0.00021953658,0.00031750347,0.00025196897],"category_scores_gemma":[0.00003076753,0.00043978557,0.0012809898,0.00038919263,0.00017201727,0.000081997365,0.00002435789,0.00021252764,0.000049050654],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021842026,0.0025917962,0.000007588838,0.00053871964,0.001729003,0.0000029527546,0.0012063865,8.931054e-7,0.0004546895,0.00020945443,0.0071078283,0.9859323],"study_design_scores_gemma":[0.0026400608,0.0073700584,0.000005236862,0.0029306074,0.00028191574,0.000064243366,0.00003532477,0.000005577991,0.0054674754,0.000020782973,0.9807923,0.00038641438],"about_ca_topic_score_codex":0.00014650321,"about_ca_topic_score_gemma":0.000002492905,"teacher_disagreement_score":0.9855459,"about_ca_system_score_codex":0.00082534814,"about_ca_system_score_gemma":0.00026815588,"threshold_uncertainty_score":0.9998054},"labels":[],"label_agreement":null},{"id":"W2012833937","doi":"10.1517/14656566.5.6.1373","title":"Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; Hamilton Health Sciences","funders":"","keywords":"Fondaparinux; Medicine; Antithrombotic; Dosing; Venous thrombosis; Heparin; Anesthesia; Thrombosis; Surgery; Internal medicine; Venous thromboembolism","score_opus":0.16283385619060706,"score_gpt":0.46512690406083856,"score_spread":0.3022930478702315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012833937","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000126051955,0.9856935,0.00024459965,0.0006861843,0.0045082765,0.007923278,0.000084128464,0.00030852167,0.0005388754],"genre_scores_gemma":[0.00001914452,0.98696077,0.0009218053,0.0048172264,0.0034271241,0.0026668087,0.00035600623,0.00040433623,0.00042675433],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963655,0.00012337691,0.001009552,0.001143946,0.00059785973,0.0007597778],"domain_scores_gemma":[0.9980416,0.00019555038,0.00049186294,0.0008020336,0.00011177755,0.00035716064],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021029757,0.0011072158,0.0034612562,0.0005199309,0.0002157494,0.00010279546,0.00041291784,0.0004314707,0.0014262198],"category_scores_gemma":[0.000019688423,0.0008175706,0.0016254056,0.00035759035,0.00009222802,0.00011356995,0.000044152035,0.0004887061,0.0002557045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018908067,0.0022768073,6.2741447e-7,0.005708877,0.0014380082,0.000011639262,0.00040094735,0.0000011325766,0.000106382926,0.0007626451,0.051337857,0.937766],"study_design_scores_gemma":[0.0061744642,0.0019219341,0.000006288859,0.016411837,0.00010064096,0.000020579442,0.000016733777,0.0000052504934,0.00061170646,0.00004332913,0.9738924,0.0007948283],"about_ca_topic_score_codex":0.000029704343,"about_ca_topic_score_gemma":4.7114955e-7,"teacher_disagreement_score":0.9369712,"about_ca_system_score_codex":0.0005523173,"about_ca_system_score_gemma":0.00059291197,"threshold_uncertainty_score":0.9994866},"labels":[],"label_agreement":null},{"id":"W2015895269","doi":"10.1517/14656566.2011.555398","title":"Lipid modification in the elderly using the combination of a statin and a cholesterol absorption inhibitor","year":2011,"lang":"en","type":"letter","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Ezetimibe; Medicine; Atorvastatin; Simvastatin; Tolerability; Statin; Combination therapy; Internal medicine; Pharmacology; Randomized controlled trial; Adverse effect","score_opus":0.07858964624462204,"score_gpt":0.3646761405947508,"score_spread":0.28608649435012873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015895269","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30733898,0.014449925,0.0030252445,0.66287994,0.0025564793,0.009137798,0.000059097536,0.00009449543,0.00045805037],"genre_scores_gemma":[0.29483536,0.03091479,0.00043705906,0.66280204,0.009557392,0.0008202257,0.0003641864,0.00016661061,0.00010233925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978983,0.0005390264,0.0004192542,0.0003176237,0.0006230265,0.00020279436],"domain_scores_gemma":[0.99902,0.00007362132,0.00028365903,0.000500217,0.000090938105,0.00003155993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078643736,0.00023956267,0.00035996962,0.00018260487,0.00008710036,0.000029715142,0.00015245972,0.00025785723,0.000037483347],"category_scores_gemma":[0.000009797144,0.00013956998,0.00015194851,0.00017798432,0.00008316906,0.000080778715,0.00000984276,0.0008239069,0.00000259453],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012525164,0.0011127625,0.0001532973,0.0008561132,0.00048694594,0.000020514692,0.029477458,0.000013815008,0.04593903,0.0002834308,0.31159824,0.6088059],"study_design_scores_gemma":[0.0074807936,0.0015184005,0.0016924564,0.00085140124,0.00003389016,0.000089447916,0.00046640035,0.001164663,0.013811387,0.00012331997,0.9724441,0.00032372057],"about_ca_topic_score_codex":0.00054192124,"about_ca_topic_score_gemma":0.0000018231976,"teacher_disagreement_score":0.6608459,"about_ca_system_score_codex":0.000087666565,"about_ca_system_score_gemma":0.00008530332,"threshold_uncertainty_score":0.56914985},"labels":[],"label_agreement":null},{"id":"W2015914873","doi":"10.1517/14656566.8.2.203","title":"Memantine in the treatment of mild-to-moderate Alzheimer’s disease","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Memantine; Medicine; Donepezil; Disease; Rivastigmine; Alzheimer's disease; Dementia; Internal medicine; Pharmacology; Intensive care medicine; Psychiatry","score_opus":0.24913044926921502,"score_gpt":0.5180378012549213,"score_spread":0.26890735198570626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015914873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005565294,0.99331075,0.000005781067,0.0007432062,0.0003439028,0.004836627,0.00017545659,0.000043093096,0.00048552844],"genre_scores_gemma":[0.00020915768,0.9955068,0.00009253397,0.0014402404,0.00077304186,0.0012827194,0.00053186214,0.00012408459,0.000039543367],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966528,0.00039490138,0.0007790676,0.0006915724,0.0008643457,0.0006173458],"domain_scores_gemma":[0.9978945,0.00030364245,0.00021283596,0.0008218301,0.00007618399,0.00069100375],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026533875,0.00074284174,0.0017041574,0.00065646437,0.000089261244,0.000026915453,0.00031324453,0.00014041549,0.00043478527],"category_scores_gemma":[0.000008635872,0.00040675365,0.00090465695,0.00065325084,0.0000862889,0.000049033428,0.000016176504,0.00023472297,0.0002085801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028693704,0.0069060493,0.000029260753,0.00056840794,0.0081037115,0.00034561226,0.0004993945,0.0000011225583,0.000002109251,0.000063140935,0.0038960816,0.97671574],"study_design_scores_gemma":[0.004384863,0.0015339601,0.00004820593,0.003805588,0.00051041774,0.000013419586,0.00002128394,0.000014828694,0.00017669186,0.000006905183,0.9891725,0.0003113068],"about_ca_topic_score_codex":0.00006439929,"about_ca_topic_score_gemma":0.0000012767077,"teacher_disagreement_score":0.98527646,"about_ca_system_score_codex":0.00021806174,"about_ca_system_score_gemma":0.0005138438,"threshold_uncertainty_score":0.9998384},"labels":[],"label_agreement":null},{"id":"W2019255097","doi":"10.1517/14656561003601994","title":"Monitoring adherence rates in glaucoma patients using the Travatan Dosing Aid. A 6-month study comparing patients on travoprost 0.004% and patients on travoprost 0.004%/timolol 0.5% fixed combination","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Travoprost; Dosing; Glaucoma; Intraocular pressure; Timolol; Latanoprost; Internal medicine; Combination therapy; Ophthalmology; Cohort; Medical record","score_opus":0.0339769156539539,"score_gpt":0.356040220446425,"score_spread":0.32206330479247114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019255097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99345344,0.00018334319,0.0000054357815,0.00020601752,0.0023987151,0.0034251048,0.0000148605495,0.00007640917,0.00023665103],"genre_scores_gemma":[0.99846214,0.0002711209,0.0000745867,0.0006366418,0.00020215899,0.00015647398,0.000086618966,0.000088668065,0.000021572509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967624,0.00028846963,0.0007047347,0.00076847576,0.00090984936,0.0005660867],"domain_scores_gemma":[0.99867254,0.0001889381,0.00031038147,0.0004124104,0.0001955637,0.00022013795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030659387,0.00057567726,0.0005661229,0.000330809,0.0004893748,0.00012459485,0.00027781492,0.0001634653,0.000040433064],"category_scores_gemma":[0.00006391016,0.00041980087,0.0001124191,0.00039787765,0.00013908117,0.0002353481,0.000040612875,0.0008883564,0.000009189919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003268302,0.00821854,0.9446831,0.000028701977,0.000064339285,0.000004103277,0.0059466423,0.0000061064784,0.01149333,0.000019184225,0.000110117224,0.02615755],"study_design_scores_gemma":[0.026989872,0.006242144,0.944512,0.00060785044,0.000014560084,0.0000014355453,0.0009457002,0.00184723,0.01797072,0.000014691545,0.0004129395,0.00044086124],"about_ca_topic_score_codex":0.00043594433,"about_ca_topic_score_gemma":0.000029786006,"teacher_disagreement_score":0.025716688,"about_ca_system_score_codex":0.00018067737,"about_ca_system_score_gemma":0.000043224227,"threshold_uncertainty_score":0.99982536},"labels":[],"label_agreement":null},{"id":"W2021118758","doi":"10.1517/14656566.4.3.385","title":"Pharmacological management of Cronkhite–Canada syndrome","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Antibiotics; Intensive care medicine; Disease; Prednisone; Regimen; Internal medicine","score_opus":0.09786737015325622,"score_gpt":0.43601168627034376,"score_spread":0.3381443161170875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021118758","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004529502,0.98781323,0.000014308713,0.00012597365,0.0048767747,0.0022889792,0.00006344873,0.000058999325,0.0047130035],"genre_scores_gemma":[0.000057865233,0.9943559,0.0007518647,0.0024327408,0.00025939615,0.0005925186,0.00007508042,0.000141252,0.00133334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967396,0.00024661238,0.000912165,0.00074042316,0.0008746192,0.0004865283],"domain_scores_gemma":[0.9986133,0.0001326881,0.00040856135,0.00048114915,0.00006810262,0.00029620106],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017922488,0.0007266603,0.0020440773,0.0001974607,0.000060094768,0.000010981986,0.00039592272,0.00027257978,0.0071265944],"category_scores_gemma":[0.000004049251,0.0005493388,0.0005684289,0.0004398777,0.00009852771,0.000022747061,0.000050157953,0.0005524343,0.000046623158],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019122256,0.00044522717,0.0000018137262,0.0053732223,0.0017593236,0.00024151347,0.000022739647,0.0000020401708,0.000071640374,0.000055730445,0.081296496,0.91053903],"study_design_scores_gemma":[0.0019283689,0.00058768556,0.000004545299,0.0063764667,0.00017416471,0.00025518335,0.000012824475,0.0000025299605,0.0006509176,0.0000037032255,0.9895382,0.0004654458],"about_ca_topic_score_codex":0.00075623475,"about_ca_topic_score_gemma":0.000018886578,"teacher_disagreement_score":0.9100736,"about_ca_system_score_codex":0.00084315357,"about_ca_system_score_gemma":0.0008146904,"threshold_uncertainty_score":0.99969584},"labels":[],"label_agreement":null},{"id":"W2023312941","doi":"10.1517/14656566.1.5.1021","title":"Current treatment of asthma - focus on leukotrienes","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Asthma; Bronchoconstriction; Leukotriene; Immunology; Leukotriene C4; Zileuton; Pathogenesis; Arachidonate 5-lipoxygenase; Arachidonic acid","score_opus":0.09749648728149901,"score_gpt":0.4545223206043935,"score_spread":0.3570258333228945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023312941","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023664783,0.9953945,0.000004117613,0.0001120126,0.0014230085,0.0015982862,0.00013604482,0.000097547876,0.0012108086],"genre_scores_gemma":[0.000013132538,0.9962236,0.000015772499,0.00035697315,0.0023355312,0.00043239642,0.00017856476,0.00013465251,0.00030932316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976029,0.00022266727,0.0007241943,0.0006251071,0.0004903944,0.00033477962],"domain_scores_gemma":[0.9986224,0.00012813634,0.00032464,0.0005575521,0.000041153817,0.0003260973],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005051584,0.00075269415,0.0019948957,0.00041509347,0.00007709111,0.000013187655,0.00016907913,0.00020205531,0.00212059],"category_scores_gemma":[0.000004080906,0.00046531958,0.0012664665,0.0002563603,0.000089897,0.000033589487,0.000007497588,0.00020074683,0.00026692107],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006869841,0.0027674274,0.0000018634544,0.001050371,0.00026495664,0.000023233286,0.0001216706,7.636427e-7,0.000009581178,0.00004836343,0.00815704,0.9868677],"study_design_scores_gemma":[0.0030946415,0.0036865491,0.000002354585,0.0103286635,0.000056523895,0.000019578925,0.000008346273,0.0000027273745,0.00079903606,0.0000044079397,0.98162484,0.00037234236],"about_ca_topic_score_codex":0.000006497545,"about_ca_topic_score_gemma":7.9056036e-8,"teacher_disagreement_score":0.9864954,"about_ca_system_score_codex":0.0002871916,"about_ca_system_score_gemma":0.0004984926,"threshold_uncertainty_score":0.9997799},"labels":[],"label_agreement":null},{"id":"W2024553259","doi":"10.1517/14656566.3.5.575","title":"Review of enoxaparin and its clinical applications in venous and arterial thromboembolism","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Medicine; Heparin; Thrombosis; Deep vein; Low molecular weight heparin; Dosing; Venous thrombosis; Enoxaparin sodium; Anticoagulant; Venous thromboembolism; Unstable angina; Anesthesia; Intensive care medicine; Surgery; Internal medicine; Myocardial infarction","score_opus":0.1385871125054735,"score_gpt":0.4784858908469179,"score_spread":0.3398987783414444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024553259","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003174053,0.9942879,0.0000038406497,0.00035825846,0.0005885136,0.0040033488,0.000033159933,0.000036925045,0.0006563113],"genre_scores_gemma":[0.000011927396,0.99356025,0.00008114999,0.004349479,0.0008698944,0.0009148507,0.000097028045,0.00008007166,0.000035351906],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972875,0.0002646072,0.0012679942,0.00066400017,0.00024410422,0.00027180646],"domain_scores_gemma":[0.9986777,0.00020966699,0.00045992385,0.00040564543,0.000048133756,0.0001989564],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045969232,0.00046432135,0.0035386619,0.00024767706,0.000051956275,0.0000142837,0.00016695268,0.00023778726,0.0003877689],"category_scores_gemma":[0.000024779718,0.00036434547,0.0003219928,0.00025291057,0.00009190046,0.00005058097,0.000064005566,0.0003904772,0.000021650116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018356703,0.0019521259,0.0000025015813,0.037521146,0.0002986174,0.0000039397723,0.00016181287,1.6823943e-8,0.000007651915,0.00064515223,0.01634406,0.9430446],"study_design_scores_gemma":[0.0013947671,0.00041318848,0.00006806818,0.0669368,0.00015155411,0.000018577452,0.000008041489,0.0000042680085,0.00000868628,0.000012187175,0.93071496,0.0002689177],"about_ca_topic_score_codex":0.000018185645,"about_ca_topic_score_gemma":5.038918e-7,"teacher_disagreement_score":0.9427757,"about_ca_system_score_codex":0.000060502065,"about_ca_system_score_gemma":0.00009388055,"threshold_uncertainty_score":0.99988085},"labels":[],"label_agreement":null},{"id":"W2025227391","doi":"10.1517/14656566.3.3.237","title":"Pharmacoeconomic evidence and considerations for triptan treatment of migraine","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GLS Industries (Canada)","funders":"","keywords":"Triptans; Sumatriptan; Medicine; Migraine; Intensive care medicine; Acute migraine; Pharmacoeconomics; Quality of life (healthcare); Perspective (graphical); Health care; Psychiatry; Alternative medicine; Internal medicine; Nursing","score_opus":0.41565463300259353,"score_gpt":0.516647603710804,"score_spread":0.10099297070821045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025227391","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012590668,0.99430263,0.0000134442735,0.0019133388,0.00022953589,0.0030885646,0.00014527135,0.000046516,0.00024809543],"genre_scores_gemma":[0.000024947414,0.99332917,0.00069971575,0.0011463475,0.0011546994,0.0011857849,0.00004915358,0.00007612427,0.0023340392],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828273,0.000098814045,0.00074384577,0.0004971115,0.00012573898,0.0002517597],"domain_scores_gemma":[0.9980691,0.0011088861,0.0003178342,0.00027229462,0.000076013945,0.0001558581],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012304519,0.0005093148,0.002026385,0.0002693006,0.00012836332,0.00001558518,0.00005758713,0.0001331442,0.0010384037],"category_scores_gemma":[0.000049596525,0.00036714607,0.0007424571,0.00009191303,0.00010223754,0.000056202778,0.000008883803,0.000112599984,0.000015263102],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001824771,0.0006269421,0.0000026147584,0.0028606267,0.0011673956,0.0000037426698,0.0012629866,9.579345e-8,0.00018075922,0.00015924101,0.21223928,0.78131384],"study_design_scores_gemma":[0.00396788,0.0017978424,8.8637495e-7,0.004751564,0.00023594582,0.00006009343,0.0000319783,0.0000461527,0.0004373977,0.000018569666,0.98837507,0.00027660126],"about_ca_topic_score_codex":0.000024156023,"about_ca_topic_score_gemma":0.0000017916956,"teacher_disagreement_score":0.7810373,"about_ca_system_score_codex":0.0001643162,"about_ca_system_score_gemma":0.00016668312,"threshold_uncertainty_score":0.99987805},"labels":[],"label_agreement":null},{"id":"W2026243499","doi":"10.1517/14656566.2013.823158","title":"Tolterodine for the treatment of urge urinary incontinence","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Humber River Regional Hospital; University of Toronto","funders":"","keywords":"Tolterodine; Medicine; Overactive bladder; Tolerability; Urinary incontinence; Urology; Population; Intensive care medicine; Adverse effect; Internal medicine; Alternative medicine","score_opus":0.21334229011155487,"score_gpt":0.5056500709038634,"score_spread":0.2923077807923085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026243499","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007200537,0.99162155,0.00006349607,0.001043607,0.0008599692,0.0058777216,0.00011591082,0.00004385522,0.00036669054],"genre_scores_gemma":[0.000007120306,0.9907617,0.00021484499,0.00031837844,0.0015008737,0.0037276654,0.00020717389,0.0001053146,0.003156926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998064,0.00015740414,0.00059347216,0.00045400683,0.00034536957,0.00038575055],"domain_scores_gemma":[0.99815154,0.0007698844,0.00023006232,0.0005650038,0.0001125273,0.00017095219],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019312781,0.0004943377,0.0014027524,0.00020843196,0.000116818825,0.000022143602,0.00027714786,0.0001515645,0.0013601312],"category_scores_gemma":[0.000009434583,0.000250275,0.0008137057,0.00020929083,0.0001066452,0.000052484556,0.000019772497,0.00019726234,0.0000686168],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005806039,0.0016422784,0.0000017975561,0.0021086384,0.0006921289,0.0000075104854,0.0003715717,1.1677559e-7,0.000107041385,0.000026850998,0.028461896,0.96599954],"study_design_scores_gemma":[0.0028242113,0.0069142175,0.0000017534875,0.0023590396,0.00006546574,0.00007185773,0.000018569819,0.000044351767,0.0008650718,0.0000058272744,0.9866119,0.00021773014],"about_ca_topic_score_codex":0.00004227737,"about_ca_topic_score_gemma":7.98634e-8,"teacher_disagreement_score":0.9657818,"about_ca_system_score_codex":0.00013564138,"about_ca_system_score_gemma":0.00024560385,"threshold_uncertainty_score":0.99999493},"labels":[],"label_agreement":null},{"id":"W2026296457","doi":"10.1517/14656566.2014.868884","title":"Raltegravir as antiretroviral therapy in HIV/AIDS","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Raltegravir; Medicine; Tolerability; Integrase inhibitor; Antiretroviral therapy; Dosing; Pharmacology; Drug; Drug resistance; Dolutegravir; Nucleoside Reverse Transcriptase Inhibitor; Lamivudine; Human immunodeficiency virus (HIV); Adverse effect; Intensive care medicine; Virology; Viral load; Virus; Chronic hepatitis","score_opus":0.08558497252242242,"score_gpt":0.42983217118888994,"score_spread":0.3442471986664675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026296457","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000072511655,0.9898049,0.0000065444533,0.0009837018,0.0013036054,0.0035442354,0.00002402972,0.00020196218,0.0040584896],"genre_scores_gemma":[0.000009751661,0.96189314,0.0009546348,0.0021202576,0.0010825102,0.0014437346,0.0006588503,0.00025969572,0.031577412],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99620837,0.0003543839,0.0010450961,0.0009968193,0.00067326304,0.0007220928],"domain_scores_gemma":[0.9984651,0.00015631027,0.00032850314,0.0006462688,0.000059196256,0.00034462815],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00025364748,0.0011702997,0.0025809668,0.0009354016,0.000101374266,0.00007332713,0.0003737146,0.00045347356,0.0066882195],"category_scores_gemma":[0.000012026596,0.0007878026,0.0008706251,0.00068693486,0.00008584898,0.00015348068,0.000033444205,0.00079579366,0.005309134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021662291,0.0009051563,0.000059802678,0.00046622413,0.00053923635,0.000081291284,0.00055252534,5.9544487e-8,0.000049894683,0.0002572231,0.07423877,0.9226332],"study_design_scores_gemma":[0.0063719475,0.0009604173,0.0000038476196,0.006965632,0.000024893852,0.00006825146,0.00004354417,0.0000056000504,0.0004343563,0.000020052148,0.984374,0.00072744506],"about_ca_topic_score_codex":0.000036442838,"about_ca_topic_score_gemma":2.3780012e-7,"teacher_disagreement_score":0.92190576,"about_ca_system_score_codex":0.0005193509,"about_ca_system_score_gemma":0.0005844567,"threshold_uncertainty_score":0.9994573},"labels":[],"label_agreement":null},{"id":"W2026753414","doi":"10.1517/14656566.2015.993380","title":"New pharmacotherapy for the treatment of onychomycosis: an update","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Pharmacotherapy; Antifungal; Intensive care medicine; Itraconazole; Dermatology; Terbinafine; Incidence (geometry); Gold standard (test); Antifungal drugs; Internal medicine","score_opus":0.12563433544611194,"score_gpt":0.5021458872599551,"score_spread":0.3765115518138432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026753414","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000444169,0.9911288,0.00062745035,0.0005171287,0.0019542484,0.005294168,0.00027368404,0.00011303628,0.00008705081],"genre_scores_gemma":[0.0000048183315,0.989612,0.0007701373,0.0024111555,0.003589069,0.0019560645,0.0006325444,0.00026251326,0.0007617309],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99734396,0.0002001354,0.0008198239,0.00075906364,0.00042031336,0.0004567186],"domain_scores_gemma":[0.99757904,0.0003635183,0.0005395287,0.000942523,0.000082134415,0.00049328496],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001236997,0.00091230805,0.0022073905,0.00023872689,0.00016147677,0.000041153333,0.0003716267,0.00020947811,0.0015668425],"category_scores_gemma":[0.0000037743346,0.0004923497,0.0018130045,0.00024017376,0.00005889794,0.000075168165,0.000007108041,0.0001434414,0.00008143025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014067002,0.0025584872,0.00000272228,0.0008042818,0.0031006632,0.0000034524494,0.0001925179,8.9556585e-7,0.000037075282,0.000117403855,0.031074736,0.96070105],"study_design_scores_gemma":[0.01254324,0.0043329047,0.0000016935827,0.002319515,0.0007061454,0.000015271498,0.000010275575,0.000059387505,0.00075713324,0.000022537783,0.97882855,0.00040336757],"about_ca_topic_score_codex":0.00007385072,"about_ca_topic_score_gemma":7.5049746e-7,"teacher_disagreement_score":0.9602977,"about_ca_system_score_codex":0.00027451516,"about_ca_system_score_gemma":0.00043621578,"threshold_uncertainty_score":0.9997528},"labels":[],"label_agreement":null},{"id":"W2026785814","doi":"10.1517/14656566.2013.838218","title":"Therapy of <i>Clostridium difficile</i> infection: perspectives on a changing paradigm","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. John’s Health Sciences Centre","funders":"","keywords":"Fidaxomicin; Medicine; Tigecycline; Vancomycin; Clostridium difficile; Metronidazole; Rifaximin; Internal medicine; Intensive care medicine; Hypoalbuminemia; Concomitant; Antibiotics","score_opus":0.12227620196616962,"score_gpt":0.435092986422962,"score_spread":0.3128167844567924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026785814","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006493199,0.9900058,0.000015939102,0.0007999016,0.001437013,0.0039450545,0.00009935349,0.0002430316,0.0028045876],"genre_scores_gemma":[0.00027924587,0.99290293,0.00004141155,0.00066469226,0.0037168665,0.0011398777,0.00019248265,0.0003226224,0.0007398852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947723,0.00043189543,0.0011880986,0.0012926456,0.0013045856,0.0010104348],"domain_scores_gemma":[0.99699485,0.0005063841,0.00063162815,0.0011689969,0.00023604698,0.0004620629],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038063817,0.0012643997,0.0029396166,0.001614627,0.00024124289,0.000080987185,0.00044497233,0.0005968831,0.0033715663],"category_scores_gemma":[0.00005402625,0.00093452027,0.0017093167,0.0014976902,0.0002377077,0.00010479829,0.00007303154,0.0014358902,0.000518238],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008257066,0.0028462342,0.0000012481167,0.0017043169,0.0011121273,0.000024343039,0.001193626,0.0000022214651,0.0022196504,0.0006039548,0.021068292,0.9683983],"study_design_scores_gemma":[0.0032933082,0.0024968665,6.3597855e-7,0.008135988,0.00003739464,0.000081989245,0.00017468672,0.0000205984,0.040318258,0.0000059920085,0.94470817,0.0007261162],"about_ca_topic_score_codex":0.000081037266,"about_ca_topic_score_gemma":1.7322662e-7,"teacher_disagreement_score":0.96767217,"about_ca_system_score_codex":0.00068272534,"about_ca_system_score_gemma":0.00063129794,"threshold_uncertainty_score":0.99931055},"labels":[],"label_agreement":null},{"id":"W2027255665","doi":"10.1517/14656566.2012.687721","title":"Pharmacogenomics of third-generation aromatase inhibitors","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"King Saud University","keywords":"Aromatase; Pharmacogenomics; Letrozole; Exemestane; Medicine; Aromatase inhibitor; Anastrozole; Breast cancer; Adverse effect; Oncology; Internal medicine; Pharmacogenetics; Pharmacology; Bioinformatics; Cancer; Genotype; Biology; Genetics","score_opus":0.07384711940890466,"score_gpt":0.3928769917480633,"score_spread":0.31902987233915864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027255665","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026812925,0.9954763,0.000031591746,0.0000202581,0.0029412848,0.00081003865,0.000159305,0.000029020544,0.00026407716],"genre_scores_gemma":[0.00009998748,0.9922018,0.00015419911,0.0003339895,0.0043556313,0.00013891027,0.0024612162,0.00013908967,0.00011518353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979868,0.0003223101,0.00062389945,0.0005024421,0.00022017237,0.00034440475],"domain_scores_gemma":[0.9988373,0.000025772057,0.000466265,0.0004414017,0.000042481697,0.00018679014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025948306,0.0005583866,0.00077886856,0.00015822859,0.00008453097,0.000018099701,0.00031681746,0.0005544266,0.000084925596],"category_scores_gemma":[0.000006307825,0.0004494814,0.0006129633,0.00014985753,0.00007086589,0.0000075013213,0.000054958356,0.00031228273,0.0000776316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008617915,0.00030239482,4.8426983e-7,0.00042502556,0.0005161997,0.0000016309067,0.00005200026,0.0000050652297,0.26168287,0.000028108845,0.036662873,0.70023715],"study_design_scores_gemma":[0.000582136,0.00020694891,3.085276e-8,0.00040923024,0.000043905293,0.000020997593,0.0000022310182,0.0000090276,0.24791552,6.191194e-7,0.75046426,0.00034506313],"about_ca_topic_score_codex":0.0000054060806,"about_ca_topic_score_gemma":8.7087976e-8,"teacher_disagreement_score":0.7138014,"about_ca_system_score_codex":0.000045482248,"about_ca_system_score_gemma":0.00015395011,"threshold_uncertainty_score":0.9997957},"labels":[],"label_agreement":null},{"id":"W2027642737","doi":"10.1517/14656560903176446","title":"New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Windsor Regional Hospital; Toronto General Hospital; University of Alberta","funders":"","keywords":"Darunavir; Etravirine; Raltegravir; Maraviroc; Rilpivirine; Medicine; Pharmacology; Drug; Intensive care medicine; Virology; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy","score_opus":0.02840759937183873,"score_gpt":0.37771341237789124,"score_spread":0.3493058130060525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027642737","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015532838,0.99008936,0.000013568382,0.0028349326,0.00045717586,0.0038321046,0.0001651204,0.000052988475,0.002539246],"genre_scores_gemma":[0.000011807566,0.98668057,0.0019830172,0.0013792731,0.0003846585,0.00008652916,0.00023422214,0.0001271,0.009112812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958486,0.00041606254,0.0015904519,0.0008608351,0.00084288156,0.00044119748],"domain_scores_gemma":[0.9975369,0.0002661528,0.0010053768,0.0007659658,0.00010908502,0.00031653073],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046593617,0.00097116036,0.002975404,0.00029322665,0.00012142484,0.000020716856,0.0004170735,0.0002334351,0.00043305315],"category_scores_gemma":[0.000041490202,0.00061573327,0.0006453343,0.0007013167,0.00025782202,0.00008830523,0.00009718242,0.00062867336,0.000013609007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000517593,0.0004167959,0.00002338848,0.02086496,0.0005510554,0.000009207946,0.00024108753,2.109728e-8,0.0001352331,0.00016346255,0.061205443,0.91587174],"study_design_scores_gemma":[0.005049688,0.00031046636,0.000093912655,0.101661265,0.00037439712,0.000036668258,0.000008220863,0.0000016857646,0.0007601971,0.000014409154,0.8912275,0.00046162677],"about_ca_topic_score_codex":0.000024138453,"about_ca_topic_score_gemma":7.6412954e-7,"teacher_disagreement_score":0.9154101,"about_ca_system_score_codex":0.00013419556,"about_ca_system_score_gemma":0.00055902306,"threshold_uncertainty_score":0.9996294},"labels":[],"label_agreement":null},{"id":"W2027808292","doi":"10.1517/14656566.7.1.s1","title":"Disease-modifying drugs for multiple sclerosis: current and future aspects","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Glatiramer acetate; Multiple sclerosis; Medicine; Disease; Demyelinating disease; Relapsing remitting; Pharmacology; Immunology; Internal medicine","score_opus":0.21579428419351418,"score_gpt":0.4665057666203509,"score_spread":0.2507114824268367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027808292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005707131,0.9898371,0.000066612105,0.0012441585,0.0025156594,0.005511499,0.00044169306,0.00021088688,0.00016664609],"genre_scores_gemma":[0.000021470953,0.9836817,0.00038398383,0.0005780704,0.010661311,0.003706651,0.00063442794,0.0002408384,0.000091546855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963004,0.00022422448,0.0007494032,0.0011563136,0.00080150727,0.00076816534],"domain_scores_gemma":[0.9977574,0.0005948048,0.0003190248,0.0005682995,0.00016147601,0.0005990124],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003123257,0.00093873317,0.002012564,0.00045256066,0.00038856803,0.0000995158,0.00027565396,0.00021216249,0.0000951216],"category_scores_gemma":[0.00007315566,0.0006901559,0.0008971118,0.00030338878,0.00015043607,0.000108709,0.00008750968,0.00068420643,0.00002742897],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043163175,0.00048998976,0.000007669423,0.009557071,0.00035914217,0.0000023612922,0.00022277016,2.7732864e-7,0.00005738423,0.000060409915,0.06263926,0.926172],"study_design_scores_gemma":[0.0058220634,0.00019684162,0.00006873175,0.017666562,0.00008219012,0.0000032692035,0.000037424597,0.00016938879,0.00005142706,0.000008956617,0.9752768,0.00061634526],"about_ca_topic_score_codex":0.000015400154,"about_ca_topic_score_gemma":6.6677774e-7,"teacher_disagreement_score":0.9255557,"about_ca_system_score_codex":0.0003482352,"about_ca_system_score_gemma":0.00031007026,"threshold_uncertainty_score":0.99955493},"labels":[],"label_agreement":null},{"id":"W2027877088","doi":"10.1517/14656566.2015.1041504","title":"Ezetimibe plus simvastatin for the treatment of hypercholesterolemia","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Ezetimibe; Simvastatin; Medicine; Pharmacology; Clinical trial; Pharmacodynamics; Combination therapy; Statin; Internal medicine; Pharmacokinetics","score_opus":0.19812055944903947,"score_gpt":0.48447515919048406,"score_spread":0.2863545997414446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027877088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003924099,0.9916635,0.00037054298,0.00045630816,0.001273372,0.0058472734,0.00013736708,0.000049560924,0.00019812358],"genre_scores_gemma":[0.0000018833958,0.99248606,0.00049744494,0.0010177039,0.0027857376,0.002402886,0.00021681617,0.0001452196,0.00044623367],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977589,0.00022850701,0.000656975,0.00046029183,0.0005653497,0.00032997457],"domain_scores_gemma":[0.9982015,0.00026436572,0.00029982344,0.0008722759,0.0001405965,0.00022146532],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050072453,0.00052265543,0.0021862246,0.00012697025,0.00008984692,0.000017309398,0.0002069234,0.00021160262,0.00010949257],"category_scores_gemma":[0.000010254461,0.00026815987,0.0016107786,0.00017249101,0.000067423956,0.000026670295,0.0000094619745,0.00018644935,0.0000245363],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036656918,0.00038347227,1.105906e-7,0.0019006777,0.0011485292,0.000002859408,0.00063540577,0.000003621007,0.0000075740404,0.000024381947,0.010445713,0.9850811],"study_design_scores_gemma":[0.0060236296,0.0022672745,4.052363e-7,0.0027322418,0.00021687117,0.000043463468,0.000049766386,0.00005018607,0.00014384466,0.0000041288436,0.98824376,0.00022441646],"about_ca_topic_score_codex":0.000067124536,"about_ca_topic_score_gemma":4.867955e-7,"teacher_disagreement_score":0.98485667,"about_ca_system_score_codex":0.000564316,"about_ca_system_score_gemma":0.00081782107,"threshold_uncertainty_score":0.99997705},"labels":[],"label_agreement":null},{"id":"W2030886922","doi":"10.1517/14656566.3.9.1235","title":"The pharmacoeconomic impact of generics: an evolutionary tale","year":2002,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Pride; Human immunodeficiency virus (HIV); Medicine; Position (finance); Law and economics; Economics; Law; Political science; Virology; Finance","score_opus":0.06265118156813454,"score_gpt":0.38548996348098574,"score_spread":0.3228387819128512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030886922","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010511117,0.08980655,0.00007071862,0.0017195819,0.8838996,0.0008522562,0.005499254,0.00012839753,0.016972512],"genre_scores_gemma":[0.002136347,0.42247272,0.00012619265,0.0019160649,0.5713834,0.0002174431,0.0004994324,0.00025847377,0.0009898905],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643594,0.00011714589,0.0015506047,0.00096761034,0.00014474659,0.0007839629],"domain_scores_gemma":[0.9966907,0.00062915584,0.0012818078,0.00089571887,0.00009659889,0.00040605143],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007083825,0.0007077685,0.001042517,0.00038934135,0.00036003362,0.00016903593,0.0013636911,0.00055913697,0.0047884183],"category_scores_gemma":[0.00006884338,0.0006344796,0.0008709006,0.00020423374,0.00026744872,0.00036917988,0.000085117455,0.0009459979,0.0010394057],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032180408,0.00039889003,0.0000514546,0.000015979962,0.0004326337,0.0000011951063,0.00022206214,0.00035216942,0.00019746553,0.0018781235,0.9871032,0.009025022],"study_design_scores_gemma":[0.0022493831,0.00045428783,0.00003241347,0.00002041798,0.0000035768653,0.0000018192835,0.0000067793376,0.016587658,0.0002144713,0.0021415362,0.9775928,0.00069485826],"about_ca_topic_score_codex":0.0003416175,"about_ca_topic_score_gemma":0.000001722034,"teacher_disagreement_score":0.33266616,"about_ca_system_score_codex":0.0008303962,"about_ca_system_score_gemma":0.00021436972,"threshold_uncertainty_score":0.9997384},"labels":[],"label_agreement":null},{"id":"W2031383197","doi":"10.1517/14656566.8.12.1851","title":"Stroke prevention in the high-risk patient","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Medicine; Stroke (engine); Carotid endarterectomy; Smoking cessation; Pharmacotherapy; Intensive care medicine; Carotid stenting; Population; Internal medicine; Physical therapy; Carotid arteries","score_opus":0.06920898370513931,"score_gpt":0.42585726233295307,"score_spread":0.3566482786278138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031383197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012240879,0.99527776,0.000041167503,0.000094035924,0.001137603,0.0023834533,0.00006129738,0.000058785405,0.00082349614],"genre_scores_gemma":[0.00010494329,0.99540985,0.00004731885,0.0021946444,0.0011642798,0.00048699335,0.0003737366,0.00007710711,0.00014110643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973757,0.00057392754,0.0006123911,0.00046727076,0.0006510436,0.0003196646],"domain_scores_gemma":[0.9988735,0.00015794765,0.000256036,0.00055520475,0.00003219291,0.00012512758],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003924203,0.00044632805,0.0009452635,0.00032411367,0.000082127684,0.00003357164,0.00022619244,0.00017305154,0.0007949755],"category_scores_gemma":[0.000013115591,0.00026779962,0.0010434005,0.00028717006,0.000040192095,0.000052711166,0.00001597371,0.0005640319,0.00011765501],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007667601,0.0008373689,0.000025198144,0.00046673577,0.00025217523,0.000007504825,0.00034554218,5.5989557e-7,0.0000021109136,0.000050740025,0.0073746797,0.9905607],"study_design_scores_gemma":[0.0019523802,0.0005761397,0.000055672976,0.0040542395,0.000082816645,0.00004115838,0.00011019913,0.0000025508534,0.000043454034,0.000008781586,0.99281144,0.00026116706],"about_ca_topic_score_codex":0.00004460007,"about_ca_topic_score_gemma":0.0000019154174,"teacher_disagreement_score":0.9902995,"about_ca_system_score_codex":0.00015134756,"about_ca_system_score_gemma":0.00015065084,"threshold_uncertainty_score":0.9999774},"labels":[],"label_agreement":null},{"id":"W2031892788","doi":"10.1517/14656566.2013.767331","title":"Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain","year":2013,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Medicine; Buprenorphine; Quality of life (healthcare); Opioid; Anesthesia; Internal medicine; Nursing","score_opus":0.0190341332925148,"score_gpt":0.30789375709569794,"score_spread":0.28885962380318314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031892788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918748,0.004891331,0.00015754164,0.00067552493,0.0002021826,0.0019718057,0.000015908243,0.000056395915,0.00015447749],"genre_scores_gemma":[0.99569625,0.0020543966,0.0003262462,0.0012411729,0.00010447581,0.00042551672,0.00007099613,0.000047417547,0.000033507655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981321,0.00022439256,0.00053917477,0.00040461688,0.0003987684,0.00030092354],"domain_scores_gemma":[0.99915504,0.00008958043,0.00015176344,0.00029199338,0.00009130623,0.00022029821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017867882,0.00029271323,0.0005453613,0.00013715506,0.00004029947,0.00001542653,0.00009937318,0.00007846931,0.0007294659],"category_scores_gemma":[0.000010735692,0.0002121278,0.00006766515,0.00019392365,0.000093390016,0.00014925073,0.000009985293,0.0001285192,0.000024246858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008323688,0.008741538,0.75819105,0.003202781,0.0006281651,0.000005965262,0.034048583,0.00011801727,0.09780925,0.0003286975,0.0024972209,0.08610508],"study_design_scores_gemma":[0.1043418,0.007845893,0.8036793,0.0028841018,0.000010642612,0.000003299462,0.0032317578,0.0042840373,0.06602325,0.000009039522,0.006564803,0.0011221106],"about_ca_topic_score_codex":0.00088087644,"about_ca_topic_score_gemma":0.000008197413,"teacher_disagreement_score":0.09601811,"about_ca_system_score_codex":0.00018486456,"about_ca_system_score_gemma":0.00012613555,"threshold_uncertainty_score":0.865032},"labels":[],"label_agreement":null},{"id":"W2033596403","doi":"10.1517/14656566.2010.490831","title":"Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Risperidone; Adjunctive treatment; Maintenance therapy; Bipolar disorder; Pharmacotherapy; Psychotherapist; Schizophrenia (object-oriented programming); Psychiatry; Pharmacology; Internal medicine; Lithium (medication); Chemotherapy; Psychology","score_opus":0.059465392711306096,"score_gpt":0.40747267229704104,"score_spread":0.34800727958573496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033596403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008865602,0.9942178,0.000059476024,0.0004440909,0.000676869,0.0033867643,0.000037634745,0.000051017214,0.00023975389],"genre_scores_gemma":[0.0005340794,0.9969413,0.00007543818,0.0005525168,0.00047111703,0.0010389072,0.00012939703,0.00014111803,0.00011611417],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975074,0.000388252,0.0006559665,0.00069167,0.00037156156,0.00038516766],"domain_scores_gemma":[0.998575,0.00026823673,0.00040683063,0.0005813617,0.0000589826,0.00010959573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002229124,0.00079070055,0.0015897668,0.0003785576,0.00013843275,0.000034394016,0.00018072779,0.00036077926,0.00022759977],"category_scores_gemma":[0.000009279961,0.00043651724,0.0005429182,0.00044770117,0.000153021,0.000091013986,0.000010158989,0.0005491367,0.000014024252],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091720826,0.0024109352,0.00063660124,0.00022667859,0.00058592425,0.000008448834,0.0036788513,4.4318656e-7,0.00008040633,0.000053680986,0.00006831303,0.99133253],"study_design_scores_gemma":[0.008263492,0.004604829,0.0003211038,0.001499599,0.00005323537,0.00017293957,0.0001902541,0.000013117699,0.00028533384,0.00001920175,0.98421603,0.0003608428],"about_ca_topic_score_codex":0.0007411539,"about_ca_topic_score_gemma":0.000049849994,"teacher_disagreement_score":0.9909717,"about_ca_system_score_codex":0.00021004607,"about_ca_system_score_gemma":0.00019007047,"threshold_uncertainty_score":0.99980867},"labels":[],"label_agreement":null},{"id":"W2034556516","doi":"10.1517/14656566.6.6.955","title":"Use of medications in Wolff-Parkinson-White syndrome","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; White (mutation); Internal medicine","score_opus":0.12960523073126573,"score_gpt":0.4496644906192648,"score_spread":0.32005925988799905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034556516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003418546,0.99616855,0.000010308212,0.00051246636,0.0009865541,0.0015232081,0.0001580109,0.000059250382,0.00054746243],"genre_scores_gemma":[0.0000629085,0.9961689,0.00058257976,0.0008381376,0.0006573343,0.0005235147,0.00043722213,0.0001204207,0.0006089487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976604,0.00017866291,0.0008624803,0.0005262155,0.00046403377,0.00030818835],"domain_scores_gemma":[0.9985741,0.00020293189,0.0003626969,0.00059952907,0.000046059024,0.00021469723],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015267116,0.00049907813,0.0019685589,0.00062613195,0.000039007115,0.0000142823665,0.00013367308,0.00026842987,0.0011333256],"category_scores_gemma":[0.000014636823,0.0003820724,0.0007669211,0.0004913567,0.000070375434,0.00009864469,0.000023733553,0.00039212985,0.00011656902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007732935,0.00062972575,0.00006258728,0.000650649,0.00068584277,0.00009445328,0.00020612925,0.0000017945808,0.0000032790967,0.000036310626,0.008878273,0.9886736],"study_design_scores_gemma":[0.0018657,0.00016957695,0.000118614815,0.009886323,0.0000772426,0.00033277585,0.000005848156,0.000010306203,0.000012693558,0.0000014695977,0.98725224,0.0002672096],"about_ca_topic_score_codex":0.000043717533,"about_ca_topic_score_gemma":0.0000013250585,"teacher_disagreement_score":0.9884064,"about_ca_system_score_codex":0.0003144752,"about_ca_system_score_gemma":0.0003048346,"threshold_uncertainty_score":0.99986315},"labels":[],"label_agreement":null},{"id":"W2037298403","doi":"10.1517/14656566.2013.786701","title":"Entecavir for the treatment of patients with hepatitis B virus-related decompensated cirrhosis","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Entecavir; Medicine; Cirrhosis; Lamivudine; Hepatocellular carcinoma; Decompensation; Hepatitis B; Internal medicine; Gastroenterology; Hepatitis B virus; Virology; Virus","score_opus":0.07463972994596137,"score_gpt":0.4024981323189573,"score_spread":0.32785840237299596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037298403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004082262,0.98856866,0.000041895644,0.00019205573,0.0011827585,0.0088772,0.0005293739,0.000101446574,0.00009837083],"genre_scores_gemma":[0.00007603418,0.9928752,0.00029722744,0.0005007583,0.00030810593,0.0048438367,0.0006581156,0.00018089516,0.00025979572],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739736,0.00017732779,0.00094912056,0.000588946,0.00046681782,0.0004203971],"domain_scores_gemma":[0.9976227,0.00066263654,0.00065308996,0.0006155493,0.00029467375,0.00015130054],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008953943,0.0008048763,0.0022225832,0.00024259581,0.00020252942,0.000022644628,0.00023534399,0.0002254996,0.0007250332],"category_scores_gemma":[0.000017107608,0.00040886333,0.0007719146,0.0003315363,0.00016014719,0.00006105618,0.000016168111,0.00018811495,0.000078338555],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035477872,0.0017236761,0.0006908041,0.00071609026,0.003628057,0.000001710464,0.00066195807,3.820651e-7,0.000013141667,0.0000179557,0.009258977,0.98293245],"study_design_scores_gemma":[0.00575352,0.0040017623,0.00032149028,0.0036886162,0.00031578922,0.0000027469493,0.000004987688,0.000028186856,0.00036998902,0.0000022542488,0.98512024,0.00039040274],"about_ca_topic_score_codex":0.0014538426,"about_ca_topic_score_gemma":0.00005978624,"teacher_disagreement_score":0.98254204,"about_ca_system_score_codex":0.00043369588,"about_ca_system_score_gemma":0.00016266946,"threshold_uncertainty_score":0.9998363},"labels":[],"label_agreement":null},{"id":"W2040234260","doi":"10.1517/14656566.8.14.2329","title":"Update on the use of letrozole in breast cancer","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Letrozole; Medicine; Tamoxifen; Breast cancer; Oncology; Adjuvant; Internal medicine; Aromatase inhibitor; Aromatase; Anastrozole; Adjuvant therapy; Clinical trial; Gynecology; Cancer","score_opus":0.10468364443771466,"score_gpt":0.421482655112988,"score_spread":0.31679901067527333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040234260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034932318,0.997673,0.00000884232,0.00034894634,0.000764005,0.0006154463,0.00011633565,0.000010422674,0.000113706556],"genre_scores_gemma":[0.00005105846,0.9964927,0.000019545312,0.0023222996,0.0006047757,0.000127191,0.00016305744,0.00007976276,0.0001396455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984511,0.0002765692,0.00039809814,0.0004010695,0.00019218336,0.00028099425],"domain_scores_gemma":[0.99919474,0.000067755725,0.00023274697,0.00040465943,0.00003063915,0.00006944422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019150959,0.00038753936,0.0005477625,0.00014647846,0.00004524435,0.000016746348,0.00031002812,0.00037319245,0.00017272857],"category_scores_gemma":[0.000005410845,0.00023274143,0.0003588423,0.00021117712,0.000073476265,0.000003618572,0.0000336042,0.00040488548,0.000026891657],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036538867,0.0002678367,0.000005475131,0.00019099537,0.00032758527,0.0000050945537,0.000029685845,0.00002794662,0.006673464,0.00011241541,0.04947191,0.9425222],"study_design_scores_gemma":[0.0005390394,0.00013262377,0.0000017979634,0.0018684634,0.000007863067,0.000012965649,0.0000019602298,0.000010038708,0.011855748,7.8738566e-7,0.98531723,0.00025147502],"about_ca_topic_score_codex":0.00004162938,"about_ca_topic_score_gemma":7.8793806e-7,"teacher_disagreement_score":0.94227076,"about_ca_system_score_codex":0.00004719669,"about_ca_system_score_gemma":0.000111778296,"threshold_uncertainty_score":0.949092},"labels":[],"label_agreement":null},{"id":"W2040605051","doi":"10.1517/14656566.2014.903925","title":"Pharmacotherapy of bone metastases in breast cancer patients – an update","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bone health and treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Denosumab; Breast cancer; Oncology; Pharmacotherapy; Incidence (geometry); Randomized controlled trial; Internal medicine; Cancer; Clinical trial; Quality of life (healthcare); Osteoporosis","score_opus":0.06639185486588313,"score_gpt":0.46925771456642085,"score_spread":0.40286585970053773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040605051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031466622,0.9941624,0.0000040416553,0.00046008933,0.0015465864,0.0023724728,0.00096725964,0.000082945604,0.00008956898],"genre_scores_gemma":[0.00021292345,0.99058855,0.00015009775,0.006002356,0.00054855994,0.0008860134,0.0013009714,0.00022985402,0.00008070094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959408,0.0005798056,0.001415875,0.0008291465,0.0006142481,0.00062011526],"domain_scores_gemma":[0.99786067,0.00010079022,0.000819501,0.00055572746,0.00013286393,0.00053046463],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031800836,0.00085902103,0.0031351626,0.00072757574,0.000069117545,0.000016298722,0.00022704006,0.00027708287,0.0021465525],"category_scores_gemma":[0.0000044367184,0.00063181005,0.0005834753,0.0005123682,0.000081477374,0.00015346959,0.000019002373,0.0005070067,0.00007427639],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012524917,0.0037419004,0.00035264273,0.0030220582,0.00053577824,0.0000130654,0.00012905175,6.145879e-7,0.00004228881,0.000020490097,0.007771231,0.9831184],"study_design_scores_gemma":[0.011328836,0.00065889163,0.000120190685,0.007950885,0.00010210369,0.000028617489,0.0000034165798,0.000017786879,0.00029715383,0.000004006089,0.9790268,0.00046132653],"about_ca_topic_score_codex":0.000491718,"about_ca_topic_score_gemma":0.000006100639,"teacher_disagreement_score":0.9826571,"about_ca_system_score_codex":0.0003395748,"about_ca_system_score_gemma":0.00046771418,"threshold_uncertainty_score":0.99961334},"labels":[],"label_agreement":null},{"id":"W2041310270","doi":"10.1517/14656566.2012.689130","title":"Sunitinib malate for the treatment of renal cell carcinoma","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Sunitinib; Sunitinib malate; Medicine; Renal cell carcinoma; Tolerability; Tyrosine-kinase inhibitor; Vascular endothelial growth factor; Pazopanib; Oncology; Clinical trial; Dosing; Internal medicine; Pharmacology; Adverse effect; Cancer; VEGF receptors","score_opus":0.19213255162905601,"score_gpt":0.4298720621045542,"score_spread":0.23773951047549818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041310270","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000115068215,0.9915311,0.000042734773,0.00021256259,0.0015085767,0.0053410064,0.00018154827,0.000049493654,0.0010179235],"genre_scores_gemma":[0.00032368582,0.99122405,0.000267175,0.00031021767,0.0026805066,0.0024285177,0.00044931527,0.00021744685,0.0020990653],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974847,0.00020614399,0.00082198915,0.00053296186,0.00041178643,0.0005424501],"domain_scores_gemma":[0.9975115,0.00072288234,0.0005506192,0.0008457459,0.0001001941,0.0002690438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018226859,0.00084515044,0.0019508054,0.0002464503,0.00013246534,0.000017445753,0.00025874848,0.00025472272,0.0008117197],"category_scores_gemma":[0.000002830485,0.000443755,0.0016932344,0.00020357357,0.00009888057,0.00004008565,0.000013694998,0.00019931581,0.00007416357],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070917956,0.0018511626,0.0000063595367,0.0021117358,0.00080127164,0.000011808677,0.00062540313,6.770964e-7,0.00034805236,0.000037833266,0.0036005746,0.98989594],"study_design_scores_gemma":[0.0049516647,0.0038265313,0.000010160679,0.001205841,0.00064977753,0.00006474386,0.000024061354,0.000011741939,0.015855417,0.000001762401,0.9730538,0.00034448833],"about_ca_topic_score_codex":0.000042537366,"about_ca_topic_score_gemma":2.9625332e-7,"teacher_disagreement_score":0.9895514,"about_ca_system_score_codex":0.0005024309,"about_ca_system_score_gemma":0.00028067417,"threshold_uncertainty_score":0.9998014},"labels":[],"label_agreement":null},{"id":"W2043626423","doi":"10.1517/14656566.2011.563506","title":"Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Fenofibrate; Fibrate; Medicine; Dyslipidemia; Metabolic syndrome; Internal medicine; Statin; Type 2 Diabetes Mellitus; Insulin resistance; Combination therapy; Type 2 diabetes; Simvastatin; Diabetes mellitus; Population; Endocrinology; Insulin; Obesity","score_opus":0.03170774920635816,"score_gpt":0.31567765092331695,"score_spread":0.2839699017169588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043626423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030387633,0.96614254,0.0000074111153,0.00006206385,0.00013406038,0.0030700883,0.0000412034,0.00006340348,0.000091605994],"genre_scores_gemma":[0.0024138498,0.9956478,0.000266519,0.0005945763,0.000078404184,0.00036408423,0.00038609206,0.00016762913,0.00008107362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972501,0.0005599032,0.0005113107,0.00069985184,0.0005560487,0.00042281038],"domain_scores_gemma":[0.99863297,0.00011265308,0.0004382188,0.00041006814,0.00018044046,0.00022566739],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053603,0.00064077764,0.0021062933,0.00033044594,0.00010053274,0.00004070156,0.000103375954,0.00023140402,0.000053903088],"category_scores_gemma":[0.000014325819,0.00036879108,0.00009698757,0.00067145884,0.000125262,0.00018676442,0.000013295255,0.0005052407,0.00000271808],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021729143,0.0007418188,0.0020408784,0.0013782679,0.0018928846,0.00001495177,0.00047035163,2.736354e-7,0.000001270223,0.00016363813,0.00016339659,0.99095935],"study_design_scores_gemma":[0.01799845,0.004283634,0.018029347,0.013961302,0.000114385424,0.000008174126,0.000013660566,0.0000040835835,0.00003296551,0.0000151100385,0.94489163,0.00064724125],"about_ca_topic_score_codex":0.00003870481,"about_ca_topic_score_gemma":0.00000901331,"teacher_disagreement_score":0.9903121,"about_ca_system_score_codex":0.00011909675,"about_ca_system_score_gemma":0.00028969717,"threshold_uncertainty_score":0.9998764},"labels":[],"label_agreement":null},{"id":"W2044618179","doi":"10.1517/14656566.4.10.1651","title":"Pharmacotherapy of postpartum psychosis","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Psychosis; Pharmacotherapy; Pregnancy; Postpartum period; Psychiatry; Lithium (medication); Postpartum psychosis; Mood; Bipolar disorder; Pediatrics; Intensive care medicine","score_opus":0.11321007406628959,"score_gpt":0.47673522707884464,"score_spread":0.36352515301255506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044618179","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015916172,0.9887216,0.000011523568,0.00034579702,0.005520072,0.0024125904,0.00013083708,0.00012879047,0.002712837],"genre_scores_gemma":[0.0000083104305,0.9896993,0.00029325346,0.006656178,0.0009860173,0.00058098685,0.00015868411,0.00024858242,0.0013687088],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99618536,0.00044064596,0.001343831,0.00076806295,0.00064275897,0.0006193436],"domain_scores_gemma":[0.99784386,0.00016769569,0.00075389,0.0006998314,0.00007991346,0.0004548311],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030969226,0.00088806794,0.002470111,0.00047550746,0.00010649313,0.000019667024,0.0003541563,0.00037676818,0.0038703464],"category_scores_gemma":[0.000005324209,0.0006888115,0.001020679,0.00039752218,0.00009925545,0.000080234226,0.000018137558,0.00070553133,0.00026620965],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010536071,0.0011997751,0.000010488061,0.034699913,0.0006248249,0.000020771226,0.0002158966,1.279934e-7,0.00010783804,0.00017781492,0.01701702,0.9448719],"study_design_scores_gemma":[0.0026910056,0.0008711403,0.0000018969828,0.073404185,0.00006130402,0.00014886378,0.000004745871,0.0000021962117,0.0035899258,0.000017450462,0.91871023,0.0004970553],"about_ca_topic_score_codex":0.00001813114,"about_ca_topic_score_gemma":8.230543e-8,"teacher_disagreement_score":0.94437486,"about_ca_system_score_codex":0.00019109302,"about_ca_system_score_gemma":0.0002500618,"threshold_uncertainty_score":0.9995563},"labels":[],"label_agreement":null},{"id":"W2049793729","doi":"10.1517/14656560903061291","title":"Pharmacotherapy of endometrial cancer","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Endometrial cancer; Oncology; Hormonal therapy; Disease; Adjuvant therapy; Malignancy; Internal medicine; Stage (stratigraphy); Cancer; Randomized controlled trial; Hormone therapy; Adjuvant; Gynecology; Intensive care medicine; Pharmacotherapy; Breast cancer","score_opus":0.1585372305893636,"score_gpt":0.5072554839571248,"score_spread":0.34871825336776124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049793729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004252625,0.9906897,0.000014375845,0.0003502365,0.003957665,0.0025187496,0.00023591638,0.00014093389,0.002088183],"genre_scores_gemma":[0.000008286237,0.988676,0.00019534964,0.003648132,0.0056629144,0.0006849462,0.00022950576,0.00018338878,0.000711485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99611783,0.00030571545,0.0012646867,0.00083024753,0.0009319534,0.00054954045],"domain_scores_gemma":[0.9977276,0.00044386808,0.000747029,0.0005414178,0.0001281461,0.00041196743],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002477241,0.0009426403,0.0036914663,0.0010996276,0.00007745265,0.000023530401,0.00040033145,0.00039454363,0.00768877],"category_scores_gemma":[0.000029531078,0.0006498117,0.0017811715,0.001635521,0.000090566464,0.000079191195,0.000021363456,0.0006170908,0.00009964924],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023516116,0.0012973963,0.0000026719092,0.0015235672,0.0016916352,0.000017296596,0.00007304751,4.3104833e-7,0.0003726989,0.000049644525,0.012161316,0.9804587],"study_design_scores_gemma":[0.016243137,0.0016308564,0.0000014478775,0.007971652,0.00022898255,0.000022606413,0.0000033238105,0.0000020678326,0.0045060026,0.000015103702,0.96887267,0.0005021457],"about_ca_topic_score_codex":0.00009439201,"about_ca_topic_score_gemma":3.0245033e-7,"teacher_disagreement_score":0.9799565,"about_ca_system_score_codex":0.0004916738,"about_ca_system_score_gemma":0.00055100775,"threshold_uncertainty_score":0.99959534},"labels":[],"label_agreement":null},{"id":"W2050289111","doi":"10.1517/14656566.2011.549126","title":"Medical management of ascites","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Ascites; Medicine; Cirrhosis; Spontaneous bacterial peritonitis; Paracentesis; Intensive care medicine; Complication; Gastroenterology; Internal medicine","score_opus":0.11192836970319525,"score_gpt":0.4566000810284927,"score_spread":0.34467171132529745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050289111","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000025006445,0.9931246,0.000059793096,0.000061692816,0.0007822791,0.00081937533,0.00003248554,0.00006018486,0.005057066],"genre_scores_gemma":[0.000006736249,0.9979991,0.00017462595,0.0006307713,0.00044067623,0.00015968447,0.00029603983,0.000060082348,0.0002323237],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984405,0.00009623599,0.00046825537,0.00032269288,0.0005012075,0.00017112642],"domain_scores_gemma":[0.99925554,0.000055399487,0.00016739331,0.000269086,0.000030900264,0.00022169076],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013324902,0.00030486853,0.0008797839,0.00019631292,0.000026226093,0.00000466387,0.00019107347,0.00017294561,0.0044365097],"category_scores_gemma":[6.9746574e-7,0.00021554217,0.00045877582,0.00016315124,0.00005044393,0.000038394297,0.000011810457,0.00020129271,0.0001621896],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020329062,0.0004146352,0.0000023876016,0.0109633,0.0021169905,0.00006049441,0.00020143538,1.1569249e-8,0.000002072716,0.0012326604,0.0027984644,0.9820043],"study_design_scores_gemma":[0.0016799552,0.00016561836,0.000006370237,0.026817787,0.00029730654,0.000027474702,0.000010797425,0.000002414949,0.00013689336,0.000011333455,0.9706641,0.00017996987],"about_ca_topic_score_codex":0.000008504895,"about_ca_topic_score_gemma":3.930125e-8,"teacher_disagreement_score":0.9818243,"about_ca_system_score_codex":0.000036805366,"about_ca_system_score_gemma":0.00013374034,"threshold_uncertainty_score":0.99647355},"labels":[],"label_agreement":null},{"id":"W2051609830","doi":"10.1517/14656566.6.2.255","title":"Current pharmacological options in the treatment of croup","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Otolaryngology and Infectious Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Child, Adolescent and Family Mental Health; University of Alberta","funders":"Canada Research Chairs","keywords":"Medicine; Croup; Heliox; Intensive care medicine; Stridor; Asthma; Respiratory distress; Quality of life (healthcare); Pediatrics; Anesthesia; Airway; Internal medicine","score_opus":0.15101432333198458,"score_gpt":0.5096861022355341,"score_spread":0.3586717789035495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051609830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010282346,0.99544394,0.000004284286,0.00035804094,0.001211886,0.0021745993,0.000054780994,0.000053265263,0.0005964042],"genre_scores_gemma":[0.00005417061,0.99531746,0.000028909544,0.0011791461,0.0018357976,0.0013169892,0.00017930857,0.000038394654,0.00004980731],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99802464,0.00050926884,0.0005828242,0.00039000344,0.0002257652,0.00026747014],"domain_scores_gemma":[0.9990678,0.00028785877,0.00021209568,0.0002964587,0.000029914281,0.000105869],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014180112,0.00043522118,0.0011969289,0.0002864752,0.000076437034,0.000009551434,0.00019364721,0.0002062574,0.0020142277],"category_scores_gemma":[0.0000071356376,0.00023275329,0.0007664648,0.00030375223,0.000121435776,0.00004187492,0.0000069330436,0.00037969268,0.00009904055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013856184,0.0069587845,0.000022934973,0.0003481472,0.00028536323,0.000011181539,0.00028103832,9.4004275e-7,0.000013324493,0.00015996695,0.009576369,0.98220336],"study_design_scores_gemma":[0.0027595272,0.0016026238,0.00006231471,0.0016348925,0.00013726582,0.00005708398,0.000009891713,0.000007150966,0.000032006254,0.0000064252763,0.9934995,0.00019131137],"about_ca_topic_score_codex":0.000006524575,"about_ca_topic_score_gemma":4.1830026e-7,"teacher_disagreement_score":0.98392314,"about_ca_system_score_codex":0.00023767595,"about_ca_system_score_gemma":0.0001978973,"threshold_uncertainty_score":0.9988981},"labels":[],"label_agreement":null},{"id":"W2054589128","doi":"10.1517/14656560903448837","title":"Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Treatment of Major Depression","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Quetiapine; Tolerability; Medicine; Quetiapine Fumarate; Major depressive disorder; Atypical antipsychotic; Psychiatry; Antidepressant; Extrapyramidal symptoms; Antipsychotic; Pharmacology; Adverse effect; Mood; Schizophrenia (object-oriented programming); Anxiety","score_opus":0.09731983139226451,"score_gpt":0.47648122177821134,"score_spread":0.3791613903859468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054589128","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003262497,0.98399407,0.00002154334,0.0028736393,0.00010983394,0.009458578,0.00016344052,0.000022275608,0.000094117415],"genre_scores_gemma":[0.00076664233,0.9963057,0.00022769236,0.00092855777,0.00013720997,0.0012287487,0.00024845262,0.00005064652,0.00010633832],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956926,0.001199331,0.0014815563,0.00089216663,0.0004776672,0.00025667012],"domain_scores_gemma":[0.9971271,0.0009172073,0.0010951404,0.00058728794,0.00010202047,0.00017122613],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006070182,0.0007482515,0.0035295915,0.00024960728,0.00007597998,0.000022968114,0.00013290648,0.00019479034,0.00009651863],"category_scores_gemma":[0.00012890926,0.00040675738,0.00043071745,0.00024161524,0.00016835041,0.00009202654,0.000017506502,0.0001382162,0.0000018737186],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003928094,0.0030015646,0.00011443476,0.00292807,0.0011339778,0.000027894288,0.00074731227,3.4262936e-7,0.0003199859,0.00009655381,0.0006406851,0.9870611],"study_design_scores_gemma":[0.034166165,0.01287422,0.0011670752,0.06973904,0.00085208553,0.00025282518,0.00004172482,0.0000071817676,0.0018437437,0.00010838774,0.8784929,0.00045463402],"about_ca_topic_score_codex":0.00024018172,"about_ca_topic_score_gemma":0.0000049760174,"teacher_disagreement_score":0.9866065,"about_ca_system_score_codex":0.00021093184,"about_ca_system_score_gemma":0.0002135767,"threshold_uncertainty_score":0.9998384},"labels":[],"label_agreement":null},{"id":"W2056471646","doi":"10.1517/14656566.9.15.2707","title":"Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"GlaxoSmithKline","keywords":"Medicine; Fluticasone propionate; Nasal spray; Dermatology; Fluticasone; Nasal administration; Mometasone furoate; Anesthesia; Pharmacology; Internal medicine; Corticosteroid; Inhalation","score_opus":0.11570090677066157,"score_gpt":0.4234541966747482,"score_spread":0.3077532899040866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056471646","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023230955,0.99467283,0.000021494026,0.0014232827,0.0008180103,0.0023460817,0.00026889908,0.000028753308,0.00018835334],"genre_scores_gemma":[0.00033570846,0.9927814,0.00018526499,0.0054726466,0.00064591184,0.00005533222,0.00035622623,0.00009792024,0.00006956278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952175,0.0011939642,0.0016774439,0.0008214102,0.00078597176,0.00030370464],"domain_scores_gemma":[0.9964274,0.00081555126,0.0011463097,0.0012172342,0.00018194645,0.0002115313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00094866223,0.0005892749,0.0023791243,0.00008023023,0.00016990685,0.000025405085,0.00053729315,0.0002750741,0.0001193138],"category_scores_gemma":[0.00020919832,0.0003136614,0.00056064007,0.00027530998,0.0008892213,0.000094342744,0.00020627567,0.0006654965,0.0000034700558],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032454845,0.00046454425,0.00003025225,0.0114459405,0.0018558848,0.00004190072,0.00028042015,8.8466116e-8,0.0001743034,0.00023222581,0.032051004,0.9530989],"study_design_scores_gemma":[0.0023447343,0.0005098811,0.00009630958,0.04429005,0.00023926505,0.0007523174,0.000038863378,0.00016693461,0.000029242628,0.000004628804,0.9512148,0.0003129968],"about_ca_topic_score_codex":0.000013249867,"about_ca_topic_score_gemma":5.0645133e-7,"teacher_disagreement_score":0.9527859,"about_ca_system_score_codex":0.000030681225,"about_ca_system_score_gemma":0.00062529754,"threshold_uncertainty_score":0.9999316},"labels":[],"label_agreement":null},{"id":"W2057355671","doi":"10.1517/14656566.2014.855197","title":"The latest pharmacotherapy options for type 1 diabetes","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"LG Display; University of Guelph","keywords":"Medicine; Insulin; Metformin; Amylin; Pharmacotherapy; Insulin resistance; Type 2 diabetes; Diabetes mellitus; Intensive care medicine; Bioinformatics; Internal medicine; Endocrinology; Islet","score_opus":0.2283835522687489,"score_gpt":0.5191175320316764,"score_spread":0.29073397976292753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057355671","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000025095262,0.9842991,0.000015428137,0.003277554,0.003910725,0.006471271,0.00004031379,0.00020581963,0.0017772428],"genre_scores_gemma":[6.315979e-7,0.9723212,0.00029676882,0.0026793743,0.0032212206,0.0038178717,0.00038138707,0.00027384114,0.017007666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969358,0.00025942764,0.0006814491,0.0006704317,0.0005556073,0.0008972951],"domain_scores_gemma":[0.9975246,0.0009659948,0.0002885561,0.0006866044,0.00023132082,0.00030291334],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006180939,0.00070391287,0.0012977412,0.00035500026,0.00053186,0.00023902854,0.000662988,0.0002515489,0.0017564057],"category_scores_gemma":[0.00004022219,0.0003963118,0.00088029855,0.0005529359,0.00018095461,0.00011595691,0.00005423766,0.00061608275,0.0008404226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007665335,0.00023234276,9.827301e-7,0.0011188132,0.00085140736,7.265985e-7,0.000025736459,5.6736735e-7,0.00015445735,0.00027490823,0.31066376,0.6865996],"study_design_scores_gemma":[0.002155289,0.0006747615,5.197862e-7,0.0027431983,0.00007895102,0.0000011476916,0.000009467609,0.00023733256,0.00024315485,0.000060351325,0.99335134,0.00044445702],"about_ca_topic_score_codex":0.000002463968,"about_ca_topic_score_gemma":1.1656395e-7,"teacher_disagreement_score":0.6861552,"about_ca_system_score_codex":0.00016647587,"about_ca_system_score_gemma":0.0002310677,"threshold_uncertainty_score":0.99993753},"labels":[],"label_agreement":null},{"id":"W2058093970","doi":"10.1517/14656560802532640","title":"Effect of omega-3-acid ethyl esters on the steady-state plasma pharmacokinetics of rosuvastatin in healthy adults","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada","keywords":"Rosuvastatin; Medicine; Pharmacokinetics; Cmax; Crossover study; Pharmacology; Bioequivalence; Concomitant; Dosing; Statin; Adverse effect; Rosuvastatin Calcium; Area under the curve; Internal medicine","score_opus":0.02710743316397679,"score_gpt":0.34600241506513363,"score_spread":0.31889498190115684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058093970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903375,0.004222495,0.000057916874,0.0022642012,0.000723856,0.0019133176,0.000031120075,0.000042270163,0.00040732726],"genre_scores_gemma":[0.9604143,0.034588438,0.00012434968,0.004298859,0.00027805907,0.00018157107,0.000017444216,0.00006614004,0.00003083],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702036,0.00069674035,0.0006610858,0.00038527272,0.0008433084,0.00039320867],"domain_scores_gemma":[0.9986019,0.0003457428,0.0002613966,0.0005223473,0.00008181358,0.00018679687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009773672,0.0003223715,0.0007315229,0.00023009513,0.00007989711,0.0000043951336,0.00018742617,0.00007954946,0.00011667557],"category_scores_gemma":[0.000038863906,0.00020912234,0.00031445525,0.00038658766,0.00015129814,0.000049279584,0.00001751039,0.00042776825,0.0000130605395],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12411016,0.0021476718,0.0016160031,0.0011605637,0.00068889424,0.000106803964,0.018634923,0.0006432703,0.2132574,0.000113870025,0.006691941,0.6308285],"study_design_scores_gemma":[0.029124621,0.013627762,0.0011107941,0.0006878559,0.000008264106,0.00005112202,0.00015629883,0.0012686097,0.91770804,0.000003576648,0.036005154,0.00024792325],"about_ca_topic_score_codex":0.00022618606,"about_ca_topic_score_gemma":0.0000021064081,"teacher_disagreement_score":0.7044506,"about_ca_system_score_codex":0.00010361805,"about_ca_system_score_gemma":0.00014929098,"threshold_uncertainty_score":0.85277617},"labels":[],"label_agreement":null},{"id":"W2058489875","doi":"10.1517/14656566.2.7.1061","title":"Vagus nerve stimulation in depression","year":2001,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Vagus Nerve Stimulation Research","field":"Neuroscience","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vagus nerve stimulation; Depression (economics); Stimulation; Anesthesia; Vagus nerve; Internal medicine","score_opus":0.12033227087873925,"score_gpt":0.44541677962254334,"score_spread":0.32508450874380407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058489875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977127,0.0017331297,0.0025335469,0.0030928785,0.0019993521,0.001371015,0.000009789642,0.00043449504,0.011698781],"genre_scores_gemma":[0.99265105,0.0027912927,0.00014972639,0.0034315318,0.00036216728,0.00009489048,0.00000803235,0.00004811731,0.00046318685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976124,0.0003821886,0.00033467513,0.00059522915,0.0006559503,0.00041954385],"domain_scores_gemma":[0.999013,0.00039935095,0.00008500575,0.0003182714,0.00003771362,0.00014662575],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000242539,0.00021192024,0.0001721577,0.0003967939,0.00016086425,0.00006484315,0.00032374536,0.00008758091,0.0021896036],"category_scores_gemma":[0.00012703174,0.00019072821,0.00007479893,0.00069938524,0.00005032433,0.00033744678,0.00003721275,0.00028089728,0.00028199138],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090926746,0.000447556,0.010966646,0.0000031028196,0.0000030800718,0.000043911314,0.00052842684,0.014258114,0.87231356,0.00048767388,0.0036043643,0.09643432],"study_design_scores_gemma":[0.0055445274,0.00020837664,0.012127915,0.000063172054,2.98987e-7,0.000020202942,0.000022136703,0.12206398,0.6865261,0.0004100761,0.17264132,0.0003718641],"about_ca_topic_score_codex":0.00006175091,"about_ca_topic_score_gemma":0.0000018650937,"teacher_disagreement_score":0.18578741,"about_ca_system_score_codex":0.00012164539,"about_ca_system_score_gemma":0.000035405006,"threshold_uncertainty_score":0.99872255},"labels":[],"label_agreement":null},{"id":"W2059539152","doi":"10.1517/14656566.1.2.187","title":"Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Breast cancer; Natural history; Oncology; Chemotherapy; Cancer; Internal medicine","score_opus":0.08829158977714896,"score_gpt":0.42387209305990864,"score_spread":0.3355805032827597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059539152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008709066,0.97506833,3.5399233e-7,0.015634872,0.0048956512,0.0029418522,0.0010233966,0.00005852803,0.00028991982],"genre_scores_gemma":[0.00023571371,0.9759558,0.000008725961,0.014312537,0.004746719,0.0023859236,0.00006841951,0.00016051838,0.002125642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973258,0.00031220244,0.0007714058,0.00059195416,0.00053021434,0.0004684529],"domain_scores_gemma":[0.997941,0.00023136074,0.0008997975,0.0006072728,0.00014828378,0.00017228011],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020018568,0.0007572501,0.0019893688,0.00027384315,0.00010314379,0.000010006467,0.0006247691,0.00021453056,0.0057688705],"category_scores_gemma":[0.0000018465047,0.0004034165,0.00084044127,0.0004755924,0.00026527824,0.00007265549,0.000032873286,0.0006080674,0.000023781387],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016144001,0.00038441553,0.0000429401,0.0013291118,0.0010995833,0.0000046387304,0.002116515,0.0000012526663,0.00031163398,0.000006025845,0.15980372,0.83328575],"study_design_scores_gemma":[0.0026616396,0.00020647643,0.000216877,0.008356499,0.00021711005,0.00015194718,0.000048326074,0.000012743981,0.0002479144,8.143878e-7,0.98751587,0.00036378278],"about_ca_topic_score_codex":0.0015797515,"about_ca_topic_score_gemma":0.000041401432,"teacher_disagreement_score":0.832922,"about_ca_system_score_codex":0.0014254628,"about_ca_system_score_gemma":0.00085630734,"threshold_uncertainty_score":0.99984175},"labels":[],"label_agreement":null},{"id":"W2060056173","doi":"10.1517/14656566.9.8.1375","title":"Sugammadex: a cyclodextrin to reverse neuromuscular blockade in anaesthesia","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Sugammadex; Rocuronium; Medicine; Neuromuscular Blockade; Blockade; Anesthesia; Neuromuscular monitoring; Neuromuscular Blocking Agents; Paralysis; Surgery; Internal medicine; Intubation; Receptor","score_opus":0.10687992274177124,"score_gpt":0.4326943480920112,"score_spread":0.32581442535023997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060056173","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002047876,0.99420893,0.00002712289,0.0016916395,0.00047077794,0.0028097755,0.000010210653,0.00012600835,0.00045071598],"genre_scores_gemma":[0.000010090435,0.9831842,0.00032668476,0.014023503,0.0008552967,0.0005206111,0.00012209744,0.00022854452,0.0007289684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962818,0.00054000295,0.0008931262,0.001026738,0.0006473097,0.0006110503],"domain_scores_gemma":[0.9983628,0.000099996105,0.00024296169,0.00075019855,0.0000512883,0.0004927826],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018038176,0.0008769763,0.0022945441,0.00092416356,0.00009023026,0.000020748997,0.000422021,0.00037018722,0.00054640125],"category_scores_gemma":[0.000033324028,0.0007021049,0.0008514894,0.0009378183,0.000064837695,0.00007510868,0.000033198256,0.00077624264,0.0006918359],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034049922,0.00068883674,0.000036374124,0.0006607204,0.00017463854,0.0012917721,0.0006759202,0.0000022242757,0.00010065916,0.000036473837,0.0506599,0.945332],"study_design_scores_gemma":[0.002151564,0.0005632249,0.0000540625,0.0058264425,0.000024661858,0.00046797772,0.000016879021,0.000011452764,0.00009267106,0.0000021779954,0.99017465,0.0006142182],"about_ca_topic_score_codex":0.000067956105,"about_ca_topic_score_gemma":7.4432205e-7,"teacher_disagreement_score":0.94471776,"about_ca_system_score_codex":0.00032068696,"about_ca_system_score_gemma":0.0003278897,"threshold_uncertainty_score":0.999543},"labels":[],"label_agreement":null},{"id":"W2061084001","doi":"10.1517/14656566.5.5.1045","title":"Pharmacotherapy for sexual dysfunction in women","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia Hospital","funders":"","keywords":"Biopsychosocial model; Sexual dysfunction; Sexual arousal; Medicine; Pharmacotherapy; Normative; Clinical psychology; Sexual desire; Arousal; Female sexual dysfunction; Human sexuality; Psychotherapist; Psychiatry; Psychology; Sexual behavior; Neuroscience","score_opus":0.13898182507787002,"score_gpt":0.46663726688432966,"score_spread":0.32765544180645967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061084001","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013760506,0.9860416,0.0006570494,0.00055167236,0.007825847,0.0038656315,0.000068967616,0.00037661628,0.0005988426],"genre_scores_gemma":[0.0000023592538,0.97609234,0.0002148998,0.011224336,0.003455466,0.0050958516,0.00027538833,0.00028292197,0.003356413],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961386,0.00019236826,0.0011445433,0.0011605851,0.0005673661,0.00079658447],"domain_scores_gemma":[0.9982865,0.0003422097,0.0004013535,0.00047770055,0.00014120486,0.00035105582],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004928932,0.0010093705,0.0023942797,0.0010365222,0.00020244207,0.000051841256,0.00019584033,0.00045527754,0.0022661046],"category_scores_gemma":[0.00003748474,0.0008023478,0.00056870293,0.0007935464,0.00008969932,0.00014332787,0.000022585347,0.0007224528,0.0002999776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003135044,0.00097368425,0.0000023604434,0.0034715787,0.0007444809,0.000009048345,0.00084542803,0.0000067204173,0.00015624647,0.00011323181,0.04673332,0.94380885],"study_design_scores_gemma":[0.014283949,0.001957285,0.000002500916,0.0043670423,0.000044524408,0.000058462818,0.00026933238,0.000017096829,0.00009727052,0.00002802662,0.97816455,0.00070998346],"about_ca_topic_score_codex":0.000030540657,"about_ca_topic_score_gemma":5.992063e-7,"teacher_disagreement_score":0.9430989,"about_ca_system_score_codex":0.0016671536,"about_ca_system_score_gemma":0.0005906178,"threshold_uncertainty_score":0.99944276},"labels":[],"label_agreement":null},{"id":"W2062935202","doi":"10.1517/14656566.7.11.1457","title":"Treating osteoporosis: economic aspects of bisphosphonate therapy","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Hamilton Health Sciences; McMaster University","funders":"","keywords":"Medicine; Osteoporosis; Intensive care medicine; Quality of life (healthcare); Bisphosphonate; Health economics; Disease; Economic evaluation; Cost effectiveness; Health care; Physical therapy; Public health; Nursing; Internal medicine; Risk analysis (engineering)","score_opus":0.09325188495053834,"score_gpt":0.4552114200073096,"score_spread":0.36195953505677125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062935202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000646822,0.9884781,0.000002222103,0.0002739214,0.0013722791,0.0027251316,0.00012643254,0.00013989682,0.0068173097],"genre_scores_gemma":[0.000047041885,0.99540824,0.00019226056,0.0012015974,0.0010454892,0.0006404861,0.00043499164,0.0002732503,0.0007566621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99589026,0.00030333755,0.0015271672,0.0008884971,0.0006203596,0.00077035674],"domain_scores_gemma":[0.9975503,0.00034276606,0.0008121102,0.0007697259,0.00009845559,0.00042666326],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046491117,0.00083965895,0.0028944223,0.00062685885,0.00014691945,0.00003769737,0.00036759514,0.0004860527,0.0017707025],"category_scores_gemma":[0.000013558073,0.00063100806,0.0010787881,0.00038830974,0.00013613793,0.000087744054,0.00003340014,0.0007791575,0.0002576579],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047575994,0.00049988774,0.000007951758,0.0030657668,0.00026939425,0.000011479482,0.0001757723,8.225146e-7,0.00014395389,0.00012794255,0.019990273,0.975231],"study_design_scores_gemma":[0.004295762,0.0012279489,0.000010915176,0.007653869,0.000023413908,0.00004785996,0.000022332066,0.000021730259,0.00313525,0.000020366431,0.983074,0.00046654153],"about_ca_topic_score_codex":0.0008197618,"about_ca_topic_score_gemma":0.000006288011,"teacher_disagreement_score":0.97476447,"about_ca_system_score_codex":0.0005747888,"about_ca_system_score_gemma":0.0015686529,"threshold_uncertainty_score":0.9996141},"labels":[],"label_agreement":null},{"id":"W2066802629","doi":"10.1517/14656566.2010.524927","title":"Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal College of Physicians and Surgeons of Canada; AstraZeneca (Canada); Université de Montréal; Institut universitaire en santé mentale de Montréal","funders":"","keywords":"Quetiapine; Medicine; Craving; Psychiatry; Detoxification (alternative medicine); Quetiapine Fumarate; Atypical antipsychotic; Bipolar disorder; Open label; Olanzapine; Clinical trial; Mood; Antipsychotic; Schizophrenia (object-oriented programming); Addiction; Internal medicine; Alternative medicine","score_opus":0.09185294993188911,"score_gpt":0.41300813000778197,"score_spread":0.32115518007589283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066802629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99391484,0.001437373,0.0000246485,0.0003629366,0.0018058469,0.002269719,0.000010443166,0.00008350048,0.000090712245],"genre_scores_gemma":[0.9876766,0.0087165125,0.0013639821,0.00044969877,0.000575215,0.0002706994,0.000091153524,0.000071071125,0.0007850404],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99808806,0.000107628235,0.00057189417,0.0005116615,0.00040853143,0.00031222028],"domain_scores_gemma":[0.99870574,0.00020079399,0.00027617742,0.00048593705,0.00014707718,0.00018428986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011611239,0.00036130322,0.0006249303,0.00012688049,0.00012181198,0.000034551562,0.00019497552,0.00013562244,0.00027921726],"category_scores_gemma":[0.000026270418,0.00023288156,0.00012950145,0.00020275802,0.00013334326,0.00032449162,0.00001082125,0.00026033155,0.000015338272],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33130303,0.020897737,0.5989644,0.00001878772,0.00088925957,0.00002565158,0.0022911606,0.000002259202,0.020334853,0.0003615016,0.0013125353,0.023598837],"study_design_scores_gemma":[0.77657783,0.01771652,0.13211754,0.0003395012,0.00007310935,0.000010464647,0.000120466066,0.00012975185,0.017639171,0.000023728217,0.054608278,0.00064364634],"about_ca_topic_score_codex":0.00012989556,"about_ca_topic_score_gemma":0.00015301902,"teacher_disagreement_score":0.46684685,"about_ca_system_score_codex":0.00020611967,"about_ca_system_score_gemma":0.00010314296,"threshold_uncertainty_score":0.94966346},"labels":[],"label_agreement":null},{"id":"W2067204192","doi":"10.1517/14656566.6.13.2353","title":"A review of exemestane in the management of breast cancer","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Exemestane; Medicine; Aromatase; Tamoxifen; Breast cancer; Oncology; Internal medicine; Cancer; Endocrine system; Gynecology; Hormone","score_opus":0.03468283152236592,"score_gpt":0.4263808611344898,"score_spread":0.3916980296121239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067204192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000538031,0.9978852,0.0000034857524,0.00020143084,0.00024785,0.0010562964,0.0000621486,0.0000039389824,0.00053422083],"genre_scores_gemma":[0.000003727954,0.9977422,0.00006228201,0.0013608399,0.00027959817,0.00030685027,0.000138661,0.000039992567,0.000065867636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985825,0.00025973763,0.0005102952,0.00029007165,0.00018902883,0.00016838337],"domain_scores_gemma":[0.9992084,0.00001634322,0.00032414062,0.00038753328,0.000030521216,0.0000330951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028417376,0.00028942752,0.0006729735,0.00006592566,0.000016832972,0.000003245136,0.0004166342,0.00016427261,0.00011394252],"category_scores_gemma":[9.765921e-7,0.0001730851,0.00038660096,0.00022033048,0.00004730065,0.0000019377148,0.000030380386,0.00017994632,0.000004075116],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054945504,0.0002188245,2.2818509e-7,0.01625386,0.0003845811,0.0000027854826,0.000027782138,7.478349e-7,0.0005788556,0.00004388486,0.013518107,0.9689154],"study_design_scores_gemma":[0.0004684892,0.000102779326,9.69316e-7,0.067749225,0.00003873584,0.000026443373,0.0000055136,6.490256e-7,0.00066336174,5.303256e-7,0.9307826,0.00016069565],"about_ca_topic_score_codex":0.000009547614,"about_ca_topic_score_gemma":1.4926032e-7,"teacher_disagreement_score":0.9687547,"about_ca_system_score_codex":0.000023852335,"about_ca_system_score_gemma":0.0000696588,"threshold_uncertainty_score":0.7058206},"labels":[],"label_agreement":null},{"id":"W2067463954","doi":"10.1517/14656566.4.10.1789","title":"The epidemiology of severe sepsis syndrome and its treatment with recombinant human activated protein C","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Drotrecogin alfa; Medicine; Intensive care medicine; Sepsis; Epidemiology; Intensive care unit; Protein C; Incidence (geometry); Severe sepsis; Septic shock; Internal medicine","score_opus":0.2697773719650954,"score_gpt":0.4863797149737627,"score_spread":0.21660234300866732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067463954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011767403,0.993419,6.4463796e-7,0.0007908459,0.0002926779,0.0040836777,0.000025393634,0.000043306805,0.00016771196],"genre_scores_gemma":[0.00045064779,0.99521834,0.00008428976,0.00046196912,0.00007798198,0.0026336035,0.00010428501,0.000115386094,0.00085352786],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972222,0.0007385557,0.0007690206,0.0006553666,0.00020989217,0.00040497992],"domain_scores_gemma":[0.99794847,0.0006640178,0.0006295509,0.0004905354,0.00006509499,0.00020232283],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002936314,0.000706945,0.0024179162,0.0001609666,0.00022854054,0.0000088958295,0.00012835658,0.0002491893,0.00024910213],"category_scores_gemma":[0.000017597025,0.0003270324,0.0004188929,0.00022032422,0.00009937274,0.0000359255,0.000013570445,0.00024747875,0.000015633854],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036853287,0.0022508826,0.00010612504,0.0013247046,0.0041570826,0.00005923528,0.00018538817,2.4622514e-7,0.0001357067,0.00059443,0.0018966834,0.988921],"study_design_scores_gemma":[0.004165874,0.0063655186,0.000039228576,0.0098173395,0.00016329506,0.00035795264,0.000015987282,0.0000011093823,0.0012775097,0.00002213268,0.9774541,0.0003199033],"about_ca_topic_score_codex":0.000044921566,"about_ca_topic_score_gemma":0.0000011010533,"teacher_disagreement_score":0.9886011,"about_ca_system_score_codex":0.0003737088,"about_ca_system_score_gemma":0.00018309696,"threshold_uncertainty_score":0.99991816},"labels":[],"label_agreement":null},{"id":"W2072750281","doi":"10.1517/14656560903025189","title":"Treatment options for epileptic myoclonus and epilepsy syndromes associated with myoclonus","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Glycogen Storage Diseases and Myoclonus","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Myoclonus; Medicine; Irritability; Etiology; Epilepsy; Epilepsy syndromes; Progressive myoclonus epilepsy; Intensive care medicine; Psychiatry; Neuroscience; Pediatrics; Psychology; Cognition","score_opus":0.09827733634555261,"score_gpt":0.4208378990022289,"score_spread":0.3225605626566763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072750281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012303788,0.99244905,0.00006347195,0.0005435219,0.0007290377,0.0049972227,0.0005450665,0.00026710363,0.00028251045],"genre_scores_gemma":[0.000086474174,0.9911855,0.0005738092,0.0014936952,0.00090419437,0.0022262952,0.0018006765,0.00024987236,0.0014795074],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968488,0.00019646487,0.00075977837,0.0010659688,0.00042508688,0.0007038935],"domain_scores_gemma":[0.99776024,0.00040224456,0.00048023116,0.0005906946,0.00014654548,0.00062004087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013940255,0.0011088575,0.0026906112,0.00040997946,0.0002933199,0.00008065115,0.00018392039,0.00040037293,0.00029079863],"category_scores_gemma":[0.00003697561,0.0007612762,0.0010034471,0.00035493696,0.00012027771,0.00009078881,0.000015151638,0.00030596205,0.000037208258],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006679266,0.0015233936,0.000002970502,0.0008717261,0.0021075804,0.0007016388,0.00016524731,0.0000011813507,0.000014410581,0.00017885765,0.007080777,0.98668426],"study_design_scores_gemma":[0.007706371,0.0061542154,0.00001384649,0.0075725582,0.0007822401,0.0016089198,0.000027514541,0.000046459212,0.000019946101,0.000016212021,0.97527117,0.0007805266],"about_ca_topic_score_codex":0.000023619323,"about_ca_topic_score_gemma":0.0000014387485,"teacher_disagreement_score":0.98590374,"about_ca_system_score_codex":0.0006483606,"about_ca_system_score_gemma":0.00050484063,"threshold_uncertainty_score":0.9994838},"labels":[],"label_agreement":null},{"id":"W2073384113","doi":"10.1517/14656566.8.11.1651","title":"Acute infectious pediatric gastroenteritis: beyond oral rehydration therapy","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Acute gastroenteritis; Intensive care medicine; Rotavirus; Ondansetron; Clinical trial; Diarrhea; Pediatrics; Vomiting; Surgery; Internal medicine","score_opus":0.13517698774905557,"score_gpt":0.4957563572399178,"score_spread":0.3605793694908622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073384113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011530849,0.99304384,0.00046167366,0.00053051393,0.0024967163,0.0022096974,0.00010025405,0.00027569535,0.00076629396],"genre_scores_gemma":[0.000029458737,0.98461455,0.00056250003,0.0076240343,0.005006386,0.0005706682,0.00097192265,0.00022203312,0.00039842117],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995245,0.0007382032,0.0012396326,0.0009663108,0.0006528806,0.0011579781],"domain_scores_gemma":[0.9981176,0.00008561386,0.00045787566,0.00058241043,0.00014028902,0.00061617175],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067591405,0.0008924715,0.0024748587,0.0009876118,0.00017453736,0.000067394,0.0003483353,0.00048423276,0.0011351197],"category_scores_gemma":[0.000043780612,0.0007015142,0.0010826805,0.0005525916,0.0001262713,0.00017458282,0.00005237165,0.0012362088,0.00031062245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011901086,0.0005464398,0.00008835784,0.00065906264,0.0006173411,0.00015289248,0.000046835023,2.6320402e-7,0.00013424094,0.000016779537,0.06902139,0.9275263],"study_design_scores_gemma":[0.004850619,0.003981195,0.00002083978,0.0015740407,0.000047716178,0.0007766526,0.0000047587137,0.000009765611,0.00003605858,0.000012294335,0.98831457,0.00037146197],"about_ca_topic_score_codex":0.000025468766,"about_ca_topic_score_gemma":0.0000016345513,"teacher_disagreement_score":0.92715484,"about_ca_system_score_codex":0.00040038594,"about_ca_system_score_gemma":0.0002594267,"threshold_uncertainty_score":0.999778},"labels":[],"label_agreement":null},{"id":"W2074772519","doi":"10.1517/14656566.8.11.1769","title":"The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Etonogestrel; Vaginal ring; Medicine; Desogestrel; Dosing; Ethinylestradiol; Gynecology; Family planning; Sterilization (economics); Population; Obstetrics; Intravaginal administration; Hormonal contraception; Research methodology; Vagina; Pharmacology; Surgery","score_opus":0.1280559089278602,"score_gpt":0.48001780177774095,"score_spread":0.3519618928498808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074772519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011020484,0.9858999,0.00018186701,0.0027906317,0.00413345,0.003671363,0.000016457212,0.00021759945,0.003077658],"genre_scores_gemma":[0.000024298308,0.9883943,0.00016712633,0.0029080652,0.0064980215,0.00063680107,0.00012719884,0.00014351952,0.0011006686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99588925,0.00048386276,0.0011029474,0.0009945993,0.00068998244,0.0008393697],"domain_scores_gemma":[0.99715346,0.00074583373,0.0006134204,0.0008345651,0.00019703303,0.00045570955],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011837562,0.0008111071,0.0017020578,0.00026857073,0.0005274187,0.00008045003,0.00035754193,0.00044743984,0.00028148174],"category_scores_gemma":[0.00007813373,0.0005109652,0.000712144,0.0003772343,0.00023908992,0.000106380445,0.000020213978,0.0016989522,0.00025295705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011902546,0.00028774617,0.0000034173452,0.000810586,0.00040065506,0.000024611525,0.00030456373,3.4133188e-7,0.00006776288,0.001044722,0.010580446,0.98528486],"study_design_scores_gemma":[0.0034117133,0.0009284833,0.000026079786,0.005026764,0.000058824935,0.00016124766,0.000066351175,0.000022187121,0.00014763947,0.000032662636,0.9896582,0.00045989387],"about_ca_topic_score_codex":0.000031021194,"about_ca_topic_score_gemma":7.15891e-7,"teacher_disagreement_score":0.984825,"about_ca_system_score_codex":0.0005198332,"about_ca_system_score_gemma":0.0006488648,"threshold_uncertainty_score":0.9997342},"labels":[],"label_agreement":null},{"id":"W2075154501","doi":"10.1517/14656566.2014.902936","title":"Teriflunomide: a novel oral treatment for relapsing multiple sclerosis","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Teriflunomide; Medicine; Tolerability; Multiple sclerosis; Intensive care medicine; Adverse effect; Oncology; Internal medicine; Fingolimod; Immunology","score_opus":0.42314524665065556,"score_gpt":0.5018911586860166,"score_spread":0.07874591203536108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075154501","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005652169,0.989071,0.001194487,0.0006590515,0.0018796497,0.0063864994,0.00033760435,0.00024037594,0.00022565536],"genre_scores_gemma":[0.000012756072,0.9831215,0.005695446,0.0011912344,0.0028783532,0.005488898,0.00050687854,0.00034668468,0.0007582268],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960963,0.0002340229,0.0010268147,0.0011795362,0.0005877611,0.0008755816],"domain_scores_gemma":[0.99702656,0.0011509643,0.00043054938,0.0008004062,0.00016368751,0.00042782965],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045278075,0.0010986797,0.003317027,0.00050264364,0.00035583196,0.00009210472,0.00033240533,0.00036494245,0.00027601185],"category_scores_gemma":[0.00020589774,0.00076022,0.0016597175,0.00029736807,0.00014930074,0.00008884777,0.000060868744,0.00040437127,0.000118855656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008231808,0.0010084255,0.000004364917,0.002359628,0.0010925971,0.0000013874348,0.00025407714,9.1402944e-7,0.0029888477,0.000015891244,0.025255911,0.96619475],"study_design_scores_gemma":[0.013377623,0.0016920295,0.0000083765035,0.01709444,0.00009746053,0.000013317227,0.000017512453,0.00044706566,0.00075353956,9.566013e-7,0.9658671,0.0006305574],"about_ca_topic_score_codex":0.00007542085,"about_ca_topic_score_gemma":0.0000027805065,"teacher_disagreement_score":0.9655642,"about_ca_system_score_codex":0.001100161,"about_ca_system_score_gemma":0.00033712445,"threshold_uncertainty_score":0.9994849},"labels":[],"label_agreement":null},{"id":"W2075399197","doi":"10.1517/14656566.9.13.2259","title":"Pharmacotherapy of relapsed metastatic testicular cancer","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Chemotherapy; Testicular cancer; Radiation therapy; Cisplatin; Oncology; Internal medicine; Cancer; Disease; Pharmacotherapy","score_opus":0.13829468147737287,"score_gpt":0.490619097376913,"score_spread":0.3523244158995401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075399197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018537885,0.99531835,0.0000476578,0.000147909,0.0012584927,0.002510968,0.00033259668,0.00016528158,0.0002001981],"genre_scores_gemma":[0.000018249686,0.99467206,0.0008345147,0.0016290398,0.0006997518,0.0010706219,0.00044881867,0.0002903646,0.00033657698],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99669737,0.00028124693,0.0009972578,0.0007897985,0.0007570443,0.00047729432],"domain_scores_gemma":[0.9977373,0.0002726339,0.0007409751,0.0006612487,0.00014143821,0.00044642776],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007674295,0.0009581272,0.0026877103,0.00042254894,0.00010756378,0.000015686255,0.00027761888,0.0001840116,0.0023573462],"category_scores_gemma":[0.000027745307,0.00067996164,0.0015336183,0.00055018975,0.00014661725,0.00007100465,0.000021090686,0.0004141287,0.000114153794],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003367905,0.0022039826,0.000018181445,0.002650704,0.0037559264,0.00022504307,0.00012792404,0.000004154714,0.00024087631,0.000029528108,0.016677614,0.97372925],"study_design_scores_gemma":[0.006958161,0.00062055193,0.000007877794,0.010779522,0.0005275337,0.00024657705,0.0000054091643,0.00004464648,0.0008263226,0.000007050142,0.9794412,0.00053513877],"about_ca_topic_score_codex":0.000078930534,"about_ca_topic_score_gemma":1.4709975e-7,"teacher_disagreement_score":0.9731941,"about_ca_system_score_codex":0.0002830302,"about_ca_system_score_gemma":0.0008333923,"threshold_uncertainty_score":0.9995652},"labels":[],"label_agreement":null},{"id":"W2075578129","doi":"10.1517/14656566.7.16.2271","title":"Famciclovir for the treatment of recurrent genital herpes: a clinical and pharmacological perspective","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Famciclovir; Medicine; Penciclovir; Viral shedding; Herpes simplex virus; Asymptomatic; Valaciclovir; Transmission (telecommunications); Adverse effect; Immunology; Dosing; Virus; Virology; Internal medicine; Herpesviridae; Viral disease","score_opus":0.21743447602998886,"score_gpt":0.5453714211799782,"score_spread":0.3279369451499893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075578129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009743252,0.9923447,0.00008940631,0.0003033089,0.001830837,0.004596737,0.00023635787,0.00006170158,0.0004395612],"genre_scores_gemma":[0.00006143068,0.9947216,0.00027030375,0.00032172957,0.0020624653,0.0020261577,0.00008799367,0.00008067073,0.00036766726],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977396,0.00026529853,0.00082571025,0.00064999267,0.00022081991,0.00029859418],"domain_scores_gemma":[0.99809456,0.00099578,0.00032748654,0.00029398603,0.00011739618,0.0001707633],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019434778,0.00058503833,0.001672091,0.00014954273,0.0001802372,0.00002198941,0.00011163799,0.00028630183,0.00020827669],"category_scores_gemma":[0.000015139988,0.00030003014,0.0013089695,0.0001837933,0.00027398625,0.000031719468,0.000012735739,0.00021219651,0.0000194466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068938744,0.005759515,0.000010707496,0.00022781508,0.0026907776,0.000008169454,0.00021316507,1.774511e-7,0.0000020955886,0.000152712,0.005173628,0.98507184],"study_design_scores_gemma":[0.0074315025,0.0051355986,0.000011511435,0.000740801,0.00061430014,0.00003944065,0.00004956111,0.00004370807,0.000057176876,0.000017213297,0.985613,0.00024622737],"about_ca_topic_score_codex":0.00007279435,"about_ca_topic_score_gemma":0.000001357806,"teacher_disagreement_score":0.9848256,"about_ca_system_score_codex":0.00038832324,"about_ca_system_score_gemma":0.00021632771,"threshold_uncertainty_score":0.99994516},"labels":[],"label_agreement":null},{"id":"W2076137665","doi":"10.1517/14656566.2010.510835","title":"Atypical antipsychotic tolerability and switching strategies in bipolar disorder","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; University Health Network","funders":"","keywords":"Tolerability; Medicine; Bipolar disorder; Atypical antipsychotic; Discontinuation; Tardive dyskinesia; Treatment of bipolar disorder; Quetiapine; Adverse effect; Extrapyramidal symptoms; Antipsychotic; Psychiatry; Risperidone; Mania; Schizophrenia (object-oriented programming); Internal medicine; Lithium (medication)","score_opus":0.0556380966803749,"score_gpt":0.4287480617266722,"score_spread":0.3731099650462973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076137665","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045941843,0.99636084,0.00007372225,0.00038737318,0.00090005656,0.0015150462,0.00001561506,0.00008792536,0.00020000267],"genre_scores_gemma":[0.00050879794,0.9981042,0.00024362099,0.0003266229,0.00038458346,0.00021724716,0.00008497228,0.00010217878,0.000027745658],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977561,0.00021284232,0.00063408073,0.00074755226,0.00027272853,0.00037669347],"domain_scores_gemma":[0.9990043,0.00014544118,0.00014787047,0.0004705297,0.000024031007,0.00020780272],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021017516,0.00062072417,0.0015680046,0.00029370913,0.00009490454,0.00006691962,0.00014666807,0.00042904838,0.0003306635],"category_scores_gemma":[0.0000099657,0.0004409189,0.00033864772,0.00025178448,0.00008188969,0.00011547287,0.000024122946,0.0011794784,0.000035326302],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023600762,0.0011366135,0.0010234477,0.0012788211,0.00014885476,0.0000066015505,0.00036396933,1.005173e-7,0.000051145005,0.00027145105,0.00008162328,0.9954014],"study_design_scores_gemma":[0.0026473538,0.0003112214,0.0010554533,0.003015379,0.000037258407,0.000074108706,0.00003996573,0.000019558878,0.000010043396,0.00008457993,0.99232215,0.0003829052],"about_ca_topic_score_codex":0.00007053845,"about_ca_topic_score_gemma":0.000029648523,"teacher_disagreement_score":0.9950185,"about_ca_system_score_codex":0.00008616052,"about_ca_system_score_gemma":0.0002233876,"threshold_uncertainty_score":0.99980426},"labels":[],"label_agreement":null},{"id":"W2078654246","doi":"10.1517/14656566.2010.508071","title":"Thorough cardiac QTc interval conductance assessment of a novel oral tranexamic acid treatment for heavy menstrual bleeding","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Medicine; Tranexamic acid; QT interval; Anesthesia; Internal medicine; Cardiology; Pharmacology; Surgery; Blood loss","score_opus":0.09651605985712917,"score_gpt":0.4475528035186238,"score_spread":0.3510367436614946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078654246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885334,0.0009931143,0.0012297619,0.001998314,0.004151002,0.0018527128,0.00030307675,0.000099907935,0.00083875516],"genre_scores_gemma":[0.9740877,0.0021614507,0.021380596,0.0007076331,0.0007676813,0.00047120097,0.00012505247,0.00006872369,0.00022992917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985762,0.00003063499,0.000374973,0.00042204998,0.0002719087,0.000324221],"domain_scores_gemma":[0.9992602,0.0000639281,0.0001366891,0.0002903664,0.000085615684,0.00016321751],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013324335,0.0003376571,0.00062121334,0.00010043854,0.0000819613,0.000019052508,0.00010302743,0.000092148424,0.00025878148],"category_scores_gemma":[0.00000435913,0.00025121693,0.00032616293,0.00009474326,0.00007160409,0.00010766765,0.000011111277,0.00015678989,0.0000026929492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013988774,0.0020165988,0.0020275575,0.000027849463,0.0007821219,0.0000045387337,0.0008698839,0.0000017320978,0.94367087,0.0008212061,0.0008898142,0.04748893],"study_design_scores_gemma":[0.023838086,0.004935071,0.0025230348,0.00012405356,0.000039226376,0.000039304483,0.00013390373,0.0013167365,0.794961,0.000013794148,0.17178276,0.00029302604],"about_ca_topic_score_codex":0.00007995908,"about_ca_topic_score_gemma":0.0000027034898,"teacher_disagreement_score":0.17089295,"about_ca_system_score_codex":0.00015120719,"about_ca_system_score_gemma":0.00011346376,"threshold_uncertainty_score":0.999994},"labels":[],"label_agreement":null},{"id":"W2078959212","doi":"10.1517/14656566.8.11.1693","title":"Novel uses for risperidone: focus on depressive, anxiety and behavioral disorders","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Risperidone; Anxiety; Medicine; Tolerability; Psychiatry; Mood disorders; Mood; Atypical antipsychotic; Bipolar disorder; Schizophrenia (object-oriented programming); Randomized controlled trial; Antipsychotic; Clinical psychology; Adverse effect; Pharmacology","score_opus":0.18192137894730873,"score_gpt":0.5018738249233845,"score_spread":0.31995244597607575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078959212","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020048914,0.9914715,0.0018441055,0.0005614861,0.0013723051,0.0037569243,0.00022030364,0.00018218644,0.00039064506],"genre_scores_gemma":[0.00014866589,0.9948656,0.00078316726,0.0014472613,0.00088566326,0.00093515747,0.0002897237,0.00030108893,0.000343656],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971803,0.000095832205,0.0006561816,0.0010171433,0.00051068934,0.0005398599],"domain_scores_gemma":[0.9983263,0.00037722153,0.00040422025,0.00052319147,0.00008758715,0.0002815038],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019508168,0.0008635117,0.0016477548,0.00044178084,0.00021509516,0.000059379,0.00019902187,0.00047729223,0.0003668841],"category_scores_gemma":[0.000029897294,0.00070109504,0.000825475,0.00026855723,0.00012560603,0.00014000137,0.000035157682,0.00067102513,0.000039742543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005915012,0.0019454906,0.000047901896,0.0009342484,0.0002976111,0.0000026155724,0.0001398072,9.1541e-7,0.000292865,0.000091598355,0.005029243,0.9906262],"study_design_scores_gemma":[0.005925251,0.00068694743,0.000019196215,0.0031992397,0.00013183829,0.000081297854,0.000073407704,0.000024265451,0.00014196591,0.0000063889584,0.9890279,0.0006823091],"about_ca_topic_score_codex":0.00004828606,"about_ca_topic_score_gemma":0.000003901082,"teacher_disagreement_score":0.9899439,"about_ca_system_score_codex":0.00016785461,"about_ca_system_score_gemma":0.00014659361,"threshold_uncertainty_score":0.999544},"labels":[],"label_agreement":null},{"id":"W2081943145","doi":"10.1517/14656566.9.8.1387","title":"Co-administration of opioid agonists and antagonists in addiction and pain medicine","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Medicine; Opioid; Addiction; Pharmacology; Opioid addiction; Chronic pain; Addiction medicine; Buprenorphine; Anesthesia; Internal medicine; Physical therapy; Psychiatry; Receptor","score_opus":0.05378495400292248,"score_gpt":0.42652186129092456,"score_spread":0.3727369072880021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081943145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002139177,0.99661183,0.00001420297,0.0007174285,0.00036196515,0.0016997013,0.000046936584,0.000051304716,0.00028268987],"genre_scores_gemma":[0.0002185437,0.9971258,0.00016026825,0.0007735256,0.00041770653,0.00027724754,0.0008757941,0.000084422005,0.00006669178],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99759036,0.00034215229,0.00085185305,0.00059510185,0.0003766442,0.00024390923],"domain_scores_gemma":[0.9988447,0.00025143247,0.0003816175,0.00029665793,0.00004335713,0.00018225837],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002830831,0.00055125065,0.0016516383,0.0004803393,0.00007500122,0.000011359097,0.00007969099,0.00027117337,0.00015835099],"category_scores_gemma":[0.000030054236,0.0004232315,0.0001463904,0.00025230928,0.00023349246,0.00006404691,0.00000888805,0.00030920218,0.0000051925203],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044882283,0.000555179,0.00006868544,0.0021429958,0.00021898378,0.000041821317,0.0012780789,4.2759083e-8,0.0001645796,0.000037914244,0.008775128,0.98626775],"study_design_scores_gemma":[0.0041541466,0.0018987594,0.00014943058,0.011464717,0.00003894818,0.00023436928,0.00006777101,0.000023195462,0.00036369968,0.0000062867025,0.9813141,0.00028455106],"about_ca_topic_score_codex":0.0000671833,"about_ca_topic_score_gemma":0.0000017278087,"teacher_disagreement_score":0.9859832,"about_ca_system_score_codex":0.00017057812,"about_ca_system_score_gemma":0.00030874394,"threshold_uncertainty_score":0.99982196},"labels":[],"label_agreement":null},{"id":"W2085923488","doi":"10.1517/14656561003614773","title":"Pharmacokinetic comparison of an oral diclofenac potassium liquid-filled soft gelatin capsule with a diclofenac potassium tablet","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Intramuscular injections and effects","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Diclofenac; Medicine; Pharmacokinetics; Potassium; Capsule; Gelatin; Pharmacology; Chromatography; Biochemistry","score_opus":0.02238942418740035,"score_gpt":0.36776019453908965,"score_spread":0.3453707703516893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085923488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883792,0.0012773634,0.0010272863,0.0021318134,0.0031435888,0.0014983892,0.00004662545,0.0003184056,0.0021773695],"genre_scores_gemma":[0.9911057,0.00036431637,0.0029881077,0.0031993967,0.0014367107,0.00022858492,0.00017146375,0.00016189988,0.00034382107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99693036,0.00025168384,0.0006616708,0.00069071015,0.0007803555,0.000685217],"domain_scores_gemma":[0.99813485,0.0000908348,0.00030765095,0.0006931718,0.0002560829,0.00051738345],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042945813,0.0005568015,0.00086238736,0.00035240783,0.0002743559,0.000047493748,0.00028808077,0.00024813766,0.0026098448],"category_scores_gemma":[0.00003106831,0.00041805496,0.00023432424,0.0005171912,0.0002592419,0.00024076017,0.000025437581,0.0010082069,0.000053389354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052554924,0.0028150163,0.0004462722,0.0000719469,0.00030298208,0.000029080216,0.0017565197,0.00024874302,0.9523023,0.00013046304,0.015464608,0.021176605],"study_design_scores_gemma":[0.013227723,0.0061440994,0.00073810003,0.0001624984,0.000052542673,0.00014737189,0.00031322488,0.018070597,0.7497143,0.0000067300844,0.21085982,0.0005630044],"about_ca_topic_score_codex":0.00032265828,"about_ca_topic_score_gemma":0.000015697535,"teacher_disagreement_score":0.20258798,"about_ca_system_score_codex":0.00008693399,"about_ca_system_score_gemma":0.00020088328,"threshold_uncertainty_score":0.99982715},"labels":[],"label_agreement":null},{"id":"W2088817500","doi":"10.1517/14656566.6.2.157","title":"Hepatitis A vaccines: the growing case for universal immunisation of children","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Hepatitis Viruses Studies and Epidemiology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Herd immunity; Hepatitis A vaccine; Hepatitis A; Hepatitis a virus; Vaccination; Immunization; Hepatitis B; Pediatrics; Environmental health; Immunology; Hepatitis; Virus; Immune system","score_opus":0.11681724765628905,"score_gpt":0.4527021299099891,"score_spread":0.33588488225370006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088817500","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016479439,0.99473965,0.00027834915,0.0013039324,0.00091789727,0.0022759698,0.00015052334,0.000051968396,0.00011691127],"genre_scores_gemma":[0.000028709566,0.9927604,0.00046111972,0.0038798433,0.0020925642,0.00036705285,0.00025071844,0.00009193162,0.00006761114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980626,0.00031338327,0.00079461845,0.0003698866,0.00015044834,0.00030902436],"domain_scores_gemma":[0.99821943,0.00073099637,0.00046655635,0.00041337794,0.00008694028,0.000082679486],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003706554,0.00041484114,0.0015789584,0.00017246541,0.0002206492,0.0000078199255,0.00019746397,0.00021732785,0.00027620714],"category_scores_gemma":[0.00006434472,0.0002596137,0.0007627241,0.00018479608,0.00007136631,0.00009926364,0.000034998087,0.00030494286,0.000013116999],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012240141,0.00012255803,0.00006830677,0.0005727525,0.0008508076,0.000014806158,0.00038586688,0.0000023066314,0.00000813995,0.00036092676,0.02167977,0.97581136],"study_design_scores_gemma":[0.001786348,0.0004255959,0.000016597647,0.0023434667,0.00012240623,0.0005956739,0.000052571362,0.00009783432,0.000016682394,0.0000049213804,0.9943088,0.0002290936],"about_ca_topic_score_codex":0.0020737862,"about_ca_topic_score_gemma":0.00002109952,"teacher_disagreement_score":0.97558224,"about_ca_system_score_codex":0.00021118169,"about_ca_system_score_gemma":0.00014922913,"threshold_uncertainty_score":0.99998564},"labels":[],"label_agreement":null},{"id":"W2090011342","doi":"10.1517/14656566.3.7.875","title":"Pharmacotherapy of acute respiratory distress syndrome","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; ARDS; Intensive care medicine; Magic bullet; Pharmacotherapy; Acute respiratory distress; Disease; Bioinformatics; Lung; Internal medicine","score_opus":0.12810905781096021,"score_gpt":0.44900790018194026,"score_spread":0.32089884237098004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090011342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030789386,0.99201614,0.000066843,0.000092937116,0.0031295512,0.0024965918,0.0004779727,0.00024531,0.0014438664],"genre_scores_gemma":[0.000010214138,0.9909942,0.00020770582,0.0042685475,0.001253855,0.00058907975,0.00034107533,0.00040403116,0.0019312649],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951816,0.00036935692,0.0016295442,0.0010939371,0.0010070218,0.00071851327],"domain_scores_gemma":[0.9970514,0.00012765243,0.000979282,0.001128698,0.00013161461,0.0005813587],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033457213,0.0012339682,0.003615359,0.00081286416,0.00012426448,0.000034970548,0.00064742996,0.00061269273,0.008375048],"category_scores_gemma":[0.0000061551973,0.0009544392,0.0017540661,0.0006470232,0.0001672314,0.00015212959,0.000045069875,0.00090607157,0.00037565024],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031223084,0.00090466643,0.0000027179622,0.002874515,0.0022666312,0.0003614063,0.00015766367,1.1578032e-7,0.003072093,0.00008537858,0.04083347,0.9491291],"study_design_scores_gemma":[0.0040232264,0.0015348487,8.6880885e-7,0.008145066,0.000275453,0.0003424231,0.000010166991,0.0000059618374,0.0060419464,0.000005510349,0.9788152,0.0007993032],"about_ca_topic_score_codex":0.0000044685553,"about_ca_topic_score_gemma":4.704858e-8,"teacher_disagreement_score":0.9483298,"about_ca_system_score_codex":0.00023583994,"about_ca_system_score_gemma":0.00033718266,"threshold_uncertainty_score":0.9992906},"labels":[],"label_agreement":null},{"id":"W2090189145","doi":"10.1517/14656560903140525","title":"The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Food and drug administration; Bioequivalence; Generic drug; MEDLINE; Drug; Substitution (logic); Drug approval; Antiepileptic drug; Alternative medicine; Epilepsy; Family medicine; Psychiatry; Pharmacology","score_opus":0.2535574849152221,"score_gpt":0.45538050080739784,"score_spread":0.20182301589217572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090189145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008359441,0.992677,0.000053941374,0.0018776554,0.0009710949,0.0011127152,0.00045422965,0.000013603243,0.0028314167],"genre_scores_gemma":[0.00005518436,0.99733245,0.00008682827,0.00192273,0.00030140838,0.00017447826,0.000052275394,0.00004594436,0.000028701668],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99632394,0.00013118015,0.0026873616,0.0004966805,0.000058114325,0.00030272544],"domain_scores_gemma":[0.9955675,0.00047410614,0.0029449093,0.0008226661,0.00007501689,0.00011581486],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010991759,0.0003857666,0.002090633,0.000281274,0.00008624232,0.000019800085,0.0008816244,0.00015258935,0.0007732454],"category_scores_gemma":[0.000079389974,0.00032477724,0.00079393585,0.00036566128,0.00020087259,0.00014066689,0.00004290134,0.00024381897,0.00011546058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027910866,0.0001253196,0.0000035843138,0.006725058,0.000231974,6.131808e-8,0.00006021839,0.000009947917,0.0000143690295,0.072260186,0.011018476,0.9095229],"study_design_scores_gemma":[0.00028300626,0.00010865496,0.0000064363344,0.013175982,0.000020933814,0.0000025965626,0.00000167988,0.00007488462,0.00015300399,0.0010539544,0.98484176,0.00027713063],"about_ca_topic_score_codex":0.000036983412,"about_ca_topic_score_gemma":4.802883e-7,"teacher_disagreement_score":0.97382325,"about_ca_system_score_codex":0.0003881249,"about_ca_system_score_gemma":0.00034693797,"threshold_uncertainty_score":0.9999204},"labels":[],"label_agreement":null},{"id":"W2090657901","doi":"10.1517/14656566.9.1.83","title":"Clinical management of chronic obstructive pulmonary disease and asthma in an obese patient","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Asthma; COPD; Obesity; Pulmonary disease; Concomitant; Intensive care medicine; Management of obesity; Disease; Respiratory system; Internal medicine; Weight loss; Physical therapy","score_opus":0.08568150894631833,"score_gpt":0.4675737346072304,"score_spread":0.3818922256609121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090657901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001996451,0.99201643,0.000012043411,0.00007374715,0.0009823944,0.0039657913,0.00015742426,0.00005788422,0.00073783594],"genre_scores_gemma":[0.0005230359,0.9967424,0.00026194626,0.00024384199,0.0010032201,0.0005061126,0.00039841828,0.00018328037,0.00013771158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946713,0.00067263894,0.0015599467,0.0014027305,0.000989094,0.0007043054],"domain_scores_gemma":[0.9972118,0.00023543912,0.0004578667,0.0009496456,0.0001214496,0.0010238079],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051788625,0.0007863701,0.0019735864,0.0007548227,0.000071768576,0.000022132095,0.00037533438,0.0003044726,0.0006679744],"category_scores_gemma":[0.000013513929,0.0006628348,0.00066212105,0.0006051852,0.00044213724,0.00017911778,0.00018055651,0.00096355594,0.000029820203],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001721932,0.0031224615,0.0003911803,0.014047455,0.0004577194,0.0010154173,0.00009938525,0.0000014606298,0.000006419368,0.00021127236,0.00020540724,0.9787199],"study_design_scores_gemma":[0.0029976387,0.0007578686,0.008375319,0.016899759,0.000081775805,0.000050983825,0.00012794948,0.00027523126,0.000009930177,0.00004551373,0.96979177,0.0005862328],"about_ca_topic_score_codex":0.000018325343,"about_ca_topic_score_gemma":9.350868e-7,"teacher_disagreement_score":0.9781337,"about_ca_system_score_codex":0.0011323659,"about_ca_system_score_gemma":0.00063769915,"threshold_uncertainty_score":0.9995823},"labels":[],"label_agreement":null},{"id":"W2091638536","doi":"10.1517/14656566.8.18.3147","title":"Prevention of Type 2 diabetes: fact or fiction?","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Prediabetes; Orlistat; Diabetes mellitus; Acarbose; Impaired glucose tolerance; Type 2 diabetes; Metformin; Internal medicine; Impaired fasting glucose; Weight loss; Obesity; Endocrinology","score_opus":0.1900839952381679,"score_gpt":0.5176337641156915,"score_spread":0.32754976887752363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091638536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007193788,0.99436086,0.00002804844,0.00007800746,0.002599391,0.0015517744,0.000026209786,0.000106352214,0.0011774383],"genre_scores_gemma":[0.000020448277,0.99486154,0.00020372822,0.0011241772,0.0008860975,0.00014481595,0.0003068597,0.000081357335,0.0023709731],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804,0.00021256831,0.0006713306,0.0004414886,0.00031242266,0.00032216447],"domain_scores_gemma":[0.9988144,0.00022340668,0.00037891822,0.00032187282,0.0000872092,0.00017417097],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025737294,0.0004795291,0.0014963362,0.00039389078,0.000077329365,0.0000066079224,0.00015748008,0.0003751044,0.0045285923],"category_scores_gemma":[0.000014465644,0.00031918846,0.0005881639,0.00040266276,0.00006678956,0.00005905741,0.000017633498,0.0004157327,0.00017899612],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075812807,0.0015712357,0.000011748464,0.0020923533,0.001249276,0.00001657504,0.00010456248,3.669855e-7,0.00015331176,0.000013469738,0.03583863,0.9581903],"study_design_scores_gemma":[0.0024415196,0.0018485042,0.000009280749,0.006040486,0.00018410529,0.000022927852,0.00000789034,0.000007401059,0.002485342,0.0000038642706,0.98669434,0.00025437152],"about_ca_topic_score_codex":0.000002959492,"about_ca_topic_score_gemma":1.4411773e-7,"teacher_disagreement_score":0.957936,"about_ca_system_score_codex":0.00024654652,"about_ca_system_score_gemma":0.00036534577,"threshold_uncertainty_score":0.99992603},"labels":[],"label_agreement":null},{"id":"W2092235705","doi":"10.1517/14656566.8.18.3097","title":"Therapeutic management of acute intracerebral haemorrhage","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Alberta","funders":"","keywords":"Medicine; Intensive care medicine; Neurointensive care; Stroke (engine); Coagulopathy; Intracerebral hemorrhage; Natural history; Surgery; Internal medicine; Subarachnoid hemorrhage","score_opus":0.1372593060256154,"score_gpt":0.4886392771859018,"score_spread":0.3513799711602864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092235705","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011220621,0.9881355,0.0004958982,0.00034825553,0.001309241,0.0027967447,0.000066701024,0.00015746852,0.0066789268],"genre_scores_gemma":[0.0000111776535,0.98946285,0.0036599566,0.0012787015,0.0011421263,0.00029779872,0.00026779846,0.0002288342,0.0036507726],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957942,0.0002149509,0.0011794679,0.00083153474,0.0011261152,0.00085374387],"domain_scores_gemma":[0.99810934,0.00013782275,0.0003954826,0.0008744456,0.00012878001,0.00035415063],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005972544,0.0008709987,0.0023925689,0.0007376122,0.00012461412,0.000034882552,0.0005723503,0.000509833,0.0033806139],"category_scores_gemma":[0.0000027527058,0.0006206796,0.0012156955,0.00077286543,0.00018236194,0.00009223848,0.00008463439,0.001206642,0.00042378576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056001334,0.0007294927,0.0000010665495,0.010361606,0.0026351346,0.00038109432,0.00013432218,1.0542909e-7,0.00008823957,0.0012172858,0.0040630163,0.9798286],"study_design_scores_gemma":[0.0022711374,0.0006265933,0.0000017493469,0.008296152,0.00027694847,0.00029456866,0.00003915564,0.00019428424,0.0013413592,0.00002566919,0.9860887,0.00054366124],"about_ca_topic_score_codex":0.000008886907,"about_ca_topic_score_gemma":7.007809e-8,"teacher_disagreement_score":0.9820257,"about_ca_system_score_codex":0.00031458124,"about_ca_system_score_gemma":0.00021660082,"threshold_uncertainty_score":0.99962443},"labels":[],"label_agreement":null},{"id":"W2093145231","doi":"10.1517/14656566.2014.931373","title":"Pityriasis versicolor: an update on pharmacological treatment options","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Pityriasis; Dosing; Dermatology; Tinea versicolor; Antifungal; Expert opinion; Malassezia; Adverse effect; Intensive care medicine; Clinical trial; Pharmacology; Internal medicine","score_opus":0.16159978007492787,"score_gpt":0.5005085718537026,"score_spread":0.3389087917787747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093145231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053815173,0.99272424,0.000010015385,0.00075293647,0.0019544128,0.0027589975,0.0003702143,0.00029237606,0.001083022],"genre_scores_gemma":[0.000051475785,0.98657,0.00017583363,0.007036217,0.0023544005,0.0014219165,0.0016714908,0.00016578988,0.00055289513],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99680597,0.00051225355,0.0006052942,0.001062785,0.00047748644,0.00053621625],"domain_scores_gemma":[0.9980322,0.00017944568,0.0002977549,0.0006560844,0.00005139888,0.0007831085],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011228985,0.001003792,0.0020466556,0.00037444793,0.00025171755,0.00005947313,0.0002721825,0.00033895005,0.004561513],"category_scores_gemma":[0.0000072100897,0.0006521721,0.0013221112,0.00025605308,0.000079548015,0.000088016306,0.000023427614,0.00035309506,0.0017461197],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010454481,0.0065875677,0.0000021067096,0.00029058338,0.001972988,0.00008315879,0.00004129726,0.0000020747018,0.000017850403,0.00036433656,0.028362906,0.9612297],"study_design_scores_gemma":[0.008002366,0.005944698,0.000004893181,0.0017607945,0.0006333644,0.000033213902,0.0000057406405,0.000032675176,0.00013967995,0.000011147712,0.9829045,0.0005269051],"about_ca_topic_score_codex":0.000028112841,"about_ca_topic_score_gemma":3.4660107e-7,"teacher_disagreement_score":0.9607028,"about_ca_system_score_codex":0.0010074824,"about_ca_system_score_gemma":0.00036812059,"threshold_uncertainty_score":0.99959296},"labels":[],"label_agreement":null},{"id":"W2096607288","doi":"10.1517/14656566.3.12.1739","title":"Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Doxorubicin; Therapeutic index; Metastatic breast cancer; Breast cancer; Pharmacology; Cumulative dose; Anthracycline; Cancer; Cardiotoxicity; Liposome; Therapeutic effect; Chemotherapy; Oncology; Internal medicine; Drug","score_opus":0.1480815675914475,"score_gpt":0.45383212290448716,"score_spread":0.30575055531303963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096607288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034481556,0.9886968,0.000006171865,0.0020804668,0.0021993641,0.0035420307,0.00019661809,0.00022776147,0.0030162951],"genre_scores_gemma":[0.000033353877,0.9813816,0.00010568468,0.0069028153,0.003957486,0.0014508703,0.0005711122,0.0003070234,0.0052900636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99567914,0.00043634302,0.0011025107,0.0013426759,0.0005535177,0.0008857902],"domain_scores_gemma":[0.99817985,0.00012895845,0.00044895333,0.00062722166,0.00006992612,0.0005450756],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0002054806,0.0013052673,0.0030411456,0.0009060163,0.000099888755,0.000056951045,0.00044843738,0.0006725003,0.018908778],"category_scores_gemma":[0.0000019616284,0.00097194297,0.00089119765,0.0012907408,0.00009804684,0.0001339625,0.000028312023,0.0011938942,0.00031022087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001125434,0.0021739157,0.000025560019,0.00075460476,0.0011342269,0.000051469156,0.0007761372,0.0000050177605,0.00037523577,0.000020414289,0.18521614,0.80834186],"study_design_scores_gemma":[0.014358928,0.00039713515,0.000026047563,0.004667742,0.00010473985,0.0002510844,0.000012358657,0.00011520621,0.00018065714,0.0000061954934,0.9790408,0.00083909306],"about_ca_topic_score_codex":0.0007463647,"about_ca_topic_score_gemma":0.000002817038,"teacher_disagreement_score":0.80750275,"about_ca_system_score_codex":0.0009392344,"about_ca_system_score_gemma":0.00086603774,"threshold_uncertainty_score":0.9999699},"labels":[],"label_agreement":null},{"id":"W2098097322","doi":"10.1517/14656566.2014.923403","title":"Desvenlafaxine for the treatment of major depressive disorder","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Treatment of Major Depression","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); University of Toronto","funders":"","keywords":"Tolerability; Major depressive disorder; Antidepressant; Medicine; Psychiatry; Placebo; Population; Reuptake inhibitor; Clinical trial; Internal medicine; Oncology; Pharmacology; Adverse effect; Mood; Alternative medicine","score_opus":0.08784260984736643,"score_gpt":0.4567015111206201,"score_spread":0.36885890127325366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098097322","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005764733,0.9908117,0.0008878894,0.00069514744,0.0014810998,0.00576446,0.00012517924,0.000089035326,0.000139737],"genre_scores_gemma":[0.000011933112,0.99161756,0.0005232093,0.00041202086,0.0016590196,0.0040772473,0.00036196003,0.00020906216,0.0011279902],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99770683,0.00018377313,0.0007222651,0.0006296749,0.0004002781,0.00035720764],"domain_scores_gemma":[0.99709284,0.0011852926,0.00058979425,0.00089274306,0.00008451897,0.00015483233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000115828036,0.00075596606,0.0021035275,0.00020837485,0.00016575995,0.000017999628,0.0002902163,0.00026794962,0.00046741238],"category_scores_gemma":[0.000021004862,0.00036845353,0.0013742365,0.00016442624,0.00009787836,0.00003611153,0.000015643884,0.00015550148,0.000042930293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006589577,0.0018604039,0.000007909073,0.001558419,0.0016052988,0.000003390382,0.00018847486,0.0000016944762,0.000061967985,0.000056262063,0.0095688375,0.9844284],"study_design_scores_gemma":[0.010198386,0.0027887025,0.0000045482184,0.0052852547,0.00046611426,0.000027042448,0.000008622613,0.000050379567,0.001407212,0.0000096355425,0.9794497,0.00030444082],"about_ca_topic_score_codex":0.000027671833,"about_ca_topic_score_gemma":7.310333e-7,"teacher_disagreement_score":0.98412395,"about_ca_system_score_codex":0.00022166883,"about_ca_system_score_gemma":0.00014408318,"threshold_uncertainty_score":0.99987674},"labels":[],"label_agreement":null},{"id":"W2098445432","doi":"10.1517/14656566.3.4.363","title":"Synthetic dopamine agonists","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Medicine; Expert opinion; Dopamine; Dopamine agonist; Pharmacology; Pharmacotherapy; Pramipexole; Endogenous agonist; Dopamine receptor; Internal medicine; Dopamine receptor D1; Dopaminergic; Intensive care medicine; Disease; Parkinson's disease","score_opus":0.16680712516147878,"score_gpt":0.46492068759023286,"score_spread":0.2981135624287541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098445432","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005343588,0.99034554,0.00005913382,0.00090969884,0.0020294113,0.0017017438,0.000039769726,0.00031884163,0.004590514],"genre_scores_gemma":[0.000013726545,0.9897747,0.000151208,0.0019474332,0.0014531735,0.0004669629,0.00021875079,0.0003150595,0.0056590084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681306,0.0002890146,0.00077675295,0.00094402744,0.00067049044,0.0005066421],"domain_scores_gemma":[0.9980877,0.00024536627,0.00040331625,0.00088629377,0.00007936671,0.00029793486],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016760878,0.00087271817,0.00224481,0.00048669757,0.00014141358,0.000056737386,0.00028691106,0.00040028157,0.010163535],"category_scores_gemma":[0.00004147806,0.0006869756,0.0011262636,0.00044596856,0.00009806832,0.00009790594,0.000034335077,0.0008529246,0.0031597544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005717413,0.0010321998,9.034646e-7,0.0017313616,0.00040745817,0.00004506184,0.00006949287,3.4855776e-7,0.00004316081,0.00005633228,0.01906551,0.977491],"study_design_scores_gemma":[0.001753575,0.00026677214,6.4756534e-7,0.008381613,0.000087691405,0.00041222322,0.000022401133,0.000037357535,0.000023877214,0.000001749214,0.98839545,0.00061662303],"about_ca_topic_score_codex":0.0000064552924,"about_ca_topic_score_gemma":9.835599e-8,"teacher_disagreement_score":0.97687435,"about_ca_system_score_codex":0.00028041523,"about_ca_system_score_gemma":0.00014350993,"threshold_uncertainty_score":0.99955815},"labels":[],"label_agreement":null},{"id":"W2099168269","doi":"10.1517/14656566.3.3.341","title":"Seretide for obstructive lung disease","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital","funders":"","keywords":"Salmeterol; Fluticasone propionate; Medicine; Inhaler; Asthma; Bronchodilator; COPD; Fluticasone; Exacerbation; Salbutamol; Maintenance therapy; Corticosteroid; Dry-powder inhaler; Intensive care medicine; Internal medicine; Chemotherapy","score_opus":0.08973338735497513,"score_gpt":0.4491465449872883,"score_spread":0.3594131576323132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099168269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000017678096,0.9932917,0.00012982849,0.00023482945,0.0019191295,0.0033059455,0.00039510897,0.00018102817,0.00054067245],"genre_scores_gemma":[0.0000023433902,0.9892772,0.00014359402,0.0033278926,0.003716291,0.0015601708,0.00040834496,0.00022943545,0.0013347275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977414,0.00014906017,0.0005630285,0.000742504,0.00037994163,0.00042407538],"domain_scores_gemma":[0.99822193,0.00020004688,0.00028696083,0.0005046046,0.0000924084,0.00069402123],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000070608265,0.000698476,0.0014818468,0.0002633349,0.00015650174,0.000031519096,0.00022339601,0.00021330529,0.0018095946],"category_scores_gemma":[0.000034530432,0.0004997925,0.0013342553,0.0002031382,0.00008778445,0.00007194115,0.000019503805,0.0003158926,0.000123489],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035093084,0.00035625085,0.00000420246,0.004765307,0.0003324812,0.000029054108,0.000061432635,3.9333983e-7,0.0000049692167,0.00010993435,0.08355383,0.9104312],"study_design_scores_gemma":[0.0021258795,0.0001895676,0.000005348781,0.009248887,0.00015076986,0.000014944973,0.00001297851,0.000089469664,0.000020665284,0.000009504645,0.9876152,0.00051676086],"about_ca_topic_score_codex":0.0000011278951,"about_ca_topic_score_gemma":1.7745224e-8,"teacher_disagreement_score":0.90991443,"about_ca_system_score_codex":0.00022229238,"about_ca_system_score_gemma":0.0003338447,"threshold_uncertainty_score":0.99974537},"labels":[],"label_agreement":null},{"id":"W2101110309","doi":"10.1517/14656566.9.3.491","title":"Alendronate for the treatment of osteoporosis in men","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada; University of Saskatchewan","funders":"","keywords":"Medicine; Osteoporosis; Bisphosphonate; Bone mineral; Regimen; Fragility fracture; Dosing; Internal medicine; Bone density; Surgery","score_opus":0.15894291898413984,"score_gpt":0.49535711169654223,"score_spread":0.33641419271240236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101110309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006544287,0.9916361,0.000004648383,0.0011616136,0.00058386964,0.0060461024,0.000113086215,0.00002819429,0.00041982066],"genre_scores_gemma":[0.0000033534845,0.99366724,0.00013833676,0.00067156705,0.0006835275,0.0035971843,0.00017713691,0.00011175373,0.0009498962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99752825,0.0001881834,0.00086099847,0.00047487277,0.00044523214,0.00050246425],"domain_scores_gemma":[0.99806905,0.0008424174,0.00028063613,0.0005228986,0.00007509313,0.0002098955],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002007271,0.0004655635,0.0017724993,0.0003527285,0.00011243132,0.0000078749235,0.00022039989,0.00024220148,0.0003237455],"category_scores_gemma":[0.000014270981,0.0002563951,0.00079511665,0.00034088432,0.00010313643,0.000029684345,0.000009729092,0.00025190084,0.000028314345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006985533,0.00103172,0.00000462737,0.0017358661,0.00021632573,0.000005467487,0.0008442487,3.6172958e-7,0.000018241231,0.000012890763,0.021690499,0.9737412],"study_design_scores_gemma":[0.0058171176,0.0026102501,0.000010494893,0.0027644369,0.000023032488,0.000037241287,0.000051766678,0.000039099385,0.00036498808,0.0000018989123,0.9880869,0.00019276739],"about_ca_topic_score_codex":0.00018031964,"about_ca_topic_score_gemma":0.000003206552,"teacher_disagreement_score":0.9735484,"about_ca_system_score_codex":0.00046185547,"about_ca_system_score_gemma":0.0006443297,"threshold_uncertainty_score":0.99998885},"labels":[],"label_agreement":null},{"id":"W2102096093","doi":"10.1517/14656566.2014.873790","title":"Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Medicine; Dopamine; Dopamine receptor D2; Antipsychotic; Schizophrenia (object-oriented programming); Clinical trial; Dopamine receptor; Pharmacology; Dopamine receptor D3; Psychiatry; Internal medicine","score_opus":0.1437235222958871,"score_gpt":0.46804408064761527,"score_spread":0.3243205583517281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102096093","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049394264,0.9890803,0.000005178366,0.0032214778,0.0010370081,0.0059119635,0.00007546113,0.00006709108,0.00010759355],"genre_scores_gemma":[0.000058361464,0.98956823,0.0012027218,0.0008536664,0.0024960814,0.0043125884,0.0011341868,0.00012763805,0.0002464951],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99398285,0.0018104844,0.0018952179,0.0007936311,0.00088546984,0.0006323437],"domain_scores_gemma":[0.9968442,0.0016239996,0.000580898,0.00049408607,0.00008245056,0.00037437456],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002320571,0.00076404214,0.002852133,0.00085090037,0.0001233331,0.00008100867,0.0004078121,0.00029740782,0.0034320566],"category_scores_gemma":[0.00038965303,0.0004291683,0.00063016714,0.00089798594,0.00015309142,0.00014029627,0.000051723444,0.0012517852,0.0004002146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058654896,0.0011015696,0.0000030219253,0.00044203424,0.0003699459,0.0000195743,0.00031648687,0.0000012152169,0.0002650438,0.00026420222,0.022337377,0.96901405],"study_design_scores_gemma":[0.041857477,0.0004221908,0.0000024270018,0.006537997,0.000026354463,0.000016280575,0.000057921727,0.000103013364,0.0004319759,0.00006886229,0.9501013,0.00037420756],"about_ca_topic_score_codex":0.00015535964,"about_ca_topic_score_gemma":0.0000031399777,"teacher_disagreement_score":0.96863985,"about_ca_system_score_codex":0.00063270767,"about_ca_system_score_gemma":0.0011577978,"threshold_uncertainty_score":0.999816},"labels":[],"label_agreement":null},{"id":"W2102201050","doi":"10.1517/14656566.4.12.2213","title":"Anti-thrombotic therapy in cancer patients","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Intensive care medicine; Cancer; Low molecular weight heparin; Thrombosis; Heparin; Venous thromboembolism; Clinical trial; Anticoagulant; Surgery; Internal medicine","score_opus":0.11896333985239967,"score_gpt":0.4575935634708984,"score_spread":0.33863022361849876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102201050","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013298054,0.99060416,0.000002403949,0.00026044445,0.003669561,0.0036741395,0.000028708857,0.00008913505,0.0015384604],"genre_scores_gemma":[0.00003214063,0.9884479,0.00004877339,0.008616961,0.00068084267,0.0015281083,0.00017419663,0.00023008122,0.00024102157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968139,0.0002930817,0.000862838,0.00086440734,0.0005621914,0.00060357864],"domain_scores_gemma":[0.9987508,0.00007896808,0.0003514429,0.00053573155,0.00006883992,0.00021419335],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021432669,0.00081688276,0.0030138555,0.00058171817,0.00008200309,0.000040909446,0.00028319648,0.00029717176,0.0030515583],"category_scores_gemma":[0.000007297168,0.0006057199,0.0006078074,0.00055407605,0.0000554167,0.00008150521,0.000026453477,0.000530765,0.00019803387],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003565533,0.0041254116,0.000085185384,0.001291049,0.0005259166,0.00001132052,0.00023255305,0.0000019497556,0.000006747908,0.00008927879,0.056108467,0.93748647],"study_design_scores_gemma":[0.004168665,0.00071790774,0.00023632696,0.009668831,0.000040781884,0.0000026648013,0.0000083454215,0.0000031896668,0.000051658855,0.00000569189,0.98452795,0.00056800875],"about_ca_topic_score_codex":0.00011325727,"about_ca_topic_score_gemma":0.0000014763355,"teacher_disagreement_score":0.93691844,"about_ca_system_score_codex":0.00049652386,"about_ca_system_score_gemma":0.0002594741,"threshold_uncertainty_score":0.9996394},"labels":[],"label_agreement":null},{"id":"W2103061944","doi":"10.1517/14656566.3.8.1131","title":"The evolution and role of macrolides in infectious diseases","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; St. Paul's Hospital; Royal University Hospital","funders":"","keywords":"Azithromycin; Clarithromycin; Erythromycin; Medicine; Antibiotics; Intensive care medicine; Macrolide Antibiotics; Antibiotic resistance; Antimicrobial; Infectious disease (medical specialty); Adverse effect; Pharmacology; Disease; Internal medicine; Microbiology; Biology","score_opus":0.03350763329633764,"score_gpt":0.3894406921246051,"score_spread":0.3559330588282674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103061944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007813179,0.997529,0.0000036111558,0.00015329149,0.00057263963,0.0007776589,0.000021389571,0.000052758158,0.0008115613],"genre_scores_gemma":[0.0007649013,0.998084,0.0000013066807,0.000286713,0.0004385636,0.00026771487,0.000010553983,0.000044368648,0.00010189049],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987158,0.00020069751,0.00043941254,0.00025946007,0.0001834196,0.00020116974],"domain_scores_gemma":[0.99919873,0.00021937917,0.0002007895,0.0002410487,0.000033853565,0.0001061883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009521416,0.00027740333,0.00073956116,0.00028542528,0.00013700707,0.000017691978,0.00008370927,0.00014651849,0.00007695605],"category_scores_gemma":[0.000023203762,0.0001666718,0.00026436077,0.00029757535,0.00012247644,0.000042737778,0.000015436617,0.0003005677,0.000016311335],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027991162,0.00028947415,0.00033411305,0.00056426536,0.00013301209,0.0000029362893,0.00010731642,7.693231e-7,0.00021996908,0.0003100467,0.0008540151,0.9971561],"study_design_scores_gemma":[0.00090150366,0.00023136861,0.00009916702,0.0027787196,0.00003010372,0.000063951185,0.00002684761,0.00003491845,0.000025392881,0.000052372412,0.99560356,0.00015207597],"about_ca_topic_score_codex":0.000029162828,"about_ca_topic_score_gemma":0.0000020060188,"teacher_disagreement_score":0.99700403,"about_ca_system_score_codex":0.0001841172,"about_ca_system_score_gemma":0.00011442308,"threshold_uncertainty_score":0.6796679},"labels":[],"label_agreement":null},{"id":"W2103158417","doi":"10.1517/14656566.2014.865724","title":"Mechanisms, treatment and prevention of cellular injury and death from delayed events after aneurysmal subarachnoid hemorrhage","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Subarachnoid hemorrhage; Ischemia; Context (archaeology); Vasospasm; Pathogenesis; Anesthesia; Cardiology; Internal medicine","score_opus":0.04896894933888376,"score_gpt":0.36300927752500767,"score_spread":0.31404032818612393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103158417","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064404365,0.989212,0.00039372136,0.00013856709,0.00032520693,0.0031502077,0.00022366382,0.00006582343,0.00005040353],"genre_scores_gemma":[0.007256613,0.9871717,0.002055318,0.00023115755,0.00029737694,0.0016458692,0.000689722,0.00009645742,0.00055575784],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816424,0.00016912818,0.000570467,0.0006325776,0.00021763128,0.0002459763],"domain_scores_gemma":[0.999004,0.00005815923,0.00030494333,0.00039254458,0.000050286093,0.00019008714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005686706,0.00060762244,0.00116366,0.0001983885,0.00008854018,0.000022382148,0.0001009773,0.0002452147,0.00070285343],"category_scores_gemma":[0.0000020886152,0.00043676584,0.0003122419,0.0001104049,0.000036079033,0.000087634195,0.000028722901,0.00018108063,0.00004191081],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006030403,0.00090174243,0.000012363419,0.00093582226,0.00026655162,0.000026189038,0.0001720652,1.9900115e-8,0.0061824843,0.0001566334,0.000052660434,0.9906904],"study_design_scores_gemma":[0.014078003,0.012530056,0.00023726412,0.0030974702,0.0025788778,0.0005265332,0.000067084395,0.00029386106,0.024026368,0.0020253751,0.938467,0.0020720905],"about_ca_topic_score_codex":0.00011757054,"about_ca_topic_score_gemma":6.630505e-7,"teacher_disagreement_score":0.9886183,"about_ca_system_score_codex":0.00011898622,"about_ca_system_score_gemma":0.00008303442,"threshold_uncertainty_score":0.99980843},"labels":[],"label_agreement":null},{"id":"W2104836659","doi":"10.1517/14656566.3.3.277","title":"Ketolides in the treatment of respiratory infections","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Ketolide; Telithromycin; Streptococcus pneumoniae; Microbiology; Medicine; Chronic bronchitis; Erythromycin; Respiratory tract infections; Streptococcus pyogenes; Pharmacology; Antibiotics; Biology; Bacteria; Staphylococcus aureus; Respiratory system; Internal medicine","score_opus":0.18356362710583396,"score_gpt":0.47271462341288684,"score_spread":0.2891509963070529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104836659","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006416853,0.9942377,0.000002901164,0.00029484543,0.0010439634,0.0015962251,0.000025157953,0.000059658734,0.0026753312],"genre_scores_gemma":[0.000025556941,0.9957323,0.0000038296466,0.0019350663,0.0010466254,0.0009937974,0.000019734458,0.000063326734,0.0001797404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980106,0.00045215985,0.0006731701,0.00034589754,0.00027136574,0.00024683774],"domain_scores_gemma":[0.9987777,0.0003102259,0.0002515359,0.0005314781,0.000038092017,0.00009100425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014196338,0.00043962465,0.0012067183,0.0006287847,0.000113932736,0.000015519448,0.00015099667,0.00023683882,0.0004881924],"category_scores_gemma":[0.000010810817,0.00024246193,0.00077333837,0.0006479888,0.000097422424,0.000040991075,0.0000045602774,0.0003208669,0.00009448038],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016061307,0.0035605168,0.000038127593,0.00052795606,0.00026310928,0.000020347,0.0008338711,0.0000012998556,0.00014148212,0.000077409284,0.004926581,0.98959327],"study_design_scores_gemma":[0.0014342082,0.0022263096,0.000017776227,0.00247972,0.00005204682,0.000061495506,0.000027219712,0.000002115867,0.000110891895,0.0000028321242,0.99338603,0.00019936476],"about_ca_topic_score_codex":0.0000170997,"about_ca_topic_score_gemma":0.000001980311,"teacher_disagreement_score":0.9893939,"about_ca_system_score_codex":0.0002793728,"about_ca_system_score_gemma":0.00017579048,"threshold_uncertainty_score":0.988731},"labels":[],"label_agreement":null},{"id":"W2105286456","doi":"10.1517/14656566.2012.681779","title":"New therapeutic options for onychomycosis","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Terbinafine; Azole; Dermatology; Pharmacotherapy; Dosing; Drug; Iontophoresis; Pharmacology; Itraconazole; Internal medicine; Antifungal","score_opus":0.22693141211679096,"score_gpt":0.5066414459557826,"score_spread":0.2797100338389917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105286456","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.4946635e-7,0.99269086,0.00061148085,0.00044020035,0.0022645553,0.0032182273,0.00016396161,0.00015123391,0.00045930082],"genre_scores_gemma":[0.0000022923543,0.987533,0.0013723115,0.0023331353,0.0035394193,0.0014994197,0.0007383275,0.00021523895,0.0027669054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817747,0.00008981903,0.00046583774,0.0005067336,0.00029294856,0.00046717192],"domain_scores_gemma":[0.99849856,0.0001722693,0.00021973264,0.0004987716,0.00004647975,0.00056420785],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000078696576,0.00062710437,0.0013118432,0.00025089266,0.00013077543,0.000035335102,0.00018186925,0.00023872434,0.002452396],"category_scores_gemma":[0.000003881831,0.00043895145,0.0013516896,0.0002186359,0.00002240249,0.000077089746,0.000012591532,0.00021947532,0.00037071703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021499807,0.00078551995,0.0000030458689,0.0010258957,0.0013424708,0.0000017391832,0.00004981474,3.5719637e-8,0.0000065544064,0.0004950249,0.04401471,0.95206016],"study_design_scores_gemma":[0.0037673712,0.00043491393,0.0000057186808,0.0034234044,0.0005397616,0.000025341331,0.000004476873,0.000002236726,0.00002691564,0.000042396307,0.9913482,0.00037926467],"about_ca_topic_score_codex":0.000016438617,"about_ca_topic_score_gemma":1.2237813e-7,"teacher_disagreement_score":0.9516809,"about_ca_system_score_codex":0.00025101073,"about_ca_system_score_gemma":0.00036969024,"threshold_uncertainty_score":0.9998062},"labels":[],"label_agreement":null},{"id":"W2106610960","doi":"10.1517/14656566.2013.797965","title":"Dutasteride for the treatment of benign prostatic hyperplasia","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dutasteride; Medicine; Hyperplasia; Urology; Finasteride; Tamsulosin; Prostatic Diseases; Prostate; Internal medicine; Cancer","score_opus":0.24295717235312522,"score_gpt":0.516529994349962,"score_spread":0.27357282199683686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106610960","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000064339315,0.9888751,0.000053783846,0.00069216907,0.00071075227,0.009104554,0.00018581635,0.00003907423,0.00033235142],"genre_scores_gemma":[0.0000030799658,0.9901384,0.0003944007,0.00029921246,0.0009275254,0.005406976,0.00027167477,0.00013848077,0.0024202287],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979899,0.00017597938,0.00061187247,0.00044003082,0.00037968793,0.00040253927],"domain_scores_gemma":[0.99808943,0.0008621814,0.00022757499,0.0005479547,0.000102587,0.00017027528],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001632292,0.0005113534,0.0014373028,0.00019828908,0.00012267436,0.000031887892,0.00021839747,0.00014098914,0.0010442736],"category_scores_gemma":[0.000009234167,0.00025542674,0.000759572,0.00018877863,0.00010463435,0.000046209185,0.000011827691,0.00018236764,0.000094053525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005571322,0.00095399824,8.481632e-7,0.0031754568,0.0009363598,0.0000049631385,0.00082132977,2.997606e-7,0.00012824152,0.000041517167,0.0149419345,0.9784379],"study_design_scores_gemma":[0.0029677893,0.0059679947,6.3448766e-7,0.0024386665,0.00009894122,0.00008061525,0.000057038767,0.000054076198,0.0010321817,0.0000093508825,0.98707306,0.00021962407],"about_ca_topic_score_codex":0.000029722816,"about_ca_topic_score_gemma":1.5917954e-7,"teacher_disagreement_score":0.9782183,"about_ca_system_score_codex":0.00016218743,"about_ca_system_score_gemma":0.0003458399,"threshold_uncertainty_score":0.9999898},"labels":[],"label_agreement":null},{"id":"W2106863992","doi":"10.1517/14656566.9.14.2545","title":"Mycophenolate mofetil in myasthenia gravis: the unanswered question","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital","funders":"","keywords":"Medicine; Myasthenia gravis; Mycophenolate; Immunosuppression; Clinical trial; Weakness; Mycophenolic acid; Disease; Intensive care medicine; Internal medicine; Transplantation; Surgery","score_opus":0.043270591970313375,"score_gpt":0.36029755492114884,"score_spread":0.3170269629508355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106863992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647251,0.01221554,0.00022743049,0.015726231,0.0018906277,0.00140619,0.0000117843665,0.0002792665,0.0035178475],"genre_scores_gemma":[0.9650283,0.022577584,0.0003328503,0.009978563,0.0007970367,0.0001607131,0.000030347412,0.000079776735,0.0010148144],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981545,0.00020285405,0.00041231434,0.0004043812,0.0004403127,0.0003856188],"domain_scores_gemma":[0.99916375,0.000072610776,0.00010344721,0.00044294228,0.00006170334,0.00015552295],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029365387,0.0002965768,0.00034328204,0.00018805638,0.00020097021,0.000018424267,0.0002070057,0.00008801966,0.0009136431],"category_scores_gemma":[0.000013597264,0.00019367893,0.00015384554,0.00035753052,0.000117368734,0.000090923815,0.000016965829,0.00036924912,0.00017892395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016580636,0.0051309513,0.024731163,0.000082886734,0.0005254463,0.0007998316,0.034761414,0.00018247117,0.52970845,0.018396342,0.1346943,0.2344061],"study_design_scores_gemma":[0.015396076,0.001088059,0.028283149,0.00036768743,0.0000057974303,0.0005473632,0.00026291094,0.0017615992,0.0447061,0.0008053162,0.9062289,0.000547037],"about_ca_topic_score_codex":0.00019045998,"about_ca_topic_score_gemma":0.0000027254937,"teacher_disagreement_score":0.7715346,"about_ca_system_score_codex":0.0001001836,"about_ca_system_score_gemma":0.000086727174,"threshold_uncertainty_score":0.99999964},"labels":[],"label_agreement":null},{"id":"W2107109865","doi":"10.1517/14656566.8.9.1221","title":"Latest medical treatment strategies for venous thromboembolism","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Fondaparinux; Warfarin; Intensive care medicine; Heparin; Anticoagulant; Low molecular weight heparin; Thrombosis; Venous thromboembolism; Coagulation cascade; Thrombus; Discovery and development of direct thrombin inhibitors; Bivalirudin; Surgery; Internal medicine; Thrombin; Myocardial infarction; Platelet; Atrial fibrillation; Percutaneous coronary intervention","score_opus":0.19151695133716443,"score_gpt":0.5131542746789183,"score_spread":0.3216373233417539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107109865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000056833946,0.9856576,0.00020728119,0.0010044279,0.003515349,0.004997205,0.00007877832,0.00029576677,0.00423795],"genre_scores_gemma":[0.000010767177,0.98591816,0.000341092,0.0054527363,0.004820199,0.0021761963,0.00062529533,0.0002936034,0.00036192333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99621713,0.0001232759,0.0010104242,0.0009738027,0.00084757665,0.0008277985],"domain_scores_gemma":[0.9978796,0.00043022013,0.00036076384,0.0006827679,0.00009207931,0.000554569],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004404364,0.0010411905,0.0039929487,0.00047432265,0.00021613763,0.000094555864,0.0003872544,0.0006357621,0.0017514752],"category_scores_gemma":[0.000020214597,0.0007300527,0.0013027973,0.00028146827,0.00011952951,0.000091634494,0.00003760548,0.00040713715,0.00022270303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011011396,0.0042180466,1.7539831e-7,0.0025710508,0.0018617866,0.00006665316,0.00050983694,7.4859395e-7,0.0000058373753,0.0031046749,0.053497747,0.9340533],"study_design_scores_gemma":[0.0035157744,0.0031716772,0.000002602543,0.00794495,0.00028423808,0.00007016125,0.00008996065,0.000017000799,0.00006345764,0.00005798224,0.9841493,0.0006329251],"about_ca_topic_score_codex":0.00008865186,"about_ca_topic_score_gemma":0.0000041737867,"teacher_disagreement_score":0.9334204,"about_ca_system_score_codex":0.00058378465,"about_ca_system_score_gemma":0.0011152516,"threshold_uncertainty_score":0.99951506},"labels":[],"label_agreement":null},{"id":"W2107352701","doi":"10.1517/14656566.2010.499125","title":"Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Medicine; Antipsychotic; Schizophrenia (object-oriented programming); Psychiatry; Intensive care medicine; Relapse prevention; Pharmacotherapy; Ziprasidone","score_opus":0.09113384902379,"score_gpt":0.44069307829564985,"score_spread":0.34955922927185984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107352701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038649116,0.9915803,0.000007157995,0.0002499751,0.000605602,0.0033167764,0.0000251025,0.000033126023,0.00031702718],"genre_scores_gemma":[0.0013966108,0.99621975,0.00043223274,0.00008309225,0.00060447847,0.00086861866,0.00020726243,0.000092569884,0.00009540806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970988,0.00055675907,0.0008317018,0.0005722245,0.00047006257,0.00047042733],"domain_scores_gemma":[0.9983744,0.00040476912,0.00033895677,0.00070856686,0.000042693715,0.0001306205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043889956,0.00059203466,0.0015323675,0.00066214614,0.000070281756,0.000034107023,0.00029421004,0.000330188,0.00020099175],"category_scores_gemma":[0.000021142494,0.00032952917,0.0006238664,0.0007255451,0.000067580964,0.00008306441,0.000012716684,0.0008006108,0.000029643903],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005484399,0.004565668,0.000095116746,0.0004114918,0.00024833714,0.000047451456,0.0011394796,0.0000010496884,0.00008326506,0.00007656073,0.000108431734,0.9877387],"study_design_scores_gemma":[0.013545818,0.003001787,0.00016622213,0.007052242,0.00003934272,0.00008314586,0.00015743125,0.000035910576,0.0011013126,0.00012681108,0.97438484,0.00030514758],"about_ca_topic_score_codex":0.000083504245,"about_ca_topic_score_gemma":0.00007498091,"teacher_disagreement_score":0.9874336,"about_ca_system_score_codex":0.0003553705,"about_ca_system_score_gemma":0.0004898149,"threshold_uncertainty_score":0.99991566},"labels":[],"label_agreement":null},{"id":"W2110210123","doi":"10.1517/14656566.2014.873789","title":"Alprostadil for the treatment of impotence","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Erectile dysfunction; cGMP-specific phosphodiesterase type 5; Sildenafil; Tadalafil; First line; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.27678807213541823,"score_gpt":0.5035388989325601,"score_spread":0.22675082679714187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110210123","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.970893e-7,0.99079996,0.00039676565,0.0007007299,0.0039337357,0.0037004577,0.000045566852,0.000068831374,0.0003532589],"genre_scores_gemma":[3.681764e-7,0.9874067,0.0001795831,0.0017661735,0.0017344856,0.0032602814,0.00007462591,0.00007046019,0.0055073234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985965,0.000059921244,0.0005146778,0.0003691667,0.00024599474,0.00021374499],"domain_scores_gemma":[0.9984521,0.000628592,0.0002807,0.0004083306,0.00013377394,0.000096470736],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000088724446,0.00042222513,0.0012327355,0.000136623,0.00014673246,0.000015242264,0.000102891296,0.00013077012,0.001090559],"category_scores_gemma":[0.000014712505,0.0002003595,0.00072487857,0.00018310414,0.0000863697,0.000029915964,0.00000653877,0.00010342901,0.00011688212],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025174467,0.00044955974,8.482054e-7,0.0005558597,0.0008221994,3.942219e-7,0.0002831998,2.5210161e-7,0.00004183478,0.00009272994,0.08442286,0.91307855],"study_design_scores_gemma":[0.0023480598,0.0023831201,0.0000011811594,0.0009140886,0.00010363462,0.000015932183,0.00008745351,0.000019502308,0.000259402,0.0000034907084,0.99368787,0.00017625384],"about_ca_topic_score_codex":0.000030324758,"about_ca_topic_score_gemma":1.1753457e-7,"teacher_disagreement_score":0.91290224,"about_ca_system_score_codex":0.00014335912,"about_ca_system_score_gemma":0.00012711795,"threshold_uncertainty_score":0.99982256},"labels":[],"label_agreement":null},{"id":"W2111074312","doi":"10.1517/14656566.6.8.1299","title":"A pharmacogeneticist’s look at drug effects and the drug development process: an overview","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Medicine; Drug; Drug development; Personalized medicine; Pharmacogenetics; Identification (biology); Drug response; Pharmacology; Drug action; Intensive care medicine; Bioinformatics; Genetics","score_opus":0.21577903902343207,"score_gpt":0.5352320778405615,"score_spread":0.3194530388171294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111074312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041811727,0.98563236,0.0000068743943,0.00081232144,0.006266891,0.0052987537,0.00011237849,0.00030771975,0.0011445686],"genre_scores_gemma":[0.000085691245,0.96760494,0.00019143308,0.021206487,0.0041225585,0.0036561927,0.00025254878,0.00040915818,0.00247097],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9891325,0.0047421088,0.0018609172,0.0018829474,0.0009270304,0.0014545019],"domain_scores_gemma":[0.9950567,0.0016862361,0.0010832301,0.0008303275,0.00016472871,0.0011788053],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0026328836,0.002099719,0.0031077515,0.0004731022,0.0014205369,0.00015656145,0.0017867575,0.00063178525,0.0027378832],"category_scores_gemma":[0.000034208824,0.0014300399,0.0008490195,0.00058677356,0.0007851757,0.00023289569,0.0003701219,0.0022826504,0.0006106823],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000991955,0.0009211986,0.0000033090582,0.0032140648,0.0013683914,0.000027377577,0.0063155773,0.000027746453,0.00021997855,0.00031974132,0.02087782,0.96571285],"study_design_scores_gemma":[0.011965494,0.00006324886,0.0000014585365,0.0016075725,0.00050531415,0.000107203035,0.000048731898,0.00039128255,0.0075537437,0.00006478649,0.9760438,0.0016473483],"about_ca_topic_score_codex":0.00001143148,"about_ca_topic_score_gemma":0.000005129186,"teacher_disagreement_score":0.9640655,"about_ca_system_score_codex":0.00039985203,"about_ca_system_score_gemma":0.0007063127,"threshold_uncertainty_score":0.9998795},"labels":[],"label_agreement":null},{"id":"W2111100080","doi":"10.1517/14656566.6.11.1911","title":"Ramipril in the treatment of vascular diseases","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Ramipril; Medicine; Heart failure; Diabetes mellitus; Cardiology; ACE inhibitor; Internal medicine; Myocardial infarction; Stroke (engine); Angiotensin-converting enzyme; Blood pressure; Endocrinology","score_opus":0.13024043692909668,"score_gpt":0.4500948359908155,"score_spread":0.31985439906171886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111100080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000027293927,0.9967599,0.000001173185,0.0007594309,0.00046587473,0.0014269742,0.000035314955,0.000033324697,0.0005152792],"genre_scores_gemma":[0.0000060756115,0.9932986,0.00004309196,0.0042330534,0.0016201684,0.00048057488,0.00008149146,0.00005546778,0.00018147714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982268,0.00027214093,0.00051931146,0.00036311752,0.0003986698,0.0002199439],"domain_scores_gemma":[0.9989067,0.00028286985,0.00016869647,0.00052672793,0.000041189483,0.00007382434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010269344,0.00043982975,0.0020854245,0.00021270114,0.000054283544,0.0000103355105,0.00017498188,0.00013450153,0.0002761705],"category_scores_gemma":[0.000004910891,0.00021667434,0.0009071917,0.00023394113,0.00006751259,0.000026087337,0.000008928184,0.00016012124,0.00003453642],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008578971,0.002214503,0.0000051814495,0.0005294899,0.0011673359,0.000019421213,0.00085807603,2.6254367e-7,0.0000032035189,0.000027378792,0.035919342,0.95917004],"study_design_scores_gemma":[0.0026292063,0.0006322507,0.000009564298,0.0028383431,0.00046299116,0.000018513476,0.000053977456,0.000002476761,0.000021628339,0.0000021163414,0.99313736,0.000191545],"about_ca_topic_score_codex":0.000022214916,"about_ca_topic_score_gemma":6.297112e-7,"teacher_disagreement_score":0.9589785,"about_ca_system_score_codex":0.00004423997,"about_ca_system_score_gemma":0.00010233086,"threshold_uncertainty_score":0.88357234},"labels":[],"label_agreement":null},{"id":"W2111872404","doi":"10.1517/14656566.2012.732998","title":"Ruxolitinib, an oral JAK1 and JAK2 inhibitor, in myelofibrosis","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Incyte; Massachusetts Medical Society","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Clinical trial; Janus kinase; Anemia; Internal medicine; Oncology; Tolerability; Adverse effect; Pharmacology; Bone marrow; Cytokine","score_opus":0.17150415643462785,"score_gpt":0.46996782130591475,"score_spread":0.2984636648712869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111872404","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040831324,0.994915,0.0000024031492,0.0004648462,0.0011644212,0.0021042102,0.00007891982,0.000096849675,0.0007650487],"genre_scores_gemma":[0.00022388835,0.992863,0.00053483865,0.0022563275,0.0019722204,0.0013360248,0.0004550589,0.00018064534,0.00017800562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968314,0.0004399289,0.00081125734,0.000861373,0.00043121228,0.0006247966],"domain_scores_gemma":[0.9984408,0.0002142247,0.00025275056,0.0004683285,0.000053598604,0.00057028345],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031064943,0.0008889435,0.0021782343,0.00047607892,0.00010774016,0.000063706415,0.00014413045,0.0003997777,0.0011105112],"category_scores_gemma":[0.000011263867,0.00064063683,0.00036216655,0.0003046674,0.000089949885,0.00020818171,0.000038407485,0.0005406461,0.00013324288],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022341516,0.0017586694,0.00038173265,0.0011887418,0.00026999903,0.000024084069,0.00066911225,6.072214e-8,0.000040785035,0.00033756107,0.0030095044,0.9920963],"study_design_scores_gemma":[0.0039612837,0.0010507075,0.00015830253,0.00653432,0.000077111086,0.00008853888,0.00003267297,0.000006809523,0.0005409996,0.000008776744,0.9869762,0.00056426646],"about_ca_topic_score_codex":0.000085983855,"about_ca_topic_score_gemma":0.0000048207385,"teacher_disagreement_score":0.9915321,"about_ca_system_score_codex":0.00031280765,"about_ca_system_score_gemma":0.00023425702,"threshold_uncertainty_score":0.9998026},"labels":[],"label_agreement":null},{"id":"W2114489138","doi":"10.1517/14656566.9.6.937","title":"Pharmacotherapy of bone metastases in breast cancer patients","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bone health and treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Denosumab; Bisphosphonate; Breast cancer; Osteoprotegerin; Osteoclast; Bone pain; Osteoporosis; Bone remodeling; Oncology; Bone Density Conservation Agents; Quality of life (healthcare); Bone metastasis; Cancer; Internal medicine; Zoledronic acid; Metastatic breast cancer; Bone density","score_opus":0.08076604072673427,"score_gpt":0.46234957995315107,"score_spread":0.3815835392264168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114489138","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016740504,0.99424046,0.0000010649318,0.00036878718,0.0014612484,0.002551845,0.0009576131,0.000070409864,0.00018113876],"genre_scores_gemma":[0.000073514515,0.9940674,0.000100714984,0.0033478073,0.00041948698,0.001005104,0.00060687447,0.0002043782,0.00017472911],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963066,0.00033487813,0.0013792661,0.00072304637,0.0006599717,0.00059622934],"domain_scores_gemma":[0.99819225,0.000137455,0.0007295238,0.00041756805,0.00012584071,0.00039735573],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000119880526,0.0008442822,0.0030062557,0.000784042,0.000074911826,0.000008018271,0.00017565748,0.00027421056,0.0017445518],"category_scores_gemma":[0.0000049385176,0.0006168544,0.0007683971,0.00066025753,0.00009813508,0.00010103921,0.000018524921,0.00053862255,0.00006321283],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001128753,0.0039490196,0.0005285461,0.0022406848,0.00067405764,0.00004263405,0.00020079176,3.7256643e-7,0.000029617677,0.0000059836516,0.023410637,0.9677889],"study_design_scores_gemma":[0.011793206,0.00041859684,0.00018533971,0.009862224,0.00005856416,0.00010264355,0.0000034129216,0.0000042085467,0.00030055997,0.0000013349892,0.97685456,0.00041537013],"about_ca_topic_score_codex":0.0005380403,"about_ca_topic_score_gemma":0.0000024106685,"teacher_disagreement_score":0.96737355,"about_ca_system_score_codex":0.0004659012,"about_ca_system_score_gemma":0.00071009446,"threshold_uncertainty_score":0.9996283},"labels":[],"label_agreement":null},{"id":"W2114606818","doi":"10.1517/14656566.2012.667073","title":"A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain","year":2012,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Medicine; Tolerability; Hydrocodone; Anesthesia; Acetaminophen; Osteoarthritis; Transdermal; Analgesic; Buprenorphine; Adverse effect; Opioid; Clinical endpoint; Randomized controlled trial; Surgery; Oxycodone; Internal medicine; Pharmacology","score_opus":0.04890670844190818,"score_gpt":0.3569356426387557,"score_spread":0.3080289341968475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114606818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801987,0.0036637145,0.00023187652,0.00090199005,0.0010188037,0.013487882,0.00009185307,0.00019504293,0.00021018107],"genre_scores_gemma":[0.99329054,0.00039972394,0.0006222031,0.0015461788,0.00058859435,0.002530849,0.00057378295,0.000160275,0.00028782323],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948831,0.0013758149,0.0009384304,0.00082156307,0.0012187042,0.0007623461],"domain_scores_gemma":[0.99794614,0.000539347,0.0002632524,0.000563129,0.00017046131,0.0005176387],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016460496,0.0006987762,0.0013637872,0.00041271985,0.00017320705,0.000054850174,0.00023566397,0.00014807115,0.0019816484],"category_scores_gemma":[0.0000383712,0.00049427006,0.00020347023,0.0004532485,0.00006104662,0.00032378116,0.000037228077,0.00031603946,0.00021101745],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8932367,0.008423379,0.026676575,0.00009012326,0.00079279626,0.00002886011,0.036156625,0.00007731995,0.0029372422,0.000003921164,0.0017332213,0.029843256],"study_design_scores_gemma":[0.96918195,0.008953772,0.0036866309,0.0010224187,0.000116613664,0.0000043808122,0.0029732948,0.0010150324,0.006534768,6.6165603e-7,0.0058307075,0.0006797953],"about_ca_topic_score_codex":0.0005342877,"about_ca_topic_score_gemma":0.000019635716,"teacher_disagreement_score":0.07594524,"about_ca_system_score_codex":0.00046517348,"about_ca_system_score_gemma":0.00012857569,"threshold_uncertainty_score":0.9997509},"labels":[],"label_agreement":null},{"id":"W2114843189","doi":"10.1517/14656566.2014.862233","title":"The mechanism, efficacy, and tolerability profile of agomelatine","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Agomelatine; Tolerability; Medicine; Antidepressant; Melatonin; Major depressive disorder; Pharmacology; Internal medicine; Psychiatry; Adverse effect; Mood; Hippocampus","score_opus":0.10513958353118176,"score_gpt":0.40294674886848725,"score_spread":0.2978071653373055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114843189","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008231665,0.9951063,0.000022868846,0.00020046509,0.0015734996,0.0021844804,0.000056024153,0.000072853756,0.000701198],"genre_scores_gemma":[0.00008608056,0.9978364,0.000057785703,0.0004168175,0.00040905035,0.0004761379,0.000007960031,0.000077207114,0.0006325359],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744135,0.0005174332,0.00068013003,0.00065977377,0.00034962074,0.00035169747],"domain_scores_gemma":[0.9976083,0.001184912,0.00045498964,0.0005595136,0.000029144465,0.00016310762],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030422996,0.00044503866,0.0009813759,0.0001074184,0.00024152937,0.000066288376,0.0004159225,0.00018989097,0.0005829808],"category_scores_gemma":[0.00008807893,0.00026549396,0.00026292537,0.00024002878,0.00021723151,0.000086002816,0.00005895484,0.00041371014,0.00013847716],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029297322,0.00011844059,1.473358e-7,0.00042162987,0.000023350145,0.0000011207875,0.00019706371,7.297708e-8,0.004919889,0.011556055,0.0019336008,0.9807993],"study_design_scores_gemma":[0.0006329929,0.0001454583,7.926127e-7,0.0010297523,0.0000060959624,0.000022700659,0.0000065794297,0.000032902695,0.038386505,0.00007555674,0.9593944,0.0002662954],"about_ca_topic_score_codex":0.0000064564865,"about_ca_topic_score_gemma":7.2303166e-8,"teacher_disagreement_score":0.98053306,"about_ca_system_score_codex":0.000054037595,"about_ca_system_score_gemma":0.00012115768,"threshold_uncertainty_score":0.99997973},"labels":[],"label_agreement":null},{"id":"W2115343619","doi":"10.1517/14656566.2011.584064","title":"A state of art review on vardenafil in men with erectile dysfunction and associated underlying diseases","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; St Joseph's Health Care","funders":"","keywords":"Vardenafil; Erectile dysfunction; Medicine; Clinical trial; Intensive care medicine; Sexual function; Sexual medicine; Sexual dysfunction; Prostatectomy; Disease; Erectile function; Placebo; Efficacy; Drug; Pharmacology; Tadalafil; Alternative medicine; Internal medicine; Gynecology; Prostate cancer; Pathology","score_opus":0.1463684454376852,"score_gpt":0.4259670341956967,"score_spread":0.27959858875801147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115343619","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008691895,0.9925254,0.000027379034,0.00017825901,0.0006736714,0.0017063617,0.000041941476,0.00011218305,0.004726114],"genre_scores_gemma":[0.000013421359,0.9937762,0.000014872927,0.0029170185,0.00013674427,0.00046259808,0.00017734338,0.00009203776,0.0024097415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977344,0.00032696253,0.00070004497,0.0005821805,0.0004004204,0.00025595032],"domain_scores_gemma":[0.99865955,0.00026678885,0.0004954321,0.00029119235,0.00012121351,0.00016584258],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026405277,0.00053661707,0.0019261754,0.0004278206,0.00007819739,0.000012500957,0.00006848182,0.000113197944,0.00088806613],"category_scores_gemma":[0.00006203513,0.00035432275,0.0002279382,0.0005215957,0.00007389947,0.00007038056,0.000017337079,0.000394295,0.00006813929],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013279741,0.000782941,0.00006490961,0.0066147186,0.00087425543,0.000008556498,0.0002087553,6.656279e-7,0.000005668555,0.000024296529,0.090528965,0.8995583],"study_design_scores_gemma":[0.0030139508,0.0015898264,0.00014163944,0.051346492,0.00014617591,0.000020627678,0.00004112914,0.000005652399,0.000009567517,0.000005526644,0.9433666,0.00031281688],"about_ca_topic_score_codex":0.00002935987,"about_ca_topic_score_gemma":0.000002287861,"teacher_disagreement_score":0.8992455,"about_ca_system_score_codex":0.00021367293,"about_ca_system_score_gemma":0.00016190438,"threshold_uncertainty_score":0.99989086},"labels":[],"label_agreement":null},{"id":"W2115535897","doi":"10.1517/14656566.6.8.1349","title":"Bivalirudin: a review","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Bivalirudin; Hirudin; Medicine; Thrombin; Direct thrombin inhibitor; Discovery and development of direct thrombin inhibitors; Tetrapeptide; Pharmacology; Heparin; Anticoagulant; Cardiology; Internal medicine; Warfarin; Biochemistry; Myocardial infarction; Percutaneous coronary intervention; Atrial fibrillation; Chemistry; Platelet; Peptide","score_opus":0.2426197530651197,"score_gpt":0.5301296405093221,"score_spread":0.28750988744420236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115535897","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.4007764e-7,0.98118705,0.0000063509856,0.003657752,0.0019289416,0.0032759141,0.0000377913,0.00031702867,0.009588936],"genre_scores_gemma":[5.0557264e-7,0.9654145,0.00030902025,0.027834635,0.0037997288,0.0008410649,0.00029708073,0.00031198421,0.001191444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960394,0.00037889834,0.0012459591,0.0010534931,0.0006280495,0.00065419887],"domain_scores_gemma":[0.99761385,0.00016837315,0.00047790763,0.0011114972,0.000094236886,0.0005341504],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00040093367,0.0010941101,0.0044293506,0.00039561605,0.00013693373,0.000039775205,0.00048562448,0.0004612655,0.008245966],"category_scores_gemma":[0.000037618887,0.0007978297,0.001651388,0.0007023332,0.000076669974,0.000114223396,0.000059808594,0.0010045765,0.0031887745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027757842,0.00038400278,2.1355021e-7,0.010348017,0.00060018885,0.00001627287,0.00003768839,1.1481986e-8,0.000042307995,0.00014337717,0.14925267,0.8391475],"study_design_scores_gemma":[0.0012679865,0.00028078066,5.817826e-7,0.11469727,0.00021218118,0.00020959754,0.0000020585783,0.0000012508791,0.00009175705,0.0000030957344,0.8825546,0.00067882775],"about_ca_topic_score_codex":0.000014042858,"about_ca_topic_score_gemma":2.4068322e-7,"teacher_disagreement_score":0.8384687,"about_ca_system_score_codex":0.00047262726,"about_ca_system_score_gemma":0.0005828218,"threshold_uncertainty_score":0.9994473},"labels":[],"label_agreement":null},{"id":"W2116030241","doi":"10.1517/14656566.2013.760543","title":"A 10-year perspective on donepezil","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Donepezil; Medicine; Dosing; Clinical trial; Cholinesterase; Intensive care medicine; Expert opinion; Disease; Rivastigmine; Pharmacology; Dementia; Internal medicine","score_opus":0.1443808273236295,"score_gpt":0.48460049836866304,"score_spread":0.34021967104503353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116030241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020663163,0.988019,0.0000022994495,0.0006747733,0.0009238272,0.002025685,0.000108512715,0.00016991109,0.008055363],"genre_scores_gemma":[0.0000031772904,0.9791898,0.000046803918,0.007487339,0.0040374873,0.00085388566,0.0002662702,0.00021288771,0.007902321],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739933,0.0002939897,0.0004953946,0.0009492757,0.00049557525,0.00036644502],"domain_scores_gemma":[0.9983758,0.00020097898,0.00023493492,0.0006226951,0.0001906577,0.0003749658],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00007085462,0.00081207947,0.0015732744,0.00039707922,0.00011422098,0.0000618857,0.0002252721,0.0002230307,0.01693916],"category_scores_gemma":[0.000038111048,0.00056082173,0.00095511356,0.00029459485,0.000069196474,0.0000831315,0.00002435652,0.00053350214,0.0054625873],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008458294,0.0010790497,2.3089984e-7,0.00068032223,0.00044806642,0.000038849063,0.00022127762,2.6546013e-7,0.00015924098,0.00037075023,0.26631325,0.72984284],"study_design_scores_gemma":[0.0027332213,0.0010286539,6.470381e-7,0.0058246185,0.000057498724,0.000032291122,0.000043519394,0.000004173433,0.0009089555,0.0000057990806,0.9888563,0.00050431927],"about_ca_topic_score_codex":0.000013215597,"about_ca_topic_score_gemma":8.133676e-8,"teacher_disagreement_score":0.7293385,"about_ca_system_score_codex":0.00034269833,"about_ca_system_score_gemma":0.00028635102,"threshold_uncertainty_score":0.99968433},"labels":[],"label_agreement":null},{"id":"W2116273754","doi":"10.1517/14656566.2011.608351","title":"Off-label use of atypical antipsychotics in personality disorders","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Personality Disorders and Psychopathology","field":"Psychology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Personality disorders; Borderline personality disorder; Impulsivity; Psychiatry; Sadistic personality disorder; Atypical antipsychotic; Olanzapine; Medicine; Schizotypal personality disorder; Antisocial personality disorder; Clinical psychology; Comorbidity; Personality; Antipsychotic; Psychology; Schizophrenia (object-oriented programming); Poison control; Psychosis; Injury prevention","score_opus":0.25951335745465576,"score_gpt":0.48830629687963023,"score_spread":0.22879293942497447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116273754","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027859322,0.9907649,0.000080235055,0.00020835116,0.005216563,0.0011961698,0.00026088627,0.000074249816,0.0019200147],"genre_scores_gemma":[0.00004866966,0.99637616,0.00027359012,0.0017836697,0.00042379793,0.0002969255,0.00016288158,0.00016876966,0.00046552235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949891,0.0014841019,0.0013143023,0.0011742103,0.00031152464,0.00072678144],"domain_scores_gemma":[0.9977053,0.00047963558,0.00064548396,0.00092381367,0.0000496967,0.00019610721],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004788397,0.00086416194,0.0021952265,0.0005663858,0.00006779404,0.000023943678,0.00072677946,0.0008468253,0.0054825107],"category_scores_gemma":[0.000021964892,0.00075944565,0.0007987123,0.0006091892,0.00035772202,0.00011367304,0.000036683465,0.0010191153,0.00026764983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021861135,0.0034428763,0.00027677498,0.00058324897,0.00033136664,0.000009487295,0.003346293,1.2093322e-7,0.0000030879269,0.004421921,0.03188013,0.95351857],"study_design_scores_gemma":[0.0028359878,0.0003905253,0.00053717307,0.0017828505,0.000022929651,0.000022473328,0.00008283786,0.000006484739,5.6231045e-7,0.00015573624,0.99345744,0.0007050018],"about_ca_topic_score_codex":0.00027689175,"about_ca_topic_score_gemma":0.00003503645,"teacher_disagreement_score":0.9615773,"about_ca_system_score_codex":0.0000859312,"about_ca_system_score_gemma":0.00011987039,"threshold_uncertainty_score":0.9994857},"labels":[],"label_agreement":null},{"id":"W2116707979","doi":"10.1517/14656566.6.14.2443","title":"An update on the treatment options for gout and calcium pyrophosphate deposition","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Gout; Synovitis; Calcium pyrophosphate; Pathogenesis; Disease; Joint disorder; Intensive care medicine; Osteoarthritis; Rheumatoid arthritis; Bioinformatics; Calcium; Internal medicine; Pathology; Alternative medicine","score_opus":0.12859370029633976,"score_gpt":0.46575608593487183,"score_spread":0.33716238563853207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116707979","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000775702,0.9905641,0.00039901744,0.0029852793,0.0010817363,0.004379382,0.00019840873,0.0001685082,0.00014596275],"genre_scores_gemma":[0.00004083006,0.9854438,0.0010794707,0.0065954668,0.0028614101,0.0026178737,0.00076695404,0.00020398459,0.0003902371],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976023,0.0002399027,0.00058003474,0.0007944081,0.0003428189,0.00044057934],"domain_scores_gemma":[0.99839246,0.00024374737,0.00024990496,0.0007499917,0.000057899222,0.0003060203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021117085,0.0007650924,0.0011845003,0.00020816932,0.0003278124,0.00007576311,0.0002252837,0.00030273048,0.00038053512],"category_scores_gemma":[0.000007796243,0.00044644243,0.0005351598,0.0001929692,0.00008712285,0.00009941904,0.000011039139,0.00034771755,0.00012230559],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045680406,0.0010549339,4.0200499e-7,0.00026963308,0.00059113174,0.00000721818,0.00036229557,0.0000051277316,0.00026525636,0.00041944438,0.008465004,0.98810273],"study_design_scores_gemma":[0.00286441,0.0022180215,0.0000015957552,0.0018826376,0.00024225353,0.00009429694,0.000027436088,0.00036879705,0.0014143813,0.000008064764,0.9904523,0.00042583543],"about_ca_topic_score_codex":0.000023017737,"about_ca_topic_score_gemma":6.2067727e-7,"teacher_disagreement_score":0.9876769,"about_ca_system_score_codex":0.00055168435,"about_ca_system_score_gemma":0.00016513212,"threshold_uncertainty_score":0.9997987},"labels":[],"label_agreement":null},{"id":"W2117294423","doi":"10.1517/14656566.7.5.583","title":"Alfuzosin: an α<sub>1</sub>-receptor blocker for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Alfuzosin; Medicine; Lower urinary tract symptoms; Hyperplasia; Urology; Urinary retention; Sexual function; Adverse effect; Urinary system; Internal medicine; Prostate","score_opus":0.0758192222938245,"score_gpt":0.41544174635158965,"score_spread":0.33962252405776516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117294423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027999743,0.9866286,0.000025017831,0.00035229535,0.0006767877,0.008598854,0.0006555878,0.00011712436,0.00014579325],"genre_scores_gemma":[0.0006985859,0.9917101,0.00010666302,0.0002413127,0.0009833723,0.0032384698,0.0020853677,0.0003188579,0.00061725744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963267,0.0004390771,0.00084516394,0.00084309286,0.0008163185,0.0007296483],"domain_scores_gemma":[0.9972622,0.0010291146,0.00046743007,0.0007189459,0.00022583736,0.0002965128],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033465083,0.00095353095,0.0019830903,0.00032482072,0.0002607738,0.000054951437,0.0002987807,0.00033656313,0.00024052832],"category_scores_gemma":[0.00001194836,0.0005175541,0.0008295562,0.00045655406,0.00021463772,0.00012018441,0.000012053211,0.00034151474,0.000026008633],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037015958,0.017427376,0.000020969606,0.0015039871,0.0025403672,0.00008302267,0.0007736529,0.0000040909104,0.000929706,0.000012346343,0.008771236,0.96423167],"study_design_scores_gemma":[0.0067169266,0.03644358,0.000018867522,0.00394414,0.00031869297,0.0002530954,0.0000377915,0.00009604954,0.0041291374,0.0000028398656,0.9475023,0.00053656014],"about_ca_topic_score_codex":0.000022624421,"about_ca_topic_score_gemma":0.0000010862785,"teacher_disagreement_score":0.9636951,"about_ca_system_score_codex":0.00048562145,"about_ca_system_score_gemma":0.0006806561,"threshold_uncertainty_score":0.9997276},"labels":[],"label_agreement":null},{"id":"W2117353601","doi":"10.1517/14656566.1.4.623","title":"Replicating herpes simplex virus vectors for cancer gene therapy","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council; World Health Organization","keywords":"Oncolytic virus; Herpes simplex virus; Medicine; Virus; Disease; Genetic enhancement; Cancer; Radiation therapy; Cancer cell; Virology; Chemotherapy; Vector (molecular biology); Cancer research; Immunology; HSL and HSV; Gene; Biology; Pathology; Internal medicine","score_opus":0.1294799134940627,"score_gpt":0.48552920033053004,"score_spread":0.3560492868364673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117353601","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031685227,0.99498665,0.00006446366,0.00018959571,0.0008086596,0.0028767048,0.0005470209,0.00008763104,0.00012241626],"genre_scores_gemma":[0.0000090952435,0.9845389,0.00021870286,0.0032264583,0.004727997,0.00497021,0.0011963204,0.00044723487,0.00066504633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605006,0.00046120197,0.00076866033,0.001477442,0.00041034585,0.0008322943],"domain_scores_gemma":[0.9979353,0.000118951364,0.00038834877,0.0011896355,0.00011329244,0.00025449003],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043450503,0.0009464846,0.0012142896,0.00022042115,0.00030016334,0.00008559659,0.0010049086,0.00055758574,0.0011814388],"category_scores_gemma":[0.000015728769,0.0007878343,0.0010157746,0.0002958302,0.000114023,0.000007663082,0.000049454233,0.00030699142,0.00005055145],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024393504,0.00025236158,1.6606603e-7,0.00023922235,0.00067467056,9.991156e-7,0.0000631541,0.000011828027,0.038743112,0.0000030149768,0.021919454,0.9356527],"study_design_scores_gemma":[0.0015571559,0.0015999875,8.324409e-8,0.00046691243,0.000009270372,0.000005066222,0.0000033247115,0.000012547121,0.1993337,0.000006742296,0.7963083,0.0006969425],"about_ca_topic_score_codex":0.000057220394,"about_ca_topic_score_gemma":0.00001078556,"teacher_disagreement_score":0.9349557,"about_ca_system_score_codex":0.00013842522,"about_ca_system_score_gemma":0.0005673632,"threshold_uncertainty_score":0.9997316},"labels":[],"label_agreement":null},{"id":"W2118731850","doi":"10.1517/14656566.2.10.1671","title":"Oseltamivir: a clinical and pharmacological perspective","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Oseltamivir; Prodrug; Medicine; Neuraminidase inhibitor; Pharmacology; Renal function; Neuraminidase; Antiviral drug; Metabolite; Pharmacokinetics; Virology; Drug; Internal medicine; Virus","score_opus":0.4206725464578862,"score_gpt":0.6191239929573048,"score_spread":0.1984514464994186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118731850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005692073,0.9877524,0.000011607349,0.0010546967,0.0012843751,0.0027136637,0.000048788665,0.00023827811,0.006890547],"genre_scores_gemma":[0.0000015002676,0.9859691,0.00025589438,0.00754638,0.0042575565,0.0006916152,0.00002972973,0.00015022376,0.0010979769],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953415,0.0009048763,0.0010535055,0.0012422834,0.00073279656,0.0007250764],"domain_scores_gemma":[0.99756545,0.00092610205,0.0002880972,0.0004098038,0.00023521499,0.0005753043],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000804331,0.00087350036,0.0029609518,0.00043760776,0.00024106113,0.000055247037,0.00030560174,0.00052856095,0.001730579],"category_scores_gemma":[0.00022135403,0.00058608927,0.0010028807,0.00051497866,0.00068327866,0.00008754971,0.00014596568,0.0018888712,0.0004091512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080995884,0.0008494272,0.000017347127,0.00065494777,0.0018640439,0.00014054021,0.00023745646,3.7861426e-8,0.000015644677,0.00034865426,0.064237915,0.93082404],"study_design_scores_gemma":[0.0048014694,0.0012350909,0.000011283469,0.003310954,0.00013107723,0.00016347163,0.000084985986,0.0000129214895,0.000017267215,0.000026261088,0.98966897,0.0005362735],"about_ca_topic_score_codex":0.000022522736,"about_ca_topic_score_gemma":2.2057438e-7,"teacher_disagreement_score":0.9302878,"about_ca_system_score_codex":0.00038615355,"about_ca_system_score_gemma":0.00042816036,"threshold_uncertainty_score":0.99965906},"labels":[],"label_agreement":null},{"id":"W2118820814","doi":"10.1517/14656566.7.2.229","title":"6th International Workshop on Clinical Pharmacology of HIV Therapy","year":2006,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical pharmacology; Antiretroviral therapy; Pharmacology; Pharmacokinetics; Pharmacodynamics; Human immunodeficiency virus (HIV); Antiretroviral drug; ANTIRETROVIRAL AGENTS; Drug; Family medicine; Viral load","score_opus":0.06906413491715782,"score_gpt":0.43962418552232163,"score_spread":0.37056005060516384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118820814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58868456,0.016239218,0.0014917648,0.26783448,0.03615347,0.0045548375,0.0001112783,0.0008639166,0.084066465],"genre_scores_gemma":[0.7748905,0.11978852,0.003765497,0.044712275,0.014665014,0.0004312789,0.00069865276,0.00021803263,0.040830217],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981671,0.00012766247,0.00059691386,0.00041362428,0.0004368036,0.00025788532],"domain_scores_gemma":[0.9991709,0.00023282038,0.00017903476,0.0002028722,0.00009089004,0.00012348218],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023243124,0.00027293753,0.00041043657,0.00023294525,0.000057242924,0.000011187795,0.00018046773,0.00011743136,0.0038621433],"category_scores_gemma":[0.000007320124,0.00020656762,0.00024517038,0.00015859396,0.00009921932,0.00005677493,0.000014957087,0.00024278107,0.00020027159],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072408305,0.0060318927,0.013009802,0.000005030113,0.0008458785,0.000039632574,0.0004776959,0.00004003586,0.042532142,0.00061072054,0.82273054,0.10643582],"study_design_scores_gemma":[0.014551117,0.0003951628,0.002443067,0.00007218267,0.000004838583,0.000007486745,0.000034312492,0.00021386053,0.12329147,0.000031521693,0.85877854,0.00017644785],"about_ca_topic_score_codex":0.0000058153487,"about_ca_topic_score_gemma":2.2698934e-7,"teacher_disagreement_score":0.22312221,"about_ca_system_score_codex":0.00009900308,"about_ca_system_score_gemma":0.00009270149,"threshold_uncertainty_score":0.99704844},"labels":[],"label_agreement":null},{"id":"W2119194124","doi":"10.1517/14656566.7.13.1835","title":"Lamivudine treatment in patients with chronic hepatitis B and cirrhosis","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Lamivudine; Medicine; Cirrhosis; Entecavir; Hepatocellular carcinoma; Adefovir; Gastroenterology; Hepatitis B virus; Internal medicine; Liver function; Hepatitis B; Liver disease; Nucleoside analogue; Immunology; Virus; Nucleoside","score_opus":0.04641000150982292,"score_gpt":0.38473039694472144,"score_spread":0.3383203954348985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119194124","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005313198,0.9955879,0.000003347563,0.00016935458,0.00040500198,0.0026750031,0.00011956602,0.000082074796,0.0004264618],"genre_scores_gemma":[0.00017341576,0.9965688,0.000117999596,0.00044468182,0.0006382243,0.0011060181,0.0004585569,0.00015637047,0.00033592284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99781865,0.00014534745,0.0005758819,0.00067494094,0.00036800778,0.0004171967],"domain_scores_gemma":[0.9991367,0.00010691129,0.00022748014,0.00033948812,0.000054221808,0.00013519304],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006493655,0.0007295521,0.0019395172,0.00039218683,0.0000858882,0.00002268775,0.00008756576,0.00018091961,0.00024804045],"category_scores_gemma":[0.0000054889965,0.0004810907,0.00020773898,0.0003072803,0.00008986868,0.000063718275,0.000022415627,0.0002475783,0.000043848402],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013607902,0.0008142616,0.022580689,0.0010828191,0.00045315226,0.000020894477,0.00014018362,2.2775187e-7,9.4469857e-7,0.0000110777755,0.004683579,0.9700761],"study_design_scores_gemma":[0.0064902105,0.0026982166,0.0063192113,0.008410348,0.00006104247,0.000005835761,6.744548e-7,0.0000052980777,0.000017400433,0.0000010029801,0.9755507,0.00044002547],"about_ca_topic_score_codex":0.0031095017,"about_ca_topic_score_gemma":0.00051718304,"teacher_disagreement_score":0.97086716,"about_ca_system_score_codex":0.0013415291,"about_ca_system_score_gemma":0.00023591211,"threshold_uncertainty_score":0.9997641},"labels":[],"label_agreement":null},{"id":"W2119624606","doi":"10.1517/14656566.9.3.459","title":"Clozapine use in children and adolescents","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Clozapine; Medicine; Schizophrenia (object-oriented programming); Adverse effect; Psychiatry; Pediatrics; Incidence (geometry); Population; Refractory (planetary science); Pharmacology","score_opus":0.08732462987944417,"score_gpt":0.43155449005393426,"score_spread":0.3442298601744901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119624606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038032615,0.9969903,0.0000013022471,0.0001337348,0.00024578674,0.0021184087,0.000049889262,0.00006356591,0.000016682037],"genre_scores_gemma":[0.00003465516,0.9974503,0.00025199977,0.0007405461,0.00068386004,0.00026416554,0.0003488731,0.00010831084,0.00011729258],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793065,0.00019521225,0.00043503483,0.0006237894,0.00041580448,0.0003995301],"domain_scores_gemma":[0.9990633,0.00006768499,0.00011244075,0.00037282327,0.00002678529,0.0003569431],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006779176,0.00052544894,0.0012535906,0.0005093921,0.000061301005,0.00003045476,0.00013148956,0.00020295613,0.00016950343],"category_scores_gemma":[0.000016871265,0.00037052395,0.00030297687,0.0002829257,0.00007460563,0.00007924602,0.000033815286,0.0005550397,0.000101929894],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015847905,0.00071352813,0.0008601108,0.0003389206,0.0003055418,0.00007711802,0.00003646038,3.4333954e-8,0.000002660519,0.000015294276,0.00661047,0.98945504],"study_design_scores_gemma":[0.009864048,0.00037547815,0.002754325,0.010445831,0.000013206446,0.0005298445,8.8201415e-7,0.0000034390803,0.000022607126,0.0000022419306,0.97569674,0.00029138304],"about_ca_topic_score_codex":0.000094540104,"about_ca_topic_score_gemma":0.0000018876168,"teacher_disagreement_score":0.9891637,"about_ca_system_score_codex":0.0002189922,"about_ca_system_score_gemma":0.0002555752,"threshold_uncertainty_score":0.99987465},"labels":[],"label_agreement":null},{"id":"W2121005224","doi":"10.1517/14656566.6.11.1851","title":"Acute adverse reactions associated with angiotensin-converting enzyme inhibitors: genetic factors and therapeutic implications","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; McGill University; McGill Genome Centre","funders":"","keywords":"Angioedema; Medicine; Bradykinin; Angiotensin-converting enzyme; Adverse effect; Enzyme; Pharmacology; Bioinformatics; Internal medicine; Biochemistry; Blood pressure; Biology; Receptor","score_opus":0.07191002089388304,"score_gpt":0.38432926286412744,"score_spread":0.3124192419702444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121005224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009771852,0.995311,0.0000548999,0.00094131153,0.00060045446,0.0015988123,0.00008494994,0.00031586204,0.00011549463],"genre_scores_gemma":[0.0021403981,0.9931635,0.00019611511,0.001762844,0.0013119744,0.0001986894,0.00049736525,0.00022347103,0.00050562184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972641,0.00017688774,0.0008783876,0.00079517846,0.0003756908,0.00050975615],"domain_scores_gemma":[0.99798274,0.00035713534,0.00066634594,0.0005083078,0.00014517475,0.0003402889],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013583635,0.0008173684,0.0014277728,0.00041760068,0.00035137078,0.000047171623,0.00015688613,0.00038686613,0.00030449187],"category_scores_gemma":[0.000022036276,0.00058781274,0.0005583343,0.0005477574,0.00014385513,0.00012522403,0.00002402867,0.0004786118,0.000028682201],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088707464,0.00039251894,0.0003820635,0.00018061168,0.0020981627,0.000008750703,0.0010906131,0.0000026863736,0.00048265036,0.000052599935,0.0030972743,0.99212337],"study_design_scores_gemma":[0.0019702562,0.00031733417,0.0016410588,0.004620502,0.00043092595,0.0001361313,0.000047935428,0.00006739898,0.00042209364,0.000007758142,0.98970026,0.0006383401],"about_ca_topic_score_codex":0.000042875927,"about_ca_topic_score_gemma":0.0000036226472,"teacher_disagreement_score":0.991485,"about_ca_system_score_codex":0.0003322974,"about_ca_system_score_gemma":0.0003516424,"threshold_uncertainty_score":0.99965733},"labels":[],"label_agreement":null},{"id":"W2121769821","doi":"10.1517/14656566.3.2.81","title":"Salvage antiretroviral therapy in HIV infection","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Salvage therapy; Discontinuation; Regimen; Intensive care medicine; Drug resistance; Antiretroviral therapy; Combination therapy; Drug; Protease inhibitor (pharmacology); Internal medicine; Viral load; Human immunodeficiency virus (HIV); Pharmacology; Immunology; Chemotherapy","score_opus":0.10216402638026828,"score_gpt":0.42054423431703697,"score_spread":0.3183802079367687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121769821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043142754,0.9932041,0.000012793912,0.0007032352,0.0013485603,0.002082329,0.000016862268,0.00021483986,0.0023741229],"genre_scores_gemma":[0.000019136973,0.98862034,0.00019845598,0.0011092228,0.0010966646,0.0006155773,0.0004107265,0.00018546858,0.0077444045],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721277,0.00027066874,0.0007954056,0.00074951904,0.00047556357,0.0004961037],"domain_scores_gemma":[0.998984,0.000098219585,0.0002642644,0.00042990257,0.000034201825,0.00018941936],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00019170337,0.00083366205,0.0018019583,0.00089124026,0.000090507776,0.000041954256,0.00015672889,0.00036520456,0.0022972743],"category_scores_gemma":[0.000007695614,0.0006070935,0.0006720641,0.0006626894,0.000049488073,0.00011411403,0.000018191067,0.0006325921,0.00095104426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013251102,0.0010764003,0.00026913674,0.00050151715,0.00037358855,0.00006723329,0.00044407844,1.5340844e-7,0.0000162949,0.00003352609,0.051603716,0.94548184],"study_design_scores_gemma":[0.0050717317,0.00047227723,0.000026547745,0.0061878995,0.0000205996,0.000049072958,0.0000050402346,0.000018186625,0.00015572304,0.0000028886288,0.9874591,0.0005309314],"about_ca_topic_score_codex":0.000020375985,"about_ca_topic_score_gemma":5.641001e-7,"teacher_disagreement_score":0.94495094,"about_ca_system_score_codex":0.00056167814,"about_ca_system_score_gemma":0.0001761679,"threshold_uncertainty_score":0.99982685},"labels":[],"label_agreement":null},{"id":"W2123938163","doi":"10.1517/14656566.6.4.609","title":"Pharmacotherapy of onychomycosis","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Pharmacotherapy; Itraconazole; Terbinafine; Dermatology; Pharmacology; Intensive care medicine; Internal medicine; Antifungal","score_opus":0.14596244719312867,"score_gpt":0.5199113413738277,"score_spread":0.373948894180699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123938163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006221245,0.9939949,0.000011692747,0.00023347547,0.0013035863,0.0020442898,0.00022923194,0.00015140603,0.002025205],"genre_scores_gemma":[0.000012387723,0.9925946,0.00036420373,0.0026960855,0.0021597394,0.00051274075,0.0004220612,0.00026365387,0.00097453204],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969807,0.00019210024,0.0009727046,0.0007479034,0.0006440175,0.00046254642],"domain_scores_gemma":[0.99809927,0.0001496111,0.0005599536,0.0006763847,0.00008750994,0.00042725532],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011447797,0.0008866096,0.0024526857,0.00051498855,0.00007754314,0.000021172236,0.00031432766,0.0002883393,0.006221418],"category_scores_gemma":[0.0000060207817,0.0006457228,0.0017140227,0.00044695556,0.00008334228,0.0000851701,0.0000211747,0.00040214794,0.00035857048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050354074,0.0022420627,0.000007161557,0.0016010823,0.0018453466,0.000020095555,0.000079965896,2.5799017e-7,0.000096147734,0.000050590657,0.032974645,0.9605791],"study_design_scores_gemma":[0.0058380472,0.0005910374,0.0000031476688,0.008251403,0.0002401412,0.00004344635,0.0000053993585,0.000006932003,0.0006717425,0.0000044013013,0.9838687,0.00047559745],"about_ca_topic_score_codex":0.000018525385,"about_ca_topic_score_gemma":1.0221942e-7,"teacher_disagreement_score":0.9601035,"about_ca_system_score_codex":0.00028865965,"about_ca_system_score_gemma":0.0003660139,"threshold_uncertainty_score":0.9995994},"labels":[],"label_agreement":null},{"id":"W2125073267","doi":"10.1517/14656566.8.9.1211","title":"A preclinical and clinical rationale for quetiapine in mood syndromes","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Quetiapine; Quetiapine Fumarate; Antidepressant; Serotonergic; Medicine; Pharmacology; Neuroscience; Dopamine receptor D2; Dopamine receptor D3; Atypical antipsychotic; Dopamine; Antipsychotic; Serotonin; Internal medicine; Psychology; Psychiatry; Receptor; Schizophrenia (object-oriented programming); Hippocampus","score_opus":0.28780102376129496,"score_gpt":0.5640704639575373,"score_spread":0.2762694401962424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125073267","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007838971,0.9943348,0.00014061025,0.00090087176,0.0007301933,0.0034732458,0.000043449025,0.000051941995,0.00031701446],"genre_scores_gemma":[0.000010373785,0.99542797,0.0010906565,0.0010089398,0.00093371386,0.00069672766,0.00039344604,0.000091989255,0.00034616832],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99752945,0.00018914764,0.0010865078,0.0006704999,0.00023552924,0.00028888273],"domain_scores_gemma":[0.99830025,0.00095385197,0.00020351341,0.00028347538,0.00004226334,0.00021663743],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006170289,0.00043118434,0.0016235098,0.00025508305,0.00004894207,0.000017559998,0.00010352362,0.000423854,0.00020564623],"category_scores_gemma":[0.00005430446,0.00031538564,0.00063825084,0.0001551146,0.000083587045,0.0000410926,0.000018521994,0.00046173763,0.000026858577],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044293623,0.0017175275,0.0002906168,0.001203071,0.00053084205,0.0000043169184,0.00007380956,3.0198116e-8,4.9160326e-7,0.00016309397,0.0024397655,0.9931335],"study_design_scores_gemma":[0.008238928,0.0012777209,0.00019482938,0.0039216042,0.000076800825,0.00007727984,0.0000071658196,0.000022784785,0.0000059564363,0.000037524962,0.98587006,0.00026932027],"about_ca_topic_score_codex":0.000008762087,"about_ca_topic_score_gemma":0.000008599652,"teacher_disagreement_score":0.9928642,"about_ca_system_score_codex":0.000098064746,"about_ca_system_score_gemma":0.0002552664,"threshold_uncertainty_score":0.99992985},"labels":[],"label_agreement":null},{"id":"W2125741987","doi":"10.1517/14656566.4.4.533","title":"Bupropion SR for smoking cessation","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bupropion; Medicine; Smoking cessation; Nicotine replacement therapy; Placebo; Varenicline; Anesthesia; Psychiatry; Pediatrics","score_opus":0.1723569181062473,"score_gpt":0.48105230155989487,"score_spread":0.30869538345364755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125741987","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011975044,0.991236,0.00085439684,0.00012500178,0.0044718343,0.0025204206,0.00003729555,0.00017709314,0.00056600187],"genre_scores_gemma":[0.0000260201,0.9933681,0.0002001602,0.0014526967,0.0018131848,0.0013521563,0.0010225186,0.00019000703,0.0005751727],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977562,0.00015784263,0.00062887784,0.00062641903,0.00049288245,0.00033781302],"domain_scores_gemma":[0.9988081,0.00013421373,0.00040387904,0.00039997714,0.00011515506,0.00013871717],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003328843,0.0005336099,0.0011234295,0.0003739237,0.0001679831,0.00005208311,0.00014975398,0.00045044953,0.00071560766],"category_scores_gemma":[0.000019524432,0.00042422628,0.0006509382,0.00029447084,0.00003226655,0.00009617904,0.000007680611,0.00040527518,0.000014291005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010914069,0.00023246584,0.00001429126,0.0017204282,0.00015490701,0.0000019028885,0.0001508434,2.635666e-7,0.00005032962,0.00020666157,0.0146185635,0.9827402],"study_design_scores_gemma":[0.0024442354,0.00032819776,0.000009001827,0.0062400484,0.0001294828,0.000034679106,0.000014246697,0.0000070891,0.0005367613,0.000017656297,0.98982066,0.0004179708],"about_ca_topic_score_codex":0.0000053287745,"about_ca_topic_score_gemma":5.5393922e-8,"teacher_disagreement_score":0.9823222,"about_ca_system_score_codex":0.00041251341,"about_ca_system_score_gemma":0.00022441793,"threshold_uncertainty_score":0.99982095},"labels":[],"label_agreement":null},{"id":"W2127370803","doi":"10.1517/14656566.2011.558006","title":"Memantine in dementia: a review of the current evidence","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Memantine; Dementia; Current (fluid); Psychiatry; Intensive care medicine; Internal medicine; Disease","score_opus":0.3722309154406039,"score_gpt":0.5328991881366025,"score_spread":0.16066827269599865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127370803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007219574,0.9922872,0.0000016537853,0.0005735519,0.0042708004,0.0025763442,0.000019650553,0.00003708984,0.0002264418],"genre_scores_gemma":[0.000015349891,0.99206245,0.0000027502629,0.00694194,0.000236303,0.00058952376,7.240213e-7,0.00006941625,0.000081514954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938574,0.0025355548,0.0011002817,0.001096634,0.00081943616,0.00059068814],"domain_scores_gemma":[0.9974252,0.0008590449,0.0007124222,0.0008216609,0.000050265473,0.00013141513],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008685736,0.00054651493,0.0013229325,0.00038026043,0.00014663604,0.000021945716,0.0024919673,0.000090310044,0.00086522807],"category_scores_gemma":[0.0004718352,0.00032859138,0.0006492953,0.0018114917,0.00039466677,0.00021177127,0.0003071644,0.0013191054,0.0001378181],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039281582,0.00043042802,0.0000021367975,0.016805781,0.000012150275,0.000011116915,0.000049219856,6.670414e-8,0.00847885,0.00012616404,0.011305421,0.9627394],"study_design_scores_gemma":[0.0002909542,0.00010877728,9.687368e-7,0.10758568,0.000016445982,0.000020572264,2.8478857e-7,0.0000034800898,0.029960034,0.0000074655704,0.86176455,0.00024080042],"about_ca_topic_score_codex":0.0000043009613,"about_ca_topic_score_gemma":1.730718e-7,"teacher_disagreement_score":0.9624986,"about_ca_system_score_codex":0.000065886634,"about_ca_system_score_gemma":0.00047240828,"threshold_uncertainty_score":0.9999166},"labels":[],"label_agreement":null},{"id":"W2130847374","doi":"10.1517/14656566.2012.651461","title":"3rd Pavia international symposium on advanced kidney cancer","year":2012,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Kidney cancer; Cancer; Viewpoints; Kidney disease; Natural history; Disease; Intensive care medicine; Oncology; Internal medicine","score_opus":0.04326929366883678,"score_gpt":0.39209366209510604,"score_spread":0.3488243684262693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130847374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7216759,0.030882781,0.0002269812,0.112479866,0.043263752,0.0034328327,0.00018463588,0.00080662407,0.08704664],"genre_scores_gemma":[0.91355556,0.0287516,0.0005373324,0.048743922,0.0044834674,0.00051448523,0.00014677881,0.00010298016,0.003163863],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853027,0.000054492008,0.0002309193,0.00032039886,0.000498548,0.00036540156],"domain_scores_gemma":[0.99904555,0.000044904158,0.00008902261,0.00027731946,0.00006279598,0.00048040596],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008989263,0.0002740337,0.00023909687,0.00010323904,0.000066553795,0.000015722942,0.00013244116,0.000068137066,0.003475167],"category_scores_gemma":[0.000008701299,0.00021042992,0.00014901777,0.00009835842,0.000032641572,0.00014588718,0.000014977825,0.00018268202,0.0002977834],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004464846,0.0020220028,0.008378751,0.000019769117,0.0004501942,0.000017931055,0.0019004429,0.00003974865,0.7345599,0.00043736122,0.14107744,0.10663164],"study_design_scores_gemma":[0.003956306,0.0003718733,0.0018379134,0.0001150636,0.0000042626516,0.000012799926,0.00002344498,0.00006232724,0.3765562,0.000003333543,0.61690736,0.00014913308],"about_ca_topic_score_codex":0.00003239699,"about_ca_topic_score_gemma":1.7318185e-7,"teacher_disagreement_score":0.4758299,"about_ca_system_score_codex":0.00044574638,"about_ca_system_score_gemma":0.00005913684,"threshold_uncertainty_score":0.9974358},"labels":[],"label_agreement":null},{"id":"W2130914578","doi":"10.1517/14656566.2013.763030","title":"Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases)","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Enterobacteriaceae; Medicine; Antimicrobial; Microbiology; Antibiotic resistance; Antibiotics; Escherichia coli; Biology; Genetics; Gene","score_opus":0.021928291009944197,"score_gpt":0.3304190644713412,"score_spread":0.30849077346139697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130914578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01294275,0.9837661,0.000078250145,0.00006253705,0.0012273882,0.0012293203,0.00018282204,0.00003259932,0.0004782352],"genre_scores_gemma":[0.008848313,0.98892325,0.00022122382,0.00012664987,0.00089140347,0.00007616227,0.00026073967,0.00013808355,0.000514191],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973175,0.00035554508,0.0007415195,0.00094261277,0.00023621584,0.00040664323],"domain_scores_gemma":[0.9983372,0.000053629265,0.0007132617,0.0007032298,0.00005446308,0.00013819145],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014397582,0.0007114709,0.001171866,0.00018472908,0.00009425091,0.0000621199,0.00040107657,0.00042833388,0.0001709065],"category_scores_gemma":[0.000021856042,0.0006013905,0.00039004648,0.00013341974,0.00026246914,0.000014962132,0.00007347255,0.00023187241,0.000018494778],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044656973,0.002301151,0.0005719138,0.010093995,0.0023512435,0.00003079008,0.00020364401,0.000002876051,0.515254,0.0015772198,0.101544805,0.36160263],"study_design_scores_gemma":[0.0010214533,0.00037020666,0.0001672557,0.0056621344,0.000026215994,0.000011282961,0.000011293596,0.0000011423597,0.04636297,0.000013480337,0.9457222,0.00063031557],"about_ca_topic_score_codex":0.000036039397,"about_ca_topic_score_gemma":0.000007884286,"teacher_disagreement_score":0.8441774,"about_ca_system_score_codex":0.00012273689,"about_ca_system_score_gemma":0.00014604883,"threshold_uncertainty_score":0.99964374},"labels":[],"label_agreement":null},{"id":"W2131349644","doi":"10.1517/14656560903329102","title":"Mecamylamine – a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Mecamylamine; Medicine; Nicotinic agonist; Pharmacology; Antagonist; Neuroscience; Internal medicine; Psychology; Receptor","score_opus":0.026188795957031805,"score_gpt":0.3739305931689614,"score_spread":0.34774179721192955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131349644","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008974192,0.9920885,0.0009083117,0.0005981613,0.002043447,0.0039056612,0.00026415847,0.000038254784,0.00006374085],"genre_scores_gemma":[0.000056468496,0.99276954,0.0007665668,0.00041510758,0.0033777715,0.0008936582,0.0009097419,0.00022318319,0.00058797136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99704343,0.00028669223,0.00084266544,0.0009927199,0.00032874505,0.00050573726],"domain_scores_gemma":[0.9979386,0.00013582253,0.00076050294,0.00094138796,0.00009507471,0.00012866074],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018382401,0.00092670275,0.0013409429,0.00014460053,0.00022482399,0.000035372388,0.0006963424,0.00031332305,0.00009508517],"category_scores_gemma":[0.00001358024,0.0005351959,0.0011140195,0.00033592427,0.00015357557,0.0000054386146,0.00003114593,0.00021783018,0.000011637893],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011271096,0.0020853588,0.0000018193102,0.00024251635,0.0010223365,1.0341989e-7,0.000070779184,0.000023949078,0.0014765162,0.000013561221,0.01566763,0.9782683],"study_design_scores_gemma":[0.0050029284,0.007266852,6.766119e-7,0.00033125345,0.00015044253,0.000014067403,0.000022493463,0.000023877197,0.0028850748,0.0000011601777,0.9837454,0.0005557676],"about_ca_topic_score_codex":0.0000127014255,"about_ca_topic_score_gemma":0.000005753952,"teacher_disagreement_score":0.9777126,"about_ca_system_score_codex":0.00007291194,"about_ca_system_score_gemma":0.00030448643,"threshold_uncertainty_score":0.99970996},"labels":[],"label_agreement":null},{"id":"W2132185981","doi":"10.1517/14656566.3.4.411","title":"Treatment options for renovascular hypertension","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Renal and Vascular Pathologies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Renovascular hypertension; Renal artery stenosis; Cardiology; Internal medicine; Angioplasty; Blood pressure; Renal artery; Pathophysiology of hypertension; Stenosis; Kidney","score_opus":0.28366608676769955,"score_gpt":0.46428817736092054,"score_spread":0.18062209059322099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132185981","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.9130097e-7,0.99490553,0.00019965785,0.00019388889,0.0009219262,0.0033629,0.00004447076,0.0002116037,0.00015962704],"genre_scores_gemma":[6.58282e-8,0.99300414,0.0015881065,0.0003997871,0.0013317649,0.002283989,0.00038372964,0.00015448887,0.0008539335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979078,0.00017912025,0.0005787882,0.0007069962,0.00025786165,0.00036939947],"domain_scores_gemma":[0.9987458,0.00017237823,0.00019250385,0.0006464603,0.00006552863,0.00017730355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011270706,0.00069809094,0.002384141,0.00033041404,0.00016287577,0.00002814459,0.00016113876,0.00032034345,0.0002991401],"category_scores_gemma":[0.000017700677,0.0004104845,0.0026731275,0.0002409832,0.000052743526,0.000045188543,0.000015350057,0.00020259905,0.00024945798],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000564438,0.0006718573,3.218189e-8,0.0017999011,0.0009190446,0.000035013243,0.000056512872,4.4883856e-7,0.000027695234,0.00007978982,0.0041870326,0.9921662],"study_design_scores_gemma":[0.003070173,0.0013215435,9.240724e-8,0.0075509422,0.0003083919,0.00062895176,0.00000773294,0.000036202182,0.00006965947,0.0000057211687,0.98659694,0.00040367633],"about_ca_topic_score_codex":0.000004801367,"about_ca_topic_score_gemma":3.721149e-8,"teacher_disagreement_score":0.9917626,"about_ca_system_score_codex":0.00026224658,"about_ca_system_score_gemma":0.000104338396,"threshold_uncertainty_score":0.9998347},"labels":[],"label_agreement":null},{"id":"W2132239648","doi":"10.1517/14656566.2014.853039","title":"An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds","year":2013,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Aspirin; Primary prevention; Disease; Secondary prevention; Intensive care medicine; Context (archaeology); Adverse effect; Platelet aggregation inhibitor; Population; Internal medicine; Environmental health","score_opus":0.02116803437083587,"score_gpt":0.33934537443845597,"score_spread":0.3181773400676201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132239648","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08773152,0.37060684,0.00055789674,0.00024368158,0.5332555,0.003428038,0.0035232236,0.00048331704,0.0001699471],"genre_scores_gemma":[0.025606876,0.5294756,0.0001163385,0.0006748706,0.44146988,0.0004254357,0.0016690115,0.00039574676,0.00016623612],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99427974,0.0006921776,0.0007199451,0.0014138321,0.0021005976,0.00079369405],"domain_scores_gemma":[0.99617875,0.00032256008,0.00038510468,0.0018537206,0.00028783697,0.00097203907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00081686786,0.0009844599,0.0018830177,0.0002750684,0.00028350868,0.0001641797,0.00043344987,0.0006586469,0.0003350987],"category_scores_gemma":[0.00007954631,0.0008627692,0.0018817396,0.0003194436,0.0003950708,0.0004234145,0.00006225187,0.0010773833,0.0000277212],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01258927,0.0015711606,0.0014223127,0.0008560983,0.033361223,0.0002977853,0.0030681398,0.00094550004,0.001247447,0.000041455427,0.7206706,0.223929],"study_design_scores_gemma":[0.010368986,0.0008122448,0.0011214011,0.0010469264,0.0004535872,0.000011625979,0.00015022265,0.00022373232,0.002412769,0.000023884397,0.98248774,0.0008868634],"about_ca_topic_score_codex":0.002150916,"about_ca_topic_score_gemma":0.000008528825,"teacher_disagreement_score":0.26181716,"about_ca_system_score_codex":0.00028763094,"about_ca_system_score_gemma":0.0005884877,"threshold_uncertainty_score":0.9993823},"labels":[],"label_agreement":null},{"id":"W2133353215","doi":"10.1517/14656566.7.2.177","title":"A review of erlotinib and its clinical use","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Erlotinib; Medicine; Rash; Epidermal growth factor receptor; Gemcitabine; Clinical trial; Oncology; Erlotinib Hydrochloride; Internal medicine; Gefitinib; Lung cancer; Tyrosine-kinase inhibitor; Pancreatic cancer; Pharmacology; Cancer","score_opus":0.22250994714479316,"score_gpt":0.5773877545529791,"score_spread":0.3548778074081859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133353215","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000012676735,0.99559927,0.0000044511003,0.00040168737,0.000872801,0.0023064592,0.00012381394,0.00004664994,0.0006436288],"genre_scores_gemma":[3.2778019e-7,0.99091595,0.00022009826,0.0064449143,0.00076735753,0.0003017855,0.00039061264,0.00008100948,0.00087792316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99792224,0.00022086994,0.0010115218,0.0004429122,0.00022655836,0.00017592314],"domain_scores_gemma":[0.9986756,0.0002892086,0.00046755586,0.000304149,0.000101893434,0.0001616157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021215569,0.00037632202,0.0018990122,0.00012947235,0.000039298615,0.000011330132,0.00008864129,0.00016688474,0.00036359832],"category_scores_gemma":[0.00003935507,0.00025047173,0.0006012141,0.00019522678,0.00004738265,0.000063690124,0.000015037787,0.0002655719,0.0000305483],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037134418,0.00044280573,0.000005377713,0.028100017,0.00052977726,0.0000058067913,0.000022464419,1.0721176e-8,0.0000015032239,0.00007791656,0.11157573,0.85920143],"study_design_scores_gemma":[0.001654351,0.00033433453,0.0000053958224,0.1354438,0.0002605537,0.000035082125,9.410353e-7,0.0000016953398,0.0000081863445,0.0000011045471,0.8620838,0.00017074237],"about_ca_topic_score_codex":0.00001853291,"about_ca_topic_score_gemma":1.5470862e-7,"teacher_disagreement_score":0.8590307,"about_ca_system_score_codex":0.00007599964,"about_ca_system_score_gemma":0.0003351844,"threshold_uncertainty_score":0.99999475},"labels":[],"label_agreement":null},{"id":"W2134373304","doi":"10.1517/14656566.1.3.575","title":"The Sixth International Conference on Endothelin","year":2000,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Endothelin receptor; Clinical trial; Pharmacology; Disease; Internal medicine; Receptor","score_opus":0.07739156945634294,"score_gpt":0.4179388430665808,"score_spread":0.34054727361023784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134373304","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11283339,0.016258862,0.00026958284,0.069813386,0.0059885043,0.0028706791,0.0001541525,0.0005317005,0.79127973],"genre_scores_gemma":[0.4842059,0.46146116,0.000118943055,0.017316425,0.0038544713,0.00022930636,0.000064830274,0.000103665756,0.032645304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998286,0.00018476984,0.00019490656,0.00033414018,0.0007279909,0.00027215845],"domain_scores_gemma":[0.99921036,0.00014037247,0.00003054012,0.00037172434,0.000104779174,0.00014225495],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002160506,0.00017975936,0.00018553801,0.000078590994,0.00018703559,0.00007590336,0.00027375942,0.00003862851,0.010289839],"category_scores_gemma":[0.000023892811,0.00011301374,0.0002195108,0.00009511129,0.00012936187,0.0000547807,0.0000141567925,0.00031244117,0.00065491576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039302353,0.00032578234,0.000059190137,0.0000038539915,0.00033634593,0.000035552086,0.00050461356,0.000023444241,0.08237993,0.0023036916,0.040231403,0.86986595],"study_design_scores_gemma":[0.0032043257,0.00033387743,0.00037020523,0.00006131832,0.0000013888911,0.000021346186,0.000067996356,0.0005797221,0.094849646,0.00004371856,0.9003532,0.00011328565],"about_ca_topic_score_codex":0.000021032012,"about_ca_topic_score_gemma":6.255494e-7,"teacher_disagreement_score":0.86975265,"about_ca_system_score_codex":0.00006341809,"about_ca_system_score_gemma":0.000059321334,"threshold_uncertainty_score":0.9906149},"labels":[],"label_agreement":null},{"id":"W2135344776","doi":"10.1517/14656566.8.11.1615","title":"Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Mount Sinai Hospital; McMaster University; University of Toronto; University Health Network","funders":"GlaxoSmithKline; AstraZeneca; Eli Lilly and Company","keywords":"Mood disorders; Mood; Medicine; Cognition; Disease; Bioinformatics; Neuroscience; Psychiatry; Psychology; Clinical psychology; Anxiety; Internal medicine; Biology","score_opus":0.18067765430314467,"score_gpt":0.45982508818113105,"score_spread":0.27914743387798635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135344776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019918843,0.98940617,0.0010380698,0.00014597381,0.002110599,0.0042774677,0.00039307633,0.000172458,0.0024362733],"genre_scores_gemma":[0.00011620071,0.9946314,0.00012313666,0.0023067205,0.0005346866,0.0016331362,0.00015279854,0.00021119167,0.0002907115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660516,0.00019417626,0.00075915887,0.0012466331,0.00044087434,0.0007539891],"domain_scores_gemma":[0.99750847,0.0016412565,0.00036172027,0.00029298954,0.000029805873,0.00016574936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019581454,0.00088470866,0.0012623287,0.00070237275,0.00018087358,0.00006549636,0.00053217233,0.00036923547,0.00018263557],"category_scores_gemma":[0.0001323644,0.0007184922,0.0006805043,0.0007755309,0.0001095766,0.00017129682,0.000034329987,0.00040587084,0.000114079085],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003389442,0.0017448753,8.5277753e-7,0.0004917542,0.00008185641,0.0000020186644,0.0004699986,0.000001102867,0.00054456864,0.0007497689,0.00086062076,0.99471366],"study_design_scores_gemma":[0.006916264,0.00039492766,0.0000020764867,0.0036126235,0.000015006304,0.00000971995,0.00008653871,0.000032743148,0.0032039585,0.00009189834,0.9848744,0.0007598115],"about_ca_topic_score_codex":0.000012791113,"about_ca_topic_score_gemma":0.0000069444086,"teacher_disagreement_score":0.9939538,"about_ca_system_score_codex":0.00018681173,"about_ca_system_score_gemma":0.00015632682,"threshold_uncertainty_score":0.9995266},"labels":[],"label_agreement":null},{"id":"W2138218422","doi":"10.1517/14656566.2012.656590","title":"Treatment-emergent adverse events associated with atypical antipsychotics","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Extrapyramidal symptoms; Adverse effect; Atypical antipsychotic; Tolerability; Discontinuation; Olanzapine; Antipsychotic; Risperidone; Clozapine; Quetiapine; Atypical depression; Side effect (computer science); Psychiatry; Intensive care medicine; Pediatrics; Internal medicine; Schizophrenia (object-oriented programming); Cognition","score_opus":0.1710411252647439,"score_gpt":0.46703920134336746,"score_spread":0.29599807607862355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138218422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020774904,0.9950757,0.0000127655785,0.00031803953,0.0012456398,0.0026776702,0.00011425426,0.00015954666,0.00018865777],"genre_scores_gemma":[0.00023446984,0.9948115,0.0003798904,0.00028543145,0.0012522977,0.00071469723,0.0011956193,0.00020529884,0.00092080206],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968726,0.0003524349,0.0005479491,0.00066981115,0.0007783003,0.0007789135],"domain_scores_gemma":[0.99808425,0.00017134193,0.00028562636,0.000596423,0.00008014409,0.00078220136],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011950328,0.0008845954,0.0017425806,0.00031959687,0.00013906452,0.000009512493,0.000189454,0.00031899128,0.0017900779],"category_scores_gemma":[0.000012572478,0.000512765,0.00081070734,0.00040622594,0.00006580223,0.00007113781,0.00001777782,0.00044094535,0.00053207227],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016296372,0.004902365,0.00015011943,0.00030816696,0.004265911,0.000097065385,0.00009064537,2.0055361e-7,0.0000040084783,0.00006536933,0.0019361323,0.97188365],"study_design_scores_gemma":[0.013080472,0.0027166728,0.00024514552,0.0043765386,0.00033304514,0.000093779745,0.000011317113,0.000008880767,0.000047270933,0.000003460687,0.97863364,0.0004497567],"about_ca_topic_score_codex":0.0000066904436,"about_ca_topic_score_gemma":0.0000020495734,"teacher_disagreement_score":0.9766975,"about_ca_system_score_codex":0.0009877637,"about_ca_system_score_gemma":0.00051522435,"threshold_uncertainty_score":0.9997324},"labels":[],"label_agreement":null},{"id":"W2138366034","doi":"10.1517/14656566.9.2.311","title":"Idursulfase for the treatment of mucopolysaccharidosis II","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Child and Family Research Institute","funders":"","keywords":"Hunter syndrome; Enzyme replacement therapy; Recombinant DNA; Medicine; Mucopolysaccharidosis; Mucopolysaccharidosis type II; Disease; Glycosylation; Genetic enhancement; Bioinformatics; Internal medicine; Biology; Genetics; Gene","score_opus":0.17781894602661114,"score_gpt":0.4863654061848031,"score_spread":0.308546460158192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138366034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009591028,0.99218637,0.00006931011,0.00093148754,0.0010783604,0.0053324886,0.00015251347,0.00006436019,0.00017550726],"genre_scores_gemma":[0.0000038762114,0.99302644,0.00014856186,0.0006123773,0.0013844457,0.0031440207,0.00016921302,0.00016865665,0.0013424188],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976229,0.00013408308,0.0006543171,0.0005569252,0.0005889992,0.00044274607],"domain_scores_gemma":[0.9980279,0.0006215834,0.0003027122,0.00072315,0.0001311829,0.00019343938],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001002873,0.00060112064,0.0017557226,0.00030141257,0.00033386156,0.000012948895,0.00037200385,0.00023831317,0.0008658657],"category_scores_gemma":[0.000025822397,0.00032532017,0.001572404,0.00038987922,0.00017230264,0.00003754224,0.000021811755,0.0002146643,0.00003905861],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057576055,0.0020013736,7.275727e-7,0.0008484807,0.001200323,0.000007912803,0.0008549267,3.2939673e-7,0.000089272726,0.000034513727,0.034406442,0.95997995],"study_design_scores_gemma":[0.0044614216,0.003556667,3.797899e-7,0.0016472923,0.000080102785,0.00005483724,0.000033932047,0.00004122488,0.0015010313,0.0000024312183,0.9883547,0.0002659922],"about_ca_topic_score_codex":0.00008406505,"about_ca_topic_score_gemma":5.0281824e-7,"teacher_disagreement_score":0.95971394,"about_ca_system_score_codex":0.00040624072,"about_ca_system_score_gemma":0.00046491853,"threshold_uncertainty_score":0.9999199},"labels":[],"label_agreement":null},{"id":"W2142447425","doi":"10.1517/14656566.2015.1067682","title":"A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lama; Bronchodilator; COPD; Asthma; Bronchodilation; Bronchodilator Agents; Muscarinic antagonist; Intensive care medicine; Population; Combination therapy; Internal medicine; Muscarinic acetylcholine receptor","score_opus":0.059781031924271165,"score_gpt":0.40154194020603706,"score_spread":0.3417609082817659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142447425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008466626,0.9823756,0.0000014612923,0.000075766875,0.00025378805,0.007413335,0.00024241957,0.000009186591,0.0011618024],"genre_scores_gemma":[0.058196213,0.9401177,0.000023355242,0.000054283933,0.00014445653,0.0010675519,0.00028607648,0.00008190169,0.000028416434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99474627,0.0010652425,0.00086270674,0.00050057104,0.0025279156,0.0002973153],"domain_scores_gemma":[0.99739295,0.00010977447,0.0008016113,0.0010248787,0.0005240194,0.00014674282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069974584,0.0004299027,0.0010841906,0.00028243972,0.000040419112,0.0000066647603,0.0006019043,0.00010107322,0.00026528677],"category_scores_gemma":[0.000018335142,0.00023081408,0.00038545206,0.0007801439,0.00031588797,0.00008678294,0.00010554381,0.00038187884,0.0000031422671],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016562968,0.0018656945,0.0014768001,0.007661237,0.0006120624,0.000013492511,0.00046366898,0.000017654995,0.000012105112,0.000098235956,0.00008664554,0.9860361],"study_design_scores_gemma":[0.018583667,0.0010563306,0.10637105,0.042838342,0.001585392,0.000017347555,0.0015088774,0.0011794788,0.0002852548,0.0003959838,0.82535416,0.00082409615],"about_ca_topic_score_codex":0.000024306017,"about_ca_topic_score_gemma":0.0000011314944,"teacher_disagreement_score":0.985212,"about_ca_system_score_codex":0.0010586375,"about_ca_system_score_gemma":0.0012086241,"threshold_uncertainty_score":0.9412325},"labels":[],"label_agreement":null},{"id":"W2143239720","doi":"10.1517/14656566.5.10.2139","title":"Etanercept in psoriasis","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Etanercept; Medicine; Psoriatic arthritis; Psoriasis; Rheumatoid arthritis; Ankylosing spondylitis; Adverse effect; Clinical trial; Arthritis; Placebo; Dermatology; Internal medicine; Immunology; Pathology","score_opus":0.0893489166961888,"score_gpt":0.45685759399466197,"score_spread":0.36750867729847314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143239720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000452078,0.99474645,0.0000099908475,0.000504426,0.0011565636,0.0015679991,0.000025111125,0.00013180707,0.0018531198],"genre_scores_gemma":[0.0000073489855,0.9967705,0.00020500082,0.00095633423,0.0008165023,0.00056337763,0.00016006731,0.00017392644,0.00034693428],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714196,0.0002792029,0.0007263662,0.00064379664,0.00061669055,0.0005919617],"domain_scores_gemma":[0.9988446,0.0001396429,0.00015758087,0.0004963291,0.000044180077,0.0003176612],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027354233,0.0006056078,0.0018484659,0.0007294254,0.000075313365,0.000050379025,0.0002913508,0.00031081488,0.0032700368],"category_scores_gemma":[0.000027045424,0.0004565824,0.00066082383,0.00050829805,0.00010157777,0.00009153071,0.000025594449,0.0008760489,0.00066501455],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020090624,0.00046640326,0.000001335733,0.0014239178,0.00021684465,0.00008163926,0.0004022003,4.4984978e-7,0.000022660579,0.00030197937,0.005362972,0.9915187],"study_design_scores_gemma":[0.004415584,0.00040718302,0.0000014132165,0.032177918,0.0000023659559,0.00013474387,0.000024423269,0.00000254685,0.00006825017,0.00005464137,0.96232337,0.00038759044],"about_ca_topic_score_codex":0.000060611357,"about_ca_topic_score_gemma":0.0000016798382,"teacher_disagreement_score":0.9911311,"about_ca_system_score_codex":0.00043629596,"about_ca_system_score_gemma":0.0006116359,"threshold_uncertainty_score":0.9997886},"labels":[],"label_agreement":null},{"id":"W2150426329","doi":"10.1517/14656566.2010.484020","title":"Beating the clock: reducing cardiovascular risk by rapid blood pressure reduction with olmesartan","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Heart and Stroke Foundation of Canada","keywords":"Olmesartan; Medicine; Valsartan; Blood pressure; Combination therapy; Risk factor; Internal medicine; Cardiology; Pharmacology","score_opus":0.04497177242538245,"score_gpt":0.3498153123478145,"score_spread":0.304843539922432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150426329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000073514234,0.99352556,0.000015687741,0.00078796176,0.001986221,0.0023805546,0.00008131079,0.00022455292,0.0009908121],"genre_scores_gemma":[0.00002180166,0.9909503,0.0003755018,0.0018691077,0.004919399,0.0006346873,0.00014430848,0.00024558228,0.00083933206],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605525,0.00064943876,0.00073541846,0.0010970136,0.000936517,0.00052638684],"domain_scores_gemma":[0.9973417,0.0002458133,0.0005685532,0.0013778447,0.00021015845,0.00025594837],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077472866,0.0009128981,0.0028480745,0.00018587221,0.00074063183,0.000081357626,0.0003502687,0.00048880314,0.00026752125],"category_scores_gemma":[0.00004130164,0.000491686,0.0012918066,0.0003946131,0.00020036977,0.00010045398,0.000053314867,0.0021404715,0.000026342103],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014079816,0.0002825205,8.2209647e-7,0.0008727288,0.016839469,0.000011403002,0.0006052887,0.0000034563914,0.0004556571,0.000007718738,0.12607822,0.85470194],"study_design_scores_gemma":[0.0023833667,0.0004571878,5.042419e-7,0.0056849173,0.008535229,0.0005250399,0.00010488633,0.000008350686,0.0016260722,0.0000012421312,0.98010564,0.0005675629],"about_ca_topic_score_codex":0.00010540569,"about_ca_topic_score_gemma":2.3225473e-7,"teacher_disagreement_score":0.8541344,"about_ca_system_score_codex":0.00001603548,"about_ca_system_score_gemma":0.00023390402,"threshold_uncertainty_score":0.9997535},"labels":[],"label_agreement":null},{"id":"W2151114022","doi":"10.1517/14656566.2010.512004","title":"Probiotic strategies for the treatment and prevention of bacterial vaginosis","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"Bacterial vaginosis; Medicine; Intensive care medicine; Probiotic; Disease; Genitourinary system; Population; Microbicide; Microbicides for sexually transmitted diseases; Vaginal disease; Clinical trial; Reproductive health; Vagina; Immunology; Gynecology; Human immunodeficiency virus (HIV); Internal medicine; Environmental health; Surgery; Health services","score_opus":0.12285491585598339,"score_gpt":0.4660475121725111,"score_spread":0.3431925963165277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151114022","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009469574,0.9927762,0.00013065955,0.000106491665,0.0032685953,0.0034246289,0.000092977985,0.000033454133,0.000072264644],"genre_scores_gemma":[0.000041064144,0.9969409,0.00006413444,0.000013872672,0.00045038763,0.0016598083,0.00021631167,0.000044972854,0.00056854944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985826,0.00035480788,0.00037627082,0.00042713212,0.000034516077,0.00022464214],"domain_scores_gemma":[0.998682,0.00059026154,0.0002519386,0.00038467874,0.0000748353,0.000016259326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026130243,0.0003271827,0.0007065419,0.00016928933,0.00019747316,0.000038409074,0.00020117717,0.00030223944,0.00065183133],"category_scores_gemma":[0.00001426003,0.00018420439,0.00034856205,0.000105600935,0.00024542358,0.00007831721,0.000014021455,0.00031682008,0.000028288176],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018856458,0.0004674961,2.825554e-7,0.0003830697,0.00078615185,5.106751e-8,0.0003299081,2.1305837e-7,0.024219101,0.00044293268,0.0014146249,0.9717676],"study_design_scores_gemma":[0.0012271863,0.001284626,0.0000017520581,0.0004822706,0.000053231553,0.000018600716,0.00004101841,3.1323768e-7,0.012534426,0.0000673098,0.98412955,0.00015971872],"about_ca_topic_score_codex":0.000029009834,"about_ca_topic_score_gemma":0.000001863844,"teacher_disagreement_score":0.98271495,"about_ca_system_score_codex":0.000067833585,"about_ca_system_score_gemma":0.00026437108,"threshold_uncertainty_score":0.75116366},"labels":[],"label_agreement":null},{"id":"W2151952082","doi":"10.1517/14656566.2010.485614","title":"Fidaxomicin (OPT-80) for the treatment of<i>Clostridium difficile</i>infection","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Fidaxomicin; Medicine; Clostridium difficile; Internal medicine; Vancomycin; Antibiotics; Diarrhea; Gastroenterology; Intensive care medicine; Surgery; Microbiology","score_opus":0.1285146787912159,"score_gpt":0.46083316786330575,"score_spread":0.33231848907208983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151952082","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022554195,0.98736656,0.00008105444,0.0009768276,0.0037612591,0.0067119934,0.00036086806,0.00012964425,0.00038625122],"genre_scores_gemma":[0.000039046914,0.98989856,0.00010013794,0.00029296675,0.0055713407,0.002234089,0.00046639523,0.00024991273,0.0011475674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963724,0.0001799733,0.0011246105,0.00089359295,0.0007084256,0.0007210153],"domain_scores_gemma":[0.9963511,0.0014150504,0.0005314893,0.0011660117,0.00023488468,0.00030145023],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031634318,0.0009901143,0.002372307,0.0004653923,0.00031321676,0.000058908547,0.0003753513,0.0006489296,0.0008136023],"category_scores_gemma":[0.000056210993,0.00057979923,0.0022500458,0.00053833966,0.0002073562,0.00004596229,0.000027559465,0.00077937735,0.000105929976],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093333056,0.0022856335,0.0000011253981,0.0014719381,0.00084801944,0.0000051868083,0.00017400291,0.0000017932532,0.004774343,0.00007255011,0.018743357,0.9706887],"study_design_scores_gemma":[0.0040962496,0.0032495784,7.893537e-7,0.001997131,0.00027304844,0.000055149587,0.00001504745,0.00008977812,0.08790724,0.0000028132617,0.90187114,0.0004420125],"about_ca_topic_score_codex":0.00015397507,"about_ca_topic_score_gemma":0.000003869649,"teacher_disagreement_score":0.97024673,"about_ca_system_score_codex":0.00060542417,"about_ca_system_score_gemma":0.00071350764,"threshold_uncertainty_score":0.9996653},"labels":[],"label_agreement":null},{"id":"W2152565098","doi":"10.1517/14656566.6.13.2327","title":"Alefacept: an expert review concerning the treatment of psoriasis","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Mediprobe Research (Canada); Dalhousie University","funders":"","keywords":"Medicine; Psoriasis; Psoriatic arthritis; Dermatology; Clinical trial; Plaque psoriasis; Topical agents; Intensive care medicine; Internal medicine","score_opus":0.12976649526910297,"score_gpt":0.4289530562968752,"score_spread":0.2991865610277722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152565098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000066348625,0.9923009,0.000006302714,0.00031784977,0.00453114,0.00210424,0.00020958025,0.00012090806,0.00040239535],"genre_scores_gemma":[0.0000024475908,0.9929606,0.00007811908,0.0013936117,0.0015513193,0.0014859316,0.0010192974,0.0001326629,0.0013760385],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99604714,0.0015113213,0.001016102,0.00079103734,0.00012664785,0.0005077424],"domain_scores_gemma":[0.99769014,0.00043792807,0.0007511198,0.0009889142,0.00006225198,0.000069638205],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002673881,0.0009949108,0.0024523677,0.00016842918,0.00028438395,0.00001850685,0.0006918698,0.00047543022,0.00596357],"category_scores_gemma":[0.000008101354,0.00055954047,0.001262226,0.00026600788,0.00019059738,0.000099368706,0.000021032582,0.0002393833,0.00062108523],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012257765,0.0009913783,5.013393e-7,0.000444532,0.0016872206,0.0000024624117,0.001276885,2.5765206e-7,0.00026838508,0.000037274494,0.021765208,0.97340333],"study_design_scores_gemma":[0.0023165517,0.0011185912,5.253495e-7,0.0074792006,0.00023712199,0.00004238519,0.000050264433,3.8068384e-7,0.0022054166,0.0000010668316,0.98602456,0.000523942],"about_ca_topic_score_codex":0.000058834834,"about_ca_topic_score_gemma":0.000001939209,"teacher_disagreement_score":0.97287935,"about_ca_system_score_codex":0.00026109183,"about_ca_system_score_gemma":0.00018466548,"threshold_uncertainty_score":0.9996856},"labels":[],"label_agreement":null},{"id":"W2152716121","doi":"10.1517/14656566.2010.482100","title":"Pharmacotherapy of neuroblastoma","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Izaak Walton Killam Health Centre","funders":"","keywords":"Neuroblastoma; Medicine; Clinical trial; Oncology; Disease; Immunotherapy; Targeted therapy; Pharmacotherapy; Combination therapy; Drug; Drug development; Internal medicine; Pharmacology; Cancer","score_opus":0.11078687250440349,"score_gpt":0.4954936893576022,"score_spread":0.3847068168531987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152716121","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048186343,0.99321884,0.000010396787,0.000250853,0.001979669,0.0024823905,0.00012539841,0.0001937569,0.0016904928],"genre_scores_gemma":[0.0000144390315,0.9948086,0.00027221188,0.0016633364,0.0013428201,0.00046393782,0.00016558394,0.00034455568,0.00092447153],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961789,0.00034034494,0.00095314055,0.0009121064,0.0009355239,0.0006799828],"domain_scores_gemma":[0.9975491,0.00031420676,0.0005224033,0.000885027,0.0001321752,0.00059709063],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018139758,0.0009552875,0.0024194766,0.0008017898,0.00010316868,0.000031872332,0.00049029576,0.00039525508,0.002659774],"category_scores_gemma":[0.00002172491,0.0006945948,0.0013067542,0.00059028977,0.00019856932,0.00009604263,0.000046886496,0.001427531,0.0004200896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008165446,0.0015635494,0.0000010484107,0.0018536713,0.0006664525,0.00011290259,0.000060312424,1.027223e-7,0.009337949,0.000045602617,0.013413592,0.9721283],"study_design_scores_gemma":[0.004832196,0.0017856342,0.0000015651933,0.004642446,0.000059404952,0.00025684742,0.0000021454966,0.000008899042,0.020713838,0.0000059161275,0.9672721,0.00041902767],"about_ca_topic_score_codex":0.000010594308,"about_ca_topic_score_gemma":2.542576e-7,"teacher_disagreement_score":0.97170925,"about_ca_system_score_codex":0.000116695635,"about_ca_system_score_gemma":0.00054743077,"threshold_uncertainty_score":0.9995505},"labels":[],"label_agreement":null},{"id":"W2153837033","doi":"10.1517/14656566.4.6.911","title":"Androgen replacement therapy in the hypogonadal ageing man","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Ageing; Medicine; Climacteric; Androgen; Androgen deficiency; Testosterone (patch); Hormone; Menopause; Intensive care medicine; Internal medicine","score_opus":0.15872693761260623,"score_gpt":0.4507242243536365,"score_spread":0.2919972867410303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153837033","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007486557,0.9907506,0.0000023917933,0.0013502099,0.0010815285,0.0024508329,0.000010469261,0.000046440222,0.0042326613],"genre_scores_gemma":[0.0000241604,0.9913613,0.000051383788,0.0056945016,0.0012263373,0.00077016704,0.00005815308,0.00009296629,0.0007210052],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970016,0.00055814645,0.00062645116,0.00079197844,0.00060576526,0.00041605876],"domain_scores_gemma":[0.9988899,0.00014926278,0.0002147906,0.0006072361,0.000049670616,0.00008912731],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006883084,0.00062257313,0.0014202314,0.000243891,0.00017815667,0.000028599605,0.00028158867,0.0001553174,0.00033793115],"category_scores_gemma":[0.000014171973,0.0003180085,0.00053883746,0.00042521788,0.000099505116,0.00004242969,0.000021640533,0.00063962006,0.00006315842],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003357517,0.0005718177,0.0000067400283,0.00042407127,0.000519094,0.000075180724,0.0017145548,1.7225703e-7,0.000036231122,0.000096896336,0.020184621,0.9760349],"study_design_scores_gemma":[0.0022633593,0.0007294169,0.000012340546,0.0021038488,0.00001903759,0.00011471093,0.00026715512,6.645217e-7,0.00010861199,0.000021885142,0.9940097,0.00034929634],"about_ca_topic_score_codex":0.000022529724,"about_ca_topic_score_gemma":7.893933e-7,"teacher_disagreement_score":0.9756856,"about_ca_system_score_codex":0.00018221412,"about_ca_system_score_gemma":0.00016393543,"threshold_uncertainty_score":0.9999272},"labels":[],"label_agreement":null},{"id":"W2155797527","doi":"10.1517/14656566.5.5.1117","title":"Gemifloxacin: a new fluoroquinolone","year":2004,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Medicine; Gemifloxacin; Pharmacology; Intensive care medicine; Antibiotics; Moxifloxacin; Microbiology","score_opus":0.046934078133935686,"score_gpt":0.38150362655071635,"score_spread":0.33456954841678066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155797527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64561343,0.060803287,0.02696942,0.20543425,0.014117767,0.0046656793,0.000041931864,0.0024806873,0.039873544],"genre_scores_gemma":[0.87075114,0.056234453,0.009283449,0.055565145,0.005324338,0.000018450124,0.000067827554,0.0001836391,0.0025715765],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985003,0.000021392274,0.00029235744,0.00040903332,0.0003779358,0.0003990029],"domain_scores_gemma":[0.99907345,0.000024135166,0.000071585855,0.00033300844,0.000054476277,0.0004433712],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000082421124,0.00028245256,0.0003074906,0.00016224435,0.000095409014,0.000028325703,0.00015640707,0.00009966461,0.0014223601],"category_scores_gemma":[0.000010576577,0.00024110825,0.00017381858,0.00023335477,0.00005991801,0.000063928186,0.000021815546,0.00028540642,0.00054914417],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017457549,0.0013127932,0.00010359469,0.000019968866,0.0002256763,0.00006517167,0.0014024673,0.00026768752,0.7208773,0.0038721387,0.13934213,0.13076533],"study_design_scores_gemma":[0.011497943,0.0006817487,0.0005653185,0.000121918936,0.0000056690174,0.000054879594,0.000023977562,0.00014427635,0.3415411,0.00020363959,0.644906,0.00025349582],"about_ca_topic_score_codex":0.000052743973,"about_ca_topic_score_gemma":1.6349267e-7,"teacher_disagreement_score":0.50556386,"about_ca_system_score_codex":0.00010884726,"about_ca_system_score_gemma":0.0001772187,"threshold_uncertainty_score":0.9994905},"labels":[],"label_agreement":null},{"id":"W2157257597","doi":"10.1517/14656566.2012.686169","title":"A review of olanzapine pamoate","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Healthcare Decision-Making and Restraints","field":"Psychology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; University of Alberta","funders":"","keywords":"Olanzapine; Medicine; Delirium; Sedation; Incidence (geometry); Side effect (computer science); Anesthesia; Schizophrenia (object-oriented programming); Intensive care medicine; Psychiatry","score_opus":0.2894159198900078,"score_gpt":0.5768339360212112,"score_spread":0.28741801613120344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157257597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.4754976e-7,0.98443663,0.00003126823,0.00043411515,0.008905458,0.0015089811,0.00012869123,0.00010816959,0.0044464394],"genre_scores_gemma":[7.1765265e-7,0.9882037,0.00010716604,0.007941395,0.002420081,0.00034864683,0.00016463661,0.0001752861,0.0006383908],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953865,0.0013316148,0.0015136001,0.0006727461,0.00046002126,0.0006355554],"domain_scores_gemma":[0.9970587,0.00052376057,0.000949982,0.001033807,0.000102302765,0.0003314363],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010993164,0.0006830641,0.0024287882,0.00035365962,0.00006606958,0.000010779973,0.0006813019,0.00048444374,0.013796421],"category_scores_gemma":[0.000038020647,0.0004721171,0.0009461307,0.00048680502,0.00007951313,0.00004448883,0.000035252313,0.0007626427,0.0021316137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003829112,0.00031709403,6.282065e-8,0.023415495,0.00028578748,0.000025354959,0.00028026383,7.1794113e-9,0.0000015658713,0.00013310241,0.06700058,0.9085024],"study_design_scores_gemma":[0.0004755036,0.00013764609,4.2974486e-7,0.15644209,0.000029518034,0.0001906691,0.000011182016,1.4372009e-7,0.0000023370335,0.000008228277,0.84233165,0.0003705804],"about_ca_topic_score_codex":0.000041250078,"about_ca_topic_score_gemma":1.2181562e-7,"teacher_disagreement_score":0.90813184,"about_ca_system_score_codex":0.00010308816,"about_ca_system_score_gemma":0.00020594177,"threshold_uncertainty_score":0.999773},"labels":[],"label_agreement":null},{"id":"W2158903958","doi":"10.1517/14656566.9.13.2349","title":"Reassessment of enfuvirtide's role in the management of HIV-1 infection","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Enfuvirtide; Medicine; Human immunodeficiency virus (HIV); Salvage therapy; Protease inhibitor (pharmacology); Pharmacology; Intensive care medicine; Virology; Internal medicine; Viral load; Antiretroviral therapy; Immunology; Chemotherapy; Gp41","score_opus":0.06095669159787775,"score_gpt":0.4238646789794652,"score_spread":0.36290798738158747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158903958","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000065537606,0.99556816,0.000012651153,0.000058692625,0.00040772787,0.001263921,0.00009650664,0.000016054988,0.0025107597],"genre_scores_gemma":[0.00048342027,0.9979954,0.0000338522,0.000058651163,0.000045615514,0.00059580884,0.0004977925,0.00002726597,0.0002621881],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979544,0.0007666594,0.0005797589,0.00030597206,0.00012369118,0.00026947356],"domain_scores_gemma":[0.9991035,0.00015615765,0.00029761606,0.00039802084,0.000026479607,0.000018228695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002267517,0.00030558356,0.00080084905,0.0002773231,0.00006383016,0.000004543835,0.00032592562,0.00016965404,0.0005858911],"category_scores_gemma":[0.0000019106099,0.00018608887,0.00035758465,0.00027341128,0.00011047614,0.000035609723,0.000033748558,0.00032905285,0.0002638032],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001237973,0.0011007092,0.000018482096,0.0006659554,0.000979216,0.000009565157,0.00042928284,6.6095043e-7,0.00015274787,0.0003600364,0.008676563,0.98748296],"study_design_scores_gemma":[0.0016916124,0.0003389047,0.00013012177,0.002286072,0.000017024198,0.000033254535,0.000053802392,1.5454077e-7,0.0008639649,0.0000079864985,0.9944407,0.00013641886],"about_ca_topic_score_codex":0.000120450415,"about_ca_topic_score_gemma":0.0000010055234,"teacher_disagreement_score":0.9873466,"about_ca_system_score_codex":0.00011259484,"about_ca_system_score_gemma":0.00008706771,"threshold_uncertainty_score":0.7588484},"labels":[],"label_agreement":null},{"id":"W2159480688","doi":"10.1517/14656566.2012.683174","title":"A review of published evidence reporting on the efficacy and pharmacology of lurasidone","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University Health Network","funders":"","keywords":"Lurasidone; Medicine; Pharmacology; Clinical pharmacology; Intensive care medicine; Antipsychotic; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.20422599979781877,"score_gpt":0.48899652151341544,"score_spread":0.2847705217155967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159480688","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009569697,0.9934986,0.000003001075,0.002114968,0.000915598,0.0028660449,0.0000138862315,0.000033065393,0.0005452584],"genre_scores_gemma":[0.00010775163,0.9952734,0.000058771857,0.00341756,0.00058279437,0.00039594213,0.00004410708,0.00007071101,0.00004894718],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965291,0.0005155742,0.0017891577,0.00047286946,0.0004041899,0.00028912563],"domain_scores_gemma":[0.9954768,0.0010642268,0.0025796026,0.0005932704,0.0001287792,0.00015734001],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013124708,0.0004806691,0.0022311616,0.00018412735,0.000061428196,0.000008814107,0.00022403811,0.00016114589,0.0017234694],"category_scores_gemma":[0.0002916954,0.00025995108,0.0005345625,0.00035991435,0.00013849809,0.000083565654,0.000042802232,0.00048040214,0.000014006551],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001911195,0.000922701,0.000022851153,0.04542056,0.0009225915,0.000002460685,0.00016464503,1.5488213e-8,0.00041358598,0.00008270669,0.01429784,0.93755895],"study_design_scores_gemma":[0.0011676986,0.0005049738,0.000024836992,0.13863876,0.000382386,0.0000758154,0.0000055152586,7.181433e-7,0.0012366511,0.0000015523863,0.8577953,0.00016576775],"about_ca_topic_score_codex":0.00001853035,"about_ca_topic_score_gemma":9.608857e-8,"teacher_disagreement_score":0.9373931,"about_ca_system_score_codex":0.000074928525,"about_ca_system_score_gemma":0.0002218611,"threshold_uncertainty_score":0.9999853},"labels":[],"label_agreement":null},{"id":"W2162326198","doi":"10.1517/14656566.2.2.303","title":"Pharmacology and clinical experience with saquinavir","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria General Hospital; Ottawa Hospital","funders":"","keywords":"Saquinavir; Ritonavir; Medicine; Pharmacology; Nelfinavir; Protease inhibitor (pharmacology); Nucleoside Reverse Transcriptase Inhibitor; Virology; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy","score_opus":0.11299448764175786,"score_gpt":0.5016361084492189,"score_spread":0.38864162080746106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162326198","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000074463765,0.993855,0.000027642649,0.001228,0.0014109056,0.0019451648,0.000011018343,0.00015883973,0.0012889755],"genre_scores_gemma":[0.0000059504173,0.9885856,0.0007384743,0.0027830834,0.0015591274,0.0007508888,0.00013788878,0.00014201677,0.0052969707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970128,0.00029620656,0.00084039144,0.0009777764,0.0003903642,0.00048246223],"domain_scores_gemma":[0.99853474,0.00028832388,0.00031100208,0.00035431513,0.000054047443,0.00045754315],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021248563,0.0007883251,0.0020783236,0.00027692306,0.00013654673,0.000031327556,0.0001948369,0.00032166997,0.0016426935],"category_scores_gemma":[0.0000065060235,0.00049612444,0.00037611823,0.00036975756,0.00025593687,0.00008219309,0.000040188246,0.0006090518,0.00020119594],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005460718,0.0008798957,0.0001737049,0.00047452946,0.0010644819,0.00025315429,0.00047098522,2.2872657e-8,0.000006169448,0.00001845307,0.03499854,0.961114],"study_design_scores_gemma":[0.005581661,0.0007800022,0.00001096148,0.004303036,0.00016372718,0.00046497775,0.000041939573,0.000006162504,0.00006673447,0.0000011496145,0.9880628,0.00051684707],"about_ca_topic_score_codex":0.000004426093,"about_ca_topic_score_gemma":3.015641e-7,"teacher_disagreement_score":0.96059716,"about_ca_system_score_codex":0.00018231932,"about_ca_system_score_gemma":0.00033822496,"threshold_uncertainty_score":0.99974906},"labels":[],"label_agreement":null},{"id":"W2166669754","doi":"10.1517/14656560903413534","title":"Examining the roles of cannabinoids in pain and other therapeutic indications: a review","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Medicine; Dronabinol; Cannabidiol; Tolerability; Cannabis; Synthetic cannabinoids; Clinical trial; Randomized controlled trial; Intensive care medicine; Cannabinoid; Pharmacology; Adverse effect; Psychiatry; Surgery; Internal medicine","score_opus":0.11635039492108899,"score_gpt":0.44611785053375647,"score_spread":0.32976745561266746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166669754","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000040901605,0.9884298,0.000011225846,0.008143619,0.000112753485,0.002763627,0.000021426462,0.000030194073,0.000483286],"genre_scores_gemma":[0.000010059742,0.97790986,0.000023472889,0.019823927,0.00032584392,0.0010394936,0.000032006832,0.000091052825,0.00074427517],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99651563,0.0011218095,0.0008992888,0.0005255168,0.0005630291,0.00037472518],"domain_scores_gemma":[0.9986207,0.00013964651,0.00039081482,0.00062621763,0.00007303024,0.00014961453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021038498,0.0004752326,0.0016189144,0.0004468436,0.00007970546,0.000025995701,0.00035485913,0.00021061752,0.00042489878],"category_scores_gemma":[0.00008055104,0.000278895,0.00031814797,0.0007429727,0.00019186849,0.00003903217,0.000030209678,0.0007273767,0.000008182168],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045658227,0.000219636,0.0000136603885,0.0061746193,0.00012395172,0.000003455157,0.00043640294,6.758594e-8,0.0000310905,0.00016304577,0.04251262,0.9502758],"study_design_scores_gemma":[0.0008254201,0.000548404,0.000033792294,0.047530167,0.000040324157,0.00003968367,0.00007715848,0.00000964412,0.00002304963,0.000019113742,0.9506093,0.00024394564],"about_ca_topic_score_codex":0.000048560712,"about_ca_topic_score_gemma":0.0000048001984,"teacher_disagreement_score":0.9500318,"about_ca_system_score_codex":0.00015035666,"about_ca_system_score_gemma":0.0005242391,"threshold_uncertainty_score":0.9999663},"labels":[],"label_agreement":null},{"id":"W2167079031","doi":"10.1517/14656566.8.12.1837","title":"Combined intravenous and intra-arterial approach in acute stroke treatment","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary General Hospital; Foothills Medical Centre","funders":"","keywords":"Medicine; Stroke (engine); Intensive care medicine; Acute stroke; Tissue plasminogen activator; Thrombolysis; Modalities; Recombinant tissue plasminogen activator; Fibrinolytic agent; Ischemic stroke; Ischemia; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.07460703907512574,"score_gpt":0.4087784671248298,"score_spread":0.33417142804970407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167079031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000101209,0.98927784,0.000210536,0.00024707697,0.0014956705,0.003770075,0.00008211471,0.00012571766,0.00468974],"genre_scores_gemma":[0.000016823198,0.9933514,0.0014668409,0.0014148281,0.001447332,0.00069483725,0.00057252136,0.00016341805,0.00087199773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99707615,0.00014908821,0.0008687583,0.000904621,0.00041866166,0.00058269995],"domain_scores_gemma":[0.9987829,0.00010804409,0.00027881004,0.0005326441,0.000025371759,0.00027222798],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023639441,0.00088996906,0.0022732127,0.00065954967,0.000058401125,0.00004427271,0.00022306542,0.00037320092,0.00027220396],"category_scores_gemma":[0.000003997629,0.00066574366,0.00038768374,0.00027623508,0.000100129546,0.00005546148,0.00004985932,0.00048197358,0.00003716654],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010308141,0.0012994002,0.0000033941922,0.00092547375,0.0014784351,0.00011008149,0.00059240416,1.4329814e-7,0.00022185009,0.000047801495,0.012291641,0.98199856],"study_design_scores_gemma":[0.009617183,0.0015151696,0.000005025086,0.0020596238,0.00016863419,0.00011662234,0.00005294697,0.000035488265,0.00030578498,0.0000010789238,0.98563415,0.00048829825],"about_ca_topic_score_codex":0.00002558088,"about_ca_topic_score_gemma":2.4307133e-7,"teacher_disagreement_score":0.9815103,"about_ca_system_score_codex":0.0007603136,"about_ca_system_score_gemma":0.00015312871,"threshold_uncertainty_score":0.99957937},"labels":[],"label_agreement":null},{"id":"W2169543120","doi":"10.1517/14656566.3.10.1405","title":"Major depressive episodes and diet pills","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Sibutramine; Medicine; Weight loss; Orlistat; Depression (economics); Serotonergic; Pill; Fenfluramine; Phenylpropanolamine; Etiology; Obesity; Caffeine; Psychiatry; Pharmacology; Internal medicine; Serotonin","score_opus":0.08915129555430716,"score_gpt":0.43682837926998763,"score_spread":0.34767708371568046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169543120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017956665,0.9947413,0.000011695429,0.00068500335,0.0012025898,0.0016629243,0.00006735379,0.00015079053,0.001460388],"genre_scores_gemma":[0.000011430604,0.99138844,0.00021480523,0.0047131246,0.0011972551,0.00061380345,0.00014522234,0.00011833082,0.0015975792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99780023,0.0002767225,0.00048883114,0.00073777966,0.0002708531,0.00042559925],"domain_scores_gemma":[0.9987107,0.0002800449,0.0002559565,0.0003611231,0.000039366907,0.00035283994],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010771187,0.0007203392,0.001755024,0.0002701619,0.00020175744,0.000025575886,0.00017729818,0.00038170727,0.0026312286],"category_scores_gemma":[0.00001121683,0.0005127414,0.00046489996,0.00016079724,0.00013887159,0.000073953765,0.00004312153,0.0005750277,0.00035212503],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037712962,0.0008943954,0.000011247133,0.0014246941,0.0012952719,0.00013361085,0.00022620648,7.7024566e-8,0.00007393612,0.000047897865,0.058496814,0.9370187],"study_design_scores_gemma":[0.0043172757,0.0008427283,0.0000075160124,0.004674507,0.00023464438,0.00023553427,0.000005369641,0.000010497883,0.0004835663,0.00001376378,0.988741,0.0004336307],"about_ca_topic_score_codex":0.000009146289,"about_ca_topic_score_gemma":1.5749983e-7,"teacher_disagreement_score":0.93658507,"about_ca_system_score_codex":0.00017229392,"about_ca_system_score_gemma":0.00008260694,"threshold_uncertainty_score":0.99973243},"labels":[],"label_agreement":null},{"id":"W2171281019","doi":"10.1517/14656566.2011.596149","title":"Therapy for prevention of post-stroke depression","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Depression (economics); Stroke (engine); Post-stroke depression; Psychological intervention; Psychiatry; Activities of daily living","score_opus":0.10707253224869083,"score_gpt":0.4536675801635518,"score_spread":0.34659504791486095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171281019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000037966834,0.99204016,0.0003279504,0.00006390507,0.002464163,0.00411133,0.0001470169,0.0000808335,0.0007266481],"genre_scores_gemma":[0.000009119324,0.9933109,0.001490943,0.00064025505,0.0009592004,0.0010126886,0.00031559516,0.00013390517,0.0021273405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979565,0.00020233532,0.00080149446,0.00050932023,0.00027748776,0.0002528289],"domain_scores_gemma":[0.99828404,0.00037871013,0.00056313665,0.00043302402,0.00019661694,0.00014444468],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022752887,0.00046388892,0.0015300023,0.0004890006,0.00006109396,0.000009439259,0.00018646283,0.00036894664,0.0010565608],"category_scores_gemma":[0.000038374023,0.00031306414,0.0017936645,0.0001411334,0.00006381132,0.00007245955,0.000012401564,0.00025704497,0.00003203516],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001293196,0.0008069126,0.000008621114,0.0025052316,0.00044256466,3.7335187e-7,0.00023704824,5.9567757e-8,0.0018417954,0.000059995014,0.004954114,0.98785007],"study_design_scores_gemma":[0.0039331047,0.0021502103,0.000014220084,0.008558781,0.000041450596,0.000015402917,0.000022978566,0.000003672307,0.004470443,0.000016544624,0.9805018,0.00027144325],"about_ca_topic_score_codex":0.0000070877036,"about_ca_topic_score_gemma":7.789654e-8,"teacher_disagreement_score":0.98757863,"about_ca_system_score_codex":0.0000880499,"about_ca_system_score_gemma":0.00024839872,"threshold_uncertainty_score":0.99993217},"labels":[],"label_agreement":null},{"id":"W2171837479","doi":"10.1517/14712598.2012.727618","title":"Letter to the Editor: The ezetimibe ‘controversy' is a misunderstanding","year":2012,"lang":"en","type":"letter","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Ezetimibe; Medicine; Intensive care medicine; Internal medicine; Statin","score_opus":0.0470890939153772,"score_gpt":0.3500374663059719,"score_spread":0.3029483723905947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171837479","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012466532,0.017532256,0.0007166292,0.9500475,0.027007584,0.0026018703,0.000052767165,0.000115164126,0.0019137532],"genre_scores_gemma":[0.00016392887,0.00766835,0.00006156211,0.6779149,0.31179047,0.0003900634,0.00005424517,0.00014295791,0.0018135488],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99584025,0.00044004552,0.0004352952,0.0006582505,0.0016970789,0.0009290599],"domain_scores_gemma":[0.99770933,0.00023023132,0.00017993078,0.001545434,0.00009287993,0.0002422055],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009196822,0.000624338,0.00070674624,0.00015279604,0.00047333268,0.00011792049,0.0005593306,0.00056721806,0.0017876228],"category_scores_gemma":[0.000018989998,0.00031792704,0.00093148404,0.00023739832,0.000099422745,0.00008323518,0.00005389096,0.0025176625,0.00052818964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027855797,0.000056668156,0.0000029300224,0.000048891492,0.00071334786,0.000020235153,0.0024066523,0.0000012104317,0.00036609455,0.000014796946,0.9822316,0.013858983],"study_design_scores_gemma":[0.002393696,0.00023721122,0.000008180261,0.00022011205,0.0000405061,0.00004944409,0.00009233003,0.00001840863,0.0017087848,0.000009701968,0.99482745,0.00039420382],"about_ca_topic_score_codex":0.00016728188,"about_ca_topic_score_gemma":7.8118535e-7,"teacher_disagreement_score":0.2847829,"about_ca_system_score_codex":0.00044885074,"about_ca_system_score_gemma":0.00015551575,"threshold_uncertainty_score":0.9999273},"labels":[],"label_agreement":null},{"id":"W2191064608","doi":"10.1517/14656566.2015.1115014","title":"Beclomethasone HFA for the treatment of allergic rhinitis","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dermatology","score_opus":0.19473610660336954,"score_gpt":0.4632658466981847,"score_spread":0.2685297400948152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191064608","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000027493322,0.9923644,0.00041446302,0.0007790406,0.002014121,0.0034158048,0.00014464784,0.00006089813,0.00080389436],"genre_scores_gemma":[0.0000040629366,0.9934586,0.0005038418,0.0008031731,0.0022932275,0.00083288515,0.000689625,0.00014363574,0.0012708976],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979457,0.00016801916,0.0007255289,0.00043706762,0.00044445173,0.000279182],"domain_scores_gemma":[0.9981055,0.0005575475,0.00044873529,0.00050471595,0.00021422427,0.0001692591],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002408882,0.0005342379,0.0018378458,0.0001928655,0.00010893209,0.000019900393,0.00016889018,0.00024566558,0.00049421727],"category_scores_gemma":[0.000017736977,0.000295538,0.0008970499,0.00023351799,0.000084547704,0.00003632609,0.000007794526,0.0001406346,0.00003446389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003291629,0.0006569507,1.4372691e-7,0.0004977944,0.0009955388,0.000006984449,0.0009917729,0.000002178682,0.0000121156245,0.00019895576,0.034248102,0.9620603],"study_design_scores_gemma":[0.004343736,0.00233365,4.064097e-7,0.0021478732,0.00012943982,0.000065952154,0.000058957514,0.00017083234,0.00010195448,0.000018416138,0.99036354,0.0002652203],"about_ca_topic_score_codex":0.000028584713,"about_ca_topic_score_gemma":6.26807e-7,"teacher_disagreement_score":0.9617951,"about_ca_system_score_codex":0.0002686169,"about_ca_system_score_gemma":0.0003404057,"threshold_uncertainty_score":0.9999497},"labels":[],"label_agreement":null},{"id":"W2266600836","doi":"10.1517/14656566.2016.1146691","title":"Topical amitriptyline and ketamine for post-herpetic neuralgia and other forms of neuropathic pain","year":2016,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Neuropathic pain; Gabapentin; Amitriptyline; Ketamine; Neuralgia; Postherpetic neuralgia; Adverse effect; Anesthesia; Peripheral neuropathy; Clinical trial; Pregabalin; Onset of action; Dosing; Pharmacology; Internal medicine; Diabetes mellitus","score_opus":0.03261861953782947,"score_gpt":0.34716190035916294,"score_spread":0.3145432808213335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266600836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9494655,0.008080999,0.02175277,0.017970325,0.00058095675,0.0018065461,0.00008436313,0.00010816248,0.000150363],"genre_scores_gemma":[0.97724944,0.006502574,0.0011597825,0.014190431,0.00030515692,0.00010062903,0.000008051572,0.000055639335,0.00042826618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907357,0.00013907661,0.00021076492,0.00026125988,0.00013495595,0.00018036374],"domain_scores_gemma":[0.9992697,0.00034002727,0.0000681552,0.00014744865,0.000046879246,0.00012778577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042474238,0.0001693509,0.00025743624,0.00007514329,0.000042284337,0.0000065870854,0.000042775355,0.000058311263,0.00012505645],"category_scores_gemma":[0.00008441196,0.00009464443,0.0000664121,0.00004349909,0.00005840977,0.000044936474,0.000010380009,0.00004988139,0.0000018954693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012834847,0.00027235015,0.0018625425,0.000044495966,0.00006752787,0.000005001012,0.00018000326,5.315125e-8,0.6098319,0.0012509458,0.00042641116,0.38477525],"study_design_scores_gemma":[0.041174464,0.012739732,0.006114339,0.00077640964,0.000036885373,0.000106068845,0.00014911722,0.0037915993,0.6484278,0.0015168241,0.28456917,0.000597638],"about_ca_topic_score_codex":0.0000067863143,"about_ca_topic_score_gemma":3.3648493e-7,"teacher_disagreement_score":0.3841776,"about_ca_system_score_codex":0.000015557287,"about_ca_system_score_gemma":0.0000153794,"threshold_uncertainty_score":0.38594875},"labels":[],"label_agreement":null},{"id":"W2282704344","doi":"10.1517/14656566.2016.1146687","title":"How effective is efinaconazole in the management of onychomycosis?","year":2016,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Dermatology; Adverse effect; Broad spectrum; Antifungal; Cure rate; Combination therapy; Surgery; Internal medicine","score_opus":0.02648377841797236,"score_gpt":0.36761610883201246,"score_spread":0.3411323304140401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282704344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86575377,0.028042736,0.0005470424,0.08776739,0.0013909843,0.005673625,0.00011536865,0.00011574333,0.010593355],"genre_scores_gemma":[0.9716558,0.021985527,0.00010354923,0.00523782,0.0001172501,0.00035219546,0.000005250754,0.000019765259,0.0005228561],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991601,0.00006371387,0.00012204147,0.00021817337,0.0002720827,0.00016386932],"domain_scores_gemma":[0.9995418,0.00007199936,0.00005510359,0.0002516071,0.000022387372,0.000057057594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007775371,0.00014365707,0.0001738095,0.00007829489,0.000028697132,0.000009521126,0.00010508287,0.000028539129,0.000274752],"category_scores_gemma":[0.0000015481036,0.00006890085,0.00012110479,0.00013346467,0.000035083118,0.00005993546,0.000009381339,0.000045824767,0.000031000855],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029202986,0.0030094706,0.009287461,0.00007834743,0.0007977847,0.00006712947,0.0014007345,1.9678899e-7,0.029360766,0.002479798,0.026883714,0.9237143],"study_design_scores_gemma":[0.033044294,0.0014862865,0.10533571,0.001070177,0.000031027135,0.000010597943,0.0004801642,0.000014422477,0.21192358,0.0004518791,0.6458929,0.00025893212],"about_ca_topic_score_codex":0.000011637394,"about_ca_topic_score_gemma":1.2550689e-7,"teacher_disagreement_score":0.92345536,"about_ca_system_score_codex":0.000067489214,"about_ca_system_score_gemma":0.000009812978,"threshold_uncertainty_score":0.30083418},"labels":[],"label_agreement":null},{"id":"W2295116138","doi":"10.1517/14656566.2015.1064897","title":"Odanacatib for the treatment of osteoporosis","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Cathepsin K; Medicine; Osteoporosis; Bone resorption; Bone mineral; Pharmacology; Internal medicine; Osteoclast; Receptor","score_opus":0.11406651901762999,"score_gpt":0.44887797703472576,"score_spread":0.3348114580170958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295116138","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000051395145,0.9968161,0.00007881479,0.00007005501,0.001151717,0.0013270193,0.0004244967,0.000010146009,0.00011648919],"genre_scores_gemma":[0.0000032619146,0.99550205,0.00013278314,0.00034145973,0.0017138405,0.0010968118,0.00065502257,0.00006778602,0.0004869767],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99889374,0.000103958664,0.00032921295,0.00035232498,0.00014177435,0.00017900301],"domain_scores_gemma":[0.99903387,0.00006576983,0.00023288217,0.0004984538,0.00007143685,0.00009758434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000983262,0.00035053949,0.000686503,0.000046909652,0.00006347659,0.000013318891,0.0002759788,0.00015291662,0.0000521817],"category_scores_gemma":[0.0000084788435,0.00019571863,0.00067319634,0.000071911956,0.00006184781,0.0000016957899,0.00001263895,0.00003307964,0.0000075020926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014520407,0.00036382405,2.651014e-7,0.00020161603,0.00031695046,9.8690855e-8,0.000081110535,9.195877e-7,0.0003668535,0.000034113167,0.048518028,0.949971],"study_design_scores_gemma":[0.0012585033,0.0007769713,2.5865168e-7,0.00017224796,0.00007213659,0.0000015682459,0.000022502407,0.000002393921,0.004114991,0.000006335165,0.993361,0.00021109196],"about_ca_topic_score_codex":0.000014283148,"about_ca_topic_score_gemma":4.680835e-7,"teacher_disagreement_score":0.9497599,"about_ca_system_score_codex":0.000025272573,"about_ca_system_score_gemma":0.00022866878,"threshold_uncertainty_score":0.7981174},"labels":[],"label_agreement":null},{"id":"W2345727571","doi":"10.1517/14656566.2016.1115481","title":"Overtreatment in cancer – is it a problem?","year":2016,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Overdiagnosis; Medicine; Disease; Cancer; Intensive care medicine; Precision medicine; Family medicine; Internal medicine; Pathology","score_opus":0.33262471852849523,"score_gpt":0.542635894490983,"score_spread":0.2100111759624878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345727571","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000066518136,0.043827847,0.00013187202,0.13888948,0.80546117,0.002008591,0.0038031794,0.00009324232,0.0057181236],"genre_scores_gemma":[0.0000723886,0.20004666,0.00040316785,0.06388066,0.721726,0.0031569877,0.00024641596,0.00024236453,0.010225357],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930246,0.00039192912,0.0040794173,0.0014114641,0.0003514402,0.0007411558],"domain_scores_gemma":[0.9950648,0.0013635966,0.0025023038,0.0007236737,0.00008946762,0.00025619287],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.004693632,0.0006521616,0.0017515444,0.00069186115,0.00013848748,0.000102769205,0.00057223317,0.00076157635,0.009378458],"category_scores_gemma":[0.00032651768,0.0006670856,0.00029908086,0.00019521355,0.000052054278,0.0003625306,0.00004211537,0.00053559546,0.003917598],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013525767,0.0003219912,0.00022310166,0.00012761781,0.00019759544,0.0000014707823,0.0031404595,0.000007991929,0.000011760027,0.0010498049,0.9930643,0.0017186451],"study_design_scores_gemma":[0.004483479,0.00018759593,0.000021729455,0.00087076984,0.0000012397178,3.4318097e-7,0.0000876402,0.00009906352,0.00007999372,0.0014815559,0.9919589,0.0007276837],"about_ca_topic_score_codex":0.0025713055,"about_ca_topic_score_gemma":0.00007579622,"teacher_disagreement_score":0.15621881,"about_ca_system_score_codex":0.0032583785,"about_ca_system_score_gemma":0.00062840787,"threshold_uncertainty_score":0.99957806},"labels":[],"label_agreement":null},{"id":"W2489102976","doi":"10.1080/14656566.2016.1215432","title":"How can the new antipsychotic medications improve quality of life in patients with schizophrenia?","year":2016,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Schizophrenia (object-oriented programming); Quality of life (healthcare); Antipsychotic; Psychiatry; Intensive care medicine","score_opus":0.03670641421594753,"score_gpt":0.36282109665944146,"score_spread":0.32611468244349395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2489102976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8685572,0.001953883,0.00030276398,0.1271984,0.000411732,0.0013892832,0.000053952903,0.00004624695,0.00008651986],"genre_scores_gemma":[0.9944366,0.002732912,0.00057259086,0.0015539776,0.0002887469,0.000098398705,0.00002009278,0.000028712175,0.00026792602],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99840534,0.00014305435,0.00027153146,0.00029338835,0.0006261565,0.00026055152],"domain_scores_gemma":[0.9987903,0.00019372629,0.00013851121,0.00045856924,0.000098603865,0.0003202708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017847528,0.00017598901,0.00028287902,0.00013762014,0.00005541813,0.000015124971,0.00017120746,0.000045827197,0.00022261089],"category_scores_gemma":[0.00006910204,0.00007708959,0.00007528115,0.00024497785,0.00012899812,0.000075006894,0.000011151814,0.0001357754,0.000009837179],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12631303,0.0037701363,0.18835005,0.000037599028,0.00095658185,0.0000037548666,0.0012421423,7.3763914e-7,0.038666204,0.003594226,0.015904274,0.6211613],"study_design_scores_gemma":[0.123111725,0.002804945,0.8135593,0.00039920374,0.000010264912,0.0000014657818,0.00012283854,0.000015934696,0.04134113,0.0004510664,0.017856935,0.00032517736],"about_ca_topic_score_codex":0.0001881148,"about_ca_topic_score_gemma":0.00004695852,"teacher_disagreement_score":0.6252093,"about_ca_system_score_codex":0.00009118045,"about_ca_system_score_gemma":0.0004475687,"threshold_uncertainty_score":0.31436226},"labels":[],"label_agreement":null},{"id":"W2512726512","doi":"10.1080/14656566.2016.1219339","title":"An update on adjuvant systemic therapy for elderly patients with early breast cancer","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Cancer; Trastuzumab; Oncology; Population; Life expectancy; Clinical trial; Geriatric oncology; Internal medicine; Adjuvant therapy; Intensive care medicine","score_opus":0.026059949225191698,"score_gpt":0.3776303086561885,"score_spread":0.3515703594309968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512726512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069832796,0.9923376,0.0000833505,0.00020832941,0.001297378,0.0023999447,0.0028957506,0.00005551937,0.000023798384],"genre_scores_gemma":[0.0009973029,0.99057263,0.000044838573,0.0012905626,0.0021169381,0.00371423,0.000938946,0.00026118537,0.000063379404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975535,0.0001909794,0.00041242616,0.0010630719,0.00030138806,0.00047861066],"domain_scores_gemma":[0.99854213,0.000038754748,0.0004076641,0.00066698686,0.00018266738,0.00016180928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007885675,0.0008670923,0.0010349073,0.00011652037,0.00017449066,0.00004464748,0.00044201844,0.0002702045,0.000106628184],"category_scores_gemma":[0.0000014723669,0.0004974868,0.00037109375,0.00009202956,0.00007477857,0.000012738297,0.000019310233,0.00012855876,0.000029185027],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026159151,0.00053069694,0.00009268387,0.00024630726,0.0011703144,6.96827e-7,0.00006384888,8.7205206e-7,0.00021273203,0.000014075108,0.005701655,0.9893502],"study_design_scores_gemma":[0.0065131392,0.0022986685,0.00012384921,0.005109875,0.00002822391,0.000008614495,0.0000046951645,3.0275237e-7,0.0006281993,0.0000019932227,0.98457474,0.0007077282],"about_ca_topic_score_codex":0.00003031676,"about_ca_topic_score_gemma":0.0000018045636,"teacher_disagreement_score":0.98864245,"about_ca_system_score_codex":0.00016587436,"about_ca_system_score_gemma":0.00020531479,"threshold_uncertainty_score":0.9997477},"labels":[],"label_agreement":null},{"id":"W2549381486","doi":"10.1080/14656566.2016.1258060","title":"Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer’s disease","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Memantine; Disease; Clinical trial; Rivastigmine; Biomarker; Alzheimer's disease; Oncology; Intensive care medicine; Donepezil; Internal medicine; Dementia","score_opus":0.25923119354640534,"score_gpt":0.4671612476598155,"score_spread":0.20793005411341015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549381486","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000049680834,0.9788557,0.000920917,0.0012077583,0.0009523747,0.0147997085,0.0028539475,0.00023374811,0.00017083908],"genre_scores_gemma":[0.000035594025,0.9769126,0.0008390869,0.00090877153,0.003138374,0.013626953,0.0030571294,0.0005902662,0.0008912167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953194,0.00022269762,0.0008854289,0.001571152,0.0007972432,0.0012040593],"domain_scores_gemma":[0.9951155,0.00053017057,0.00045359024,0.0011330397,0.00010523087,0.0026624722],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00018820915,0.0014318303,0.0021554655,0.0005007658,0.0004034426,0.00012804,0.00047803653,0.00026998762,0.00047664388],"category_scores_gemma":[0.00002495892,0.00094054913,0.002682906,0.0002329648,0.0001362912,0.0002585121,0.000042247946,0.00024946433,0.0001828564],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01039141,0.002059364,0.000021565225,0.0013654791,0.03620858,0.000032138905,0.000091583745,2.993151e-7,0.0000023219861,0.00044394183,0.015200393,0.93418294],"study_design_scores_gemma":[0.01856851,0.0011059528,0.000021623275,0.006951103,0.0022591874,0.00000480483,0.0000054081665,0.00007533626,0.000040891744,0.00077726063,0.9692815,0.000908416],"about_ca_topic_score_codex":0.000017071996,"about_ca_topic_score_gemma":8.7166406e-8,"teacher_disagreement_score":0.9540811,"about_ca_system_score_codex":0.00046784696,"about_ca_system_score_gemma":0.0021475551,"threshold_uncertainty_score":0.9998432},"labels":[],"label_agreement":null},{"id":"W2626261656","doi":"10.1080/14656566.2017.1340938","title":"Novel therapy for childhood acute lymphoblastic leukemia","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Clinical trial; Intensive care medicine; Disease; Minimal residual disease; Oncology; Risk stratification; Lymphoblastic Leukemia; Expert opinion; Internal medicine; Leukemia","score_opus":0.17184688914497115,"score_gpt":0.48562954739914893,"score_spread":0.3137826582541778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626261656","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000033655335,0.984981,0.0004614745,0.0004797272,0.0034059868,0.007968266,0.00037302577,0.00027494825,0.0020522105],"genre_scores_gemma":[0.0000012644957,0.9746264,0.0007409585,0.0031172845,0.006554798,0.003341942,0.0007708848,0.00067599764,0.010170474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951146,0.00017772138,0.001064735,0.0014872211,0.0010400043,0.0011157036],"domain_scores_gemma":[0.995912,0.00062391855,0.0007216477,0.0019321864,0.00022165048,0.00058860844],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005993195,0.0013812516,0.0034493918,0.0007066356,0.00050265365,0.00021928748,0.0012317409,0.00074300537,0.004429816],"category_scores_gemma":[0.00006047216,0.0010300193,0.0023543346,0.0002870339,0.0002234224,0.00015152752,0.000074458534,0.0009665324,0.000276819],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016046425,0.00090520777,2.8104867e-7,0.0010827385,0.0029553485,0.000016745174,0.00025431573,4.087932e-7,0.0039722547,0.00006186347,0.0302221,0.9589241],"study_design_scores_gemma":[0.015396504,0.0017943823,0.0000029384926,0.0074429014,0.00010728869,0.00032679382,0.000006741064,0.000049810027,0.0014281197,0.000014451793,0.97249454,0.0009355074],"about_ca_topic_score_codex":0.000029426092,"about_ca_topic_score_gemma":3.4706554e-7,"teacher_disagreement_score":0.95798856,"about_ca_system_score_codex":0.0013127311,"about_ca_system_score_gemma":0.0025165624,"threshold_uncertainty_score":0.9998938},"labels":[],"label_agreement":null},{"id":"W2753504277","doi":"10.1080/14656566.2017.1369957","title":"Time for new low density lipoprotein cholesterol (LDL-C) targets?","year":2017,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Kexin; Proprotein convertase; PCSK9; Subtilisin; Medicine; Cholesterol; Ldl cholesterol; Lipoprotein; Low-density lipoprotein; Internal medicine; Endocrinology; Pharmacology; LDL receptor; Biochemistry; Enzyme; Biology","score_opus":0.03531593968877128,"score_gpt":0.36188147889046013,"score_spread":0.32656553920168885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753504277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.703007,0.049772304,0.039775554,0.14612895,0.017269436,0.030206153,0.00017614964,0.0019119601,0.011752529],"genre_scores_gemma":[0.78808814,0.034799132,0.016206993,0.086743094,0.04781342,0.0018840649,0.00030643606,0.00073819485,0.02342055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813104,0.00006342942,0.0002982104,0.00054074667,0.00050710933,0.0004594468],"domain_scores_gemma":[0.9979654,0.00002562755,0.00019023847,0.0012414397,0.00011011908,0.0004671935],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004616088,0.00031050286,0.0005453879,0.00008046624,0.0005365236,0.0001000977,0.0003025748,0.00015177761,0.0005541615],"category_scores_gemma":[0.00005328416,0.00025751084,0.00048538618,0.000042596574,0.000081392114,0.00018661152,0.000034015848,0.0002319991,0.00024224527],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019003233,0.00037653005,0.00006192926,0.000079573474,0.0003745234,0.0000114315635,0.0005091617,0.0000040464306,0.08034684,0.00007870126,0.082335494,0.83392143],"study_design_scores_gemma":[0.010919652,0.00064767915,0.0030860084,0.00019929103,0.000009493691,0.00003031926,0.000012964614,0.0005130426,0.29569164,0.0000837024,0.68851787,0.00028830813],"about_ca_topic_score_codex":0.0007141039,"about_ca_topic_score_gemma":0.000004891578,"teacher_disagreement_score":0.8336331,"about_ca_system_score_codex":0.00010807941,"about_ca_system_score_gemma":0.00020545564,"threshold_uncertainty_score":0.9999877},"labels":[],"label_agreement":null},{"id":"W2774490089","doi":"10.1080/14656566.2017.1410540","title":"Efficacy of levomilnacipran extended release in treating major depressive disorder","year":2017,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Treatment of Major Depression","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Milnacipran; Major depressive disorder; Medicine; Reuptake inhibitor; Psychiatry; Vortioxetine; Antidepressant; Cognition","score_opus":0.03819352289831413,"score_gpt":0.4015517016384805,"score_spread":0.36335817874016635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774490089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98361063,0.0072323647,0.00011565093,0.003255293,0.00062245363,0.00115316,0.000014371708,0.0001038493,0.0038922415],"genre_scores_gemma":[0.99207926,0.0054754745,0.00090831827,0.00056206825,0.00031973308,0.00012539323,0.000029072124,0.00006954073,0.00043111618],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983344,0.00010383935,0.00040497843,0.00047112769,0.00038453925,0.0003011023],"domain_scores_gemma":[0.99843526,0.00015652576,0.00034692674,0.0008477832,0.00004865844,0.00016484351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011426395,0.00029000564,0.00046168754,0.00020122885,0.00021924387,0.000028501363,0.00026695494,0.000108407105,0.0005216712],"category_scores_gemma":[0.00013143223,0.00022721261,0.00017297472,0.00007240016,0.00010992881,0.00018984063,0.00004200103,0.00021613632,0.00002574508],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01181199,0.004572783,0.08093082,0.00005300313,0.00024760092,0.00011781965,0.0019184544,0.000037529077,0.34162736,0.00017031102,0.002761994,0.55575037],"study_design_scores_gemma":[0.07959326,0.0010689322,0.39255625,0.0011922668,0.000021316475,0.000024693967,0.0001282549,0.00075979944,0.4911923,0.00006462205,0.03297296,0.00042533525],"about_ca_topic_score_codex":0.0002963805,"about_ca_topic_score_gemma":0.0000054272014,"teacher_disagreement_score":0.55532503,"about_ca_system_score_codex":0.0000822201,"about_ca_system_score_gemma":0.000057516725,"threshold_uncertainty_score":0.92654616},"labels":[],"label_agreement":null},{"id":"W2883176237","doi":"10.1080/14656566.2018.1499727","title":"A pharmacoeconomic evaluation of cholinesterase inhibitors and memantine for the treatment of Alzheimer’s disease","year":2018,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; MEDLINE; Cochrane Library; Donepezil; Economic evaluation; Disease; Mood; Memantine; Rivastigmine; Cognition; Cognitive decline; Dementia; Quality of life (healthcare); Placebo; Psychiatry; Alternative medicine; Intensive care medicine; Pathology","score_opus":0.4774879761810773,"score_gpt":0.538269756086534,"score_spread":0.060781779905456745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883176237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8184403,0.12951252,0.0011121182,0.040143136,0.0042873374,0.0053720046,0.00076780433,0.000044462733,0.0003203249],"genre_scores_gemma":[0.9696332,0.019999096,0.0004550875,0.0065930025,0.0022945323,0.0008956254,0.000041525516,0.00005020667,0.000037705224],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970822,0.0002193463,0.0019812144,0.0004033284,0.00011122441,0.00020271052],"domain_scores_gemma":[0.997311,0.0006279146,0.0014242585,0.00034911843,0.0001546814,0.0001330069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048278407,0.00019912515,0.00057712576,0.00021030227,0.00014313638,0.000020798276,0.00013760358,0.00004673235,0.0005766913],"category_scores_gemma":[0.00014879066,0.00017641288,0.00015910683,0.00008602285,0.0001532309,0.00019298171,0.000008697671,0.000033780776,0.000044009103],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009940565,0.011371312,0.041260995,0.0009344254,0.006984151,8.0310383e-7,0.08003537,0.0031632003,0.015280711,0.08362116,0.2983194,0.4490879],"study_design_scores_gemma":[0.017092805,0.001348041,0.0071849423,0.00012699133,0.000062491396,0.0000014867667,0.00046123474,0.15269287,0.028781729,0.0019223327,0.7898093,0.0005157551],"about_ca_topic_score_codex":0.00015910991,"about_ca_topic_score_gemma":0.000004077275,"teacher_disagreement_score":0.49148992,"about_ca_system_score_codex":0.00014698504,"about_ca_system_score_gemma":0.00011152397,"threshold_uncertainty_score":0.71939087},"labels":[],"label_agreement":null},{"id":"W2886451501","doi":"10.1080/14656566.2018.1502270","title":"Choosing oral drug therapy for overactive bladder in older people","year":2018,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; University of Alberta","funders":"","keywords":"Mirabegron; Medicine; Overactive bladder; Tolerability; Anticholinergic; Oxybutynin; Polypharmacy; Older people; Adverse effect; Clinical trial; Solifenacin; Urinary incontinence; Intensive care medicine; Tolterodine; Pharmacotherapy; Alternative medicine; Internal medicine; Urology; Gerontology","score_opus":0.05773820357586884,"score_gpt":0.4449890274900204,"score_spread":0.38725082391415155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886451501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9310663,0.0149074495,0.001445558,0.032398105,0.0034605456,0.007161927,0.00006447923,0.0003259415,0.009169744],"genre_scores_gemma":[0.9523044,0.026187787,0.0013133592,0.01463335,0.0027237362,0.0005994559,0.000088580775,0.00014601153,0.002003295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982054,0.00013508183,0.0002699447,0.0004806921,0.0003809776,0.0005278688],"domain_scores_gemma":[0.9991245,0.00019952659,0.00006004488,0.0002705486,0.00016151309,0.00018382401],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035984092,0.00025985533,0.00033583958,0.00027465113,0.00016397983,0.00004301563,0.00013660986,0.00007846003,0.0027762481],"category_scores_gemma":[0.000014943536,0.00021038344,0.00013732299,0.0003305796,0.00008382443,0.00020910056,0.000017089738,0.00027951077,0.00007547598],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033167064,0.0046018898,0.008458201,0.00005478968,0.0004952474,0.00002291464,0.044700094,0.0000057092793,0.23869409,0.00023022124,0.30265376,0.366916],"study_design_scores_gemma":[0.020974156,0.0023206486,0.013719686,0.00011818259,0.0000021586359,0.000020851832,0.0005563516,0.0012959458,0.27245724,0.000175665,0.68800735,0.00035174604],"about_ca_topic_score_codex":0.00015453012,"about_ca_topic_score_gemma":0.00000824629,"teacher_disagreement_score":0.3853536,"about_ca_system_score_codex":0.00011963389,"about_ca_system_score_gemma":0.00015343832,"threshold_uncertainty_score":0.9981353},"labels":[],"label_agreement":null},{"id":"W2911702342","doi":"10.1080/14656566.2019.1570132","title":"An evaluation of roflumilast and PDE4 inhibitors with a focus on the treatment of asthma","year":2019,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Roflumilast; Medicine; Asthma; Intensive care medicine; Internal medicine; COPD","score_opus":0.07748991243654003,"score_gpt":0.4016291271319666,"score_spread":0.32413921469542656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911702342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055775815,0.99246806,0.00002722479,0.00007403741,0.00045937815,0.0012149794,0.00003526829,0.000005978952,0.00013748762],"genre_scores_gemma":[0.004734088,0.9943453,0.000020035965,0.00008890393,0.00033722084,0.00017685627,0.00019784787,0.000038494523,0.00006124394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864113,0.000365333,0.00027912622,0.0003305681,0.00028626353,0.000097574426],"domain_scores_gemma":[0.9991533,0.000034100467,0.0003167142,0.00035568327,0.00009789887,0.000042304397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002219995,0.0002742685,0.00043408663,0.000076089724,0.000042006188,0.000009850321,0.000084271225,0.00014208288,0.000058646823],"category_scores_gemma":[0.0000032468297,0.00014526294,0.00015251116,0.00007978444,0.00006674782,0.0000041381713,0.0000053189187,0.000049158058,0.0000024354085],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037867256,0.00043365202,0.0000044294425,0.00012890111,0.00025472665,8.498726e-8,0.00019464442,0.000032792967,0.010331967,0.00004271269,0.00071498525,0.9874824],"study_design_scores_gemma":[0.0014698738,0.004039355,0.0000077929735,0.0007766543,0.000035104567,0.000003833587,0.000028709097,0.00008212728,0.08715187,0.0000033766403,0.9062409,0.00016043118],"about_ca_topic_score_codex":0.000009568381,"about_ca_topic_score_gemma":0.0000015369341,"teacher_disagreement_score":0.987322,"about_ca_system_score_codex":0.00004372196,"about_ca_system_score_gemma":0.00012656127,"threshold_uncertainty_score":0.5923651},"labels":[],"label_agreement":null},{"id":"W3010618473","doi":"10.1080/14656566.2020.1735353","title":"Current and future pharmacological agents for the treatment of back pain","year":2020,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.04506430274158087,"score_gpt":0.4164827542350792,"score_spread":0.37141845149349834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010618473","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001801195,0.10492051,0.00033137915,0.0174575,0.87191784,0.0048155636,0.00023910141,0.0000632352,0.000074758886],"genre_scores_gemma":[0.00007722901,0.38178495,0.00016240578,0.0012658311,0.61554754,0.00052462926,0.00043308243,0.00005096615,0.00015340462],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809533,0.00030320848,0.0004080375,0.0004857625,0.0004895635,0.00021810412],"domain_scores_gemma":[0.99739444,0.0019007104,0.00020016471,0.00019523532,0.00012860603,0.00018084797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034182324,0.0003952259,0.0005928403,0.00006977791,0.00009664333,0.000015483527,0.000123781,0.00030335717,0.00063266023],"category_scores_gemma":[0.00006800678,0.0002122645,0.00042498505,0.00010058042,0.00011806583,0.000024493667,0.000008835745,0.0002982996,0.000010187173],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001938602,0.0008182423,0.0000073663114,0.00038466472,0.00033002262,3.8848057e-7,0.0009226164,7.464532e-7,0.0026033404,0.000012884436,0.71587664,0.27710447],"study_design_scores_gemma":[0.008334084,0.0057081715,0.000052466214,0.00017206093,0.000034298646,1.9229866e-7,0.00009377169,0.0005513086,0.001020126,0.000010107787,0.983827,0.0001964311],"about_ca_topic_score_codex":0.0000056717713,"about_ca_topic_score_gemma":1.4816925e-7,"teacher_disagreement_score":0.27690804,"about_ca_system_score_codex":0.0001290036,"about_ca_system_score_gemma":0.00011752605,"threshold_uncertainty_score":0.8655895},"labels":[],"label_agreement":null},{"id":"W3015809125","doi":"10.1080/14656566.2020.1721465","title":"Current pharmacotherapy for tic disorders","year":2020,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Tics; Medicine; Topiramate; Tourette syndrome; Ziprasidone; Comorbidity; Aripiprazole; Antipsychotic; Pharmacotherapy; Psychiatry; Tic disorder; Clozapine; Schizophrenia (object-oriented programming); Epilepsy","score_opus":0.0794798536636295,"score_gpt":0.48001872941399254,"score_spread":0.40053887575036307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015809125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.178283e-7,0.96513194,0.0016652353,0.0015220629,0.022320839,0.0065218583,0.00043494336,0.00057891133,0.0018237233],"genre_scores_gemma":[0.0000023685159,0.9835595,0.00019393825,0.0038522603,0.0049006734,0.005841969,0.0005406962,0.00077169033,0.00033693935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99376523,0.0008615048,0.0013672598,0.0021359308,0.00059182284,0.0012782527],"domain_scores_gemma":[0.9967061,0.0007975261,0.0009856947,0.00092180236,0.000072328556,0.00051649206],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00024884733,0.0017893622,0.0029004456,0.0006388937,0.0003099068,0.00011791965,0.0015611502,0.00045642574,0.009205476],"category_scores_gemma":[0.000022299224,0.0015789216,0.002215223,0.0008230633,0.00020119065,0.00014401822,0.000058323913,0.001250298,0.0020954688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039367593,0.00089165766,9.4788817e-7,0.0011488759,0.0011091032,0.000004315164,0.0010898856,0.0000010609656,0.000012514891,0.0017726561,0.1688373,0.824738],"study_design_scores_gemma":[0.0061656306,0.00063350826,7.262066e-7,0.0021907315,0.00008897438,0.000009650148,0.00007051623,0.000043304386,0.000025115221,0.00026908785,0.9888288,0.0016739494],"about_ca_topic_score_codex":0.000020972133,"about_ca_topic_score_gemma":0.0000011621433,"teacher_disagreement_score":0.8230641,"about_ca_system_score_codex":0.0003644171,"about_ca_system_score_gemma":0.00032769638,"threshold_uncertainty_score":0.9994852},"labels":[],"label_agreement":null},{"id":"W3133361374","doi":"10.1080/14656566.2021.1892073","title":"Important considerations with respect to reducing the transition from acute to persistent postoperative pain","year":2021,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Anesthesia; Intensive care medicine","score_opus":0.036262437718385804,"score_gpt":0.3394034596894778,"score_spread":0.30314102197109205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133361374","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24867989,0.0027745622,0.01186221,0.7327378,0.0003616456,0.0024323445,0.000025160425,0.00015715465,0.00096927007],"genre_scores_gemma":[0.475662,0.0017990349,0.007623137,0.512951,0.00065285503,0.0003391215,0.00012183603,0.000059100512,0.0007918851],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984873,0.0003485345,0.0002361718,0.0004045149,0.00032318363,0.00020030186],"domain_scores_gemma":[0.99915034,0.00018560023,0.00003941744,0.00032177955,0.00011780345,0.00018506178],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035836062,0.00019002872,0.00021877533,0.00007508672,0.0002591182,0.00006313599,0.000060348804,0.00003280446,0.0013469632],"category_scores_gemma":[0.000021223588,0.000122012,0.000115305826,0.00021854878,0.000027186166,0.000047495334,0.000006761523,0.000135261,0.00003606091],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004600127,0.00075564353,0.00038250678,0.0000103385355,0.0016515651,0.00077074516,0.10299909,0.001884794,0.5612294,0.0017395079,0.312956,0.011020252],"study_design_scores_gemma":[0.0037341795,0.003109111,0.001309441,0.0004463601,0.000061518534,0.00015214842,0.010277642,0.002107178,0.1628419,0.00007324037,0.81541705,0.0004702359],"about_ca_topic_score_codex":0.00008692392,"about_ca_topic_score_gemma":0.00000988072,"teacher_disagreement_score":0.502461,"about_ca_system_score_codex":0.000101075915,"about_ca_system_score_gemma":0.0001223923,"threshold_uncertainty_score":0.99956596},"labels":[],"label_agreement":null},{"id":"W3134513179","doi":"10.1080/14656566.2021.1902504","title":"Evaluating the combination of emtricitabine/ tenofovir alafenamide fumarate to reduce the risk of sexually acquired HIV-1-infection in at-risk adults","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Tenofovir alafenamide; Emtricitabine; Medicine; Pre-exposure prophylaxis; Human immunodeficiency virus (HIV); Cobicistat; Tenofovir; Microbicides for sexually transmitted diseases; Prodrug; Pharmacology; Men who have sex with men; Elvitegravir; Pill; Internal medicine; Virology; Viral load; Antiretroviral therapy; Population; Environmental health; Syphilis","score_opus":0.08268813015531437,"score_gpt":0.44715164221954157,"score_spread":0.3644635120642272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134513179","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022619963,0.9697819,0.000040923445,0.0017657671,0.0010056412,0.0044317357,0.000089651956,0.000047144928,0.00021732031],"genre_scores_gemma":[0.00088223023,0.99484426,0.00037153598,0.00022702901,0.00026999283,0.0008672415,0.00040428803,0.000093627765,0.0020397697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952195,0.001688099,0.0013202546,0.0006248491,0.0008177891,0.00032946275],"domain_scores_gemma":[0.9968421,0.0008911057,0.0012431061,0.000646203,0.0002754905,0.000102026024],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016149135,0.00056766625,0.0015210706,0.0004437878,0.00020271109,0.000019369003,0.00026824724,0.00018857463,0.00025819172],"category_scores_gemma":[0.00023783665,0.00031190776,0.00049375603,0.0011801857,0.0000758941,0.00006627959,0.00007940993,0.0003717936,0.000048821723],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089337,0.00096548896,0.0006666583,0.000884581,0.0010753719,0.0000049745813,0.005949724,0.00006959942,0.00052240596,0.000026409576,0.0053552096,0.9835862],"study_design_scores_gemma":[0.011389671,0.001567533,0.001501813,0.019620089,0.0005063672,0.000037945036,0.00031764427,0.0011365828,0.0055671777,0.00001785137,0.9576674,0.00066989276],"about_ca_topic_score_codex":0.00015054032,"about_ca_topic_score_gemma":0.000012659774,"teacher_disagreement_score":0.9829163,"about_ca_system_score_codex":0.0006910781,"about_ca_system_score_gemma":0.00067147793,"threshold_uncertainty_score":0.9999333},"labels":[],"label_agreement":null},{"id":"W3142645707","doi":"10.1080/14656566.2021.1904891","title":"Escalating antimicrobial resistance among Enterobacteriaceae: focus on carbapenemases","year":2021,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Enterobacteriaceae; Antibiotic resistance; Antimicrobial; Microbiology; Klebsiella pneumoniae; Citrobacter; Enterobacter; Carbapenem-resistant enterobacteriaceae; Multiple drug resistance; Medicine; Antibiotics; Biology; Escherichia coli; Genetics","score_opus":0.01587479053287727,"score_gpt":0.3082440871677065,"score_spread":0.29236929663482925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142645707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913867,0.0018243046,0.0003735468,0.00093285466,0.0019186203,0.0002363711,0.00004409788,0.000050776034,0.003232737],"genre_scores_gemma":[0.98477113,0.0074898247,0.0011967153,0.0031897156,0.0013539176,0.000020024709,0.00018473453,0.00008458659,0.0017093336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982438,0.00018730304,0.00032154893,0.0006839803,0.00020374877,0.0003596055],"domain_scores_gemma":[0.99911165,0.00003167992,0.00014931675,0.00051381957,0.00008405855,0.00010945273],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010337167,0.0003071431,0.00024976363,0.000044447002,0.00014984887,0.00008534523,0.00023451386,0.00014842322,0.00029157466],"category_scores_gemma":[0.00003662851,0.0003013838,0.0001613335,0.00011011823,0.000097286334,0.000010610898,0.000051007704,0.00013531509,0.000025714133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000761565,0.00020409035,0.004694272,0.000012796326,0.00008170162,0.000017416432,0.00008258049,0.000008450632,0.96313554,0.00011387481,0.029310051,0.0015776689],"study_design_scores_gemma":[0.0012809129,0.00012414812,0.003602571,0.0001720263,0.0000015084969,0.000005960677,0.000034914265,0.000007811347,0.8344343,0.000011790695,0.16002487,0.00029921083],"about_ca_topic_score_codex":0.000007869535,"about_ca_topic_score_gemma":0.000013153532,"teacher_disagreement_score":0.1307148,"about_ca_system_score_codex":0.00004106682,"about_ca_system_score_gemma":0.000071746654,"threshold_uncertainty_score":0.99994385},"labels":[],"label_agreement":null},{"id":"W3155205222","doi":"10.1080/14656566.2021.1915988","title":"What impact does bipolar disorder staging have on the use of pharmacotherapy?","year":2021,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Pharmacotherapy; Bipolar disorder; Psychiatry; Intensive care medicine; Mood","score_opus":0.07537272316824038,"score_gpt":0.3961063187687885,"score_spread":0.3207335956005481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155205222","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6283052,0.31207207,0.00054111076,0.050736826,0.0049020043,0.0025051231,0.00021755708,0.00030368404,0.00041644185],"genre_scores_gemma":[0.4857819,0.4890527,0.00032510355,0.022133855,0.0006967786,0.00018054602,0.00013932213,0.0001893196,0.001500433],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978777,0.00028305838,0.00037935065,0.0004923247,0.0005608595,0.00040668345],"domain_scores_gemma":[0.9985689,0.0003314022,0.0001451233,0.0006255993,0.00013839615,0.00019055932],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015269994,0.00042183956,0.00044083296,0.00015534242,0.0001817139,0.00012438941,0.00015296528,0.00008717367,0.004556601],"category_scores_gemma":[0.000017009863,0.00022382267,0.00043061003,0.0002696482,0.00010419326,0.00034713515,0.000023966153,0.0003351121,0.00003536371],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031453266,0.0053215628,0.044490457,0.000049083963,0.0024486573,0.00003231789,0.0071657626,0.00016122837,0.44217822,0.0005027592,0.015951851,0.47855276],"study_design_scores_gemma":[0.004368084,0.00044587188,0.002470483,0.00019761719,0.000015620646,0.000011432254,0.0005040281,0.00048547654,0.37335077,0.00003184888,0.6179105,0.00020828],"about_ca_topic_score_codex":0.00016731005,"about_ca_topic_score_gemma":0.000009394523,"teacher_disagreement_score":0.60195863,"about_ca_system_score_codex":0.000115282295,"about_ca_system_score_gemma":0.00013812796,"threshold_uncertainty_score":0.9963534},"labels":[],"label_agreement":null},{"id":"W3155326873","doi":"10.1080/14656566.2021.1915989","title":"Pneumocystis jirovecii: a review with a focus on prevention and treatment","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Medicine; Pneumocystis jirovecii; Intensive care medicine; Dapsone; Pentamidine; Pneumonia; Trimethoprim; Atovaquone; Pneumocystis pneumonia; Clindamycin; Immunology; Internal medicine; Antibiotics; Malaria","score_opus":0.0814376463522127,"score_gpt":0.4306934843465176,"score_spread":0.34925583799430493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155326873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007397468,0.9919057,0.000022124532,0.0018012844,0.000582205,0.0041635786,0.000061659164,0.0001933635,0.0012627059],"genre_scores_gemma":[0.000013811464,0.9916419,0.00017727572,0.002587113,0.00059431634,0.002503301,0.00028522962,0.00021356577,0.0019834815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99645334,0.00043712818,0.0007821484,0.0012696498,0.00061308814,0.00044466608],"domain_scores_gemma":[0.99800813,0.0002134532,0.0004677914,0.00079222774,0.00007640607,0.00044201847],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013305055,0.0011689386,0.0030826419,0.0003413906,0.0001669938,0.0000617329,0.00011471149,0.00025405103,0.00060498464],"category_scores_gemma":[0.000016676386,0.0007306143,0.0008504813,0.0004588876,0.000068516674,0.000066014516,0.000022965214,0.00043041425,0.00014206611],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030300053,0.0015136437,8.8885815e-7,0.0032730894,0.0013769879,0.00029359173,0.000053519034,1.3002102e-7,0.000044329616,0.00008750897,0.0023906368,0.9906627],"study_design_scores_gemma":[0.004206686,0.0067408825,0.0000035952635,0.10028873,0.0004976085,0.0016079809,0.000006582098,0.0000031854895,0.0002590615,0.0000039876745,0.88583463,0.0005470769],"about_ca_topic_score_codex":0.000020930247,"about_ca_topic_score_gemma":0.0000025474985,"teacher_disagreement_score":0.9901156,"about_ca_system_score_codex":0.0008468159,"about_ca_system_score_gemma":0.0004570522,"threshold_uncertainty_score":0.9995145},"labels":[],"label_agreement":null},{"id":"W3158733857","doi":"10.1080/14656566.2021.1921736","title":"An update on antidepressant pharmacotherapy in late-life depression","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Treatment of Major Depression","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"Polypharmacy; Medicine; Pharmacotherapy; Adverse effect; Major depressive disorder; Depression (economics); Psychiatry; Antidepressant; Late life depression; Intensive care medicine; Mood; Cognition; Pharmacology; Anxiety","score_opus":0.09534354125489485,"score_gpt":0.47319554317915885,"score_spread":0.377852001924264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158733857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048404827,0.99169904,0.000031430034,0.00056672184,0.0028674628,0.003021442,0.00010630511,0.0004564967,0.0007670501],"genre_scores_gemma":[0.00025848995,0.98564744,0.0003958526,0.008635827,0.0019281558,0.0009103547,0.0013653012,0.000563168,0.00029542053],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99271697,0.0013367564,0.001505514,0.0021959643,0.0012923722,0.0009524219],"domain_scores_gemma":[0.99628115,0.00033020796,0.00067783194,0.0017343063,0.00009693519,0.0008795777],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00046932924,0.0016597414,0.0036539736,0.0011400789,0.0001872328,0.00012668241,0.00070307194,0.0007802253,0.0038997626],"category_scores_gemma":[0.000032610344,0.0012255891,0.0010596316,0.0007655238,0.00009003321,0.00031354197,0.000069209666,0.0015618309,0.00037577393],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013722087,0.004469221,0.000100066325,0.0010238382,0.00063267665,0.0004928787,0.00024732394,0.000047320496,0.0021304938,0.000033433724,0.023746913,0.9657036],"study_design_scores_gemma":[0.010581688,0.000745437,0.000039159655,0.029002579,0.000091935086,0.000060273782,0.000012468371,0.00020563982,0.0063082078,0.000006334523,0.95189184,0.0010544101],"about_ca_topic_score_codex":0.00004154339,"about_ca_topic_score_gemma":8.795102e-7,"teacher_disagreement_score":0.9646492,"about_ca_system_score_codex":0.00048328517,"about_ca_system_score_gemma":0.0005638373,"threshold_uncertainty_score":0.99961495},"labels":[],"label_agreement":null},{"id":"W3174714141","doi":"10.1080/14656566.2021.1940953","title":"What is the real value of metronomic chemotherapy in the treatment of gastrointestinal cancer?","year":2021,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Chemotherapy; Cancer; Drug; Gastrointestinal cancer; Intensive care medicine; Oncology; Internal medicine; Pharmacology; Colorectal cancer","score_opus":0.03143953758171897,"score_gpt":0.3911318410502958,"score_spread":0.35969230346857684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174714141","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018677315,0.09017747,0.000040465973,0.031654183,0.854927,0.0035312998,0.00019133955,0.000054829066,0.0007461047],"genre_scores_gemma":[0.0009333455,0.70785546,0.00016341261,0.0022757736,0.28730989,0.00033165334,0.00015253075,0.000074797324,0.0009031354],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99757886,0.00019752925,0.0006132991,0.00045382534,0.00084711896,0.0003093473],"domain_scores_gemma":[0.9980659,0.00067185226,0.00045038367,0.0006405782,0.000118118056,0.0000531741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030864927,0.000436388,0.0008664402,0.00020719644,0.000048493905,0.000044460783,0.00041013534,0.00012664434,0.00079785055],"category_scores_gemma":[0.000011092655,0.00024376738,0.0004885898,0.00033766116,0.00012403575,0.000074759664,0.000015254272,0.000324656,0.000002338134],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021482334,0.0011401941,0.00078620244,0.0000826947,0.0005376652,0.000009622594,0.0056623076,0.000020432804,0.001175349,0.00003832995,0.9185887,0.0698103],"study_design_scores_gemma":[0.0087172445,0.0018394201,0.0007778584,0.0007993122,0.00004350631,0.0000024585106,0.0013402348,0.00008768444,0.0069725155,0.000008538654,0.9792428,0.00016840083],"about_ca_topic_score_codex":0.0017767543,"about_ca_topic_score_gemma":0.00002450897,"teacher_disagreement_score":0.617678,"about_ca_system_score_codex":0.0004884608,"about_ca_system_score_gemma":0.00041470118,"threshold_uncertainty_score":0.99405456},"labels":[],"label_agreement":null},{"id":"W3192632021","doi":"10.1080/14656566.2021.1965574","title":"Medications to manage infant pain, distress and end-of-life symptoms in the immediate postpartum period","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen's University; Children's Hospital of Eastern Ontario; Kingston Health Sciences Centre; University of Ottawa","funders":"","keywords":"Medicine; Palliative care; Limiting; Distress; Pain management; Postpartum period; End-of-life care; Pain medicine; Health care; Nursing; Intensive care medicine; Pregnancy; Psychiatry; Anesthesiology; Physical therapy","score_opus":0.08817008056009416,"score_gpt":0.47728330813362,"score_spread":0.38911322757352584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192632021","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047888247,0.9872126,0.00003222974,0.009157514,0.0004835767,0.0027439042,0.00012325573,0.000027584209,0.00017146365],"genre_scores_gemma":[0.00007600826,0.9835028,0.00006241403,0.013885615,0.0006137909,0.001438017,0.000270273,0.00008483905,0.00006623072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955366,0.0013432895,0.0009481518,0.0006408036,0.0010318354,0.00049931504],"domain_scores_gemma":[0.9971676,0.0011312638,0.00024690694,0.00076514465,0.00010352449,0.00058556424],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001653877,0.0004408799,0.0014597225,0.00053275446,0.00010453292,0.000038654143,0.00049334473,0.00020364988,0.00057730725],"category_scores_gemma":[0.00038962532,0.00028601597,0.00025590888,0.00083410204,0.00017698541,0.000051586136,0.00008899843,0.0008256108,0.00003096676],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000142524,0.00025952165,0.000013227775,0.0068179965,0.00015844754,0.00006892361,0.0014610437,1.3298813e-7,0.000020929505,0.00023377627,0.0033242041,0.9874993],"study_design_scores_gemma":[0.0012698469,0.00037622097,0.00003282235,0.012048194,0.000017362489,0.00003009307,0.00017942987,0.000015927122,0.000019580048,0.000002149129,0.98578024,0.00022813714],"about_ca_topic_score_codex":0.00007360865,"about_ca_topic_score_gemma":0.0000052683113,"teacher_disagreement_score":0.98727113,"about_ca_system_score_codex":0.00016772521,"about_ca_system_score_gemma":0.0008578194,"threshold_uncertainty_score":0.9999592},"labels":[],"label_agreement":null},{"id":"W4210486996","doi":"10.1080/14656566.2022.2029409","title":"An up-to-date evaluation of dolutegravir/abacavir/lamivudine for the treatment of HIV","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Dolutegravir; Medicine; Abacavir; Lamivudine; Emtricitabine; Tolerability; Pharmacology; Fixed-dose combination; Integrase inhibitor; Human immunodeficiency virus (HIV); Virology; Viral load; Antiretroviral therapy; Adverse effect; Hepatitis B virus; Virus","score_opus":0.26138356818045766,"score_gpt":0.51806958953392,"score_spread":0.25668602135346236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210486996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004832964,0.98905283,0.00012238773,0.0009929147,0.0013583638,0.007858644,0.00031008566,0.000043004846,0.00021342137],"genre_scores_gemma":[0.000032670792,0.9887853,0.00060989306,0.00021211068,0.00054653495,0.005876545,0.0019308218,0.0001240269,0.0018820632],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968239,0.0004205342,0.000895851,0.00059144787,0.00097390177,0.0002943783],"domain_scores_gemma":[0.9979877,0.0004482534,0.00050610374,0.00073369365,0.00016613943,0.00015810825],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007674562,0.0005970106,0.0016459095,0.00040001993,0.00015400602,0.000012024151,0.00029115065,0.000118595206,0.0017587614],"category_scores_gemma":[0.00001668348,0.0003455075,0.0007799998,0.00041798886,0.00004965177,0.00004904707,0.000014462664,0.0001285339,0.000025404708],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006792976,0.0016672873,0.0000033980032,0.00044590383,0.0016799171,0.0000012358034,0.0030399049,0.000011487133,0.00011037722,0.00007362877,0.006666015,0.9856216],"study_design_scores_gemma":[0.006861893,0.0020121448,0.0000035032983,0.0011527592,0.00068055035,0.000007924894,0.00021009574,0.0003156048,0.0016522165,0.000007681909,0.9868141,0.0002815388],"about_ca_topic_score_codex":0.000016881588,"about_ca_topic_score_gemma":9.0408554e-7,"teacher_disagreement_score":0.98534,"about_ca_system_score_codex":0.000569546,"about_ca_system_score_gemma":0.0006593283,"threshold_uncertainty_score":0.9998997},"labels":[],"label_agreement":null},{"id":"W4225326877","doi":"10.1080/14656566.2022.2072212","title":"Comprehensive overview of the available pharmacotherapy for the treatment of non-neurogenic overactive bladder in children","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Overactive bladder; Oxybutynin; Intensive care medicine; Pharmacotherapy; Quality of life (healthcare); Tolterodine; Anticholinergic; Mirabegron; Pharmacology; Internal medicine; Alternative medicine","score_opus":0.24743543452977995,"score_gpt":0.4966767790766242,"score_spread":0.24924134454684427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225326877","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018532696,0.9877134,0.0000041283106,0.00028310122,0.00078505697,0.010235286,0.00054038886,0.00001814928,0.00023518688],"genre_scores_gemma":[0.000023184872,0.99470097,0.000031486405,0.0010122915,0.0004475816,0.002734712,0.00017044996,0.00016735187,0.00071198924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965505,0.0006736347,0.000911957,0.0006541805,0.0007272915,0.00048242477],"domain_scores_gemma":[0.99685717,0.0014675767,0.0005875561,0.00087594305,0.000103936145,0.0001078146],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026624984,0.0006622314,0.0018706811,0.0003046854,0.00019710486,0.000014999696,0.0006017091,0.00013615962,0.0050903265],"category_scores_gemma":[0.000007782371,0.0003534331,0.0015340539,0.0007618962,0.0001755364,0.000062883315,0.000058710684,0.0005501025,0.000016201458],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018538173,0.0031711906,0.00004356152,0.0016144338,0.0042211274,0.0000040998157,0.0013355968,0.000011695502,0.00085430784,0.0000110429955,0.013391737,0.9734874],"study_design_scores_gemma":[0.007366144,0.0027214598,0.000048216745,0.001115934,0.00018687117,0.000058786685,0.000054947588,0.00008482254,0.005154374,0.000004571342,0.9829277,0.00027616927],"about_ca_topic_score_codex":0.00019820627,"about_ca_topic_score_gemma":5.4760386e-7,"teacher_disagreement_score":0.9732112,"about_ca_system_score_codex":0.00034672368,"about_ca_system_score_gemma":0.0007243157,"threshold_uncertainty_score":0.99989176},"labels":[],"label_agreement":null},{"id":"W4230738500","doi":"10.1517/14656566.2.8.1325","title":"Dalteparin sodium","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Vancouver Coastal Health","funders":"","keywords":"Medicine; Antithrombotic; Low molecular weight heparin; Enoxaparin sodium; Thrombosis; Heparin; Warfarin Sodium; Deep vein; Anticoagulant; Warfarin; Venous thrombosis; Anesthesia; Clinical trial; Surgery; Internal medicine","score_opus":0.12945234621695814,"score_gpt":0.46550829278913325,"score_spread":0.3360559465721751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230738500","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.519311e-7,0.971137,0.000037924532,0.00083419704,0.0032292835,0.0022405433,0.000015665928,0.0002582199,0.022246651],"genre_scores_gemma":[6.711406e-7,0.98376775,0.00018657562,0.008446068,0.0035699687,0.0008561504,0.00027296663,0.00022494055,0.0026749216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972291,0.00015748307,0.0007238966,0.00081135094,0.000525949,0.00055220607],"domain_scores_gemma":[0.9984732,0.000093271534,0.00030432944,0.00076402386,0.000046096924,0.00031903744],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00022259424,0.0007547505,0.0026062946,0.00042313902,0.00014300717,0.000054856297,0.0003426107,0.00028836465,0.004408869],"category_scores_gemma":[0.000009118498,0.0005696899,0.0009150796,0.00041443107,0.00005459497,0.000060256312,0.000059174192,0.00052631035,0.0012637686],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003815888,0.0008954287,4.3125382e-7,0.0014906158,0.0005173911,0.000037049573,0.0000745095,1.6747912e-7,0.0000035885419,0.00044796718,0.26785168,0.728643],"study_design_scores_gemma":[0.0015581758,0.00042711478,0.0000020606287,0.008388726,0.00011244019,0.00005951447,0.000011600897,0.0000057355273,0.000036249963,0.0000135497785,0.98885864,0.00052618916],"about_ca_topic_score_codex":0.00004148944,"about_ca_topic_score_gemma":3.9439846e-7,"teacher_disagreement_score":0.7281168,"about_ca_system_score_codex":0.00027965897,"about_ca_system_score_gemma":0.00019548992,"threshold_uncertainty_score":0.99967545},"labels":[],"label_agreement":null},{"id":"W4230819912","doi":"10.1517/14656566.3.9.1341","title":"Quinupristin/dalfopristin","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Health Authority; Royal University Hospital","funders":"","keywords":"Quinupristin; Dalfopristin; Medicine; Antimicrobial; Antibiotic resistance; Penicillin; Methicillin-resistant Staphylococcus aureus; Staphylococcus aureus; Drug resistance; Streptococcus pneumoniae; Enterococcus; Microbiology; Antibiotics; Vancomycin; Biology; Bacteria","score_opus":0.12594548311954487,"score_gpt":0.44880702804811207,"score_spread":0.3228615449285672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230819912","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.2156527e-7,0.9852803,0.000112115005,0.0002893519,0.0024901917,0.0019612762,0.00009181105,0.00035442848,0.009419741],"genre_scores_gemma":[0.0000016445122,0.98624545,0.00092606904,0.0033173962,0.0031321242,0.00033567657,0.0001927493,0.0003484824,0.005500387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962637,0.00023359565,0.0010995076,0.0010533986,0.0006561348,0.00069367205],"domain_scores_gemma":[0.99768597,0.00028739736,0.0005641195,0.0009586459,0.00010906909,0.00039479145],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00020969442,0.0010476538,0.0027192,0.0004629409,0.00016224652,0.000059375845,0.00048119915,0.00054533966,0.005591877],"category_scores_gemma":[0.000060405488,0.0008298925,0.0012769217,0.0005709878,0.00018113277,0.00005972912,0.000045961588,0.0010778328,0.0020902567],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011665908,0.00033946533,5.533169e-7,0.0019325021,0.00023371026,0.000060901828,0.00008422124,7.402343e-8,0.00010714129,0.00007201857,0.2639431,0.73310965],"study_design_scores_gemma":[0.0014989325,0.00027881487,6.760356e-7,0.016361194,0.000060110484,0.00011608526,0.0000069384946,0.0000075919656,0.00017040872,0.000004975734,0.9807639,0.0007303555],"about_ca_topic_score_codex":0.000013176099,"about_ca_topic_score_gemma":1.8971265e-7,"teacher_disagreement_score":0.7323793,"about_ca_system_score_codex":0.0004738357,"about_ca_system_score_gemma":0.00028410752,"threshold_uncertainty_score":0.9994152},"labels":[],"label_agreement":null},{"id":"W4233171052","doi":"10.1517/eoph.4.12.2355.22419","title":"Tinzaparin in the treatment of venous thromboembolism","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Medicine; Venous thromboembolism; Internal medicine; Venous thrombosis; Intensive care medicine; Thrombosis","score_opus":0.05540608515966367,"score_gpt":0.3817815458490013,"score_spread":0.32637546068933765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233171052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9121476,0.025370214,0.000056046134,0.005720271,0.0020001568,0.0029625865,0.00000830083,0.000092183596,0.051642653],"genre_scores_gemma":[0.8796997,0.111929975,0.00024929654,0.007378169,0.0002915093,0.0002929017,0.000011513768,0.000037437672,0.00010947615],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987215,0.00015318251,0.0002973381,0.0002611122,0.0003016572,0.00026520938],"domain_scores_gemma":[0.9993663,0.00008398824,0.00008191053,0.00037912835,0.000025587211,0.000063115964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020569508,0.00020425559,0.0005070453,0.00013793615,0.000058505386,0.0000120007535,0.000118611424,0.000051368126,0.0006626925],"category_scores_gemma":[0.0000070556034,0.00012828043,0.00014676728,0.00021748568,0.00005039715,0.00003529117,0.0000034245716,0.00008022236,0.00003988858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001547093,0.12342489,0.0046261856,0.00013177376,0.0016594182,0.00017462859,0.10763133,0.00022670053,0.08523752,0.10327186,0.12271278,0.4493558],"study_design_scores_gemma":[0.0047729835,0.002981078,0.009538184,0.000057667596,0.00000860972,0.000011292234,0.00060009153,0.000025049127,0.058600184,0.00018472546,0.9230799,0.00014024157],"about_ca_topic_score_codex":0.00013038094,"about_ca_topic_score_gemma":0.0000032186658,"teacher_disagreement_score":0.8003671,"about_ca_system_score_codex":0.000098074495,"about_ca_system_score_gemma":0.000044562355,"threshold_uncertainty_score":0.7256018},"labels":[],"label_agreement":null},{"id":"W4233763517","doi":"10.1517/eoph.4.5.693.22210","title":"Best pharmacological practice: urinary tract infections","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Urinary Tract Infections Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Medicine; Urinary system; Nitrofurantoin; Genitourinary system; Trimethoprim; Fosfomycin; Bacteriuria; Intensive care medicine; Acute Cystitis; Internal medicine; Antimicrobial; Antibiotic resistance; Antibiotics","score_opus":0.06248632098873857,"score_gpt":0.42927523277062724,"score_spread":0.36678891178188866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233763517","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19469163,0.019965535,0.0039681722,0.043090478,0.015532643,0.0058695483,0.000024869554,0.0022219126,0.7146352],"genre_scores_gemma":[0.8919943,0.06233618,0.00330048,0.034991834,0.0017043601,0.0008658478,0.000039125276,0.0001467747,0.004621114],"study_design_codex":"nonrandomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979115,0.00033759567,0.00038317585,0.00051104964,0.00043175803,0.00042492102],"domain_scores_gemma":[0.9987921,0.00029404234,0.00014150694,0.00034799273,0.00012321626,0.00030111318],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00038408831,0.000343571,0.00029858845,0.0003343669,0.0003232183,0.000044910765,0.00010955855,0.00012351474,0.007567237],"category_scores_gemma":[0.000108626096,0.00030192235,0.00022298183,0.000473334,0.0000846914,0.0003887766,0.00001738559,0.0005844946,0.00095525925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046298825,0.5401983,0.0049320525,0.00007531663,0.0025996915,0.0015067403,0.0016703437,0.000490157,0.080544494,0.020265603,0.27859145,0.06449597],"study_design_scores_gemma":[0.004886932,0.012304289,0.00038879373,0.000042363474,0.000038428407,0.0015708391,0.00017201509,0.00008319924,0.016055385,0.000037674054,0.9641138,0.0003063148],"about_ca_topic_score_codex":0.000015785774,"about_ca_topic_score_gemma":6.196327e-8,"teacher_disagreement_score":0.7100141,"about_ca_system_score_codex":0.0002725547,"about_ca_system_score_gemma":0.000103290324,"threshold_uncertainty_score":0.9999433},"labels":[],"label_agreement":null},{"id":"W4238121547","doi":"10.1517/eoph.5.5.1117.31079","title":"Gemifloxacin: a new fluoroquinolone","year":2004,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Gemifloxacin; Moraxella catarrhalis; Microbiology; Streptococcus pneumoniae; Topoisomerase IV; Quinolone; Medicine; DNA gyrase; Trovafloxacin; Chronic bronchitis; Haemophilus influenzae; Pharmacology; Biology; Antibiotics; Escherichia coli","score_opus":0.046934078133935686,"score_gpt":0.38150362655071635,"score_spread":0.33456954841678066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238121547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64561343,0.060803287,0.02696942,0.20543425,0.014117767,0.0046656793,0.000041931864,0.0024806873,0.039873544],"genre_scores_gemma":[0.87075114,0.056234453,0.009283449,0.055565145,0.005324338,0.000018450124,0.000067827554,0.0001836391,0.0025715765],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985003,0.000021392274,0.00029235744,0.00040903332,0.0003779358,0.0003990029],"domain_scores_gemma":[0.99907345,0.000024135166,0.000071585855,0.00033300844,0.000054476277,0.0004433712],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000082421124,0.00028245256,0.0003074906,0.00016224435,0.000095409014,0.000028325703,0.00015640707,0.00009966461,0.0014223601],"category_scores_gemma":[0.000010576577,0.00024110825,0.00017381858,0.00023335477,0.00005991801,0.000063928186,0.000021815546,0.00028540642,0.00054914417],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017457549,0.0013127932,0.00010359469,0.000019968866,0.0002256763,0.00006517167,0.0014024673,0.00026768752,0.7208773,0.0038721387,0.13934213,0.13076533],"study_design_scores_gemma":[0.011497943,0.0006817487,0.0005653185,0.000121918936,0.0000056690174,0.000054879594,0.000023977562,0.00014427635,0.3415411,0.00020363959,0.644906,0.00025349582],"about_ca_topic_score_codex":0.000052743973,"about_ca_topic_score_gemma":1.6349267e-7,"teacher_disagreement_score":0.50556386,"about_ca_system_score_codex":0.00010884726,"about_ca_system_score_gemma":0.0001772187,"threshold_uncertainty_score":0.9994905},"labels":[],"label_agreement":null},{"id":"W4247691111","doi":"10.1517/14656566.6.6.1019","title":"Intranasal zolmitriptan","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Zolmitriptan; Medicine; Nasal administration; Systemic circulation; Pharmacokinetics; Pharmacology; Onset of action; Drug; Internal medicine; Sumatriptan; Receptor","score_opus":0.1793706590767419,"score_gpt":0.5145638946286409,"score_spread":0.33519323555189906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247691111","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.0904112e-7,0.9858987,0.00002140965,0.0019871418,0.0005797522,0.0012173685,0.00002924504,0.00020662653,0.010059574],"genre_scores_gemma":[5.50898e-7,0.977424,0.0003439335,0.0069953725,0.008128951,0.00028530377,0.00015085598,0.00016333401,0.0065076705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976867,0.00012964684,0.0006895353,0.00060552446,0.00043249168,0.0004561251],"domain_scores_gemma":[0.99890286,0.00011491338,0.00020474283,0.00046366846,0.000057273202,0.0002565466],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000171513,0.0006983854,0.0021058738,0.00035694052,0.00012869538,0.000022657347,0.00021501999,0.00030295033,0.0031629137],"category_scores_gemma":[0.000013904781,0.00049411383,0.0010749721,0.00030853442,0.000076255405,0.000048971928,0.000024952977,0.00073767325,0.00048548233],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006220593,0.00018526978,2.5342032e-7,0.00075267727,0.00039751458,0.000009654332,0.00020906772,2.0027745e-8,0.000006497671,0.00011002458,0.38117737,0.61708945],"study_design_scores_gemma":[0.0016210637,0.0003409946,6.490573e-7,0.0059413677,0.00007119772,0.00007682,0.000024072042,0.000004469948,0.00002566522,0.0000036895424,0.991441,0.0004490115],"about_ca_topic_score_codex":0.000013757765,"about_ca_topic_score_gemma":0.0000012929282,"teacher_disagreement_score":0.61664045,"about_ca_system_score_codex":0.00020700114,"about_ca_system_score_gemma":0.00027239497,"threshold_uncertainty_score":0.99975103},"labels":[],"label_agreement":null},{"id":"W4253846085","doi":"10.1517/14656560802233827","title":"Effect of omega-3-acid ethyl esters on steady-state plasma pharmacokinetics of atorvastatin in healthy adults","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"American College of Clinical Pharmacy","keywords":"Medicine; Pharmacokinetics; Atorvastatin; Plasma levels; Pharmacology; Plasma concentration; Traditional medicine; Internal medicine","score_opus":0.024148094478118772,"score_gpt":0.35244344519124926,"score_spread":0.3282953507131305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253846085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99163043,0.004602157,0.000064752814,0.00069275044,0.0008868868,0.0016478511,0.000035124463,0.000054836608,0.00038519246],"genre_scores_gemma":[0.9588304,0.03767176,0.0002665427,0.0026481745,0.00031081494,0.00013728172,0.000027844395,0.00007897636,0.000028181737],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99695814,0.00053534476,0.0007457695,0.00045641593,0.0008764442,0.0004278867],"domain_scores_gemma":[0.9986949,0.00019380018,0.0002759493,0.0004741377,0.00008966463,0.00027156877],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000718738,0.00035574983,0.00090815505,0.00034705029,0.00005697183,0.000003437818,0.00015148243,0.00009927164,0.00010132405],"category_scores_gemma":[0.000028199578,0.00028712853,0.00032867663,0.00039143793,0.000119797376,0.000062341904,0.000015976551,0.00039380192,0.000015641448],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13323158,0.0021968454,0.002474826,0.001548724,0.0005552847,0.0001447621,0.01154914,0.00047274755,0.18075673,0.000040883402,0.0032751933,0.6637533],"study_design_scores_gemma":[0.043029465,0.018418608,0.0015420797,0.0008238189,0.000008402875,0.00005699486,0.00008907234,0.0009299515,0.8994522,0.0000020532057,0.035350613,0.00029670735],"about_ca_topic_score_codex":0.00024058773,"about_ca_topic_score_gemma":0.000001968064,"teacher_disagreement_score":0.7186955,"about_ca_system_score_codex":0.00013960533,"about_ca_system_score_gemma":0.0001755636,"threshold_uncertainty_score":0.9999581},"labels":[],"label_agreement":null},{"id":"W4256199820","doi":"10.1517/eoph.4.12.2213.22421","title":"Anti-thrombotic therapy in cancer patients","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Hospital","funders":"","keywords":"Medicine; Cancer; Internal medicine; Oncology","score_opus":0.048720981824851274,"score_gpt":0.38352336621916144,"score_spread":0.33480238439431015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256199820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756714,0.010300579,0.000023357354,0.0027106118,0.0027768388,0.001571259,0.000006014615,0.000111233756,0.006828702],"genre_scores_gemma":[0.8403137,0.13835266,0.00012214627,0.020480178,0.00022688699,0.00029426755,0.000015100425,0.000060840288,0.00013424715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99847406,0.00010602134,0.00029951218,0.00039715378,0.00034862885,0.00037460003],"domain_scores_gemma":[0.9994498,0.000032799995,0.000076813965,0.0002508419,0.00005420403,0.0001355416],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015149145,0.00025250274,0.00046557927,0.00020718225,0.000068208625,0.000020544929,0.00010171888,0.00006731641,0.003063128],"category_scores_gemma":[0.000010199479,0.00020407833,0.0001071478,0.00026793947,0.000036502504,0.000086399625,0.000008100424,0.00016244201,0.00007710282],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010553595,0.036677293,0.23929198,0.00010344012,0.0009816384,0.00004547835,0.008026103,0.00035789527,0.07462175,0.0077423784,0.28883258,0.34226412],"study_design_scores_gemma":[0.012213454,0.0011342369,0.14017661,0.00018229599,0.0000035796008,0.0000012573942,0.000076097465,0.00006164472,0.063212745,0.00006961453,0.78253126,0.00033721523],"about_ca_topic_score_codex":0.00014002244,"about_ca_topic_score_gemma":0.000002550709,"teacher_disagreement_score":0.4936987,"about_ca_system_score_codex":0.00015191527,"about_ca_system_score_gemma":0.000059865335,"threshold_uncertainty_score":0.9978482},"labels":[],"label_agreement":null},{"id":"W4291513501","doi":"10.1080/14656566.2022.2112945","title":"Colesevelam – a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia","year":2022,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Bile acid; Adverse effect; Internal medicine; Cholesterol; Diabetes mellitus; Glycemic; Pharmacology; Endocrinology; Gastroenterology","score_opus":0.031668729767103776,"score_gpt":0.34460110448075304,"score_spread":0.31293237471364926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291513501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.962212,0.02457296,0.002131972,0.004747943,0.0015108411,0.0037068068,0.00012267826,0.00030610987,0.0006886635],"genre_scores_gemma":[0.9815913,0.0031120789,0.0024412074,0.009465863,0.0012148037,0.0017138135,0.00007831879,0.00010215733,0.00028048787],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983572,0.00012437915,0.0002787517,0.00046169478,0.0004278444,0.00035016402],"domain_scores_gemma":[0.9993143,0.00004939653,0.00008248872,0.00030726,0.00004652047,0.00019999786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005169778,0.0002226513,0.00036435117,0.00011419887,0.00044750105,0.000029941535,0.00009584194,0.000056363697,0.00018599867],"category_scores_gemma":[0.000013734926,0.0001946849,0.00021066943,0.00013661609,0.000035495596,0.00007259309,0.000037703576,0.00029023332,0.000002454679],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021828818,0.00025459705,0.00018586151,0.000114958006,0.00013980994,0.000016001719,0.0015564223,0.000033355285,0.53775316,0.0001160929,0.0024630337,0.45518383],"study_design_scores_gemma":[0.019842114,0.0035832322,0.00048217166,0.00010241035,0.000023717785,0.00054183276,0.0012365774,0.003960328,0.17423116,0.000039976865,0.795473,0.0004834817],"about_ca_topic_score_codex":0.00011893439,"about_ca_topic_score_gemma":8.390005e-7,"teacher_disagreement_score":0.79301,"about_ca_system_score_codex":0.00022854323,"about_ca_system_score_gemma":0.00017440738,"threshold_uncertainty_score":0.793902},"labels":[],"label_agreement":null},{"id":"W4292295394","doi":"10.1080/14656566.2022.2114345","title":"The pharmacotherapeutic management of premenstrual dysphoric disorder","year":2022,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Menstrual Health and Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Premenstrual dysphoric disorder; Medicine; Psychiatry; Distress; Irritability; Psychosis; Fluoxetine; Menstrual cycle; Anxiety; Internal medicine; Clinical psychology; Serotonin","score_opus":0.03757674095811869,"score_gpt":0.3970023324843206,"score_spread":0.3594255915262019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292295394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6475458,0.22255625,0.00091626367,0.042676356,0.018407818,0.010724465,0.00013698239,0.00071427523,0.056321777],"genre_scores_gemma":[0.8716177,0.10310029,0.00051728875,0.019864352,0.00039373603,0.0012619682,0.00005363982,0.000120384946,0.0030706755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978522,0.0001781426,0.00044078784,0.00032865017,0.0007676397,0.00043259858],"domain_scores_gemma":[0.99918115,0.00007599177,0.00016026576,0.00036613253,0.000041800155,0.00017468177],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035576976,0.00022292844,0.00024562448,0.00010844583,0.0006007623,0.0000108495715,0.00025958513,0.000027148088,0.0026556232],"category_scores_gemma":[0.000001857918,0.00016297027,0.00014045839,0.00038947613,0.000094613875,0.000037439986,0.00005341284,0.00029113318,0.000021242122],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007870784,0.0016672814,0.0007587004,0.00015070672,0.00058625167,0.000015587939,0.0016779257,0.00013952005,0.010484657,0.004438762,0.041136708,0.9310731],"study_design_scores_gemma":[0.007766331,0.0011541551,0.00052008725,0.000031483054,0.000010063755,0.0000214371,0.0018428294,0.0007574763,0.00572599,0.00012018487,0.9818689,0.00018101443],"about_ca_topic_score_codex":0.00003705594,"about_ca_topic_score_gemma":3.098583e-7,"teacher_disagreement_score":0.94073224,"about_ca_system_score_codex":0.00012064475,"about_ca_system_score_gemma":0.00008834335,"threshold_uncertainty_score":0.9982561},"labels":[],"label_agreement":null},{"id":"W4292495455","doi":"10.1080/14656566.2022.2116274","title":"Pharmacotherapy considerations for morning symptoms in chronic obstructive pulmonary disease","year":2022,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Pharmacotherapy; Pulmonary disease; Morning; Internal medicine; Intensive care medicine","score_opus":0.03477255731698455,"score_gpt":0.3906271809190423,"score_spread":0.3558546236020578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292495455","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018924283,0.11770815,0.00012744247,0.004554554,0.85333735,0.012699475,0.0069682426,0.000658123,0.0020542499],"genre_scores_gemma":[0.0076290686,0.06353796,0.00039170234,0.0033618326,0.8983567,0.014823051,0.0076786084,0.0010751924,0.003145896],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99227566,0.00062569376,0.0011418612,0.0022009048,0.0023581851,0.0013976764],"domain_scores_gemma":[0.994528,0.002517746,0.00046930095,0.0010549714,0.00046334625,0.0009666387],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005568446,0.0012356907,0.0013671005,0.0012231653,0.0006572707,0.00012694005,0.0005863512,0.0005106066,0.013804202],"category_scores_gemma":[0.00034181235,0.0012993838,0.0008508419,0.0006461119,0.00035545835,0.0003410561,0.00014957432,0.0026386988,0.00005224866],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0112017905,0.0017478117,0.00018592643,0.00078990846,0.0008205919,0.0005645972,0.0006149627,0.0006745939,0.014586629,0.00034646317,0.93077356,0.037693188],"study_design_scores_gemma":[0.0145056425,0.0004783991,0.00051324867,0.0004906877,0.00005403833,0.000020990145,0.00013523038,0.007869909,0.0014721063,0.0005966987,0.9727089,0.0011541587],"about_ca_topic_score_codex":0.00010013079,"about_ca_topic_score_gemma":0.0000033436338,"teacher_disagreement_score":0.054170184,"about_ca_system_score_codex":0.007157329,"about_ca_system_score_gemma":0.0060932897,"threshold_uncertainty_score":0.9996623},"labels":[],"label_agreement":null},{"id":"W4306639578","doi":"10.1080/14656566.2022.2135989","title":"Fedratinib: a pharmacotherapeutic option for JAK-inhibitor naïve and exposed patients with myelofibrosis","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Extramedullary hematopoiesis; Clinical trial; Internal medicine; Bone marrow; Haematopoiesis","score_opus":0.10124681455615386,"score_gpt":0.4063206045908273,"score_spread":0.30507379003467344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306639578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031086823,0.98819464,0.00008844312,0.00041095976,0.0012333423,0.00897686,0.00046706162,0.00017052781,0.0001472698],"genre_scores_gemma":[0.00007085528,0.9819113,0.0012178809,0.0030936215,0.0010373557,0.010400792,0.0016942781,0.00034025774,0.00023366505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964196,0.00031443598,0.0008020282,0.001199504,0.0007240518,0.0005403705],"domain_scores_gemma":[0.99796087,0.0005852123,0.0005446464,0.00042495562,0.00012720774,0.0003571098],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001874692,0.0010880088,0.0020315533,0.00039263326,0.00045009528,0.00010009012,0.00017266325,0.00022333574,0.0014698181],"category_scores_gemma":[0.000013603855,0.0007521397,0.00057415204,0.00034369604,0.00008673533,0.0001404291,0.000036667316,0.00044499597,0.000022800054],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002212585,0.0021167225,0.0000794622,0.001977919,0.0014130848,0.000006569223,0.0005041795,5.7589216e-7,0.00008540697,0.00008556511,0.005615981,0.98590195],"study_design_scores_gemma":[0.0124280555,0.0052524284,0.000021341917,0.0039375783,0.0003029276,0.000022426218,0.000031604675,0.000035949528,0.0013517065,0.000004888026,0.97587043,0.0007406361],"about_ca_topic_score_codex":0.0000053020353,"about_ca_topic_score_gemma":3.3870373e-7,"teacher_disagreement_score":0.9851613,"about_ca_system_score_codex":0.0004656863,"about_ca_system_score_gemma":0.00029448123,"threshold_uncertainty_score":0.99949294},"labels":[],"label_agreement":null},{"id":"W4310032409","doi":"10.1080/14656566.2022.2150966","title":"Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Immunotherapy; Chemotherapy; Oncology; Intensive care medicine; Clinical trial; Quality of life (healthcare); Internal medicine; Cancer","score_opus":0.06604193749230337,"score_gpt":0.38864061052098337,"score_spread":0.32259867302868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310032409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010371502,0.98901314,0.0000017192477,0.0030922503,0.0014027669,0.002837292,0.00019768954,0.000070440685,0.0032809868],"genre_scores_gemma":[0.000111335496,0.9876846,0.0000428837,0.0076004304,0.0029292686,0.00092151697,0.000067021116,0.00022921266,0.0004137369],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972063,0.00042514355,0.00052473997,0.00080802036,0.00068434095,0.00035146336],"domain_scores_gemma":[0.9983885,0.00031733024,0.0003559185,0.0007294983,0.000049158447,0.0001595621],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023609046,0.0008058198,0.0015863341,0.00027970408,0.00025536877,0.0000312947,0.00035925597,0.00021965898,0.0067744516],"category_scores_gemma":[0.0000056651725,0.00046021427,0.0007558669,0.0003564031,0.00019046554,0.000045853543,0.000032529588,0.00075948774,0.00001648542],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015360025,0.00088378054,0.0000061694354,0.0003585376,0.0009722913,0.000009957944,0.0047930228,5.7052045e-8,0.00007455513,0.0010568821,0.011630995,0.97867775],"study_design_scores_gemma":[0.0047760094,0.0024734745,0.000010046713,0.00065536663,0.000050677223,0.000055674496,0.0011274428,0.0000016516288,0.00051694515,0.00003561948,0.98991716,0.00037991995],"about_ca_topic_score_codex":0.000027341886,"about_ca_topic_score_gemma":1.8762383e-7,"teacher_disagreement_score":0.9782978,"about_ca_system_score_codex":0.0002492566,"about_ca_system_score_gemma":0.00040796978,"threshold_uncertainty_score":0.99978495},"labels":[],"label_agreement":null},{"id":"W4367314129","doi":"10.1080/14656566.2023.2206015","title":"Recent advances in treating hypertriglyceridemia in patients at high risk of cardiovascular disease with apolipoprotein C-III inhibitors","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Hypertriglyceridemia; Apolipoprotein B; Internal medicine; Disease; Clinical trial; Triglyceride; Endocrinology; Cholesterol; Bioinformatics; Pharmacology; Biology","score_opus":0.013825625386093941,"score_gpt":0.29455047781402866,"score_spread":0.2807248524279347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367314129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518409,0.04585854,0.0000077687255,0.0003274971,0.00063598884,0.0010532103,0.000027564558,0.00007593304,0.0001726301],"genre_scores_gemma":[0.6189171,0.3796518,0.000121412144,0.00048056236,0.00034543828,0.00025659642,0.00011875505,0.000060197395,0.00004808697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980016,0.00017850588,0.0004308533,0.0004433758,0.000605342,0.00034032104],"domain_scores_gemma":[0.9991949,0.00006289104,0.00013707092,0.00036169062,0.000057465135,0.00018598573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002843582,0.00025158492,0.00054780935,0.0003962075,0.000053352855,0.0000051067177,0.000088375404,0.000060234117,0.00010773326],"category_scores_gemma":[0.000060586637,0.00018690336,0.00015946174,0.0008258748,0.000059276077,0.00015697407,0.000024259818,0.00017039652,0.000013512028],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012336265,0.0008740573,0.25359988,0.00007755994,0.00026188575,0.00001732584,0.0016296409,0.0048858654,0.0009711445,0.000020376052,0.001254816,0.7240712],"study_design_scores_gemma":[0.0538822,0.0007558902,0.13756953,0.00066341,0.00004201651,8.4267435e-7,0.00043410968,0.0006157312,0.031057553,0.000042957916,0.7744142,0.00052157545],"about_ca_topic_score_codex":0.0006465131,"about_ca_topic_score_gemma":0.000012766524,"teacher_disagreement_score":0.7731594,"about_ca_system_score_codex":0.00013647562,"about_ca_system_score_gemma":0.000072784984,"threshold_uncertainty_score":0.7621698},"labels":[],"label_agreement":null},{"id":"W4377094746","doi":"10.1080/14656566.2023.2216379","title":"Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitis","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Mepolizumab; Granulomatosis with polyangiitis; Benralizumab; Eosinophilic; Rituximab; Azathioprine; Immunology; Cyclophosphamide; Dermatology; Intensive care medicine; Asthma; Vasculitis; Internal medicine; Disease; Pathology; Chemotherapy; Eosinophil","score_opus":0.07481286407682784,"score_gpt":0.43485941717268783,"score_spread":0.36004655309586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377094746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006949953,0.99369705,0.000025766138,0.0007974452,0.0005735845,0.0024359294,0.00006484511,0.00011566138,0.0022827415],"genre_scores_gemma":[0.0000454093,0.9965454,0.00008859326,0.0012294971,0.00029896494,0.0012510743,0.00018366678,0.00015362183,0.00020380213],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974713,0.00026969585,0.0007236599,0.0005150249,0.00062838185,0.00039194388],"domain_scores_gemma":[0.99887836,0.00016754944,0.00030937456,0.00051401753,0.00003531617,0.000095390256],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023273396,0.0005390936,0.0012983505,0.00053814985,0.000102815065,0.000022140917,0.00038627343,0.00017427541,0.0003724156],"category_scores_gemma":[9.89186e-7,0.0002970062,0.000593365,0.0012560757,0.00012745261,0.000088560126,0.000017116477,0.0005284056,0.00009646684],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010758129,0.00048398098,0.0000022493825,0.005525219,0.001129204,0.00012858027,0.00043527942,0.0000026540488,0.000010945799,0.00092112663,0.0016155211,0.9896377],"study_design_scores_gemma":[0.0033102906,0.00035889633,0.000009193136,0.03039468,0.0002421401,0.00017881075,0.00015809086,0.000007470624,0.00004980664,0.000041206113,0.96493155,0.00031786715],"about_ca_topic_score_codex":0.0000139189815,"about_ca_topic_score_gemma":7.2823104e-7,"teacher_disagreement_score":0.9893198,"about_ca_system_score_codex":0.00009519905,"about_ca_system_score_gemma":0.00008521383,"threshold_uncertainty_score":0.9999482},"labels":[],"label_agreement":null},{"id":"W4386347365","doi":"10.1080/14656566.2023.2254698","title":"Promising translatable pharmacological interventions for body weight management in individuals with severe mental illness – a narrative review","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada; University of Toronto; Centre for Addiction and Mental Health","funders":"Novo Nordisk Fonden; Steno Diabetes Center Copenhagen","keywords":"Medicine; Psychological intervention; Narrative review; Mental illness; Weight management; Intensive care medicine; Psychiatry; Weight loss; Mental health; Internal medicine; Obesity","score_opus":0.15446556808005968,"score_gpt":0.5043530853702125,"score_spread":0.3498875172901528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386347365","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009539133,0.97922415,0.000043460397,0.0021707301,0.0004968787,0.017367179,0.00031154082,0.00014374209,0.00023278994],"genre_scores_gemma":[0.0000036012248,0.9777682,0.0018958454,0.00079333864,0.00031646108,0.016655782,0.0015456188,0.00014826246,0.00087288005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964956,0.00041012318,0.0009059537,0.0009074149,0.00064502045,0.00063587393],"domain_scores_gemma":[0.9988547,0.0002106732,0.00027931336,0.00030684128,0.000059439964,0.00028901416],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058441237,0.0007163492,0.0020695645,0.0005676921,0.00021130209,0.000046417943,0.0003049521,0.00015373228,0.001026054],"category_scores_gemma":[0.000009546985,0.00045159206,0.0009398327,0.00081067166,0.00007270968,0.00012041891,0.00004502111,0.00052998814,0.00006773654],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00240015,0.0019462557,0.0000020992848,0.040244482,0.005164563,0.00016568962,0.0006121462,2.3248201e-7,0.0000053886356,0.00016649866,0.034300316,0.91499215],"study_design_scores_gemma":[0.012772759,0.001065286,0.0000024042504,0.15249729,0.00037703052,0.00010206603,0.00010887535,0.000012685373,0.000045701625,0.000026220807,0.8325493,0.00044041284],"about_ca_topic_score_codex":0.000006150053,"about_ca_topic_score_gemma":0.00000278281,"teacher_disagreement_score":0.9145518,"about_ca_system_score_codex":0.000506072,"about_ca_system_score_gemma":0.00028535016,"threshold_uncertainty_score":0.99988717},"labels":[],"label_agreement":null},{"id":"W4387865677","doi":"10.1080/14656566.2023.2273395","title":"Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pulmonary hypertension; Connective tissue disease; Disease; Connective tissue; Cardiology; Pathology; Intensive care medicine; Internal medicine; Autoimmune disease","score_opus":0.17825983050877048,"score_gpt":0.46322636161496494,"score_spread":0.28496653110619447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387865677","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018283617,0.9921868,0.0000033530732,0.00043477325,0.0019518265,0.003978365,0.00038329206,0.00030146973,0.00057731173],"genre_scores_gemma":[0.00027601843,0.99415714,0.00006160219,0.0007777396,0.0006134995,0.0010356365,0.0015248812,0.00020043933,0.0013530377],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959108,0.00051037665,0.0008782157,0.0010174235,0.0010152307,0.0006679204],"domain_scores_gemma":[0.99790496,0.00035046955,0.00038821116,0.00048623246,0.00016824597,0.00070189673],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024709097,0.0008013941,0.0023422076,0.00048758864,0.00015782379,0.000020045507,0.00032610833,0.00031509815,0.0011566281],"category_scores_gemma":[0.000030506215,0.00056039443,0.00080442725,0.0006901095,0.0001452831,0.000073542884,0.00012712643,0.00048235516,0.0005578353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033686808,0.006238768,0.0000038361236,0.003480996,0.0055600214,0.01348466,0.000018516019,5.8602035e-7,0.0008793862,0.000056477416,0.02351092,0.94339716],"study_design_scores_gemma":[0.0046702786,0.00089607347,0.00009998684,0.01524288,0.0005091253,0.00015146365,0.000025508827,0.000091524686,0.00025054146,0.000035382756,0.9775329,0.00049430056],"about_ca_topic_score_codex":0.000012294121,"about_ca_topic_score_gemma":6.3238055e-8,"teacher_disagreement_score":0.954022,"about_ca_system_score_codex":0.0003264236,"about_ca_system_score_gemma":0.00023522615,"threshold_uncertainty_score":0.99975646},"labels":[],"label_agreement":null},{"id":"W4387893581","doi":"10.1080/14656566.2023.2272659","title":"Ivosidenib in acute myeloid leukemia","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Medicine; Venetoclax; Myeloid leukemia; Midostaurin; Cytarabine; Oncology; Hedgehog; Pharmacology; Leukemia; Cancer research; Internal medicine; Signal transduction","score_opus":0.12946871703231508,"score_gpt":0.47556122090816166,"score_spread":0.34609250387584656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387893581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011545546,0.9914255,0.000012945848,0.0010112562,0.0018961863,0.003347064,0.00008616414,0.0005145319,0.0016947633],"genre_scores_gemma":[7.1628733e-7,0.9838864,0.00025897706,0.003059446,0.0025155966,0.0016072163,0.00056848704,0.00058996235,0.0075131604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945561,0.00049906434,0.0013444606,0.0013476008,0.0011130535,0.0011397176],"domain_scores_gemma":[0.9973666,0.0005739841,0.0003446862,0.001097713,0.0000939983,0.00052300555],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00071160356,0.0010981387,0.003161775,0.0018046325,0.000114546456,0.000074851116,0.0008245701,0.0007962629,0.0013813473],"category_scores_gemma":[0.00006771406,0.0008676185,0.0010193503,0.0018948315,0.00014170096,0.00013990642,0.00015295122,0.0024312446,0.0040759128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037029546,0.00015042022,0.0000019385395,0.0026643542,0.0008714852,0.0005919037,0.00026135254,9.195943e-7,0.00020685758,0.00008391554,0.1492562,0.84554034],"study_design_scores_gemma":[0.0041896626,0.00035531982,0.0000038974135,0.016267639,0.000055957862,0.00023327544,0.000025642837,0.00008232838,0.00027914473,0.000019297946,0.9777712,0.0007166227],"about_ca_topic_score_codex":0.00015406622,"about_ca_topic_score_gemma":0.0000028599914,"teacher_disagreement_score":0.8448237,"about_ca_system_score_codex":0.004180758,"about_ca_system_score_gemma":0.0027695943,"threshold_uncertainty_score":0.9998702},"labels":[],"label_agreement":null},{"id":"W4389244496","doi":"10.1080/14656566.2023.2291075","title":"Novel pharmacotherapy for drug-induced immune hemolytic anemia","year":2023,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Blood groups and transfusion","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministero della Salute","keywords":"Medicine; Autoimmune hemolytic anemia; Drug; Pharmacotherapy; Hemolytic anemia; Immune system; Immunology; Cold agglutinin disease; Pharmacology; Anemia; Internal medicine; Antibody","score_opus":0.04252043142967242,"score_gpt":0.3930771774995247,"score_spread":0.35055674606985227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244496","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050948956,0.013039378,0.00055241864,0.0041219285,0.97613215,0.0036780715,0.0006576222,0.00093439245,0.00037455108],"genre_scores_gemma":[0.00028342966,0.12015254,0.00081291125,0.003920688,0.8652468,0.0014688969,0.0026173166,0.00097475905,0.0045227073],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99462616,0.000098484365,0.0010944795,0.0015177042,0.001578966,0.0010841768],"domain_scores_gemma":[0.9963282,0.001439956,0.0004180159,0.00088440813,0.00043082723,0.00049859344],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006853021,0.0012232829,0.0015827089,0.00058021187,0.0003535023,0.000100651814,0.00059506233,0.0010794615,0.0006996687],"category_scores_gemma":[0.00009024223,0.0010814659,0.0010402915,0.00054500625,0.00008832758,0.00014460844,0.000035979425,0.0016644411,0.00020849917],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037054752,0.00090864586,6.1297436e-7,0.00024277627,0.00045448093,0.000014173629,0.00047954684,0.000001922074,0.36875913,0.000022170967,0.59608066,0.029330416],"study_design_scores_gemma":[0.028350802,0.0010659673,0.000003531416,0.0008041957,0.000061150145,0.000009133574,0.000043326734,0.00023936268,0.18047225,0.000019461699,0.7880767,0.00085411756],"about_ca_topic_score_codex":0.00026032227,"about_ca_topic_score_gemma":0.000003787081,"teacher_disagreement_score":0.19199604,"about_ca_system_score_codex":0.0003368122,"about_ca_system_score_gemma":0.00062153453,"threshold_uncertainty_score":0.99916357},"labels":[],"label_agreement":null},{"id":"W4389570956","doi":"10.1080/14656566.2023.2288287","title":"Can we manage gut microbiome imbalances in patients with bipolar disorder with pharmacotherapy?","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Bipolar disorder; Pharmacotherapy; Microbiome; Gut microbiome; Medicine; Psychological intervention; Psychiatry; Gut flora; Bioinformatics; Mood; Immunology; Biology","score_opus":0.009650823100651452,"score_gpt":0.2983900876893935,"score_spread":0.28873926458874205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389570956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98774767,0.007291683,0.00004165331,0.0033012587,0.00047552586,0.0008202766,0.0001197054,0.000089954556,0.0001122495],"genre_scores_gemma":[0.9159705,0.07095342,0.00036896172,0.009633926,0.0005496545,0.00020628957,0.0010628754,0.00021176925,0.0010426268],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983239,0.00010284564,0.00023998317,0.00059601257,0.00019366287,0.0005435901],"domain_scores_gemma":[0.9993991,0.0000111540685,0.000105689825,0.00030811835,0.000049415263,0.00012651709],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011375094,0.00034707756,0.00024472098,0.00024157074,0.0001274151,0.000033000786,0.00027723995,0.00010334397,0.0001370898],"category_scores_gemma":[0.0000011028341,0.00025961114,0.000059449758,0.00048619634,0.000088178036,0.000011421914,0.000028583043,0.00016120082,0.000035785913],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021902393,0.00056585675,0.041546065,0.000037224345,0.00015410875,0.0000060450147,0.00080452906,0.0000894802,0.9178066,0.000025322643,0.016419742,0.02035478],"study_design_scores_gemma":[0.00883826,0.0010712801,0.022110745,0.00008247101,0.0000019429901,0.0000024399615,0.000085661915,0.000023094886,0.072566345,0.0000052952796,0.89474595,0.00046651048],"about_ca_topic_score_codex":0.000104602,"about_ca_topic_score_gemma":0.000066051514,"teacher_disagreement_score":0.87832624,"about_ca_system_score_codex":0.000041717652,"about_ca_system_score_gemma":0.00007048702,"threshold_uncertainty_score":0.99998564},"labels":[],"label_agreement":null},{"id":"W4390016361","doi":"10.1080/14656566.2023.2298345","title":"Levodopa-induced dyskinesia: do current clinical trials hold hope for future treatment?","year":2023,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Levodopa; Dyskinesia; Clinical trial; Intensive care medicine; Internal medicine; Disease; Parkinson's disease","score_opus":0.4465294891526701,"score_gpt":0.6024239904510121,"score_spread":0.15589450129834204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390016361","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017368904,0.0026734583,0.000017012393,0.0042119566,0.9851191,0.0042535923,0.001299574,0.0006176525,0.00007077278],"genre_scores_gemma":[0.0002412132,0.28844726,0.000007319623,0.0019488895,0.70538396,0.0019765196,0.00007999021,0.00033980358,0.0015750113],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98545086,0.0054342765,0.0020739427,0.0033652522,0.0020944492,0.0015812088],"domain_scores_gemma":[0.9740856,0.022755357,0.0010940051,0.0010628997,0.00025650588,0.00074558746],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0043573542,0.0012961426,0.0022862817,0.0007951707,0.0007949232,0.00042059293,0.0020783336,0.0011057085,0.00037165885],"category_scores_gemma":[0.0062230006,0.000979659,0.0016019503,0.0010636551,0.00035905855,0.00034089744,0.0001569481,0.0024384432,0.0006359767],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002752598,0.00097446766,0.0000017209736,0.00002835645,0.00004589708,0.00006068372,0.000089846355,0.0000010476475,0.26695162,0.000038595477,0.6420429,0.08701228],"study_design_scores_gemma":[0.009038564,0.003053204,0.0000013748704,0.000080762315,0.000017471237,0.0000032145224,0.000014217688,0.000116413335,0.22424053,0.00002883296,0.76274735,0.00065806945],"about_ca_topic_score_codex":0.000004988832,"about_ca_topic_score_gemma":6.381939e-7,"teacher_disagreement_score":0.2857738,"about_ca_system_score_codex":0.0002842172,"about_ca_system_score_gemma":0.0011679049,"threshold_uncertainty_score":0.999979},"labels":[],"label_agreement":null},{"id":"W4390506313","doi":"10.1080/14656566.2023.2298340","title":"The efficacy of zuranolone in postpartum depression and major depressive disorder: a review &amp; number needed to treat (NNT) analysis","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Toronto Western Hospital; Brain and Cognition Discovery Foundation; University Health Network","funders":"","keywords":"Medicine; Neuroactive steroid; Major depressive disorder; Antidepressant; Postpartum depression; Depression (economics); Psychiatry; Premenstrual dysphoric disorder; Vortioxetine; Childbirth; Number needed to treat; Mental health; Pregnancy; GABAA receptor; Internal medicine; Mood; Anxiety; Receptor; Relative risk; Menstrual cycle","score_opus":0.04628690862008795,"score_gpt":0.4446966970871853,"score_spread":0.39840978846709735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390506313","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005144542,0.9927657,0.0000059236827,0.0025882602,0.00065947435,0.0031652187,0.00007164821,0.0000541235,0.00017516263],"genre_scores_gemma":[0.00010587144,0.9950751,0.000050573537,0.0024410484,0.00022020923,0.00092198886,0.00014935725,0.00009173144,0.0009441256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690574,0.00044215206,0.0011229535,0.00069855514,0.00041365923,0.0004169134],"domain_scores_gemma":[0.9981656,0.0005005543,0.00036026532,0.00064252404,0.000045423778,0.00028560974],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033738176,0.0005927239,0.002153064,0.00037976558,0.00012412456,0.000032889366,0.00026568654,0.00018890994,0.00028344325],"category_scores_gemma":[0.000047868427,0.00033366468,0.0006205348,0.0009928085,0.00006442657,0.000046844765,0.00008565095,0.00050953164,0.00012018261],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017486046,0.00048758744,0.00022959468,0.10987203,0.0011250546,0.00003435508,0.0006550937,6.1126445e-7,0.000024672774,0.00002505646,0.007812275,0.87798506],"study_design_scores_gemma":[0.0014171499,0.00012341911,0.000055468205,0.22914438,0.000681209,0.000053314085,0.000007392975,0.0000034086274,0.00015895272,0.0000037077684,0.76810485,0.0002467498],"about_ca_topic_score_codex":0.00024941788,"about_ca_topic_score_gemma":0.00001271701,"teacher_disagreement_score":0.8777383,"about_ca_system_score_codex":0.000115609466,"about_ca_system_score_gemma":0.00010411569,"threshold_uncertainty_score":0.99991155},"labels":[],"label_agreement":null},{"id":"W4390881919","doi":"10.1080/14656566.2024.2305304","title":"Effectiveness and safety of oral terbinafine for dermatophyte distal subungual onychomycosis","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Terbinafine; Medicine; Adverse effect; Dermatophyte; Regimen; Intensive care medicine; Pharmacology; Dermatology; Surgery; Itraconazole; Antifungal","score_opus":0.023115722261216096,"score_gpt":0.39172699380255943,"score_spread":0.3686112715413433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390881919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93724406,0.0541599,0.0015097408,0.0019290821,0.0018690629,0.0023273244,0.00042668494,0.00019557324,0.00033856445],"genre_scores_gemma":[0.9891266,0.009609816,0.0002524773,0.00043628574,0.0001720057,0.00018957777,0.000086598186,0.00004460755,0.000081985876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99919915,0.000041710828,0.00017652984,0.00027571683,0.00014769244,0.00015916952],"domain_scores_gemma":[0.99955463,0.00014409414,0.000028630957,0.00011782218,0.00003343164,0.00012141627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074172094,0.00017381858,0.00026813473,0.00008849033,0.000050438273,0.00001752101,0.000036925554,0.00004058871,0.00013037508],"category_scores_gemma":[0.0000052140713,0.00012938557,0.00015706162,0.000103089515,0.000046194073,0.00007021026,0.000008910213,0.000056964254,0.0000053415765],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02626366,0.0023008583,0.00933405,0.0017471691,0.001916483,0.00007735209,0.000894638,0.0000041486437,0.24542318,0.00259221,0.010181211,0.69926506],"study_design_scores_gemma":[0.025856066,0.0026705114,0.04295687,0.0015837561,0.0000821826,0.00006930539,0.00006248249,0.0011464973,0.44393572,0.00030437775,0.4809301,0.00040211616],"about_ca_topic_score_codex":0.000025676258,"about_ca_topic_score_gemma":2.184019e-7,"teacher_disagreement_score":0.6988629,"about_ca_system_score_codex":0.000053347147,"about_ca_system_score_gemma":0.000044440654,"threshold_uncertainty_score":0.52761906},"labels":[],"label_agreement":null},{"id":"W4391530799","doi":"10.1080/14656566.2024.2314087","title":"Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Minoxidil; Medicine; Finasteride; Dutasteride; Hair loss; Dermatology; Safety profile; Male-pattern baldness; Adverse effect; Pharmacology; Clinical trial; Internal medicine; Scalp; Prostate cancer; Prostate","score_opus":0.027994995930931098,"score_gpt":0.3656503400913742,"score_spread":0.3376553441604431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391530799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93102384,0.059261177,0.0001218199,0.0034475648,0.0005126889,0.0012005385,0.0000123528425,0.000038805523,0.0043812194],"genre_scores_gemma":[0.9579619,0.040093858,0.00024162131,0.0015034605,0.00007565431,0.00003106142,0.000012448864,0.000018698902,0.000061263476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991472,0.000057624376,0.0002502724,0.00018779203,0.00022122228,0.00013590431],"domain_scores_gemma":[0.99969345,0.000058123267,0.000026814241,0.00015711431,0.000012888686,0.000051604817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018190297,0.00011850277,0.00018610056,0.00011785277,0.000017818,0.000007412394,0.000086059095,0.000033062508,0.00017296788],"category_scores_gemma":[0.0000019994536,0.00007813125,0.00005816359,0.00024629175,0.00006558639,0.000028327755,0.000011274606,0.000082958904,0.000007318568],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009131297,0.0022774898,0.0020604816,0.0013732766,0.0006520064,0.00012269664,0.014371377,0.000052386273,0.070403896,0.0042672646,0.017393624,0.8778942],"study_design_scores_gemma":[0.03409275,0.0017242874,0.04553985,0.0024977387,0.000035214867,0.00004197361,0.0022127402,0.0016386763,0.08012507,0.00016709129,0.831507,0.0004175888],"about_ca_topic_score_codex":0.000013446799,"about_ca_topic_score_gemma":9.412474e-7,"teacher_disagreement_score":0.87747663,"about_ca_system_score_codex":0.000014401181,"about_ca_system_score_gemma":0.000026704904,"threshold_uncertainty_score":0.31860998},"labels":[],"label_agreement":null},{"id":"W4391948899","doi":"10.1080/14656566.2024.2319686","title":"An update on the current and emerging pharmacotherapy for the treatment of human ascariasis","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Ascaris lumbricoides; Ascariasis; Medicine; Pharmacotherapy; Mebendazole; Neglected tropical diseases; Pyrantel; Albendazole; Ascaris; Sanitation; Helminthiasis; Environmental health; Helminths; Public health; Immunology; Internal medicine; Surgery; Pathology; Biology","score_opus":0.12764501340618836,"score_gpt":0.513468251862264,"score_spread":0.3858232384560756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391948899","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060088954,0.9907208,0.00003724311,0.001027906,0.0056516533,0.0019101143,0.00046374343,0.00006736505,0.000061104845],"genre_scores_gemma":[0.000097744625,0.99622786,0.0000064133947,0.00062078534,0.00075494585,0.0015631561,0.00031397355,0.000096536314,0.00031855996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981627,0.0003915973,0.0005358068,0.0005335743,0.00006350968,0.00031279665],"domain_scores_gemma":[0.99836445,0.00076838525,0.00030181184,0.00048749716,0.000043344255,0.000034510616],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020113164,0.000576295,0.0008588329,0.00020103627,0.0005288927,0.0000608452,0.00040575364,0.00014466576,0.0009996694],"category_scores_gemma":[0.000003184772,0.0002688768,0.00069353654,0.00014205842,0.00014454,0.00005308441,0.000012294563,0.0004133574,0.00011657199],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015504366,0.0006634571,2.4329972e-7,0.00016105417,0.0019219981,3.2460002e-7,0.0011186989,8.675825e-7,0.003218273,0.0018375502,0.028648889,0.9622736],"study_design_scores_gemma":[0.0010875196,0.0011034888,3.8421132e-7,0.0011230661,0.00023530416,0.000009238866,0.000053611366,0.000018931805,0.0046686186,0.00004324325,0.991383,0.00027360208],"about_ca_topic_score_codex":0.000030025101,"about_ca_topic_score_gemma":0.0000016997014,"teacher_disagreement_score":0.9627341,"about_ca_system_score_codex":0.000097376345,"about_ca_system_score_gemma":0.000058959355,"threshold_uncertainty_score":0.99997634},"labels":[],"label_agreement":null},{"id":"W4393091416","doi":"10.1080/14656566.2024.2334424","title":"Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic review","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Ottawa; University Health Network; University of Toronto; McMaster University; Brain and Cognition Discovery Foundation","funders":"","keywords":"Tolerability; Medicine; Placebo; Randomized controlled trial; Positive and Negative Syndrome Scale; Antipsychotic; Akathisia; Internal medicine; Nausea; Adverse effect; Schizophrenia (object-oriented programming); Constipation; Psychiatry; Psychosis; Alternative medicine","score_opus":0.06289328350617082,"score_gpt":0.44579859724465326,"score_spread":0.38290531373848247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393091416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000012199896,0.98096955,0.000064243664,0.003492903,0.0005284103,0.014509114,0.0002826009,0.00010527285,0.000046709894],"genre_scores_gemma":[0.000006712943,0.9955487,0.00056231086,0.00043893722,0.0005246062,0.0021989294,0.0003895861,0.00015416692,0.00017605032],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960804,0.00035415264,0.0017550149,0.00085838255,0.00053743576,0.00041462586],"domain_scores_gemma":[0.9976736,0.0006764832,0.0004599745,0.00080251956,0.000057479516,0.00032997457],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077497086,0.00076665456,0.0047707786,0.0003625604,0.00007703463,0.000032561806,0.00025207282,0.0001860114,0.00024589562],"category_scores_gemma":[0.00016134321,0.00046342605,0.0012929298,0.00044540022,0.00011230041,0.00004348508,0.00005824215,0.00044215325,0.00006287805],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032375709,0.00054682686,1.4439408e-7,0.62869143,0.0013504957,0.0000045110796,0.000031537766,2.7652053e-8,0.0000013520805,0.0004655885,0.0016668981,0.3640036],"study_design_scores_gemma":[0.0044407225,0.0009858992,5.205366e-7,0.46899801,0.00083652145,0.00004732963,0.0000028761044,0.000023804098,0.000013670919,0.00012553994,0.5242575,0.0002676401],"about_ca_topic_score_codex":0.000013605221,"about_ca_topic_score_gemma":0.000002815221,"teacher_disagreement_score":0.5225906,"about_ca_system_score_codex":0.00024406305,"about_ca_system_score_gemma":0.0004925054,"threshold_uncertainty_score":0.9997817},"labels":[],"label_agreement":null},{"id":"W4394847340","doi":"10.1080/14656566.2024.2343079","title":"An update on antifungal resistance in dermatophytosis","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Antifungal; Itraconazole; Dermatology; Voriconazole; Terbinafine; Intensive care medicine; Pharmacology","score_opus":0.026568070107928412,"score_gpt":0.4041246774393287,"score_spread":0.3775566073314003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394847340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.868085,0.09839206,0.000095122145,0.01661897,0.004095376,0.0014143416,0.0001529512,0.00077524816,0.010370883],"genre_scores_gemma":[0.96700233,0.021895116,0.00022394415,0.009822985,0.00047824945,0.000095820986,0.00007686173,0.000058088106,0.00034660255],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886185,0.000059073656,0.00018747423,0.00040227486,0.00026135732,0.00022798865],"domain_scores_gemma":[0.99949336,0.000033436994,0.000021326628,0.00026291786,0.000015774993,0.00017315596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005484155,0.00019571737,0.00019363758,0.00020425748,0.000047528374,0.00004649983,0.00007818969,0.00004862322,0.000846724],"category_scores_gemma":[0.0000023263692,0.00015441744,0.00010387119,0.00024127573,0.0000224125,0.00012613751,0.0000041703465,0.0001439548,0.0002647428],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019518748,0.011786333,0.019573571,0.0004158331,0.0010262317,0.0029244756,0.0033730112,0.000034655888,0.19487622,0.017197767,0.38656002,0.34271315],"study_design_scores_gemma":[0.005993586,0.00061868195,0.011409113,0.0009044544,0.000007894684,0.000011261341,0.000039437215,0.0007338041,0.09214532,0.0002965599,0.8875297,0.00031022247],"about_ca_topic_score_codex":0.000011585884,"about_ca_topic_score_gemma":0.0000014826282,"teacher_disagreement_score":0.50096965,"about_ca_system_score_codex":0.000107721135,"about_ca_system_score_gemma":0.000054806565,"threshold_uncertainty_score":0.9271034},"labels":[],"label_agreement":null},{"id":"W4394853841","doi":"10.1080/14656566.2024.2343780","title":"Momelotinib in myelofibrosis","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Discontinuation; Anemia; Janus kinase; Bone marrow; Constitutional symptoms; Disease; Internal medicine; Immunology; Receptor","score_opus":0.041051992191448325,"score_gpt":0.4061195072751803,"score_spread":0.365067515083732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394853841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68533576,0.15151617,0.00035423346,0.10568771,0.010190661,0.004450312,0.00009988012,0.0015464772,0.040818818],"genre_scores_gemma":[0.9208278,0.063757814,0.0008063955,0.011324654,0.0011850205,0.00070154574,0.00006501399,0.00010092886,0.0012308244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986532,0.000058584894,0.00027357778,0.00045096505,0.0002889285,0.0002747762],"domain_scores_gemma":[0.99947387,0.00013880509,0.000023037666,0.00018942094,0.000025990425,0.0001488995],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011923512,0.00024544608,0.00029581942,0.0002903279,0.000046215035,0.000051457984,0.000063987565,0.000072438146,0.0023955612],"category_scores_gemma":[0.000007818309,0.00018239256,0.0001402457,0.00033946644,0.00003150963,0.00009347235,0.00001019096,0.00019876745,0.00043762362],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022023728,0.0033854125,0.018155346,0.00016810103,0.00067699834,0.00045731233,0.006737067,0.0000380154,0.13944292,0.012141386,0.2003996,0.61619544],"study_design_scores_gemma":[0.003326031,0.000718132,0.0054430487,0.0005354567,0.000003489927,0.000028464041,0.00005444682,0.0010351572,0.17092232,0.00008605212,0.81764144,0.00020597788],"about_ca_topic_score_codex":0.000035870235,"about_ca_topic_score_gemma":0.0000014796396,"teacher_disagreement_score":0.6172418,"about_ca_system_score_codex":0.0001749068,"about_ca_system_score_gemma":0.000085146836,"threshold_uncertainty_score":0.9985164},"labels":[],"label_agreement":null},{"id":"W4396952607","doi":"10.1080/14656566.2024.2354466","title":"A Systematic Review on Safety and Efficacy of Migalastat for the treatment of Fabry’s Disease","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Intensive care medicine; Fabry disease; Disease; Internal medicine; Pharmacology","score_opus":0.09354327336123898,"score_gpt":0.4751570944619119,"score_spread":0.38161382110067293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396952607","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.96861e-7,0.9837116,0.00004640647,0.0011017567,0.00037048658,0.014414462,0.00026437422,0.000028614979,0.00006152082],"genre_scores_gemma":[0.000005011972,0.9961096,0.000020537113,0.0005378065,0.00022420418,0.0023467643,0.000118616525,0.000112716094,0.0005247488],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973937,0.00030469042,0.0010351692,0.00047203287,0.0005563355,0.00023802082],"domain_scores_gemma":[0.997308,0.0013631673,0.000379803,0.0006569901,0.00009118572,0.0002008143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031725052,0.0005143666,0.0028483428,0.00019630943,0.000057774134,0.000013464526,0.00021323642,0.00008589167,0.00012759048],"category_scores_gemma":[0.00012811036,0.00023785883,0.001174659,0.0002952507,0.00010785525,0.000018346207,0.000016520498,0.00016332629,0.000021227663],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007922192,0.0007478841,8.570803e-8,0.5439044,0.0013528577,0.0000054522884,0.00019158717,1.3214532e-7,0.0000022791412,0.00009128549,0.0027587868,0.450153],"study_design_scores_gemma":[0.0016968673,0.0011668844,2.1749001e-7,0.3857238,0.0008749066,0.0000063201314,0.000011535038,0.00003781748,0.000010466487,0.0000017603392,0.61035466,0.00011475082],"about_ca_topic_score_codex":0.000009451915,"about_ca_topic_score_gemma":1.2931501e-7,"teacher_disagreement_score":0.6075959,"about_ca_system_score_codex":0.00023585957,"about_ca_system_score_gemma":0.00027251657,"threshold_uncertainty_score":0.96996015},"labels":[],"label_agreement":null},{"id":"W4398221864","doi":"10.1080/14656566.2024.2357188","title":"Juxtaglomerular apparatus-mediated homeostatic mechanisms: therapeutic implication for chronic kidney disease","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Genetic and Kidney Cyst Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Japan Society for the Promotion of Science; Bayer Yakuhin; Otsuka Pharmaceutical; Chugai Pharmaceutical; Daiichi-Sankyo; Eisai Canada; Eisai; Kyorin Pharmaceutical","keywords":"Medicine; Homeostasis; Tolvaptan; Autosomal dominant polycystic kidney disease; Polycystic kidney disease; Kidney; Kidney disease; Disease; Renin–angiotensin system; Internal medicine; Endocrinology; Vasopressin; Blood pressure","score_opus":0.017482673222393694,"score_gpt":0.3391253516318833,"score_spread":0.32164267840948957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398221864","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029769428,0.6331632,0.28248677,0.029231256,0.011111275,0.008345744,0.003894628,0.0010017182,0.0009959659],"genre_scores_gemma":[0.9180588,0.050608058,0.0008279653,0.02081435,0.0021817912,0.002214988,0.004429748,0.00021752238,0.00064675574],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845177,0.000073751,0.00024724237,0.0006454891,0.00020305422,0.0003786891],"domain_scores_gemma":[0.99896526,0.000036390593,0.00005293886,0.00038655582,0.000058731297,0.00050013803],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011658997,0.00030260184,0.00016435554,0.00009928606,0.00011957922,0.0000787974,0.00023333798,0.00009919586,0.000245032],"category_scores_gemma":[0.00002976924,0.00026924943,0.00021837982,0.0001476544,0.000054354045,0.0000092209175,0.000020840112,0.00007538451,0.00009209571],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045928845,0.00014230823,0.0000050185636,0.000085647516,0.00017230523,0.0000011582681,0.00006743878,0.000020651189,0.86906254,0.0009244872,0.12181659,0.0072425916],"study_design_scores_gemma":[0.0013217457,0.00043643505,0.00005934567,0.000053964864,0.000011517621,0.00000207137,0.000020736537,0.001923808,0.27218774,0.00087062025,0.7228165,0.00029550598],"about_ca_topic_score_codex":0.0000025597597,"about_ca_topic_score_gemma":1.04035564e-7,"teacher_disagreement_score":0.8882894,"about_ca_system_score_codex":0.00005512373,"about_ca_system_score_gemma":0.00049834,"threshold_uncertainty_score":0.999976},"labels":[],"label_agreement":null},{"id":"W4399503531","doi":"10.1080/14656566.2024.2365326","title":"Pharmacotherapeutic advances in fibromyalgia: what’s new on the horizon?","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Society for Exercise Physiology","funders":"","keywords":"Fibromyalgia; Medicine; Fibromyalgia syndrome; Chronic pain; Intensive care medicine; Physical therapy","score_opus":0.051220894104285104,"score_gpt":0.40547017802617996,"score_spread":0.35424928392189486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399503531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033922102,0.79767877,0.00027054653,0.15141827,0.008207138,0.0028007065,0.000012818792,0.00068547146,0.005004163],"genre_scores_gemma":[0.30881938,0.6802192,0.00016411483,0.0035405916,0.001241111,0.00036564693,0.00003656693,0.00023120847,0.0053822286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973309,0.00020284753,0.00037629905,0.000655779,0.00080709835,0.000627073],"domain_scores_gemma":[0.99873656,0.00047729004,0.000041410403,0.00044562132,0.000031906347,0.0002672251],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036512766,0.00039160272,0.0003502211,0.00037727205,0.00011562209,0.00021826355,0.00032392435,0.00011910387,0.006793582],"category_scores_gemma":[0.00001330495,0.00024829194,0.00022734633,0.00073633634,0.00011739096,0.00051749,0.00002285427,0.00084736623,0.0007686758],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002410296,0.0007378383,0.000054270764,0.0009888659,0.00038576848,0.00021137542,0.0031734945,0.000063133535,0.14265591,0.008589974,0.20916827,0.6315608],"study_design_scores_gemma":[0.0038138882,0.0021657336,0.00008324821,0.004753808,0.0000054872003,0.00007119872,0.00039592577,0.0022955227,0.08553598,0.00058653107,0.899932,0.00036063098],"about_ca_topic_score_codex":0.000029145389,"about_ca_topic_score_gemma":2.5629416e-7,"teacher_disagreement_score":0.6907638,"about_ca_system_score_codex":0.00031603145,"about_ca_system_score_gemma":0.0004345276,"threshold_uncertainty_score":0.99999696},"labels":[],"label_agreement":null},{"id":"W4401219225","doi":"10.1080/14656566.2024.2387673","title":"Cytokine release syndrome after CAR T-cell therapy for B-cell acute lymphoblastic leukemia in children and young adolescents: storms make trees take deeper roots","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Chimeric antigen receptor; Cytokine release syndrome; Lymphoblastic Leukemia; Cytokine storm; Immune system; Cytokine; Immunology; Leukemia; Acute lymphocytic leukemia; Receptor; T cell; Adverse effect; Internal medicine; Disease","score_opus":0.027437902744180738,"score_gpt":0.36035886421433105,"score_spread":0.3329209614701503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401219225","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01318111,0.97629577,0.00003518623,0.00010866269,0.0015703244,0.007887294,0.00061802805,0.00021126536,0.00009235682],"genre_scores_gemma":[0.0023652115,0.98476064,0.000116981755,0.0014176467,0.001458295,0.003124833,0.0007230201,0.0007752739,0.005258102],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99425334,0.0003552264,0.0012732331,0.0019026066,0.0010108285,0.0012047689],"domain_scores_gemma":[0.9977768,0.00015953426,0.00030940087,0.0010070684,0.00011512993,0.0006320869],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0004957089,0.0016211966,0.0028293994,0.0013041081,0.00012182689,0.00017963086,0.0005659848,0.00074313435,0.0010733855],"category_scores_gemma":[0.000011642124,0.001194274,0.0011817106,0.00076767046,0.00018550798,0.0001429917,0.00010041744,0.0013483473,0.000141788],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007189407,0.0016446696,0.00032260915,0.0063641737,0.0019256799,0.00055080873,0.0008011779,0.000003092254,0.006610992,0.0000049421496,0.008583394,0.96599907],"study_design_scores_gemma":[0.020557433,0.0020592243,0.00030099924,0.014040482,0.00028322538,0.001001353,0.000022095885,0.00009877185,0.0009629149,0.000008872487,0.95935416,0.001310448],"about_ca_topic_score_codex":0.00013447744,"about_ca_topic_score_gemma":0.000010186155,"teacher_disagreement_score":0.9646886,"about_ca_system_score_codex":0.002163616,"about_ca_system_score_gemma":0.0010581722,"threshold_uncertainty_score":0.9998398},"labels":[],"label_agreement":null},{"id":"W4402554993","doi":"10.1080/14656566.2024.2402022","title":"Current approaches to the pharmacological management of metastatic breast cancer in older women","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Context (archaeology); Breast cancer; Intensive care medicine; Oncology; Cancer; Personalized medicine; Internal medicine; Bioinformatics","score_opus":0.2769222624376801,"score_gpt":0.49914402222175996,"score_spread":0.22222175978407988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402554993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005362468,0.98742956,0.00000797177,0.0036381711,0.0035763036,0.0045679384,0.00039109556,0.00006200457,0.00027333552],"genre_scores_gemma":[0.00012636413,0.986877,0.000046965826,0.0014349953,0.0010416063,0.009741198,0.00007787847,0.00010514197,0.0005488305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971894,0.00031647002,0.00077306735,0.00075128116,0.00043041707,0.0005393851],"domain_scores_gemma":[0.99913585,0.00010290833,0.00020039605,0.00029729007,0.000023902072,0.00023967489],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035399583,0.00067300315,0.0016622873,0.0004562805,0.00004632488,0.000022306103,0.00037161703,0.000097876764,0.004128148],"category_scores_gemma":[7.336768e-7,0.00036476023,0.0005079114,0.0008867449,0.000075574724,0.00003593687,0.00009256533,0.00064700586,0.00014508356],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005741642,0.0018431778,0.0000028361815,0.007005663,0.0026516533,0.00004920239,0.0012870339,0.000009813065,0.0000113881415,0.0001301811,0.050510157,0.9359247],"study_design_scores_gemma":[0.0030329647,0.00027644873,0.000020669519,0.009497948,0.0006166016,0.000040547588,0.0000863804,0.000038264767,0.00003935136,0.000009519854,0.9860189,0.0003223824],"about_ca_topic_score_codex":0.000021738337,"about_ca_topic_score_gemma":0.0000011697888,"teacher_disagreement_score":0.93560237,"about_ca_system_score_codex":0.0009253683,"about_ca_system_score_gemma":0.0002350919,"threshold_uncertainty_score":0.99988043},"labels":[],"label_agreement":null},{"id":"W4402574457","doi":"10.1080/14656566.2024.2406270","title":"Expanding therapeutic options: overview of novel pharmacotherapies for dyslipidemia","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Dyslipidemia; Intensive care medicine; Pharmacology; Internal medicine; Disease","score_opus":0.27724691296550846,"score_gpt":0.5227339994316352,"score_spread":0.24548708646612677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402574457","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000010773964,0.9876484,0.0020493707,0.0005010086,0.0037310184,0.005407215,0.00026956658,0.00022401613,0.00016830317],"genre_scores_gemma":[0.0000034105374,0.9870427,0.0016935399,0.0029271669,0.004471845,0.0028184608,0.00022942148,0.00039337834,0.00042002913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961598,0.00023880751,0.001356717,0.00093145116,0.0007423974,0.00057084026],"domain_scores_gemma":[0.99797577,0.0002738639,0.00049647584,0.0008493834,0.00014283559,0.00026170237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011032769,0.0009321112,0.0033247417,0.0006140929,0.00013731743,0.000050134862,0.00034565077,0.0004223373,0.0003745595],"category_scores_gemma":[0.000018669407,0.0006464611,0.0033558272,0.0006221929,0.000095371695,0.00010026393,0.00003618855,0.0006785831,0.00004153733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000197349,0.0004818241,1.07486045e-7,0.030559568,0.0037233992,0.0000026160928,0.00024725706,0.0000011969577,0.00074465293,0.0017162954,0.014304739,0.948021],"study_design_scores_gemma":[0.0038300643,0.00048804234,1.7667985e-7,0.032715056,0.0006652024,0.00007356626,0.00003398778,0.00008271637,0.0006724531,0.000044061555,0.9608496,0.0005451027],"about_ca_topic_score_codex":0.000019281979,"about_ca_topic_score_gemma":1.7247528e-7,"teacher_disagreement_score":0.9474759,"about_ca_system_score_codex":0.00035349448,"about_ca_system_score_gemma":0.00064231496,"threshold_uncertainty_score":0.9995987},"labels":[],"label_agreement":null},{"id":"W4403353674","doi":"10.1080/14656566.2024.2416924","title":"Efinaconazole 10% solution: a comprehensive review of its use in the treatment of onychomycosis","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Dermatology; Intensive care medicine","score_opus":0.2269679694706943,"score_gpt":0.49324307262383776,"score_spread":0.26627510315314346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403353674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018875546,0.99513495,4.07844e-7,0.00049771223,0.00048656037,0.0032396943,0.00041748752,0.000024649284,0.00017965349],"genre_scores_gemma":[0.000008580605,0.9964405,0.000034021486,0.0014242851,0.0002548341,0.0009673925,0.00050983194,0.0000662593,0.00029435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774504,0.00030434402,0.000859534,0.00043725164,0.00043024414,0.00022359967],"domain_scores_gemma":[0.99865067,0.00025343386,0.00035165576,0.0005279178,0.00011924454,0.00009709031],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000078283534,0.0005368797,0.0020340695,0.00025521213,0.000029329265,0.000012205182,0.00017086805,0.000118677184,0.00087707926],"category_scores_gemma":[0.000009480949,0.00028458895,0.001249258,0.0005113878,0.000051819763,0.00005084157,0.000012250564,0.00014628332,0.00012853189],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025646764,0.0036696226,0.000004037534,0.061924003,0.0013746194,0.00005974719,0.00021151958,8.204988e-8,0.000013451576,0.00007848379,0.042861782,0.88954616],"study_design_scores_gemma":[0.0020943128,0.001175223,0.000008802326,0.13185398,0.0005471201,0.000028152333,0.000008710927,0.0000036526603,0.000054690336,0.0000016258102,0.86406213,0.00016157917],"about_ca_topic_score_codex":0.000050851613,"about_ca_topic_score_gemma":3.9014142e-7,"teacher_disagreement_score":0.8893846,"about_ca_system_score_codex":0.00026711778,"about_ca_system_score_gemma":0.0002442607,"threshold_uncertainty_score":0.9999606},"labels":[],"label_agreement":null},{"id":"W4404500638","doi":"10.1080/14656566.2024.2432488","title":"Systemic approaches in biliary tract cancers: a review in the era of multidirectional precision medicine","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"Deutsche Forschungsgemeinschaft","keywords":"Medicine; Biliary tract cancer; Precision medicine; Biliary tract; Internal medicine; Intensive care medicine; Oncology; Cancer; Pathology; Gemcitabine","score_opus":0.20856439588691122,"score_gpt":0.4589524563060369,"score_spread":0.2503880604191257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404500638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014396818,0.9915935,0.00000223299,0.0028947701,0.0014687742,0.0032779097,0.000031635216,0.00003647361,0.00068035384],"genre_scores_gemma":[0.00023909689,0.99466187,0.000025731584,0.0018555721,0.0012588961,0.0017212627,0.00010114038,0.000074659685,0.00006174839],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966128,0.00054120884,0.0012508678,0.00066022546,0.00066842255,0.00026651408],"domain_scores_gemma":[0.9986218,0.0004987714,0.00031384593,0.00045724405,0.000043473134,0.000064825384],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010948316,0.00056118506,0.00243001,0.00044716417,0.00003381355,0.000008588112,0.00030416064,0.00017633602,0.00016415313],"category_scores_gemma":[0.000051930467,0.00029014863,0.00055429724,0.0010629932,0.000108372085,0.00005570503,0.000026436132,0.0011159874,0.000016244376],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012465849,0.0002750974,0.000028664286,0.039851446,0.0002493083,0.00004032751,0.0027802195,8.604296e-7,0.000010940952,0.000017404556,0.04329398,0.9133271],"study_design_scores_gemma":[0.0011609445,0.00023114884,0.000042180454,0.2775629,0.00012385142,0.00022814545,0.00018861199,0.000021070506,0.000005018315,0.0000037228447,0.7202452,0.00018723622],"about_ca_topic_score_codex":0.00034007113,"about_ca_topic_score_gemma":0.000012140742,"teacher_disagreement_score":0.9131399,"about_ca_system_score_codex":0.00060107413,"about_ca_system_score_gemma":0.0004539259,"threshold_uncertainty_score":0.99995506},"labels":[],"label_agreement":null},{"id":"W4404833735","doi":"10.1080/14656566.2024.2435946","title":"Advances in pharmacotherapy for the treatment of peritoneal metastases from colorectal cancer","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Colorectal cancer; Pharmacotherapy; Oncology; Internal medicine; Cancer","score_opus":0.08920077745056175,"score_gpt":0.4832486527606451,"score_spread":0.39404787531008334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404833735","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013833465,0.9894594,0.000012367465,0.0006226177,0.003927519,0.0037427407,0.0019350281,0.000076215445,0.0000857788],"genre_scores_gemma":[0.000047238722,0.989967,0.00014751308,0.00068616425,0.0032022123,0.005324197,0.00031660762,0.00016201788,0.00014706662],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751467,0.00014705282,0.0008418307,0.0006854518,0.0003700924,0.0004408975],"domain_scores_gemma":[0.99862844,0.00064377266,0.0002947854,0.0002570945,0.000055637873,0.00012025552],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012432598,0.00078263663,0.0021340437,0.00025435138,0.00010203486,0.000035169545,0.00026445827,0.00018461003,0.000996824],"category_scores_gemma":[0.0000036584363,0.0004090617,0.0011388763,0.00036691007,0.00017567251,0.00008825195,0.0000109041475,0.00026934655,0.000021769707],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015006297,0.00096675154,0.0000019757176,0.0018665373,0.0011218641,0.000020981974,0.0011714041,0.0000031109207,0.0020921386,0.000108985616,0.0032137337,0.9879319],"study_design_scores_gemma":[0.003127033,0.0016389431,7.8758575e-7,0.0070074284,0.0003787437,0.000015156962,0.0001041323,0.0001061964,0.017275054,0.000020431495,0.9699529,0.0003731841],"about_ca_topic_score_codex":0.0004132096,"about_ca_topic_score_gemma":0.000018569292,"teacher_disagreement_score":0.9875587,"about_ca_system_score_codex":0.00033576714,"about_ca_system_score_gemma":0.00036192778,"threshold_uncertainty_score":0.9999164},"labels":[],"label_agreement":null},{"id":"W4405694336","doi":"10.1080/14656566.2024.2444986","title":"Advances in the pharmacological management of hyperlipidemia through the use of combination therapies","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Hyperlipidemia; Combination therapy; Intensive care medicine; Ezetimibe; Disease; Pharmacology; Internal medicine; Statin; Diabetes mellitus","score_opus":0.184755032120173,"score_gpt":0.4709485409633059,"score_spread":0.2861935088431329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405694336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020932235,0.99331856,0.00008028601,0.0014221566,0.0011097161,0.0033316573,0.000019407198,0.00003198919,0.0006653218],"genre_scores_gemma":[0.00014730326,0.99590284,0.00026402838,0.0021970351,0.0004993572,0.0008268239,0.000043000713,0.00005354894,0.000066042165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969047,0.0008592883,0.00083495246,0.00038748427,0.000776687,0.00023692193],"domain_scores_gemma":[0.99872595,0.000314119,0.0003270102,0.0005446141,0.000053462507,0.00003485826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087397214,0.00039034738,0.0013252912,0.00012671434,0.000060872888,0.00002077242,0.00037608406,0.0001539862,0.00011075666],"category_scores_gemma":[0.00000762965,0.00016581206,0.0009096121,0.00058787747,0.00015192508,0.00012225815,0.00003687167,0.0005848373,0.000010374934],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012607675,0.00043241616,7.160289e-7,0.0062026223,0.00087152276,0.000012519587,0.00097394106,0.0000035375751,0.00001017536,0.0037718583,0.0056537623,0.98194087],"study_design_scores_gemma":[0.0012888423,0.0003136166,0.000005515042,0.008285163,0.00025378517,0.000026384847,0.00022589402,0.00001920068,0.000061319006,0.000113928836,0.9892555,0.00015083342],"about_ca_topic_score_codex":0.00003398102,"about_ca_topic_score_gemma":3.2205855e-7,"teacher_disagreement_score":0.98360175,"about_ca_system_score_codex":0.000099140496,"about_ca_system_score_gemma":0.000087491055,"threshold_uncertainty_score":0.676162},"labels":[],"label_agreement":null},{"id":"W4406682967","doi":"10.1080/14656566.2025.2452938","title":"Palovarotene in fibrodysplasia ossificans progressiva: review and perspective","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Heterotopic Ossification and Related Conditions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Fibrodysplasia ossificans progressiva; Medicine; Perspective (graphical); Myositis ossificans; Dermatology; Heterotopic ossification; Surgery","score_opus":0.06339211992534607,"score_gpt":0.4872423812636997,"score_spread":0.4238502613383536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406682967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.509278e-7,0.9833488,0.000011359409,0.0070110173,0.0004496883,0.0040431134,0.00004492645,0.00009954845,0.0049912864],"genre_scores_gemma":[0.0000013721603,0.9907945,0.00012715689,0.0045894072,0.00025409227,0.0016985578,0.00016693879,0.000049339404,0.0023186808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99787533,0.0002735595,0.0006750897,0.00068691635,0.00021428058,0.00027482715],"domain_scores_gemma":[0.99893165,0.000138493,0.00021820138,0.00044451834,0.000085766595,0.00018137664],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015788723,0.0004679717,0.0015937546,0.0004671065,0.00009010608,0.000026948304,0.00015459003,0.00032423472,0.00088597264],"category_scores_gemma":[0.000050295468,0.00033767597,0.00033419725,0.00068437034,0.00010749777,0.00004956016,0.000020158308,0.0007716736,0.00005859052],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027403386,0.0003599233,0.000002416359,0.01672037,0.00031683946,0.00002477289,0.00021488949,2.6869875e-8,0.000009315007,0.0011793842,0.01580362,0.96534103],"study_design_scores_gemma":[0.001124724,0.000116467025,0.0000093401395,0.094873436,0.000109494766,0.000069140755,0.000029493764,0.000002506192,0.00001144655,0.000017862807,0.90337443,0.00026166596],"about_ca_topic_score_codex":0.00001072001,"about_ca_topic_score_gemma":2.8384704e-7,"teacher_disagreement_score":0.96507937,"about_ca_system_score_codex":0.00026614292,"about_ca_system_score_gemma":0.00047380113,"threshold_uncertainty_score":0.99990755},"labels":[],"label_agreement":null},{"id":"W4406938337","doi":"10.1080/14656566.2025.2461169","title":"Efficacy and safety of dutasteride in the treatment of alopecia: a comprehensive review","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Dutasteride; Safety profile; Dermatology; Pharmacology; Intensive care medicine; Adverse effect; Internal medicine; Prostate cancer","score_opus":0.08395254459504231,"score_gpt":0.4553852353721652,"score_spread":0.3714326907771229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406938337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010700504,0.99444276,0.000004347458,0.00074436294,0.0002173971,0.0036250236,0.000049319446,0.000010726316,0.0008953827],"genre_scores_gemma":[0.000003541371,0.9962238,0.000043702727,0.0031499204,0.00011509951,0.00026916957,0.000121873985,0.000024906692,0.0000480069],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99814606,0.00035462208,0.0007989036,0.00030754588,0.00022614573,0.00016675169],"domain_scores_gemma":[0.9986908,0.00056418777,0.00026171378,0.00037442945,0.00004526121,0.000063603424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011754368,0.00037405093,0.0021119318,0.00021217087,0.000024678313,0.0000034893937,0.00014158599,0.00010059386,0.00014873789],"category_scores_gemma":[0.000017858274,0.00020814907,0.0003916654,0.00039133662,0.000085403626,0.000017922188,0.000010181338,0.00013815689,0.000003971401],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050202047,0.000881617,0.0000023707082,0.026503045,0.00023203892,0.00000669572,0.00062724965,1.01561014e-7,0.000008453204,0.000041929918,0.004115572,0.9670789],"study_design_scores_gemma":[0.0047384417,0.00087879825,0.0000131149845,0.07385398,0.00008917281,0.000015685127,0.00004562308,6.977091e-7,0.000024406652,0.0000016789727,0.9202128,0.00012560292],"about_ca_topic_score_codex":0.000023021601,"about_ca_topic_score_gemma":6.57594e-7,"teacher_disagreement_score":0.9669533,"about_ca_system_score_codex":0.000058318452,"about_ca_system_score_gemma":0.00021044671,"threshold_uncertainty_score":0.8488073},"labels":[],"label_agreement":null},{"id":"W4410000312","doi":"10.1080/14656566.2025.2501146","title":"Advances in pharmacotherapy of juvenile idiopathic arthritis","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Medicine; Pharmacotherapy; Arthritis; Juvenile; Intensive care medicine; Internal medicine","score_opus":0.04866952293392416,"score_gpt":0.44724674393646713,"score_spread":0.39857722100254295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410000312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000030453132,0.9915521,0.00003738523,0.00025952622,0.0010961576,0.0021633871,0.000041266954,0.000092673814,0.0047544637],"genre_scores_gemma":[0.000017894721,0.99665344,0.000057321486,0.0010401632,0.00041978943,0.0008239669,0.00011365811,0.00012355979,0.000750187],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99572176,0.00049692014,0.0018483417,0.0007104439,0.00066819665,0.00055431755],"domain_scores_gemma":[0.9983538,0.00021874155,0.0005706135,0.00060253387,0.000106857944,0.00014747809],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066087436,0.00068525993,0.003724769,0.0011811662,0.0000753812,0.00001952155,0.00046178044,0.0003707373,0.0016359575],"category_scores_gemma":[0.00004644059,0.0005719388,0.000850379,0.0010181708,0.00013679854,0.000204944,0.000044075987,0.0010145433,0.000076345925],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000397551,0.0006365176,0.000005878107,0.0105441855,0.00013717273,0.000033886306,0.00024352917,0.0000014923464,0.00035984252,0.000115649214,0.004788058,0.98273623],"study_design_scores_gemma":[0.0049324906,0.00042462637,9.0339574e-7,0.06025189,0.0000130121825,0.0000199327,0.00003487405,0.00001701975,0.0016993718,0.000025717556,0.9321824,0.00039777678],"about_ca_topic_score_codex":0.000022933164,"about_ca_topic_score_gemma":0.0000013099177,"teacher_disagreement_score":0.9823385,"about_ca_system_score_codex":0.00024566552,"about_ca_system_score_gemma":0.0014211662,"threshold_uncertainty_score":0.9996732},"labels":[],"label_agreement":null},{"id":"W4411191877","doi":"10.1080/14656566.2025.2516622","title":"Advancing care in primary biliary cholangitis: emerging insights and novel therapies","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Primary care; Primary sclerosing cholangitis; Intensive care medicine; Internal medicine; Disease; Family medicine","score_opus":0.02973413109779734,"score_gpt":0.38999110581406654,"score_spread":0.3602569747162692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411191877","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012654024,0.9960228,0.000019034473,0.0001700732,0.0009742691,0.001383391,0.000057352845,0.00009561088,0.0011508933],"genre_scores_gemma":[0.00004086657,0.9952482,0.0002032805,0.0031536173,0.00048582093,0.0002577633,0.00038012804,0.000081130485,0.00014921915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981854,0.00017721462,0.00051245384,0.0005515803,0.00025812283,0.0003152461],"domain_scores_gemma":[0.9990267,0.0001969078,0.00015707858,0.00041241077,0.000055942022,0.00015093813],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000100043355,0.00052966765,0.0013434454,0.0005805771,0.00012306428,0.000036553312,0.00018628169,0.00019449629,0.00012521468],"category_scores_gemma":[0.0000145987715,0.0004038676,0.0003429444,0.00039000565,0.000052879906,0.00016225399,0.00006905482,0.0005734754,0.0000063314014],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001716457,0.0002974444,0.000042235784,0.010048068,0.00024536246,0.0000142653425,0.0022235154,2.5939704e-7,0.00015418392,0.000035137615,0.0011567642,0.98561114],"study_design_scores_gemma":[0.0026743386,0.00018035759,0.00017127779,0.034225192,0.000046828012,0.00001403381,0.00044191902,0.0000047875433,0.00003967096,0.0000054588604,0.9618255,0.00037062986],"about_ca_topic_score_codex":0.000058003978,"about_ca_topic_score_gemma":0.0000010475908,"teacher_disagreement_score":0.98524046,"about_ca_system_score_codex":0.0003495501,"about_ca_system_score_gemma":0.00047625325,"threshold_uncertainty_score":0.99984133},"labels":[],"label_agreement":null},{"id":"W4413590258","doi":"10.1080/14656566.2025.2552901","title":"Aprocitentan: a new horizon in the treatment of hypertension","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Intensive care medicine; Internal medicine","score_opus":0.18073181706599895,"score_gpt":0.4379124233417812,"score_spread":0.25718060627578226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413590258","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000032775097,0.9935794,0.0000042135675,0.0020875728,0.0010109138,0.0020687566,0.000016929964,0.000041112995,0.0011878472],"genre_scores_gemma":[0.000004653834,0.9917632,0.00011743946,0.0055175233,0.001071945,0.00030930742,0.0000748043,0.000046842066,0.0010943084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795455,0.00023272297,0.000659945,0.00048964896,0.00040062435,0.00026249388],"domain_scores_gemma":[0.99861616,0.0004791432,0.00020983572,0.0005471613,0.00006371693,0.00008397613],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012376625,0.0005396387,0.00257642,0.00039149294,0.00006888013,0.000013122873,0.00020617206,0.00023047773,0.000119826764],"category_scores_gemma":[0.000011134216,0.00027326512,0.000755179,0.0005114823,0.000047573278,0.000028557168,0.00001556563,0.0002483412,0.000022200411],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022077677,0.0012262972,0.0000014492637,0.0011822,0.00067105034,0.00003896147,0.0007076128,5.6904398e-8,0.000045113284,0.000045489276,0.110537924,0.88532305],"study_design_scores_gemma":[0.003437974,0.0018706324,0.000002354792,0.0106382705,0.00039538118,0.00006480596,0.00008904827,0.0000018189767,0.00016011232,0.000008433716,0.98311913,0.00021203302],"about_ca_topic_score_codex":0.0001033055,"about_ca_topic_score_gemma":0.000001629344,"teacher_disagreement_score":0.88511103,"about_ca_system_score_codex":0.000058232046,"about_ca_system_score_gemma":0.00030160145,"threshold_uncertainty_score":0.9999719},"labels":[],"label_agreement":null},{"id":"W4413955067","doi":"10.1080/14656566.2025.2557457","title":"Emerging pharmacotherapies for brain metastases: a spotlight on angiogenesis inhibitors","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Angiogenesis; Pharmacology; Internal medicine","score_opus":0.07013125570456824,"score_gpt":0.46161726607136544,"score_spread":0.3914860103667972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413955067","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002337862,0.98360425,0.00030152,0.005081006,0.0033784523,0.0059138974,0.0010511518,0.00031274755,0.00035461143],"genre_scores_gemma":[0.000001350134,0.97045356,0.0016924393,0.017951762,0.0025591173,0.0038218764,0.0012179634,0.0003355331,0.0019664213],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99547553,0.0005877229,0.0011522159,0.0013650769,0.00064374553,0.0007757084],"domain_scores_gemma":[0.9967316,0.0014689085,0.0005147723,0.0008056351,0.00010993625,0.0003691531],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006657211,0.0014275977,0.0030252468,0.0012379711,0.0003111263,0.00007844485,0.00035821265,0.00031524172,0.0011668184],"category_scores_gemma":[0.000058669586,0.0010281926,0.0029521647,0.00080522645,0.00007982568,0.000086361106,0.000037842045,0.0004015952,0.00009665593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007476667,0.0010436039,3.303278e-7,0.004233388,0.0033476346,0.000032359356,0.00014166179,0.0000020470989,0.00010138023,0.0003823566,0.22905761,0.76091],"study_design_scores_gemma":[0.006880014,0.001188289,1.4714868e-7,0.01631468,0.0005412316,0.000033442164,0.000039950555,0.000013343673,0.0036661306,0.000017239794,0.97052294,0.0007826171],"about_ca_topic_score_codex":0.000017423388,"about_ca_topic_score_gemma":3.7172524e-7,"teacher_disagreement_score":0.76012737,"about_ca_system_score_codex":0.00042137963,"about_ca_system_score_gemma":0.0005095154,"threshold_uncertainty_score":0.9998474},"labels":[],"label_agreement":null},{"id":"W4414080279","doi":"10.1080/14656566.2025.2558999","title":"Emerging pharmacological strategies for the treatment of cannabis use disorder","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Endocannabinoid system; Clinical trial; Cannabis; Translational research; Clinical research; Effects of cannabis; Clinical efficacy","score_opus":0.056105881452332196,"score_gpt":0.44054246619941156,"score_spread":0.38443658474707937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414080279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4598772,0.113511644,0.011014829,0.39423946,0.0065126237,0.011554138,0.00021318792,0.00034667953,0.0027302369],"genre_scores_gemma":[0.58047557,0.31780726,0.0006874238,0.025477178,0.0023873542,0.008017671,0.00011203288,0.00016056508,0.064874925],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99882144,0.000060695817,0.00027123402,0.00028751433,0.00024914357,0.00030998228],"domain_scores_gemma":[0.9993779,0.00008886346,0.00005726964,0.00023477872,0.00015351827,0.00008764432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011679521,0.00020524871,0.00029417526,0.00014464384,0.00019086551,0.000045443667,0.00013480408,0.0000621653,0.0006409229],"category_scores_gemma":[0.000012952527,0.00011583271,0.00027063806,0.0002630099,0.0001388516,0.00007525745,0.000010604326,0.000101772144,0.0000022345994],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004654104,0.0022423752,0.0004989456,0.000044813303,0.00070249045,0.000003930077,0.0018190834,0.00018219436,0.11398583,0.003320106,0.51068366,0.36186245],"study_design_scores_gemma":[0.005761606,0.0014389621,0.0009721592,0.000029281484,0.000017654826,0.0000018446409,0.0007719917,0.00197897,0.06509295,0.000058991533,0.9237747,0.000100846],"about_ca_topic_score_codex":0.00029947126,"about_ca_topic_score_gemma":0.000006498995,"teacher_disagreement_score":0.41309106,"about_ca_system_score_codex":0.00012959025,"about_ca_system_score_gemma":0.00027657047,"threshold_uncertainty_score":0.70176566},"labels":[],"label_agreement":null},{"id":"W4417458063","doi":"10.1080/14656566.2025.2605201","title":"The relationship between cognition and the pharmacotherapy of depression","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Royal Ottawa Mental Health Centre; University of British Columbia","funders":"","keywords":"Depression (economics); Pharmacotherapy; Cognition; Disease; MEDLINE; Drug","score_opus":0.05443614985082489,"score_gpt":0.4205489728344058,"score_spread":0.3661128229835809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417458063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71480143,0.17092463,0.0025068533,0.08566883,0.0032210161,0.006495845,0.00004962542,0.00045883877,0.01587295],"genre_scores_gemma":[0.9734178,0.022126973,0.0001428859,0.0030275667,0.000309313,0.00019290912,0.000029192879,0.00002813241,0.0007252201],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984999,0.00032673683,0.00036754573,0.00027476173,0.00034641766,0.00018465548],"domain_scores_gemma":[0.99684876,0.0025126787,0.00016595631,0.00033127112,0.00007029776,0.00007103224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046715306,0.00020245455,0.0002780672,0.00012341945,0.0004339743,0.000030377207,0.00014945072,0.00008562352,0.00007000264],"category_scores_gemma":[0.0000892264,0.0001009757,0.0001263672,0.0002305501,0.00029669367,0.00008086174,0.000025904752,0.00025893367,0.0000074676727],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021556292,0.000694201,0.26512003,0.00008278672,0.0009552829,0.000003097411,0.0020753192,0.0000061630176,0.124806836,0.009154513,0.047505282,0.52804023],"study_design_scores_gemma":[0.05201827,0.00032485882,0.18289156,0.000899368,0.0000878416,0.000010278288,0.00019729772,0.00030857703,0.47163567,0.0042234464,0.2871645,0.00023831891],"about_ca_topic_score_codex":0.000017660313,"about_ca_topic_score_gemma":3.0588458e-7,"teacher_disagreement_score":0.5278019,"about_ca_system_score_codex":0.000037533166,"about_ca_system_score_gemma":0.000049971026,"threshold_uncertainty_score":0.41176695},"labels":[],"label_agreement":null},{"id":"W4417498622","doi":"10.1080/14656566.2025.2601050","title":"Novel pharmacotherapies and breakthroughs in psoriatic arthritis treatment","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society; University of Toronto; University Health Network","funders":"","keywords":"Psoriatic arthritis; Disease; Precision medicine; Psoriasis; Clinical Practice; Clinical trial; Personalized medicine; Biosimilar","score_opus":0.030876277308090946,"score_gpt":0.38023486887078833,"score_spread":0.3493585915626974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417498622","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44548467,0.5102785,0.00037811065,0.025216468,0.0043575014,0.0033957507,0.00009687332,0.00036825662,0.010423831],"genre_scores_gemma":[0.40013418,0.58637106,0.0010250902,0.010570035,0.00037353794,0.0005474021,0.000027477858,0.000050129358,0.0009010867],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987021,0.000039455565,0.00031538476,0.0004477781,0.00017114473,0.00032415506],"domain_scores_gemma":[0.99953353,0.0000867026,0.000051839976,0.00019824342,0.00003090172,0.00009879924],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000063566345,0.00032179925,0.00048835,0.00024910393,0.00012924822,0.000027347181,0.00005297379,0.000067913024,0.00034176966],"category_scores_gemma":[0.000005749264,0.00026319042,0.00010612046,0.0002691051,0.000083375075,0.000079793084,0.000015399759,0.00010655035,0.00001784075],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019152464,0.002642468,0.0038878,0.000021126716,0.00069156144,0.00005238711,0.0022959851,0.0000031662487,0.045356706,0.0011093385,0.00527714,0.9367471],"study_design_scores_gemma":[0.065170065,0.0015175479,0.009068106,0.00069181196,0.000014848166,0.00006800393,0.0003999205,0.0001948299,0.05342912,0.00013576465,0.868969,0.00034098126],"about_ca_topic_score_codex":0.00033771776,"about_ca_topic_score_gemma":0.000027227965,"teacher_disagreement_score":0.9364061,"about_ca_system_score_codex":0.00021330512,"about_ca_system_score_gemma":0.000061877625,"threshold_uncertainty_score":0.99998206},"labels":[],"label_agreement":null},{"id":"W4417506570","doi":"10.1080/14656566.2025.2608081","title":"Recalcitrant dermatophytosis: clinicomycological features and challenges in management","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Ketoconazole; Antifungal; Itraconazole; MEDLINE; Disease management","score_opus":0.18642530198875784,"score_gpt":0.47682716906005035,"score_spread":0.2904018670712925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417506570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000030514318,0.9925907,9.598672e-7,0.0013704407,0.00065165997,0.0020255288,0.000025616962,0.0000763227,0.003255678],"genre_scores_gemma":[0.000009870464,0.9963204,0.00017027374,0.001748311,0.0002176109,0.0010452692,0.000079089965,0.000043982574,0.00036518415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980502,0.00021986305,0.0005030983,0.00070002576,0.0002320287,0.0002947423],"domain_scores_gemma":[0.9991621,0.00020202743,0.00011898209,0.00032617984,0.000014485095,0.00017622045],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010925353,0.0005032923,0.0014570147,0.0003968034,0.00005034986,0.000020962387,0.00013603915,0.00026540403,0.00016657884],"category_scores_gemma":[0.000006440662,0.0003394491,0.00043248816,0.0002006789,0.000040097475,0.000030214942,0.000041849467,0.00033352038,0.000025003059],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030677437,0.0010965725,0.00001143662,0.012307262,0.00058517157,0.00020008672,0.000049100843,3.3607e-8,2.5139704e-7,0.00043501824,0.004604375,0.9804039],"study_design_scores_gemma":[0.0037126874,0.00026443793,0.00023454064,0.028108492,0.00011291173,0.000050329167,0.000030649135,8.36113e-7,0.0000046379673,0.000039017705,0.967185,0.0002564565],"about_ca_topic_score_codex":0.0000031394216,"about_ca_topic_score_gemma":2.9100823e-7,"teacher_disagreement_score":0.9801475,"about_ca_system_score_codex":0.00011298722,"about_ca_system_score_gemma":0.00007234855,"threshold_uncertainty_score":0.99990577},"labels":[],"label_agreement":null}]}